Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,-0.8472556829370225,-1.8848282540018624,0.0,0.0,0.0,33/81,6.96%,IFI44L;RSAD2;CD74;VCAM1;EPSTI1;MX1;SAMD9L;PARP14;LAP3;DDX60;XAF1;PARP12;ISG15;STAT1;IFIH1;TDRD7;IFI27;PSMB9;IRF2;RNF213;IRF1;SOD2;OAS3;NLRC5;TNFSF10;TAP1;HERC6;GBP4;HLA-B;EIF2AK2;WARS1;LY6E;SAMHD1
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,-0.851760101929784,-1.8243087583414648,0.0,0.03988562978859831,0.08,23/47,5.32%,IFI44L;RSAD2;CD74;EPSTI1;MX1;SAMD9L;PARP14;LAP3;DDX60;PARP12;ISG15;IFIH1;TDRD7;IFI27;PSMB9;IRF2;IRF1;NUB1;HLA-C;TAP1;HERC6;GBP4;EIF2AK2
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.9049535922647155,-1.7437010178122814,0.0,0.23598997624920667,0.47,8/20,5.32%,RSAD2;MX1;ISG15;IFIH1;OAS3;ZC3HAV1;TNIP1;EIF2AK2
prerank,GO_Biological_Process_2021__gland development (GO:0048732),-0.8797399876588446,-1.7181309943102419,0.0,0.30163507527627476,0.65,2/13,0.36%,HES1;TBX3
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),0.7329150153002439,1.7135167797710495,0.0,1.0,0.56,8/43,6.57%,GRIK2;NOVA1;GRM5;SLC12A6;SNAP25;GRIA2;HOMER1;NRXN1
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,-0.8917786203003529,-1.7119855754238524,0.0,0.2712222825624685,0.7,2/19,1.01%,HES1;KIAA1217
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),-0.8559894068228212,-1.692043837177938,0.015151515151515152,0.36561827306215117,0.79,9/25,6.18%,RSAD2;MX1;ISG15;IFIH1;OAS3;ZC3HAV1;TNIP1;EIF2AK2;PABPC1
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),-0.8714675381327687,-1.6840130216554463,0.0,0.32407074203236125,0.83,14/23,6.96%,RSAD2;MX1;XAF1;ISG15;STAT1;IFI27;IRF2;HLA-F;IRF1;OAS3;SP100;HLA-C;HLA-B;SAMHD1
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),-0.8714675381327687,-1.6840130216554463,0.0,0.32407074203236125,0.83,14/23,6.96%,RSAD2;MX1;XAF1;ISG15;STAT1;IFI27;IRF2;HLA-F;IRF1;OAS3;SP100;HLA-C;HLA-B;SAMHD1
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,-0.9177861374950286,-1.6817950473188603,0.0,0.30135809173607614,0.84,4/20,0.67%,IFI44L;RSAD2;MX1;BTG2
prerank,PanglaoDB_Augmented_2021__Germ Cells,0.8593461228740154,1.6616134012539174,0.0,1.0,0.82,1/11,0.03%,CREB5
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),-0.8722136771785103,-1.6613343716838669,0.018518518518518517,0.3878877496941186,0.92,2/16,0.36%,HES1;TBX3
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,0.6991047439423282,1.6572132756035673,0.0,1.0,0.87,15/34,10.83%,ZNF385D;NOVA1;NREP;CADM2;MAPK10;GRIA2;PRKG1;NTM;ROBO2;SGIP1;NRXN1;ADGRB3;RBFOX1;FGF14;PDZRN3
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),-0.8312110556405323,-1.650115645558711,0.0,0.42786402864132733,0.95,5/20,5.14%,CD74;CX3CL1;IFIH1;PLCG2;HLA-B
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.9575722683170771,-1.647894682385422,0.0,0.4063348534713453,0.95,1/7,0.18%,CD74
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),-0.8556172541611716,-1.6463274402912094,0.03389830508474576,0.3804475456758608,0.95,1/17,0.36%,TBX3
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),0.8768044302794964,1.6392464026438853,0.0,1.0,0.92,2/9,5.58%,PDK4;PIK3CA
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),-0.9421564811361224,-1.6324202634912022,0.019230769230769232,0.45013782189989526,0.97,2/9,0.44%,HES1;CX3CL1
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),0.7051460710786978,1.6309206470806765,0.0,1.0,0.94,6/49,9.09%,TRIM5;AFF3;NOVA1;UTY;NOVA2;REST
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),0.9653303585177054,1.6283180086654738,0.0,0.8764651015211069,0.94,1/8,0.05%,PDK4
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),-0.9353619890955671,-1.6270916913059201,0.0,0.45536094008649736,0.98,2/11,0.36%,HES1;TBX3
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.8084523214459979,-1.6180483484859298,0.0,0.4557519756726601,0.99,12/37,5.32%,IFI44L;RSAD2;MX1;ISG15;STAT1;IFIH1;IFI27;IRF2;IRF1;OAS3;NLRC5;EIF2AK2
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.8084523214459979,-1.6180483484859298,0.0,0.4557519756726601,0.99,12/37,5.32%,IFI44L;RSAD2;MX1;ISG15;STAT1;IFIH1;IFI27;IRF2;IRF1;OAS3;NLRC5;EIF2AK2
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),-0.9632872685820715,-1.6147109543681297,0.017543859649122806,0.4548069730061002,0.99,1/5,0.13%,RSAD2
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,-0.8259825822532841,-1.613719565057811,0.04081632653061224,0.4371674949197683,0.99,7/18,13.08%,CD74;HLA-C;HLA-B;LCP2;LGALS3;HLA-A;GIMAP8
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),-0.8056404411224788,-1.612376603039355,0.038461538461538464,0.42228910538678466,0.99,6/20,11.60%,CX3CL1;OPTN;TNIP1;SERPINE1;NFKBIA;CD47
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.9688136923525754,-1.6113095799809145,0.0,0.4102521921112969,0.99,2/11,0.18%,RSAD2;CD74
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,0.7219161467704222,1.6086963811013142,0.0,1.0,0.98,6/32,6.57%,CREB5;GRM5;GRIA2;ST18;PEX5L;NRXN1
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),-0.9596229354539902,-1.6050137568085072,0.0,0.4265042912621706,0.99,1/8,0.44%,CX3CL1
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),0.8775840451645682,1.602560914149579,0.0,0.9797508267480696,0.98,2/8,5.58%,PDK4;PIK3CA
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),-0.9649435491667816,-1.5972132236673362,0.0,0.4560835058435372,0.99,1/6,0.18%,CD74
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),-0.9736246722917066,-1.5962394303736354,0.0,0.44289668077756045,0.99,1/7,0.26%,HES1
prerank,PanglaoDB_Augmented_2021__Monocytes,-0.8458984138308906,-1.5852721279946196,0.0,0.5013623664426808,1.0,6/17,8.33%,MX1;GBP1;FN1;TNFSF10;LY6E;LCP2
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),0.8198782019629468,1.5787759771060812,0.022222222222222223,1.0,0.99,5/13,8.57%,GRIK2;GRM5;GRIA2;HOMER1;PLCB1
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,0.9588505119092974,1.5771530918362484,0.0,1.0,1.0,2/7,1.92%,MMRN1;SLC26A3
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.9059083470229661,-1.57598931949065,0.01818181818181818,0.5507285036194921,1.0,6/13,4.98%,PARP12;IFIH1;HLA-F;IRF1;HLA-C;TAP1
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),-0.7651916152622671,-1.5744999692377883,0.017241379310344827,0.5414104932415289,1.0,5/23,9.16%,CYLD;TMSB4X;EIF2AK2;NR3C2;NFKBIA
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.8270107658300139,1.5721440025331683,0.04878048780487805,1.0,1.0,2/13,1.71%,TEAD4;YWHAB
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.8698618309335123,1.5711708490709655,0.043478260869565216,0.9994043857993539,1.0,3/12,5.24%,CALR;CRY1;CNOT2
prerank,PanglaoDB_Augmented_2021__Transient Cells,-0.6981058574129776,-1.5703004879449487,0.018867924528301886,0.5566182085676711,1.0,7/34,9.99%,KIAA1217;TMEM117;DSP;SUN1;COL18A1;ARHGEF37;TMEM50B
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),-0.890520538426816,-1.56836366770625,0.0196078431372549,0.5484274095932268,1.0,1/13,1.45%,OPTN
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.8946985992124316,-1.5680010331780823,0.037037037037037035,0.5321407774295491,1.0,2/12,3.48%,CD74;CXCL12
prerank,MSigDB_Hallmark_2020__UV Response Up,-0.7393490864211051,-1.5673536400904835,0.046875,0.5188348455565248,1.0,9/40,9.50%,BTG2;NR4A1;HLA-F;IRF1;SOD2;CHKA;TAP1;NFKBIA;TFRC
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),-0.9252921047541055,-1.5641766996114161,0.0,0.5231872844926294,1.0,1/6,0.26%,HES1
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,0.7115605171012769,1.5606774859077157,0.0,1.0,1.0,5/28,7.55%,PDK4;GRM5;GRIA2;NRXN1;BAALC
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.9106684911802001,-1.560190275999587,0.017857142857142856,0.538758166008112,1.0,5/10,8.33%,EPSTI1;ITGB5;SP100;ARHGAP15;LCP2
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.9305308019584007,-1.559731442147406,0.0425531914893617,0.5261383811819513,1.0,2/7,4.75%,CD74;PRKN
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),0.6163101974554251,1.5597277917790255,0.030303030303030304,0.9957006755830025,1.0,10/54,8.20%,GRIK2;NOVA1;GRM5;SLC12A6;SNAP25;GRIA2;DLGAP2;HOMER1;NRXN1;DNAJC5
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.9123312990065524,1.5594948255729935,0.0,0.9319968598617573,1.0,4/8,4.85%,ERBB4;CDH2;SEMA3F;PHACTR4
prerank,PanglaoDB_Augmented_2021__Macrophages,-0.881960478433691,-1.5592208774894485,0.0,0.5139548295616525,1.0,7/15,8.80%,CD74;PARP14;PPARG;CPM;SLCO2B1;LCP2;LGALS3
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.9011637161293347,-1.5579072830805594,0.0,0.5082647962644299,1.0,3/7,8.98%,CYLD;TNFSF10;PMAIP1
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),-0.9399629062807557,-1.5558787971157326,0.023255813953488372,0.5128537397817742,1.0,1/6,0.18%,CD74
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),-0.8802980194808778,-1.5528306724220204,0.057692307692307696,0.49557895012333397,1.0,1/8,1.04%,GBP1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),-0.8802980194808778,-1.5528306724220204,0.057692307692307696,0.49557895012333397,1.0,1/8,1.04%,GBP1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),-0.8802980194808778,-1.5528306724220204,0.057692307692307696,0.49557895012333397,1.0,1/8,1.04%,GBP1
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),-0.8609061108298511,-1.5516481016342967,0.021739130434782608,0.49127422056688164,1.0,3/13,4.44%,CD74;SHLD1;VAV3
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.8832857856136032,-1.54959088435529,0.019230769230769232,0.49049828061454825,1.0,4/14,4.75%,CD74;PARP14;NLRC5;PRKN
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,0.6544128711048497,1.5492711085636892,0.0,0.9916684104281036,1.0,9/48,10.28%,HDAC9;SNAP25;IGFBP3;MAP7;EVI5;DUSP6;ANKH;ITGA2;ADGRL4
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),0.840767879338298,1.547922796454725,0.08,0.9504549708906481,1.0,2/9,4.60%,DTWD1;TRMT9B
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),0.9151801004336424,1.5419076641806502,0.02564102564102564,0.9745935098339027,1.0,1/7,0.49%,GRIK2
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),-0.8587110031851022,-1.5410316147744931,0.01694915254237288,0.5368327497709598,1.0,5/14,7.11%,CX3CL1;ULK4;NTNG1;CTNNA2;SRGAP2C
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,-0.7109938319865288,-1.5408089670740708,0.028985507246376812,0.5259917428371402,1.0,19/70,11.53%,HES1;BTG2;NR4A1;IFIH1;PLK2;IRF1;SAT1;SOD2;TNIP1;TAP1;SLC2A3;SERPINE1;SMAD3;JUN;NFKBIA;TANK;NFKB1;IFNGR2;BHLHE40
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),-0.789319215168392,-1.539371506703017,0.06,0.5227233370627967,1.0,4/23,6.93%,HES1;STAT1;PLXND1;MAML3
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",0.7950144769853111,1.539367837180975,0.022727272727272728,0.9549913038671123,1.0,7/13,14.49%,GRM5;CDH2;HOMER1;NRXN1;LRRK2;NLGN1;DGKI
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.8090285491115035,1.5379490693745386,0.04878048780487805,0.9232991145794869,1.0,3/13,4.02%,PRKD1;IL6R;BMP6
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.8571566061152736,-1.537598095555464,0.0,0.523065351521129,1.0,6/15,6.96%,PARP14;PPARG;ISG15;OAS3;NLRC5;SAMHD1
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),-0.9348013117392777,-1.5374414405270824,0.0,0.512997089515057,1.0,1/5,1.45%,OPTN
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),-0.8746379633613435,-1.5369743396528113,0.0,0.5041792890465004,1.0,3/10,2.65%,XAF1;STAT1;IRF1
prerank,PanglaoDB_Augmented_2021__Beta Cells,0.6959028811552466,1.5349188469547046,0.0,0.9103958660838107,1.0,13/27,9.48%,SMAD9;NOVA1;SNAP25;CADM2;MAPK10;GRIA2;FGF12;ROBO2;NRXN1;ADGRB3;RBFOX1;NOVA2;CNTN1
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),0.8831451460432356,1.5342994511186416,0.0196078431372549,0.8772253939408858,1.0,2/8,1.64%,ANO5;SLC12A6
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),0.7708602687901065,1.5340603008920046,0.023809523809523808,0.8408305263679919,1.0,1/22,0.05%,PDK4
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),-0.9706529382834677,-1.5324601290154922,0.022222222222222223,0.5048269417360824,1.0,1/5,0.18%,CD74
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),-0.9706529382834677,-1.5324601290154922,0.022222222222222223,0.5048269417360824,1.0,1/5,0.18%,CD74
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),-0.9706529382834677,-1.5324601290154922,0.022222222222222223,0.5048269417360824,1.0,1/5,0.18%,CD74
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),0.7309823259418986,1.5287037202766756,0.023255813953488372,0.8597386682859713,1.0,6/14,15.08%,ABL2;YWHAB;PHACTR4;ABL1;PSEN1;SSBP1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),-0.9362133736090588,-1.5272229680153533,0.0,0.5321279935738477,1.0,2/6,1.19%,CX3CL1;CEMIP
prerank,PanglaoDB_Augmented_2021__Plasma Cells,-0.9034186474224701,-1.527071832261121,0.0,0.5234048210937758,1.0,1/9,0.18%,CD74
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.7259962599777915,-1.526440574598052,0.015151515151515152,0.5177745644779151,1.0,6/29,11.63%,CD74;HLA-F;SEC23A;HLA-A;CLTA;HLA-E
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),-0.8888709486615474,-1.5263553197522715,0.0,0.5087230781218494,1.0,1/10,0.26%,HES1
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),-0.8999393211242577,-1.5261100556879588,0.015151515151515152,0.49227264133822646,1.0,1/8,0.36%,TBX3
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),-0.8999393211242577,-1.5261100556879588,0.015151515151515152,0.49227264133822646,1.0,1/8,0.36%,TBX3
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),-0.8617690519714339,-1.52555617069067,0.017241379310344827,0.4875674400020035,1.0,3/13,2.67%,CD74;IFIH1;PLCG2
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),0.6772085320464851,1.5240483292160787,0.02702702702702703,0.8767327244528692,1.0,6/23,10.10%,ABL2;YES1;CSNK1G3;PPP4R2;ABL1;ST8SIA4
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),-0.8233553781075008,-1.5238981502558246,0.0392156862745098,0.4877539303809098,1.0,6/19,11.60%,CX3CL1;TNIP1;SERPINE1;NFKBIA;RPS19;CD47
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),-0.7938807718633334,-1.5238978245126917,0.05084745762711865,0.4796246982078947,1.0,3/21,6.67%,BTG2;NR4A1;SMAD3
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),-0.9496246548400944,-1.5234713030418257,0.03389830508474576,0.474377449370952,1.0,1/7,0.36%,TBX3
prerank,GO_Biological_Process_2021__translation (GO:0006412),-0.6831071403899426,-1.5186188556376348,0.014084507042253521,0.4980878849003587,1.0,31/67,20.15%,RPL31;TNIP1;RPS18;RPS12;RPL15;WARS1;RPS8;RPS28;RPL7A;RPS6;RPL38;RPS15;RPL30;LARS1;RPS14;RPL34;RPS19;RPS7;RPL24;RPL11;GSPT1;RPL23;RPL41;PPA2;RPL36;RPL10;RPS27;RPL9;RPL27A;LARS2;EEF1A1
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),0.8487343650089387,1.5183537498832276,0.022222222222222223,0.9036133893104427,1.0,1/8,0.91%,ABL2
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),-0.7748713033858725,-1.51565234076429,0.043478260869565216,0.5060093588656698,1.0,13/32,11.63%,RSAD2;VCAM1;HLA-F;IRF1;HLA-C;HLA-B;SAMHD1;ERAP1;B2M;APPL2;SPPL2A;HLA-A;HLA-E
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.8176162110154626,-1.5149041934023106,0.0392156862745098,0.5023096501501599,1.0,5/13,6.96%,ISG15;OAS3;NLRC5;CDC37;SAMHD1
prerank,PanglaoDB_Augmented_2021__Astrocytes,0.6463959282546147,1.5144808322900163,0.0,0.9158651442527599,1.0,11/32,10.12%,GRM5;SNAP25;CADM2;GRIA2;NTM;NRXN1;ADGRB3;SLC25A46;BAALC;RBFOX1;S1PR1
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),-0.8319934453172998,-1.5142930377369697,0.05555555555555555,0.4988771848943142,1.0,2/17,1.04%,CX3CL1;GBP1
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),-0.9598233815344873,-1.5142882909693316,0.0,0.4839853286288123,1.0,1/5,0.18%,CD74
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),-0.9598233815344873,-1.5142882909693316,0.0,0.4839853286288123,1.0,1/5,0.18%,CD74
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),-0.653006230431666,-1.5138911402143123,0.02857142857142857,0.4787741958079908,1.0,9/91,4.52%,CD74;HES1;CX3CL1;RIMS1;HGSNAT;SPG7;CXCL12;FN1;ZNHIT6
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),-0.9703514285338518,-1.513689971816171,0.0,0.47356959716390096,1.0,2/5,2.67%,CD74;PLCG2
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),-0.8435873407132912,-1.5131013449440562,0.0,0.4690834960494794,1.0,2/15,1.79%,MX1;RIMS1
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.7855871977879648,-1.5117364803128837,0.01694915254237288,0.47090322775059906,1.0,5/22,9.16%,CYLD;TMSB4X;UFL1;NLRC5;NFKBIA
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),-0.9077256971482658,-1.5106504929251574,0.09523809523809523,0.47114900187781755,1.0,1/6,0.26%,HES1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),-0.9120575214244214,-1.5095586684481812,0.0392156862745098,0.47207101558012243,1.0,2/7,1.19%,CX3CL1;CEMIP
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),-0.9499818474741559,-1.5075159235335505,0.0,0.47038452730686936,1.0,1/5,0.65%,CYLD
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),-0.9499818474741559,-1.5075159235335505,0.0,0.47038452730686936,1.0,1/5,0.65%,CYLD
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),-0.6845605239875683,-1.5065360115253057,0.015384615384615385,0.4693121636638689,1.0,26/54,19.76%,RPL31;RPS18;RPS12;RPL15;RPS8;RPS28;RPL7A;SRP14;RPS6;RPL38;RPS15;RPL30;RPS14;RPL34;RPS19;RPS7;RPL24;RPL11;RPL23;RPL41;RPL36;RPL10;RPS27;TRAM1;RPL9;RPL27A
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.915780932823078,-1.5057617535523682,0.0425531914893617,0.4680086560259554,1.0,2/8,4.75%,CD74;PRKN
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),0.8701103085901236,1.5054308079412588,0.0,0.9867400863498941,1.0,3/9,3.06%,PNP;BCL6;ZBTB1
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,-0.7953342613716354,-1.5051236591944213,0.06779661016949153,0.4659715403187206,1.0,5/16,4.02%,SAMD9L;IFIH1;IRF1;DDX60L;SP100
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.7607694318902154,-1.4995415022512586,0.03571428571428571,0.49175447359613605,1.0,3/18,4.47%,BTG2;PLK2;CNOT8
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,0.6882370906414051,1.499457001228967,0.027777777777777776,1.0,1.0,8/24,8.49%,GRM5;SNAP25;CADM2;GRIA2;NRXN1;ADGRB3;NEGR1;RBFOX1
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),-0.7104208167028435,-1.4957114948508317,0.04918032786885246,0.5087910649908072,1.0,4/40,3.30%,CD74;HES1;RIMS1;SPG7
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.8395821575942506,-1.4952438751400443,0.017543859649122806,0.505464184913533,1.0,3/13,6.78%,CD74;TNFSF10;DSP
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),-0.6433725169728447,-1.4943605775442803,0.0273972602739726,0.5047721013794866,1.0,8/101,4.47%,CD74;HES1;TBX3;CX3CL1;STAT1;UFL1;FN1;CNOT8
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.6830248195920029,-1.4939713949885907,0.03125,0.5009731211399245,1.0,25/51,19.76%,RPL31;RPS18;RPS12;RPL15;RPS8;RPS28;RPL7A;RPS6;RPL38;RPS15;RPL30;RPS14;RPL34;RPS19;RPS7;RPL24;RPL11;GSPT1;RPL23;RPL41;RPL36;RPL10;RPS27;RPL9;RPL27A
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.6892948382692666,-1.4934942596783751,0.016129032258064516,0.49773942173688307,1.0,25/51,19.76%,RPL31;RPS18;RPS12;RPL15;RPS8;RPS28;RPL7A;SRP14;RPS6;RPL38;RPS15;RPL30;RPS14;RPL34;RPS19;RPS7;RPL24;RPL11;RPL23;RPL41;RPL36;RPL10;RPS27;RPL9;RPL27A
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),-0.8763816883978797,-1.4927135825848024,0.037037037037037035,0.49657609086804894,1.0,1/11,0.26%,HES1
prerank,GO_Biological_Process_2021__artery development (GO:0060840),-0.8382843406508361,-1.492704171954017,0.07547169811320754,0.49080195027656004,1.0,1/10,0.26%,HES1
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.923727067423598,-1.491882745515055,0.022222222222222223,0.4910058563630895,1.0,2/8,1.19%,CX3CL1;CEMIP
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),-0.9708916405092611,-1.4917316240527032,0.043478260869565216,0.4804201700379481,1.0,1/5,0.57%,DDX60
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.9708916405092611,-1.4917316240527032,0.043478260869565216,0.4804201700379481,1.0,1/5,0.57%,DDX60
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),-0.7190951794379404,-1.49147743548297,0.028985507246376812,0.47641168914159093,1.0,11/52,4.08%,CD74;MX1;CYLD;PPARG;ISG15;IFIH1;IFI27;PLCG2;NUB1;SP100;NLRC5
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),-0.9230316593355797,-1.4902938761197904,0.022222222222222223,0.4787371333691923,1.0,2/6,1.09%,PARP14;PARP12
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.738398476647521,-1.4893335256162785,0.017857142857142856,0.47938625150807157,1.0,6/23,9.71%,BTG2;PLK2;SP100;CNOT8;NDRG1;ACER2
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.6498122430119033,-1.4888253069821233,0.013888888888888888,0.47626872989503677,1.0,37/89,21.11%,RPL31;TNIP1;RPS18;RFC3;RPS12;RPL15;WARS1;MEF2A;RPS8;RPS28;RPL7A;RPS6;RPL38;TOPBP1;RPS15;RPL30;RPS14;RPL34;POLR2A;RPS19;PTMA;RPS7;GCNT1;RPL24;RPL11;ATM;GSPT1;RPL23;RPL41;RPL36;RPL10;RPS27;RPL9;RPL27A;EEF1A1;ORC2;RPL28
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),-0.8601367751401178,-1.4881327288244885,0.02040816326530612,0.4750208781737852,1.0,8/16,7.35%,CD74;CX3CL1;GBP1;STAT1;NUB1;SP100;GBP4;CALCOCO2
prerank,PanglaoDB_Augmented_2021__Principal Cells,-0.8046437272121055,-1.4860595639011358,0.07142857142857142,0.48104168768722644,1.0,7/18,9.71%,HES1;KIAA1217;NR3C2;DSP;ARHGEF37;LGALS3;ACER2
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.8437879223482899,-1.4858392348575964,0.0425531914893617,0.47727726270471155,1.0,4/8,6.96%,ISG15;OAS3;NLRC5;SAMHD1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.6772223891214321,-1.4856754604033748,0.0,0.4734876567172263,1.0,27/60,19.76%,RPL31;RPS18;RPS12;RPL15;PABPC1;RPS8;RPS28;RPL7A;RPS6;RPL38;RPS15;RPL30;RPS14;RPL34;RPS19;RPS7;RPL24;UPF3A;RPL11;GSPT1;RPL23;RPL41;RPL36;RPL10;RPS27;RPL9;RPL27A
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),-0.8940349554054934,-1.485270703172897,0.017857142857142856,0.4699788877386112,1.0,2/11,0.65%,CX3CL1;CYLD
prerank,PanglaoDB_Augmented_2021__Immature Neurons,0.6684384120169387,1.485037483520921,0.02702702702702703,1.0,1.0,11/37,9.01%,ATRNL1;NOVA1;SOX5;SNAP25;CADM2;GRIA2;ROBO2;NRXN1;ADGRB3;RBFOX1;NOVA2
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.7715075147333071,-1.4839928154962094,0.03636363636363636,0.47258428022248306,1.0,10/30,12.62%,CYLD;ISG15;IFIH1;IRF1;NLRC5;TRIM25;NFKB1;LRRFIP1;TBK1;NPLOC4
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),0.8240531503792263,1.4819964665488643,0.02,1.0,1.0,2/8,4.08%,CRY1;HECTD4
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,0.7335875857126885,1.4813063257545782,0.05405405405405406,1.0,1.0,6/19,10.93%,IL1R1;ITGA1;ITGA2;ITGA5;ITPR2;PGR
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),-0.9319412362531113,-1.4811845921057283,0.0196078431372549,0.48480983008041245,1.0,2/7,1.48%,MX1;STAT1
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.9394108928633007,-1.4808126598505682,0.020833333333333332,0.4816880884618098,1.0,1/7,0.21%,VCAM1
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.7272740559298908,-1.4802105778286028,0.016129032258064516,0.4801916998078306,1.0,1/26,0.18%,CD74
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.8527706516559905,-1.480026052481597,0.09615384615384616,0.47688498140445457,1.0,3/11,4.23%,PARP14;PARP12;ZC3HAV1
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),0.8826097678987213,1.4798394935436843,0.02127659574468085,1.0,1.0,1/6,0.13%,TRIM5
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.7829418796015254,-1.4796600048298278,0.03125,0.47469652183497657,1.0,2/28,0.44%,CD74;CX3CL1
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.6863036624978744,-1.4795333535996638,0.016129032258064516,0.47055546572024914,1.0,6/39,4.08%,HES1;CYLD;TMSB4X;UFL1;SP100;NLRC5
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),-0.7467085136383956,-1.4782926039472102,0.01818181818181818,0.4738299935027587,1.0,8/30,11.60%,CX3CL1;DDX60;OPTN;TNIP1;SERPINE1;NFKBIA;SCARF1;CD47
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),-0.8935126256837254,-1.4778232970978316,0.0196078431372549,0.4711722995587689,1.0,1/10,0.13%,RSAD2
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.7202387394300259,-1.4769287490132337,0.04838709677419355,0.4711490018778175,1.0,10/30,9.16%,PARP12;IFIH1;IRF2;SAT1;OAS3;HLA-C;TNIP1;TNFSF10;LGALS3;NFKBIA
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),0.7707430589124963,1.476002964398265,0.045454545454545456,1.0,1.0,7/12,18.74%,HSD17B4;ACAT1;ETFA;ACOX1;SCP2;HADHB;DECR1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),-0.797385192714434,-1.475611179547771,0.04081632653061224,0.4740535173498083,1.0,3/12,9.40%,CD74;SERPINE1;AFAP1L2
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),0.8840928720388692,1.4749869061498322,0.046511627906976744,1.0,1.0,1/6,0.13%,TRIM5
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.9148769637075834,-1.4742930329194996,0.058823529411764705,0.47572678438764526,1.0,2/8,3.48%,CD74;CXCL12
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),-0.6813683434078874,-1.4735378144200293,0.029411764705882353,0.4749444249827011,1.0,5/48,4.91%,HES1;CX3CL1;EML1;SMARCA1;GPM6A
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),-0.7348887434152929,-1.4728589888211523,0.07142857142857142,0.4698915456289513,1.0,8/29,9.50%,SLC22A5;SLC16A2;SLC6A6;SLC5A6;SLC2A3;SLC38A3;SLCO2B1;TFRC
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),-0.7348887434152929,-1.4728589888211523,0.07142857142857142,0.4698915456289513,1.0,8/29,9.50%,SLC22A5;SLC16A2;SLC6A6;SLC5A6;SLC2A3;SLC38A3;SLCO2B1;TFRC
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),0.882579057282874,1.4725457677087828,0.019230769230769232,1.0,1.0,1/9,0.05%,PDK4
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.6811638597383005,-1.4715590057918013,0.015384615384615385,0.4716300785528993,1.0,31/55,23.91%,RPL31;RPS18;RPS12;RPL15;RPS8;RPS28;RPL7A;SRP14;RPS6;RPL38;RPS15;RPL30;RPS14;RPL34;RPS19;RPS7;RPL24;RPL11;RPL23;RPL41;RPL36;RPL10;RPS27;RPL9;RPL27A;RPL28;RPL3;SPCS3;RPL27;RPL19;RPL37
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),0.9230709299702975,1.4714698489211426,0.08888888888888889,1.0,1.0,2/5,4.67%,CALR;HSP90B1
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),-0.7558270707145808,-1.4713744405724327,0.03571428571428571,0.46856944212518536,1.0,9/22,5.32%,RSAD2;MX1;ISG15;STAT1;IFIH1;OAS3;ZC3HAV1;TNIP1;EIF2AK2
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.9470366310710412,-1.470310348430718,0.0,0.4691719124701931,1.0,2/6,3.66%,CD74;OAS3
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.7393893491026324,-1.4702536098973955,0.03571428571428571,0.46541757323832345,1.0,8/27,11.11%,ISG15;STAT1;IFIH1;IRF1;OAS3;NFKB1;LRRFIP1;TBK1
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),0.751506219240105,1.46998188910365,0.047619047619047616,1.0,1.0,7/15,18.74%,HSD17B4;ACAT1;ACOX1;AIG1;SCP2;HADHB;DECR1
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),-0.892644707412752,-1.4694980226003724,0.021739130434782608,0.4648534946336426,1.0,1/8,0.26%,HES1
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),-0.9306366961935508,-1.467743148151224,0.0196078431372549,0.47008063679419443,1.0,2/6,2.80%,SLC16A2;SLC6A6
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),-0.8459764830675613,-1.466988888772253,0.016129032258064516,0.4694871006366259,1.0,2/13,1.90%,CYLD;ULK4
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),-0.7506702383000919,-1.4666528270004833,0.015625,0.46717280014785917,1.0,3/29,1.48%,CD74;CYLD;STAT1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.7625645272718784,-1.4662944192303429,0.03508771929824561,0.46481470616343973,1.0,3/16,4.47%,BTG2;PLK2;CNOT8
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),-0.8961721214118407,-1.4655872321019117,0.043478260869565216,0.4639541855287564,1.0,1/8,0.26%,HES1
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.8490931166142716,-1.4654035755827635,0.02127659574468085,0.4611775944306679,1.0,1/14,0.18%,CD74
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),0.9013851610704336,1.4648013196521636,0.0,1.0,1.0,2/6,4.85%,PRKD1;PHACTR4
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),-0.7544297771843141,-1.4646686860790556,0.08064516129032258,0.461716050432814,1.0,2/17,3.58%,CD74;FN1
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),-0.752229338580048,-1.4642362292456472,0.06557377049180328,0.4605049201187571,1.0,5/26,9.50%,CX3CL1;SMAD3;WARS1;LGALS3;TFRC
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),-0.8024909977011933,-1.4641838185107894,0.09090909090909091,0.45719295720277164,1.0,2/17,0.44%,HES1;CX3CL1
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.916428739204007,-1.4627647803012054,0.044444444444444446,0.45985326687909345,1.0,2/6,2.18%,CYLD;TMSB4X
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.6695364455003883,1.4626085318704882,0.02702702702702703,1.0,1.0,6/23,14.30%,ABL2;ERBB4;TPST2;ABL1;EPHA4;FES
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,-0.9555159744632555,-1.4609376341005023,0.0,0.4645593702121625,1.0,1/5,0.21%,VCAM1
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),-0.8901064755496175,-1.4598712963901992,0.017543859649122806,0.46689197792922676,1.0,2/10,1.51%,RSAD2;IFIH1
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),-0.9228864475897725,-1.4593042812102066,0.0,0.4659920335225169,1.0,1/6,1.35%,PPARG
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.7371830089280247,1.4588391422381168,0.05,1.0,1.0,8/18,15.78%,ITPR3;STIM1;ATP2A2;ITPR2;ATP2B4;SLC8A1;ANK2;RYR2
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),-0.916263295749094,-1.4586835689861575,0.0625,0.46601221622322536,1.0,2/6,4.78%,VCAM1;TNIP1
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.9522803115512608,-1.458023274447622,0.0,0.46580717645970166,1.0,1/7,0.13%,RSAD2
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),-0.8476695926741078,-1.4577603626769668,0.01694915254237288,0.4633727923388091,1.0,1/15,0.26%,HES1
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),-0.9591710646294404,-1.4575086362435536,0.018867924528301886,0.46119606000001456,1.0,3/5,4.02%,MX1;ISG15;SP100
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),-0.8665821132520459,-1.4573615441962693,0.034482758620689655,0.45853810422406954,1.0,2/10,3.58%,CD74;FN1
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),0.9377673029738144,1.4571955368599538,0.0,1.0,1.0,1/5,4.13%,NAA50
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),-0.6863775135246127,-1.4554434618924836,0.04838709677419355,0.4658175741734109,1.0,4/50,1.66%,HES1;TBX3;PPARG;ABCA5
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),-0.8526215145493721,-1.4554032460946098,0.037037037037037035,0.46280336738400757,1.0,1/8,0.57%,DDX60
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),0.6749201496625951,1.455239866826681,0.0,1.0,1.0,7/29,14.12%,NRG2;ERBB4;PIK3CA;HSP90AA1;GAREM1;PRKCA;RPS6KA5
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),-0.7452117454605952,-1.4549355520848646,0.03333333333333333,0.46227157978008543,1.0,3/27,4.39%,CD74;NLRC5;TIE1
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,0.7285859169079768,1.4544745284372365,0.05,1.0,1.0,7/15,15.78%,ANO5;CADM2;CKMT2;RBFOX1;ADCY2;LRP1B;RYR2
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),0.6127283478072204,1.4534309975257929,0.024390243902439025,1.0,1.0,8/45,7.40%,HDAC9;RBM20;ERBB4;HSPG2;FGF12;PIK3CA;TAB2;UTY
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),0.7391479436428348,1.452250220639732,0.11627906976744186,1.0,1.0,2/13,1.64%,ANO5;SLC12A6
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.6966728720727688,-1.4517448862533155,0.01694915254237288,0.4739267510952378,1.0,1/28,0.18%,CD74
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.8302342184314148,-1.451401633629158,0.058823529411764705,0.4726164253141888,1.0,4/12,3.66%,ISG15;IFIH1;IRF1;OAS3
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.9133170264154324,-1.4513872979046938,0.04,0.4692881406288776,1.0,1/7,0.18%,CD74
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),0.9358219255882373,1.451165830161227,0.020833333333333332,1.0,1.0,1/5,0.05%,PDK4
prerank,PanglaoDB_Augmented_2021__Luteal Cells,-0.7277529534193913,-1.450826703687168,0.05084745762711865,0.46865615001603017,1.0,8/34,12.59%,KIAA1217;ITGB5;SLC16A2;CHKA;SMARCA1;KCTD3;ADAMTS1;RORA
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.9279719213082784,-1.4508194584944116,0.0,0.46540159341869664,1.0,2/7,3.22%,PSMB9;PSMA1
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),-0.8410560007871328,-1.4506772845778724,0.037037037037037035,0.46322345216551414,1.0,1/12,0.29%,SLC22A5
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),-0.8549933048189907,-1.4505121930593536,0.1016949152542373,0.46073366190733595,1.0,1/10,0.26%,HES1
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),0.8044482209532986,1.449976999749337,0.09803921568627451,1.0,1.0,5/9,13.66%,FUT8;MCFD2;MGAT5;STT3B;UBE2J1
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),0.8044482209532986,1.449976999749337,0.09803921568627451,1.0,1.0,5/9,13.66%,FUT8;MCFD2;MGAT5;STT3B;UBE2J1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),-0.8867477403202393,-1.4484593286755865,0.022727272727272728,0.4668246670155333,1.0,2/12,1.48%,PPARG;STAT1
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),-0.9392336235362768,-1.448199186076462,0.01818181818181818,0.4648831850360276,1.0,2/5,4.75%,IFI27;PRKN
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.8810847018867678,-1.4478328298527208,0.06666666666666667,0.4637039073912713,1.0,6/7,11.63%,HLA-F;HLA-C;HLA-B;B2M;HLA-A;HLA-E
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,0.6652276626669459,1.4461080060806533,0.05714285714285714,1.0,1.0,12/25,12.93%,GRM5;ITPR3;SNAP25;CADM2;GRIA2;PRKG1;NRXN1;ADGRB3;CNTNAP2;RBFOX1;PRKCA;SLC24A2
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),0.8851146889535415,1.4426474135514817,0.08695652173913043,1.0,1.0,1/6,0.31%,HSD17B4
prerank,PanglaoDB_Augmented_2021__Delta Cells,0.6775959095461255,1.4425903502527608,0.05128205128205128,1.0,1.0,5/20,9.48%,SNAP25;MAPK10;GRIA2;NRXN1;CNTN1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.8001791545258139,-1.4425462299150242,0.057692307692307696,0.4881336325627956,1.0,5/14,8.98%,SP100;TNFSF10;SERPINE1;LGALS3;PMAIP1
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),-0.7993908153916939,-1.4424125840123685,0.09090909090909091,0.4854292459867321,1.0,3/15,8.98%,CYLD;TNFSF10;PMAIP1
prerank,PanglaoDB_Augmented_2021__Stromal Cells,-0.7496513700800698,-1.4422441420840157,0.047619047619047616,0.4829572475389157,1.0,4/26,5.40%,VCAM1;LAMA4;CXCL12;MMRN2
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.910147289328229,1.4421054654059873,0.019230769230769232,1.0,1.0,1/6,0.36%,HDAC9
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,0.6364792217244248,1.4413852606926834,0.08333333333333333,1.0,1.0,1/29,0.05%,PDK4
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),0.7504356125376278,1.4397491464787344,0.08333333333333333,1.0,1.0,6/12,18.74%,HSD17B4;ACAT1;ACOX1;SCP2;HADHB;DECR1
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),-0.8308651185477749,-1.4392232927783897,0.058823529411764705,0.4946600164958516,1.0,6/17,9.16%,HES1;PPARG;SP100;PRKN;JUN;NFKBIA
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),-0.8672451835361668,-1.4389931273117753,0.1509433962264151,0.49235443005276225,1.0,1/6,0.36%,TBX3
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),-0.819541423410254,-1.4388902515667679,0.0392156862745098,0.48636179016257136,1.0,2/9,13.24%,ITGB5;RHOA
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),-0.819541423410254,-1.4388902515667679,0.0392156862745098,0.48636179016257136,1.0,2/9,13.24%,ITGB5;RHOA
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),-0.8388405978586367,-1.438444368545167,0.08928571428571429,0.48624901538456794,1.0,2/9,4.44%,CD74;VAV3
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),-0.8314119399968709,-1.435691372577608,0.05555555555555555,0.49585663488768494,1.0,3/10,5.32%,CD74;OAS3;EIF2AK2
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),-0.799477300149973,-1.4355456884698796,0.08928571428571429,0.4931770324804043,1.0,1/16,0.39%,MX1
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),-0.8368834414449522,-1.4350990457484694,0.1320754716981132,0.49221360010992105,1.0,2/10,4.75%,MX1;PRKN
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),-0.7269889509502377,-1.4335594380754566,0.09433962264150944,0.49689814874832955,1.0,4/24,6.18%,BTG2;ZC3HAV1;CNOT8;PABPC1
prerank,MSigDB_Hallmark_2020__Notch Signaling,-0.9157270377208875,-1.4333154424785737,0.08064516129032258,0.49500036228380806,1.0,1/9,0.26%,HES1
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),-0.8587053783225218,-1.4329965084157448,0.08,0.4936764300521294,1.0,2/11,1.58%,PPARG;RREB1
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),-0.6782716681017438,-1.4324713193858916,0.029411764705882353,0.49297665598468765,1.0,29/60,20.15%,RPL31;TNIP1;RPS18;RPS12;RPL15;WARS1;RPS8;RPS28;RPL7A;DMD;RPS6;RPL38;RPS15;RPL30;RPS14;RPL34;RPS19;RPS7;RPL24;RPL11;GSPT1;RPL23;RPL41;RPL36;RPL10;RPS27;RPL9;RPL27A;EEF1A1
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),-0.7878835885117412,-1.431856996300272,0.09259259259259259,0.4929501245236309,1.0,9/12,18.59%,RPS28;RPS6;RPS15;RPS14;RPS19;RPS7;RIOK3;NPM1;RPS27
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),-0.864967807256035,-1.4305569504594202,0.10204081632653061,0.49592734869678856,1.0,2/7,4.44%,CD74;VAV3
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),0.6823234759102427,1.4303431826689408,0.047619047619047616,1.0,1.0,2/16,0.93%,PDK4;PSMD14
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),-0.7986756102309096,-1.4292814149458362,0.1016949152542373,0.4992271716504049,1.0,7/15,12.62%,CYLD;ISG15;IFIH1;NLRC5;TRIM25;TBK1;NPLOC4
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.9247108639352728,1.4275554150017742,0.019230769230769232,1.0,1.0,1/5,1.64%,SLC12A6
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),0.9247108639352728,1.4275554150017742,0.019230769230769232,1.0,1.0,1/5,1.64%,SLC12A6
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),-0.8823229411060414,-1.426074301550441,0.0784313725490196,0.5101443274300632,1.0,1/6,0.13%,RSAD2
prerank,MSigDB_Hallmark_2020__Apoptosis,-0.6660862123595561,-1.4244192863894096,0.014492753623188406,0.5152090522397048,1.0,11/57,8.98%,CYLD;BTG2;IRF1;SAT1;SOD2;TNFSF10;TAP1;JUN;IGF2R;LGALS3;PMAIP1
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.6723960956334897,-1.4239007722135761,0.078125,0.5151111776521623,1.0,6/42,3.22%,CX3CL1;GBP1;STAT1;PSMB9;TMSB4X;PSMA1
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),-0.9764229491673515,-1.4224041949690704,0.0,0.5186298119002827,1.0,2/5,1.51%,CD74;IFIH1
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.6929369097547528,-1.4220576985730686,0.046153846153846156,0.5173537212695514,1.0,5/47,4.78%,CD74;CX3CL1;GBP1;FN1;TNIP1
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),-0.659896525408507,-1.4217152615621191,0.04285714285714286,0.515746553971644,1.0,11/54,7.35%,CD74;MX1;XAF1;KLHL20;ISG15;STAT1;NUB1;SP100;EIF2AK2;SMAD3;CALCOCO2
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,0.626605511330825,1.421650052862523,0.0,1.0,1.0,15/36,15.21%,NOVA1;GRM5;SNAP25;CADM2;MAPK10;GRIA2;NRXN1;ADGRB3;NKAIN2;PRKX;RBFOX1;GCNT2;CREBRF;LSAMP;ANK2
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),-0.8876629205602995,-1.421593878817567,0.034482758620689655,0.5135274835282032,1.0,1/9,0.26%,HES1
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),0.7855909027195731,1.4198162742788192,0.08,1.0,1.0,3/11,13.99%,BTBD10;PSEN1;NRP1
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),0.7054381181622875,1.4188126768674567,0.057692307692307696,1.0,1.0,9/18,21.05%,NRXN1;CNTNAP2;ABL1;PPM1F;NLGN1;NRP1;IL1RAPL1;ROCK1;RAC1
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),-0.927474982331514,-1.4184067766840769,0.037037037037037035,0.5229889894581691,1.0,1/5,0.39%,MX1
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),-0.927474982331514,-1.4184067766840769,0.037037037037037035,0.5229889894581691,1.0,1/5,0.39%,MX1
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),0.8571671355473952,1.417145644984218,0.0425531914893617,1.0,1.0,1/6,0.91%,ABL2
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),-0.7418473123781752,-1.4163104401285205,0.12962962962962962,0.530400006298945,1.0,3/13,12.67%,LRPAP1;AHI1;MTMR2
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),-0.7602382519212646,-1.4160694544589985,0.038461538461538464,0.528316537270043,1.0,3/18,5.56%,CD74;TMSB4X;SERPINE1
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),-0.9013336493978852,-1.4149900198860956,0.018518518518518517,0.5307685483600065,1.0,2/7,2.75%,PLK2;CENATAC
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),-0.7816135701333752,-1.4144765506866455,0.0,0.5299803058160001,1.0,5/13,11.47%,ISG15;OAS3;NLRC5;SAMHD1;RPS19
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),0.6318951727410985,1.4139674468898078,0.07142857142857142,1.0,1.0,6/20,20.30%,CCDC88A;CNOT2;RALB;G3BP1;RAB3GAP2;FSCN1
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),-0.8195237981453399,-1.4135957352745347,0.08,0.5316247616850466,1.0,6/12,13.73%,LRPAP1;OPTN;PRKN;NFKB1;MTMR2;ITGAV
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),-0.7974184113111333,-1.4132642902543262,0.11320754716981132,0.5297995055710791,1.0,3/10,10.88%,MAP3K2;IRF1;NFKB1
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),-0.8743637366427269,-1.4130215190839284,0.03773584905660377,0.527776243350223,1.0,5/9,11.63%,HLA-F;PLCG2;B2M;HLA-A;HLA-E
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),-0.8402039250571327,-1.4118082105279883,0.08955223880597014,0.5298935979251553,1.0,2/10,8.23%,SERPINE1;CST3
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),-0.8580051172552121,-1.411553310845398,0.017857142857142856,0.528053398701213,1.0,4/11,4.75%,CX3CL1;SNX6;SOD2;PRKN
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),-0.8556372390387468,-1.411350100551442,0.09433962264150944,0.5262865962831581,1.0,3/10,3.48%,CX3CL1;NR4A1;CXCL12
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),-0.8916828656618887,-1.4113137367489133,0.02,0.5208999603109362,1.0,1/6,1.79%,RIMS1
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),-0.8916828656618887,-1.4113137367489133,0.02,0.5208999603109362,1.0,1/6,1.79%,RIMS1
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),0.671081975062271,1.4110814209137326,0.06666666666666667,1.0,1.0,5/19,19.26%,NAA50;MORF4L1;ZZZ3;EP300;CREBBP
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),0.7372638795936942,1.410912134146845,0.06976744186046512,1.0,1.0,1/11,0.91%,ABL2
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),0.8418213752491042,1.4108692209989884,0.13559322033898305,1.0,1.0,1/6,0.18%,ARHGEF4
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),-0.8772424776978742,-1.4098964829711633,0.11764705882352941,0.5251607922165444,1.0,1/5,1.79%,RIMS1
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),-0.8763835173377857,-1.4094733987659918,0.1016949152542373,0.5248109182710303,1.0,2/6,4.75%,ATP9A;PRKN
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.9009915910637317,1.4093479983853243,0.04,1.0,1.0,2/5,2.96%,UGP2;FUT8
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.684628343789088,1.4085695446307809,0.13157894736842105,1.0,1.0,7/13,22.09%,SEMA3F;ALCAM;HSP90AA1;PPP3CB;NRP1;USP9X;CYFIP1
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),-0.7895983126998527,-1.4084542608741246,0.03773584905660377,0.5270750240126814,1.0,3/13,1.48%,CX3CL1;PPARG;STAT1
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),0.8122940214178369,1.408351630815573,0.0,1.0,1.0,7/15,13.55%,ITPR3;CHD7;SNAP25;ITPR2;PRKCA;PPP3CB;CACNA1C
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),0.888426076442283,1.4066236889032946,0.0,1.0,1.0,1/5,2.62%,UBQLN1
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),0.9333539473754263,1.4063491738519824,0.0,1.0,1.0,1/5,0.36%,HDAC9
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),0.8424344201233237,1.406080698485193,0.06666666666666667,1.0,1.0,5/7,15.78%,ITPR3;ATP2B4;CACNA1C;SLC8A1;RYR2
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),0.6159644053745614,1.4050214927530267,0.1282051282051282,1.0,1.0,14/34,15.78%,CALR;STIM1;VAPB;PACS2;ATP2A2;PDZD8;ATP2B4;MICU3;NPTN;SLC24A2;PSEN1;SLC8A1;ANK2;RYR2
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,0.6141333795547205,1.4047322213083022,0.0625,1.0,1.0,13/40,15.21%,ATRNL1;NOVA1;SNAP25;CADM2;GRIA2;ADGRB3;SLC25A46;CNTNAP2;RAB11FIP2;SMAD1;CHN1;NLGN1;ANK2
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),-0.9055771450768599,-1.404670275097381,0.05454545454545454,0.5437533123523755,1.0,2/6,2.65%,STAT1;IRF1
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),0.7559387006132097,1.4044389302331441,0.0,1.0,1.0,1/14,0.05%,PDK4
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.7506977233069483,1.4038399093225424,0.1111111111111111,1.0,1.0,3/9,13.84%,PACS2;ATP2A2;PSEN1
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),-0.9040058898777159,-1.4036820346946777,0.09615384615384616,0.5450691635618035,1.0,3/7,4.75%,HES1;PPARG;PRKN
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),-0.7425969937832164,-1.4031469977906763,0.07017543859649122,0.5443668880039235,1.0,1/20,0.26%,HES1
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.8627756131827716,1.4028604732072094,0.0625,1.0,1.0,2/6,7.32%,ROBO2;SMAD6
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),0.6866896740359063,1.401905533061954,0.07317073170731707,1.0,1.0,7/17,15.78%,ABL2;ITPR3;ABL1;NPTN;CACNA1C;SLC8A1;RYR2
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,-0.788099030872657,-1.4014102381694162,0.15384615384615385,0.5500126077002095,1.0,2/12,8.33%,PPARG;LCP2
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.6955091842968346,-1.4008531959939032,0.05714285714285714,0.5501062690103489,1.0,4/37,2.67%,CD74;HES1;PARP14;PLCG2
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.9348810088769328,-1.4002074451926305,0.05357142857142857,0.5507557585402769,1.0,1/5,2.23%,SHLD1
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.8216901710119282,1.3999371956725093,0.13636363636363635,1.0,1.0,2/5,8.90%,BMP6;PPM1F
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),0.8456412755750429,1.3967467249534822,0.07142857142857142,1.0,1.0,3/7,11.79%,PCM1;PEX14;CLASP1
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),-0.8732536585867124,-1.3954749271181865,0.08,0.5722479940503064,1.0,2/6,4.98%,SLC5A6;TAP1
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),0.9445544294735246,1.3946021042893864,0.0,1.0,1.0,2/5,4.60%,DTWD1;TRMT9B
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.8287232191603948,-1.3931144585565385,0.061224489795918366,0.5813981940164651,1.0,2/12,1.19%,CX3CL1;CEMIP
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),0.7338200001285914,1.39281917898035,0.06976744186046512,1.0,1.0,5/10,13.53%,FGF12;HOMER1;DPP10;ATP2B4;WNK1
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),0.7985629301253307,1.3925880451274322,0.0196078431372549,1.0,1.0,1/7,0.31%,HSD17B4
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),-0.8964636635327894,-1.3921546284302757,0.09090909090909091,0.583177764546543,1.0,1/5,0.44%,CX3CL1
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),-0.7724603876697224,-1.3921327935147059,0.12280701754385964,0.5803259916256506,1.0,1/12,0.18%,CD74
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),0.942325009568699,1.3920826633422636,0.0,1.0,1.0,1/5,0.31%,HSD17B4
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),-0.7516562593710056,-1.3917132489082085,0.0784313725490196,0.5795757170147683,1.0,1/15,0.65%,CYLD
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),-0.8142159035720122,-1.3909558871011969,0.15,0.5792257961418119,1.0,2/8,2.67%,ISG15;PLCG2
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.9413262316924087,-1.3902804005586693,0.023255813953488372,0.579416979796623,1.0,1/6,0.21%,VCAM1
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),0.8149790740019118,1.3896884230943651,0.16666666666666666,1.0,1.0,2/6,6.39%,TET2;WDR82
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),-0.8744164880895442,-1.3891571977956585,0.08163265306122448,0.5835948612239056,1.0,2/6,4.47%,ZC3HAV1;CNOT8
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),-0.8496024464583244,-1.3891329096637532,0.08163265306122448,0.5808102813512028,1.0,1/9,0.44%,CX3CL1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),0.8181923104048691,1.3854274222253478,0.10638297872340426,1.0,1.0,1/6,1.40%,ERBB4
prerank,GO_Biological_Process_2021__heart development (GO:0007507),0.5762484918609302,1.3851424992126307,0.046511627906976744,1.0,1.0,7/47,7.40%,HDAC9;RBM20;ERBB4;CHD7;FGF12;TAB2;UTY
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),0.8147101495570311,1.384378193052226,0.0851063829787234,1.0,1.0,1/7,1.40%,ERBB4
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),0.6785354010235729,1.3832610608523273,0.02631578947368421,1.0,1.0,6/20,24.53%,PIK3CA;GAREM1;RPS6KA5;ADAM17;GRB2;PTK2
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,-0.6988662286699371,-1.3811774872667097,0.10909090909090909,0.6205394721458012,1.0,4/33,4.10%,KIAA1217;ATP9A;SLC16A2;SMARCA1
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),-0.78836856869575,-1.3805923425110926,0.12727272727272726,0.6200489611607338,1.0,3/11,6.93%,STAT1;PLXND1;MAML3
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),0.7590929694270088,1.3804667133752626,0.13157894736842105,1.0,1.0,2/8,8.26%,HSD17B4;INSIG1
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),0.7542997243749362,1.3804112847655186,0.0975609756097561,1.0,1.0,7/12,19.47%,TRAK2;TRAK1;ERCC6;ANXA1;RYK;CDK5RAP2;CDK6
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),-0.8969672696605202,-1.3781642523094286,0.058823529411764705,0.6304410430939451,1.0,1/5,0.29%,SLC22A5
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),-0.6307531928722991,-1.37811162448223,0.04918032786885246,0.6279612547073959,1.0,27/52,23.91%,RPL31;RPL15;RPS28;RPL7A;RPS6;RPL38;RPS15;RPL30;RPS14;RPL34;RPS19;RPS7;RPL24;RPL11;RIOK3;RPL23;RPL41;RPL36;RPL10;RPS27;RPL9;RPL27A;RPL28;RPL3;RPL27;RPL19;RPL37
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),0.6214895987763415,1.3777939241072297,0.08695652173913043,1.0,1.0,5/27,3.58%,NRG2;ABL2;ERBB4;INPP5F;PRAG1
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),0.7163129569659198,1.3762149191747906,0.11363636363636363,1.0,1.0,4/15,7.89%,NRG2;ERBB4;PIK3CA;HSP90AA1
prerank,PanglaoDB_Augmented_2021__T Helper Cells,-0.8113879578373002,-1.3759049870786888,0.14814814814814814,0.6366105673959809,1.0,5/11,15.06%,PPARG;LCP2;NFKB1;RORA;IL18R1
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,-0.7232301002714517,-1.3751570888963174,0.1076923076923077,0.6371353079202272,1.0,2/29,1.35%,TBX3;PPARG
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),-0.8590574573983023,-1.3747517618904648,0.1590909090909091,0.6360166271219444,1.0,1/6,1.66%,ABCA5
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.7735494466178813,1.3739176450919306,0.06382978723404255,1.0,1.0,1/8,0.05%,PDK4
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),0.6421701572514631,1.373262717741169,0.07317073170731707,1.0,1.0,13/28,15.78%,CALR;MT2A;STIM1;VAPB;ATP2A2;MT1M;MT1E;ATP2B4;NPTN;SLC24A2;SLC8A1;ANK2;RYR2
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.7503222794378926,-1.3729661147886474,0.1320754716981132,0.6413851565888502,1.0,5/22,8.80%,CYLD;SP100;TNFSF10;BCL2L14;LGALS3
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),-0.8654588443013287,-1.37253527448789,0.0975609756097561,0.6403498726641591,1.0,3/6,9.16%,PPARG;ABCA5;NFKBIA
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),0.7391164521836884,1.3716927902610156,0.11320754716981132,1.0,1.0,4/12,11.97%,CRY1;MAPK10;UBE2B;ERCC6
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),-0.8503010414991826,-1.3714964025140137,0.08333333333333333,0.6413092234064904,1.0,1/8,0.44%,CX3CL1
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.6782528078724395,-1.3709974678765169,0.08928571428571429,0.6413866596650406,1.0,12/32,5.14%,VCAM1;CX3CL1;GBP1;STAT1;IRF2;HLA-F;IRF1;OAS3;SP100;HLA-C;GBP4;HLA-B
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),-0.7926931966079234,-1.370642906595169,0.12244897959183673,0.6398624714595204,1.0,1/9,0.36%,TBX3
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,0.6054136860804645,1.3703864307373703,0.03125,1.0,1.0,17/48,15.21%,ATRNL1;NOVA1;TAFA1;SNAP25;CADM2;MAPK10;GRIA2;FBXO7;PIK3CA;NRXN1;ADGRB3;RBFOX1;CNTN1;GCNT2;PARVA;LSAMP;ANK2
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),0.7280491898801509,1.3699364322292553,0.08,1.0,1.0,7/11,19.18%,ITPR3;ATP2A2;MICU3;CACNA1C;SLC8A1;RYR2;MICU2
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.8492786445912894,-1.3699247401928212,0.09433962264150944,0.6372182604521631,1.0,1/8,0.44%,CX3CL1
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),-0.8492786445912894,-1.3699247401928212,0.09433962264150944,0.6372182604521631,1.0,1/8,0.44%,CX3CL1
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.5703486312959858,1.36961530472126,0.0,1.0,1.0,2/49,0.36%,PDK4;HDAC9
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),0.8511224754433911,1.3695874384691717,0.058823529411764705,1.0,1.0,3/5,14.51%,TMTC1;TMTC2;TMTC4
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),0.7770223531580251,1.3691613899944808,0.1111111111111111,1.0,1.0,5/11,18.20%,SLC12A6;ATP2B4;SLC24A2;SLC8A1;SLC39A10
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),-0.5919565272707084,-1.3684406406300957,0.056338028169014086,0.6415540384209042,1.0,31/85,19.76%,RPL31;CNOT8;RPS18;RPS12;RPL15;PABPC1;RPS8;RPS28;RPL7A;RPS6;RPL38;RPS15;RPL30;RPS14;NBDY;RPL34;RPS19;RPS7;RPL24;PARN;UPF3A;RPL11;ATM;GSPT1;RPL23;RPL41;RPL36;RPL10;RPS27;RPL9;RPL27A
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),-0.8403798045923866,-1.367801906831146,0.09433962264150944,0.6417633765985278,1.0,2/8,3.32%,PPARG;SNX6
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",-0.8851052768390953,-1.3677038278436149,0.16279069767441862,0.6366120442039559,1.0,5/5,11.63%,HLA-F;HLA-C;HLA-B;HLA-A;HLA-E
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),-0.8851052768390953,-1.3677038278436149,0.16279069767441862,0.6366120442039559,1.0,5/5,11.63%,HLA-F;HLA-C;HLA-B;HLA-A;HLA-E
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),-0.711523818230616,-1.367377759128458,0.14516129032258066,0.6358212561966888,1.0,9/20,11.63%,ISG15;OPTN;OAS3;GBP4;SERPINE1;RPL30;HLA-A;RPS19;HLA-E
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),0.7501740003567464,1.3668020294163334,0.16326530612244897,1.0,1.0,3/10,7.87%,CRY1;WRNIP1;ABL1
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.9319461366863255,-1.3665112545587033,0.041666666666666664,0.6344362896880236,1.0,1/5,1.04%,GBP1
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.9319461366863255,-1.3665112545587033,0.041666666666666664,0.6344362896880236,1.0,1/5,1.04%,GBP1
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.7322641393336208,1.365989717481841,0.09803921568627451,1.0,1.0,4/11,19.26%,NAA50;MORF4L1;EP300;CREBBP
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.6305368497796469,-1.3655907851750475,0.07936507936507936,0.6363332384036243,1.0,26/49,23.91%,RPL31;RPL15;RPS28;RPL7A;RPS6;RPL38;RPS15;RPL30;RPS14;RPL34;RPS19;RPS7;RPL24;RPL11;RPL23;RPL41;RPL36;RPL10;RPS27;RPL9;RPL27A;RPL28;RPL3;RPL27;RPL19;RPL37
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),-0.9149152119391895,-1.3642453008337212,0.02040816326530612,0.6402601532877179,1.0,1/5,3.30%,SPG7
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),0.583919964972406,1.3641343584553898,0.045454545454545456,1.0,1.0,2/38,0.91%,PDK4;ABL2
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.8113302681883099,-1.3636098283811704,0.10526315789473684,0.6405545436158044,1.0,2/10,1.51%,CYLD;IFIH1
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.8653671524737433,-1.3622253283276256,0.125,0.6446881827843244,1.0,4/6,11.63%,HLA-F;HLA-B;HLA-A;HLA-E
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.7989434605965157,-1.3618814660966752,0.1694915254237288,0.6442302854539872,1.0,1/9,0.21%,VCAM1
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),-0.8346866204061212,-1.3618608694312735,0.125,0.6416793273071278,1.0,3/8,11.34%,HLA-F;B2M;HLA-A
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),-0.8597113146624472,-1.361180857614551,0.10204081632653061,0.6418773947710004,1.0,2/8,2.67%,CX3CL1;PLCG2
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),-0.7865890142737323,-1.3609033398546637,0.14583333333333334,0.6402067896280546,1.0,3/9,2.54%,OMD;CEMIP;HGSNAT
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.6017397901158805,1.360670662257934,0.10526315789473684,1.0,1.0,4/33,10.36%,PDK4;PIK3CA;IDE;GRB10
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),-0.6023865505960319,-1.3596900787401827,0.125,0.6435360458793865,1.0,28/53,23.91%,RPL31;RPL15;RPS28;RPL7A;RPS6;RPL38;RPS15;RPL30;RPS14;RPL34;RPS19;RPS7;RPL24;RPL11;NPM1;RPL23;RPL41;RPL36;RPL10;RPS27;RPL9;RPL27A;DHX29;RPL28;RPL3;RPL27;RPL19;RPL37
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),-0.8605437233868708,-1.3590189755803785,0.17647058823529413,0.6445652408874748,1.0,1/5,2.49%,RNF213
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.729705043459312,1.3583626250245546,0.12,1.0,1.0,1/10,0.05%,PDK4
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),-0.649917329807863,-1.3582532662236668,0.1111111111111111,0.6453763038482861,1.0,2/30,1.82%,CYLD;PLK2
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),-0.7808416569253359,-1.3582005864419837,0.25,0.6429263128057531,1.0,2/10,8.59%,PLCG2;VIM
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),-0.9316539551666608,-1.3574115485914922,0.10204081632653061,0.6438205408376244,1.0,1/5,4.75%,PRKN
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),0.7608116232533747,1.3563572490683733,0.08571428571428572,1.0,1.0,1/9,0.05%,PDK4
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),0.6867276350158187,1.356280843118486,0.14705882352941177,1.0,1.0,4/15,10.46%,TEAD4;RARB;PBX3;TBC1D23
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),0.8336881538041765,1.3558122192421396,0.05454545454545454,1.0,1.0,4/7,13.55%,FGF12;PIK3CA;GSN;CACNA1C
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),-0.7583242227118652,-1.3557024255475418,0.10526315789473684,0.650003365123319,1.0,4/16,3.66%,ISG15;IFIH1;IRF1;OAS3
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),0.8194645869828395,1.3552225799062048,0.15,1.0,1.0,3/7,8.72%,SEMA3F;ROBO2;ANGPT2
prerank,MSigDB_Hallmark_2020__Glycolysis,0.5943313365363325,1.3542044237159063,0.08571428571428572,1.0,1.0,10/34,15.39%,UGP2;FUT8;P4HA1;IGFBP3;HOMER1;PKM;EXT1;AK3;GLCE;PPP2CB
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.7993811722227061,-1.3536616924089047,0.09090909090909091,0.6579068706968483,1.0,7/14,11.27%,PARP14;PPARG;STAT1;NLRC5;CDC37;PARP9;IFNGR2
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),0.4666696881354435,1.3533262361001173,0.05263157894736842,1.0,1.0,28/179,14.54%,PDK4;ABL2;CRY1;ERBB4;PRKD1;MAPK10;TAF1;PRKG1;PRAG1;MORC3;BCR;IGFBP3;STK38L;CSNK1G3;ABL1;PRKX;PXK;YWHAZ;NLK;PRKCA;OXSR1;LRRK2;PPP3CB;EPHA4;WNK1;RPS6KA5;FES;ADAM10
prerank,PanglaoDB_Augmented_2021__B Cells Memory,0.8069859125499355,1.3531845647720546,0.14893617021276595,1.0,1.0,2/6,13.68%,BACH2;DENND5B
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.767078601354424,-1.3531103509213147,0.15517241379310345,0.6579487531176803,1.0,5/8,19.26%,TMEM117;MAP3K5;ERO1A;DNAJC10;TNFRSF10B
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),0.623842795123755,1.352990183053555,0.15151515151515152,1.0,1.0,5/24,14.30%,ABL2;ERBB4;ABL1;EPHA4;FES
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",-0.8674462230497548,-1.3526485213205826,0.0392156862745098,0.6574590287284524,1.0,2/5,4.75%,ATP9A;PRKN
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),-0.8236280615587754,-1.3522491701591555,0.10638297872340426,0.6566477051114746,1.0,5/8,13.73%,PPARG;ABCA5;NFKBIA;NFKB1;ITGAV
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),0.7212346613682279,1.3517090633855535,0.16666666666666666,1.0,1.0,5/10,16.90%,ABL2;ABL1;NRP1;FES;ESAM
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),-0.7022380174712882,-1.3514255939100297,0.11864406779661017,0.6579507548054145,1.0,4/27,3.66%,CX3CL1;IFIH1;PLCG2;OAS3
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),-0.8377718869937746,-1.3514020904857451,0.08196721311475409,0.655488836920517,1.0,3/7,11.47%,DDX60;APPL2;RPS19
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.8655599387533216,-1.3511917453472733,0.12,0.6537705043977909,1.0,1/6,3.74%,CDK14
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),-0.5676031821589804,-1.3508084609003392,0.046153846153846156,0.6529069358165732,1.0,5/105,1.82%,CD74;TBX3;CX3CL1;KLHL20;PLK2
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.8651025074503564,-1.3506077193758759,0.12244897959183673,0.6510930206690788,1.0,4/7,11.63%,HLA-F;HLA-B;HLA-A;HLA-E
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),-0.6392078541117223,-1.3503422078908143,0.10294117647058823,0.649611372811912,1.0,8/46,4.08%,CX3CL1;CYLD;GBP1;ISG15;IFIH1;TMSB4X;FN1;NLRC5
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),0.8047506782226097,1.349376314204141,0.09090909090909091,1.0,1.0,1/6,4.88%,CCDC88A
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.8607316566700098,1.3484497081872113,0.125,1.0,1.0,2/6,7.87%,ABL2;ABL1
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),-0.6855686720108505,-1.3482825406047314,0.13333333333333333,0.6551847798012012,1.0,3/33,3.58%,VCAM1;ITGB5;FN1
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),0.6173470963085268,1.3478736354315444,0.12,1.0,1.0,6/29,9.03%,RBM20;NOVA1;PTBP3;MBNL1;NOVA2;HNRNPLL
prerank,PanglaoDB_Augmented_2021__B Cells Naive,-0.8343891950571503,-1.3469358004051735,0.07142857142857142,0.6596499859404841,1.0,1/10,0.18%,CD74
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),-0.579155734810946,-1.346768890809735,0.05970149253731343,0.6576810589058932,1.0,21/89,15.55%,HES1;TBX3;BTG2;PPARG;SLC16A2;IRF1;SOD2;EIF2AK2;WARS1;COL18A1;B2M;APPL2;BRD7;ADAMTS1;CDH13;SMYD2;JAK2;RAPGEF2;SMARCA2;FTH1;PDS5B
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,0.6372538077721518,1.3465510113793084,0.13513513513513514,1.0,1.0,10/29,9.48%,NOVA1;SNAP25;GRIA2;NTM;ROBO2;NRXN1;ADGRB3;RBFOX1;NOVA2;CNTN1
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),-0.8443519380114466,-1.3459574488572499,0.1320754716981132,0.6597161374151392,1.0,1/7,0.44%,CX3CL1
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.8042578004333243,-1.345510044843774,0.0625,0.659008760149702,1.0,6/7,11.63%,HLA-F;TAP1;ERAP1;B2M;HLA-A;HLA-E
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),-0.8433014809429241,-1.3449670224886612,0.1568627450980392,0.6591992705333515,1.0,1/5,1.09%,PARP12
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),0.8553071757350413,1.3447834512840715,0.041666666666666664,1.0,1.0,1/7,0.31%,HSD17B4
prerank,PanglaoDB_Augmented_2021__Basophils,0.6877896244160141,1.3445999538072677,0.17073170731707318,1.0,1.0,2/18,1.92%,JAZF1;SLC26A3
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),-0.6969252934106692,-1.34452996381391,0.11538461538461539,0.6586926245029855,1.0,6/28,7.79%,SLC22A5;ABCA5;SLCO1A2;CHKA;TAP1;SLCO2B1
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),-0.7364089374886265,-1.344391584784924,0.1864406779661017,0.6569964018749326,1.0,7/14,18.09%,NR4A1;RNF213;EFNB2;RECK;CDH13;OTULIN;ACVRL1
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),-0.7365445944652748,-1.3433236553279737,0.1111111111111111,0.6596086026289445,1.0,6/22,13.24%,CX3CL1;SERPINE1;PLXND1;ACER2;CDH13;RHOA
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),0.7414269169348673,1.343273676126136,0.08695652173913043,1.0,1.0,5/11,16.07%,FGF12;NKAIN2;ATP2B4;WNK1;ANK3
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),-0.6642966579849234,-1.3431176375709333,0.12698412698412698,0.658227505390575,1.0,9/46,12.41%,CD74;CX3CL1;TPM1;SERPINE1;SRGAP2C;LIMCH1;TMEFF2;BST2;RECK
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),0.6325555129209471,1.3409384678025809,0.06976744186046512,1.0,1.0,8/25,21.68%,TRAM2;VAPB;RTN4;LRRK2;TOR1AIP2;ATL2;RTN3;REEP5
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),-0.866892523969,-1.3404203642291255,0.06521739130434782,0.669949180504481,1.0,1/6,2.93%,UFL1
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),0.8124464358476928,1.3398635112855792,0.09090909090909091,1.0,1.0,3/5,10.62%,ZBTB1;ABL1;CBFB
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.7845288490649042,1.3394834671350124,0.13636363636363635,1.0,1.0,3/9,10.96%,SMAD9;SMAD5;SMAD1
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),0.8731162423474355,1.339220843359239,0.05128205128205128,1.0,1.0,1/6,0.91%,ABL2
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),0.9294546337948273,1.339027627440962,0.03636363636363636,1.0,1.0,2/5,4.39%,MCPH1;TENT4A
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),0.7565256549955479,1.3388567975466572,0.21428571428571427,1.0,1.0,4/10,13.99%,ROBO2;SMAD6;PARVA;NRP1
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),0.6758651317054738,1.3383267217774402,0.15217391304347827,1.0,1.0,7/12,25.18%,NAV3;CLASP1;FES;CDK5RAP2;RAC1;HSPA1A;CLIP1
prerank,PanglaoDB_Augmented_2021__Spermatozoa,-0.6644260257059473,-1.3361852724835641,0.11428571428571428,0.6861693231122169,1.0,5/25,7.79%,CD74;SOD2;CPM;PLA1A;SLCO2B1
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),-0.7791641249464508,-1.3358132912671945,0.10909090909090909,0.6855720324742878,1.0,2/13,3.32%,VCAM1;SNX6
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,-0.62843000739147,-1.3351870794181961,0.0684931506849315,0.686032832363891,1.0,10/47,8.59%,VCAM1;ITGB5;TPM1;SAT1;CXCL12;FN1;SERPINE1;IL32;JUN;VIM
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),-0.6723283407950389,-1.3348954793832803,0.10344827586206896,0.6847283023670457,1.0,8/42,5.56%,CX3CL1;CYLD;PPARG;TMSB4X;UFL1;SNX6;TNIP1;SERPINE1
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),0.7722901615341292,1.3348772072830961,0.20689655172413793,1.0,1.0,1/7,1.17%,CRY1
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),-0.7313258828352376,-1.3325724635519907,0.14285714285714285,0.6932929132917032,1.0,4/14,7.24%,SCN3A;SLC6A6;SLC5A6;SCN2A
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),-0.6949406380562183,-1.3322613284037677,0.125,0.6923058894369858,1.0,4/14,12.12%,NDRG1;PMAIP1;ACER2;FHIT
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.6917457508616782,-1.3322072472243716,0.08333333333333333,0.6901400143160998,1.0,8/18,20.30%,CYLD;PRKN;SPPL2A;OTULIN;CCDC3;CARD8;PTPN2;RACK1
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),-0.711233367567786,-1.3315525483308943,0.1724137931034483,0.6911662606422384,1.0,2/19,3.32%,VCAM1;SNX6
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,0.5739758179517176,1.3308493563876467,0.11627906976744186,1.0,1.0,14/30,12.93%,GRM5;SNAP25;CADM2;GRIA2;SGIP1;NRXN1;ADGRB3;NCAM1;CNTNAP2;RBFOX1;NLK;FRMD3;PRKCA;SLC24A2
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),0.7454729314984838,1.330761080963018,0.10869565217391304,1.0,1.0,3/12,12.75%,KDM4C;UTY;KDM5A
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),0.7705147028686534,1.330728295437067,0.16981132075471697,1.0,1.0,1/6,2.41%,CHD7
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),-0.7213247281879626,-1.3302621023649441,0.16923076923076924,0.6942822402961822,1.0,1/20,0.44%,CX3CL1
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),-0.8227175466836488,-1.3296479223162239,0.08333333333333333,0.6946624989560196,1.0,1/9,0.44%,CX3CL1
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.7401269559363464,1.328617207397532,0.23404255319148937,1.0,1.0,1/9,0.36%,HDAC9
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),-0.6022249644037586,-1.327730278588067,0.056338028169014086,0.7001900394207231,1.0,9/76,9.40%,TBX3;CYLD;NR4A1;IRF1;GRK5;SMAD3;JUN;CDC14A;AFAP1L2
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),-0.8689244777792448,-1.3274131541587748,0.125,0.6992358492318685,1.0,4/5,11.63%,HLA-F;HLA-B;HLA-A;HLA-E
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.6209035969717849,1.3273571310250398,0.11627906976744186,1.0,1.0,6/25,9.09%,NOVA1;MBNL1;RBFOX1;KHDRBS3;NOVA2;REST
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),0.5867503647912361,1.327197052617352,0.08571428571428572,1.0,1.0,10/38,11.50%,NRG2;ABL2;ERBB4;INPP5F;PRAG1;ABL1;PRKX;FRMD5;HACE1;DIAPH1
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.6654314769881556,-1.3271694317026217,0.1323529411764706,0.6976721843294729,1.0,11/24,22.51%,PPARG;TNFSF10;SMAD3;ACER2;JAK2;CARD8;TNFRSF10B;NOD1;RACK1;NLRP1;HIP1R
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),-0.8622332842730627,-1.3268542567879849,0.07142857142857142,0.6964088766349827,1.0,3/6,9.16%,PPARG;ABCA5;NFKBIA
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),-0.7664696567130614,-1.3261640680915086,0.125,0.6969185854758694,1.0,2/14,3.32%,VCAM1;SNX6
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),-0.9312031002757565,-1.3257585031647547,0.06666666666666667,0.6964561812996525,1.0,1/5,0.18%,CD74
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),-0.6606081429765339,-1.3248667270881582,0.16129032258064516,0.6977126028073621,1.0,7/24,13.32%,SCN3A;SLC6A6;SLC5A6;SCN2A;TRPM3;TRPM6;NDFIP1
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.6040952248510326,-1.3244588174758605,0.07936507936507936,0.6972506657419343,1.0,12/74,4.96%,CD74;CX3CL1;OPTN;STAT1;PLK2;APOL3;SHISA5;PLCG2;UFL1;PRKN;TNIP1;TNFSF10
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,0.613953030924071,1.3244381926969635,0.07317073170731707,1.0,1.0,4/31,4.44%,PDK4;IL1R1;MT2A;ATP2A2
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),0.7632442528188788,1.3228816041481966,0.11320754716981132,1.0,1.0,2/6,7.19%,YWHAB;URI1
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.7806071825668307,-1.322328772608384,0.11475409836065574,0.7049536667084466,1.0,2/11,0.47%,HES1;PARP14
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.7226192831026338,-1.3222994751346684,0.1206896551724138,0.7027013482170339,1.0,3/13,16.02%,SHLD1;POLR2A;MSH2
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),0.6646977013955927,1.3222519643827835,0.18,1.0,1.0,3/13,13.53%,BMP6;PPM1F;WNK1
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),-0.6289792609932934,-1.3220059634197103,0.08571428571428572,0.7020505066588527,1.0,7/56,9.16%,MX1;IFI27;IRF1;SCN2A;BCL2L14;PMAIP1;NFKBIA
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),-0.643461801460586,-1.3216407097628404,0.1076923076923077,0.7010531425959,1.0,5/44,3.58%,CD74;CX3CL1;ULK4;PLCG2;FN1
prerank,GO_Biological_Process_2021__cognition (GO:0050890),0.7615083947557485,1.3214372801960927,0.1276595744680851,1.0,1.0,3/11,2.80%,GRM5;CHD7;SOBP
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.8516738956846869,-1.3209935305691962,0.14285714285714285,0.7011123994155452,1.0,1/8,1.19%,CEMIP
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,0.6693037565707961,1.3209610389823816,0.14893617021276595,1.0,1.0,10/15,16.15%,GRM5;SNAP25;CADM2;GRIA2;ADGRB3;NKAIN2;RBFOX1;HS6ST3;ANK2;CTNND2
prerank,PanglaoDB_Augmented_2021__Satellite Cells,-0.6707083446820852,-1.3206927539127287,0.14285714285714285,0.6999160996556916,1.0,6/41,8.90%,VCAM1;KIAA1217;IRF2;FOXK1;LIMCH1;DMD
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),-0.6884968176471302,-1.3202009013303502,0.1346153846153846,0.6994924952385451,1.0,1/17,0.65%,CYLD
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),-0.6345467312371377,-1.32015447472375,0.1076923076923077,0.6972368165649243,1.0,3/35,4.75%,HES1;PPARG;PRKN
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),0.8368886598355842,1.320126828974609,0.08888888888888889,1.0,1.0,2/8,5.30%,PCM1;SYNE2
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),-0.8725475843062507,-1.3196024052263322,0.13725490196078433,0.6969979302417599,1.0,2/5,8.98%,PPARG;PMAIP1
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),-0.8692004082951799,-1.3193795358705422,0.08928571428571429,0.6956947823385428,1.0,2/7,2.80%,SLC16A2;SLC6A6
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),0.8031298523435497,1.3192987692197755,0.19607843137254902,1.0,1.0,1/7,3.87%,KDM4C
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),-0.7501589084411739,-1.3192493254680824,0.18181818181818182,0.6938866007037077,1.0,2/14,6.83%,CYLD;CDC37
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.8373002059087887,1.3189343974882937,0.11764705882352941,1.0,1.0,4/5,16.07%,SLC12A6;TMTC2;SLC8A1;ANK3
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),0.8078116296802017,1.3188895182283331,0.10416666666666667,1.0,1.0,1/6,1.17%,CRY1
prerank,PanglaoDB_Augmented_2021__Osteoblasts,-0.6870100738014157,-1.3185898348680662,0.13846153846153847,0.6948226963258646,1.0,5/36,3.58%,VCAM1;CX3CL1;SLC6A6;CXCL12;FN1
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),-0.8561698024521506,-1.3184211398574146,0.16363636363636364,0.6931999941672006,1.0,1/5,1.48%,STAT1
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.6881683522441877,1.317542545082858,0.23255813953488372,1.0,1.0,6/10,25.18%,NAV3;CLASP1;FES;CDK5RAP2;RAC1;CLIP1
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),0.6483446201792602,1.3170002233658546,0.075,1.0,1.0,9/18,17.89%,UGCG;NRXN1;ANXA2;STX2;NLGN1;IL1RAPL1;ANK3;PTEN;PICALM
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),0.7843110767437316,1.3163460507335563,0.08333333333333333,1.0,1.0,5/8,12.28%,RALA;FBXO7;DNAJC15;HSPD1;MFF
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.8543955056941572,-1.3161059293592972,0.16,0.7015597382458811,1.0,2/6,9.50%,SHLD1;TFRC
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),-0.8169989237194221,-1.3160300137880803,0.12727272727272726,0.6994857820722487,1.0,2/10,3.48%,STAT1;CXCL12
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),0.638338865740455,1.314803166582807,0.13157894736842105,1.0,1.0,8/20,15.78%,ABL2;ITPR3;ABL1;ATP2B4;NPTN;CACNA1C;SLC8A1;RYR2
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),0.7336423377221463,1.314649937991504,0.18867924528301888,1.0,1.0,3/10,8.98%,GLO1;PKM;SLC16A1
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),-0.8421070324134234,-1.3142541116324635,0.14754098360655737,0.7048707075140465,1.0,1/6,2.75%,CENATAC
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),-0.8636300015288978,-1.313901834433305,0.19230769230769232,0.704243241115857,1.0,2/6,7.50%,DOK5;ZDHHC17
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),-0.816989011161301,-1.3136206826007628,0.14035087719298245,0.7008332023473189,1.0,2/8,1.51%,STAT1;IFIH1
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),-0.816989011161301,-1.3136206826007628,0.14035087719298245,0.7008332023473189,1.0,2/8,1.51%,STAT1;IFIH1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.8230013615361037,-1.3132178917281354,0.17391304347826086,0.7005578492119054,1.0,4/8,11.63%,HLA-F;HLA-B;HLA-A;HLA-E
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),-0.8949605474217572,-1.3131514554104975,0.08163265306122448,0.6963806439332176,1.0,1/6,1.12%,OMD
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),-0.8949605474217572,-1.3131514554104975,0.08163265306122448,0.6963806439332176,1.0,1/6,1.12%,OMD
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),-0.7627881377075316,-1.312943318437715,0.1320754716981132,0.6952341707210625,1.0,2/12,6.83%,CYLD;CDC37
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),-0.7591575061133938,-1.312509579600546,0.10909090909090909,0.6947840544260603,1.0,1/12,0.44%,CX3CL1
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.7999623012963398,-1.3124162891810862,0.1836734693877551,0.6928983915897972,1.0,2/5,7.17%,ZNHIT6;RPL7A
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),-0.8249743684256882,-1.312291224213124,0.08771929824561403,0.6912531574391633,1.0,1/5,0.78%,NR4A1
prerank,MSigDB_Hallmark_2020__Inflammatory Response,-0.588271075536969,-1.3118999844376746,0.15384615384615385,0.6903656849809912,1.0,13/52,12.02%,CX3CL1;BTG2;IRF1;TNFSF10;EIF2AK2;SERPINE1;LY6E;LCP2;NFKBIA;NFKB1;SCARF1;IFNGR2;BST2
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),-0.6445818390196743,-1.3117912779541439,0.1875,0.6883508608483582,1.0,2/25,4.80%,CX3CL1;CARMIL1
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.5723006925351822,1.3116508208843023,0.08888888888888889,1.0,1.0,3/27,4.08%,PDK4;CRY1;HECTD4
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),-0.8192102457579309,-1.3113059781444227,0.16666666666666666,0.6884143529774821,1.0,1/7,1.82%,PLK2
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,0.7066744830523034,1.3105334333526681,0.05555555555555555,1.0,1.0,10/14,25.47%,NRCAM;DPYSL2;RTN1;NRP1;UNC5C;CDK6;OPHN1;RASA1;NF1;ADGRG1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),0.802294660501326,1.309505331867462,0.09803921568627451,1.0,1.0,2/5,13.47%,ANXA2;EPHA4
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),-0.5443480865783629,-1.309148933082627,0.05194805194805195,0.6959720739805659,1.0,9/135,4.47%,HES1;TBX3;CX3CL1;TPM1;SLC6A6;UFL1;CXCL12;FN1;CNOT8
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.8229419176981992,-1.3084838068267735,0.16981132075471697,0.696908399585991,1.0,2/5,12.05%,PRKN;RPS7
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),-0.8547598521752258,-1.30847003402521,0.1568627450980392,0.6924871683025252,1.0,2/5,9.50%,SHLD1;TFRC
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),-0.8547598521752258,-1.30847003402521,0.1568627450980392,0.6924871683025252,1.0,2/5,9.50%,SHLD1;TFRC
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),0.6625218643605112,1.3071690156742692,0.14634146341463414,1.0,1.0,2/17,4.67%,YWHAB;HSP90B1
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),0.6478339968263028,1.3071233576872032,0.20408163265306123,1.0,1.0,3/15,10.12%,ARHGEF4;CCDC88A;S1PR1
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),-0.7425873783202578,-1.3070896128216571,0.18333333333333332,0.6967282783135723,1.0,5/13,18.93%,ATP6V1E1;TFRC;IREB2;FTH1;LMTK2
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),-0.8088404721804228,-1.3068680532692363,0.125,0.6959725845493036,1.0,4/7,16.46%,NLRC5;RPS19;HLA-E;RIOK3
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.7652727419514266,1.3064547666276465,0.22641509433962265,1.0,1.0,4/8,22.14%,NAA50;EP300;CREBBP;NAA25
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),-0.8446745488497082,-1.3061164877303826,0.18,0.6973043093895929,1.0,2/6,2.67%,GBP1;PLCG2
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),-0.7398731745132765,-1.3059546817849,0.125,0.6935145236119724,1.0,1/9,0.73%,TLL1
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),-0.7398731745132765,-1.3059546817849,0.125,0.6935145236119724,1.0,1/9,0.73%,TLL1
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),-0.8562890604820669,-1.305684802081315,0.21818181818181817,0.6925595717838434,1.0,1/5,2.52%,TPM1
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),0.6264599216122808,1.3053375479133698,0.1111111111111111,1.0,1.0,11/23,15.78%,CALR;STIM1;VAPB;ATP2A2;TMTC2;ATP2B4;NPTN;SLC24A2;SLC8A1;ANK2;RYR2
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),0.5369810428406826,1.3051691298699601,0.09523809523809523,1.0,1.0,18/60,24.12%,NOVA1;PRPF8;TENT4A;MBNL1;HNRNPR;PPIG;IVNS1ABP;DICER1;SETX;CELF2;RBPMS;CDK12;RSRC1;SRSF7;XRN2;TCERG1;SRSF11;TUT7
prerank,PanglaoDB_Augmented_2021__B Cells,-0.7642990135444983,-1.3047590141355727,0.13559322033898305,0.6944150467491511,1.0,1/15,0.18%,CD74
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),0.5829616395798186,1.3043661981246633,0.14705882352941177,1.0,1.0,11/34,14.49%,GRIK2;GRM5;CDH2;DLGAP2;BCR;HOMER1;PXK;USP46;LRRK2;NLGN1;DGKI
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),0.6229005156924466,1.303935683186038,0.09090909090909091,1.0,1.0,9/27,17.99%,TMTC1;TET2;TRAK1;GXYLT1;TMTC2;GALNT10;TMTC4;GALNT2;C1GALT1
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),0.7531480669635544,1.30384956057914,0.23404255319148937,1.0,1.0,2/7,12.28%,PEX14;MFF
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),-0.7745564220105967,-1.303842757888752,0.2,0.6966627875925969,1.0,1/10,0.78%,NR4A1
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),-0.86635782759238,-1.3036900675815315,0.07142857142857142,0.6949947122247764,1.0,3/7,6.70%,SP100;PLXND1;WARS1
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,0.5977183645027296,1.303171901861,0.17142857142857143,1.0,1.0,3/21,3.17%,HSPG2;COL4A2;SEMA3F
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),-0.6332350124235062,-1.3026220349776125,0.14285714285714285,0.6977206802260917,1.0,3/37,5.50%,CD74;TIE1;RFC3
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.6645318414125811,1.302590790861984,0.1276595744680851,1.0,1.0,3/17,9.09%,HDAC9;MORF4L1;REST
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),0.7918050398544121,1.3018727006636972,0.11363636363636363,1.0,1.0,3/8,10.10%,FUT8;MAN1A2;ST8SIA4
prerank,PanglaoDB_Augmented_2021__Nuocytes,-0.8575711848038339,-1.3014938702485834,0.1320754716981132,0.700337493417703,1.0,3/6,13.08%,CYLD;RORA;GIMAP8
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,-0.8180843230718899,-1.3014803011693434,0.13953488372093023,0.6982746525836223,1.0,1/10,0.13%,RSAD2
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),-0.8302017566971678,-1.3006738587153515,0.16,0.6997419882467513,1.0,1/6,1.04%,GBP1
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),0.6762865550550544,1.300396941043175,0.12,1.0,1.0,1/12,0.31%,HSD17B4
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),0.8401359785935869,1.3002793734207367,0.07547169811320754,1.0,1.0,2/6,4.39%,MCPH1;TENT4A
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),-0.7388634333647102,-1.2997511555110022,0.18,0.7014442981858768,1.0,1/11,0.36%,TBX3
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.5476134158670002,-1.2986596674614035,0.07228915662650602,0.7043218528523214,1.0,23/165,5.76%,RSAD2;VCAM1;MX1;CX3CL1;GBP1;XAF1;ISG15;STAT1;IFI27;PSMB9;IRF2;HLA-F;TMSB4X;IRF1;PSMA1;SOD2;CXCL12;FN1;OAS3;SP100;HLA-C;HLA-B;IL32
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),-0.5919968595912993,-1.2982285145217343,0.11475409836065574,0.70372677664245,1.0,13/56,12.41%,VCAM1;TLL1;ITGB5;LAMA4;FN1;SERPINE1;COL8A1;COL18A1;ITGA10;ADAMTS1;NID1;CD47;RECK
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),-0.8509360617485884,-1.2981929503816318,0.14,0.7017755695759059,1.0,1/6,1.66%,ABCA5
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),0.5171268966927622,1.298037000791951,0.0,1.0,1.0,14/73,12.44%,PDK4;ABL2;SLC26A3;PRKD1;SLC38A9;TAF1;HSP90B1;INSIG1;CPEB3;CAPN2;NCOA3;ATP2B4;ACTB;SETX
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.6869436341968188,-1.2965343026337384,0.23076923076923078,0.706463673846238,1.0,5/16,13.84%,HMGN1;RFC3;POLR2A;RFC1;UBC
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),-0.7384729467829935,-1.2964285455202909,0.10909090909090909,0.7049664927695629,1.0,7/17,14.07%,PPARG;STAT1;LGALS3;AHI1;PGK1;JAK2;MFSD2A
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),0.8411187316319714,1.2962489118354987,0.16981132075471697,1.0,1.0,3/5,11.84%,CALR;CTBP2;KLF2
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),-0.704316020804714,-1.2948519869248036,0.14035087719298245,0.7095569695725418,1.0,1/17,0.44%,CX3CL1
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),-0.6760840881969172,-1.2945499055828757,0.13114754098360656,0.7084476009606571,1.0,1/23,1.45%,OPTN
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),0.8089922342304906,1.2923451631897889,0.14893617021276595,1.0,1.0,3/6,18.35%,HSP90B1;URI1;PPP6R3
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),0.6326554666212933,1.2919661431236638,0.13636363636363635,1.0,1.0,6/22,12.62%,SMAD9;BMP6;SMAD6;SMAD5;SMAD1;HIVEP1
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),0.6326554666212933,1.2919661431236638,0.13636363636363635,1.0,1.0,6/22,12.62%,SMAD9;BMP6;SMAD6;SMAD5;SMAD1;HIVEP1
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.72628581735002,-1.291208856366328,0.19298245614035087,0.7197867907073764,1.0,2/11,5.56%,TNFSF10;SERPINE1
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),-0.6218857780492744,-1.2906167081889208,0.14285714285714285,0.7178821587025017,1.0,12/43,12.41%,VCAM1;ITGB5;LAMA4;FN1;SERPINE1;COL8A1;COL18A1;ITGA10;ADAMTS1;NID1;CD47;RECK
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),-0.6218857780492744,-1.2906167081889208,0.14285714285714285,0.7178821587025017,1.0,12/43,12.41%,VCAM1;ITGB5;LAMA4;FN1;SERPINE1;COL8A1;COL18A1;ITGA10;ADAMTS1;NID1;CD47;RECK
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),0.6909218313693343,1.2900574179019364,0.21568627450980393,1.0,1.0,1/8,1.71%,YWHAB
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),-0.8469660158656996,-1.289983076581658,0.15517241379310345,0.7188558735641828,1.0,1/6,2.80%,SLC6A6
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),0.8080514897633337,1.2897500843908105,0.13636363636363635,1.0,1.0,3/6,14.12%,PRKD1;CRTC3;RPS6KA5
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.6804680795566413,-1.2890117857851826,0.15942028985507245,0.7207650975957323,1.0,2/25,2.67%,CD74;PLCG2
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),-0.6499782518422177,-1.2886846850405833,0.13793103448275862,0.7197596516704262,1.0,2/27,3.74%,PLK2;CDK14
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),-0.8142501562976336,-1.2882296184287025,0.22916666666666666,0.7194326610622318,1.0,3/7,13.60%,TNIP1;ALG11;GCNT1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),-0.7615913472075272,-1.2869567976655922,0.16666666666666666,0.7226354782970827,1.0,3/16,4.44%,CD74;VCAM1;VAV3
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),-0.8435208055370063,-1.286465304045199,0.22641509433962265,0.7230869312914037,1.0,2/5,9.16%,TMSB4X;NFKBIA
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.5369643458720765,1.2864518829590612,0.10256410256410256,1.0,1.0,5/32,7.89%,HSPH1;BAG3;NUP58;RANBP2;HSP90AA1
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.6623318998905372,-1.2862942826258046,0.25396825396825395,0.7217675739361178,1.0,3/16,13.24%,EIF2AK2;NR3C2;RHOA
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),-0.7719870713545199,-1.286041538867768,0.13793103448275862,0.7207159887018025,1.0,2/10,4.91%,UFL1;GPM6A
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),0.7358073750558569,1.2857899142773181,0.1951219512195122,1.0,1.0,4/8,15.39%,PPM1F;PPP3CA;PPP2R2B;PPP2CB
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.6284806614459568,1.2853953832025151,0.1111111111111111,1.0,1.0,4/19,7.50%,PDK4;CRY1;HECTD4;KLF7
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),0.754950504504798,1.285279663873265,0.16279069767441862,1.0,1.0,2/8,4.60%,DTWD1;TRMT9B
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),-0.8647709736965402,-1.2847366856402114,0.17777777777777778,0.7243679947517475,1.0,2/6,4.75%,RSAD2;PRKN
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),-0.7864594940167151,-1.284222490260184,0.19607843137254902,0.7248092508341608,1.0,2/9,4.75%,MX1;PRKN
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),-0.7707610267421515,-1.2841129328683323,0.17543859649122806,0.7232422280847772,1.0,1/10,1.22%,KLHL20
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.8049216890782493,-1.2838021599626963,0.12,0.722369898241498,1.0,2/9,6.18%,BTG2;PABPC1
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),-0.7082356291888012,-1.283658594428054,0.21818181818181817,0.7187367761050835,1.0,3/12,8.28%,CEMIP;CLIC5;CDC14A
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),-0.7082356291888012,-1.283658594428054,0.21818181818181817,0.7187367761050835,1.0,3/12,8.28%,CEMIP;CLIC5;CDC14A
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.6656180190414567,1.2835874930024216,0.2,1.0,1.0,3/13,3.95%,ANO5;SLC12A6;CLIC1
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),-0.7370511453054429,-1.2832272359851988,0.2153846153846154,0.7187061884705452,1.0,1/10,0.13%,RSAD2
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,-0.6570606819437267,-1.2831174386677124,0.19642857142857142,0.7170939077998277,1.0,4/22,4.41%,ZIC1;PARP12;ISG15;MAP2
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.8122707754016056,-1.283077897852473,0.14285714285714285,0.7152372257006273,1.0,2/7,11.92%,VPS36;MVB12B
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),0.6342588773375414,1.281835203204619,0.13513513513513514,1.0,1.0,9/24,20.43%,EIF4G3;HSPB1;EIF5;YTHDF2;EIF3E;KHDRBS1;EIF5B;EIF4A2;AGO2
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,0.70152364192224,1.2816023679488935,0.15,1.0,1.0,10/18,12.38%,BTBD10;SNAP25;GRIA2;FGF12;ADGRB3;KCTD8;RBFOX1;TOX2;DPP10;PRKCA
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),0.691858246000419,1.2804089241680385,0.125,1.0,1.0,8/14,26.17%,GRIA2;DLGAP2;LRRC7;NLGN1;DLGAP1;GRIA4;DLGAP4;MEF2C
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),0.8025701942764136,1.279657025776616,0.125,1.0,1.0,2/6,2.13%,PNP;HSPH1
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),0.8120712570295199,1.2794226977253405,0.17647058823529413,1.0,1.0,1/5,5.37%,TUBB4B
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),0.8120712570295199,1.2794226977253405,0.17647058823529413,1.0,1.0,1/5,5.37%,TUBB4B
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.8608774452933448,-1.2792332991956472,0.17543859649122806,0.7297384943012565,1.0,3/5,11.47%,RPS8;RPS14;RPS19
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),-0.5444720932985965,-1.2786829203591212,0.08,0.7299294327885336,1.0,16/140,8.13%,CD74;CX3CL1;CEMIP;ULK4;TMSB4X;TPM1;SOD2;CXCL12;NTNG1;CARMIL1;SERPINE1;PLXND1;CTNNA2;SRGAP2C;CASS4;LIMCH1
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),-0.7848266440093411,-1.2776472260514657,0.18518518518518517,0.7320465484099251,1.0,5/7,18.59%,RPS28;RPS15;RPS14;RPS19;RPS27
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),0.8260402649653135,1.2776218497839449,0.08888888888888889,1.0,1.0,5/6,17.50%,PACS2;ATP2A2;PDZD8;VMP1;CALM1
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.643527919033914,-1.2773571428966395,0.14035087719298245,0.7311994086663987,1.0,10/26,5.14%,VCAM1;GBP1;STAT1;IRF2;HLA-F;IRF1;OAS3;SP100;HLA-C;HLA-B
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),-0.8354093564608109,-1.2772123533863307,0.1276595744680851,0.7296626006591069,1.0,1/6,1.64%,ATP9A
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,-0.7383539863731865,-1.2771303646607897,0.1864406779661017,0.7278850452878993,1.0,1/13,0.44%,CX3CL1
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),-0.6688442035583761,-1.27701702902613,0.2,0.7263106892598287,1.0,4/33,6.15%,SLC22A5;SLC6A6;TMEM30A;SLC38A3
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),-0.8036846204201686,-1.275602455970474,0.21666666666666667,0.730061278948211,1.0,2/7,9.06%,RIMS1;ARHGAP17
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),-0.6571421713011333,-1.2747287179770628,0.11940298507462686,0.7325001404564481,1.0,4/27,5.32%,HES1;PSMB9;PSMA1;EIF2AK2
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),-0.8407367192225501,-1.2741948988248948,0.2,0.7326519015769656,1.0,3/6,11.63%,SHLD1;TFRC;HLA-E
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),0.6420851848224517,1.2739187749083791,0.1282051282051282,1.0,1.0,9/22,17.50%,GRIA2;FGF12;HOMER1;LRRC7;FGF14;NLGN1;ANK2;ANK3;CALM1
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.6993742269997913,-1.2737847505211985,0.1896551724137931,0.7321471769413936,1.0,1/8,1.38%,ISG15
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),-0.8252747097279733,-1.2732993713711926,0.14545454545454545,0.7319721417556495,1.0,2/6,5.32%,CD74;EIF2AK2
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,0.5424500710957956,1.2731150308070898,0.13636363636363635,1.0,1.0,6/32,11.47%,CALR;BAG3;HSP90B1;CNOT2;YWHAZ;HSPA9
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),-0.8124102682748415,-1.2727808999041552,0.22448979591836735,0.7323142913433857,1.0,1/5,2.49%,RNF213
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),0.600484879171166,1.2724481570282722,0.17073170731707318,1.0,1.0,5/29,8.67%,NOVA1;PRPF8;MBNL1;PPIG;IVNS1ABP
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),-0.6487508317830021,-1.2721749517350969,0.15384615384615385,0.7325191003430481,1.0,2/29,4.39%,CD74;TIE1
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),0.6724903254996621,1.2717767139385283,0.17142857142857143,1.0,1.0,7/15,22.09%,SEMA3F;ALCAM;HSP90AA1;PPP3CB;NRP1;USP9X;CYFIP1
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),-0.6669885874842062,-1.2716791542759827,0.15384615384615385,0.7326147081291929,1.0,5/25,13.73%,CX3CL1;PRKN;LGALS3;CLU;ITGAV
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),0.7335767631638997,1.2714600814892283,0.22641509433962265,1.0,1.0,4/7,10.80%,CNOT2;REST;ZNF706;NCOA3
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.8205585615001482,-1.2711508893880397,0.14583333333333334,0.7325481006173508,1.0,4/6,13.73%,PPARG;ABCA5;NFKBIA;ITGAV
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),0.8001186843517809,1.2704341471448584,0.19230769230769232,1.0,1.0,2/5,15.45%,CHPT1;AGPS
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),-0.79762598624829,-1.2699376778902136,0.18032786885245902,0.7351426859688281,1.0,3/10,7.61%,CX3CL1;CXCL12;STK39
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),0.7485201060479919,1.2682992983485961,0.19642857142857142,1.0,1.0,4/9,15.78%,FGF12;CACNA1C;ANK2;RYR2
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),-0.6621034120435139,-1.2678853177583316,0.19298245614035087,0.7419852944745899,1.0,6/20,13.24%,CX3CL1;TPM1;CARMIL1;LIMCH1;CD47;RHOA
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),0.7435287903959917,1.2675264311766128,0.2,1.0,1.0,1/8,4.54%,PCM1
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),-0.7145165975308096,-1.2668471047419914,0.22033898305084745,0.7445406670524475,1.0,4/11,14.43%,ISG15;PLCG2;CD47;VSIR
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),-0.8302744772810648,-1.2656326270938514,0.2127659574468085,0.7468957439156371,1.0,1/6,1.35%,PPARG
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.6997543725879078,1.2653315130809117,0.14035087719298245,1.0,1.0,3/9,18.04%,SLC12A6;SLC24A2;KCNT2
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),-0.80879447117031,-1.264348195717082,0.26,0.7496371166667757,1.0,1/6,1.48%,STAT1
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.6035986524558792,1.2642938493596398,0.25,1.0,1.0,6/18,14.28%,SLC12A6;SLC26A3;ANO6;SLC24A2;WNK1;SLC8A1
prerank,MSigDB_Hallmark_2020__p53 Pathway,-0.5947255499995814,-1.2639940867768653,0.15,0.7490754647664547,1.0,8/51,8.57%,BTG2;PLK2;SAT1;TAP1;RPS12;BLCAP;JUN;NDRG1
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),0.6991567392859764,1.2638362572106712,0.13953488372093023,1.0,1.0,4/8,14.25%,KPNA3;RANBP2;CBLB;KPNA1
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),0.6675680365553429,1.263811567602009,0.15555555555555556,1.0,1.0,4/13,18.35%,HSP90B1;ITGA1;CALM1;PPP6R3
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),0.7885018619783455,1.2637564423626153,0.08571428571428572,1.0,1.0,5/10,12.28%,FBXO7;HSP90AA1;DNAJC15;HSPD1;MFF
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.7547921209492839,1.263756406761198,0.22916666666666666,1.0,1.0,2/6,12.98%,TPST2;PAPSS2
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),-0.7522525245979,-1.2636106243831298,0.13043478260869565,0.7488341847312967,1.0,1/18,0.39%,MX1
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),-0.7102782970243532,-1.2633888583377917,0.22641509433962265,0.7478291791514375,1.0,3/12,7.24%,SCN3A;SLC6A6;SCN2A
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),-0.7751083081264107,-1.2633076069802263,0.24561403508771928,0.7442606037460617,1.0,1/6,1.19%,CEMIP
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),-0.7751083081264107,-1.2633076069802263,0.24561403508771928,0.7442606037460617,1.0,1/6,1.19%,CEMIP
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),0.6476696822761834,1.2632543727258003,0.16666666666666666,1.0,1.0,5/17,13.63%,PSMD14;YY1;MORF4L1;SEM1;INO80
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),0.6260748144531214,1.2625794985369494,0.22857142857142856,1.0,1.0,3/22,3.43%,VAPB;PRKD1;KDSR
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),-0.8515297983154276,-1.2623731596599892,0.20454545454545456,0.7458665113814064,1.0,1/6,1.69%,IFI27
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),0.7538377166622193,1.261564128999217,0.175,1.0,1.0,3/9,13.14%,INPP5A;PPP3CA;PPP3CB
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),-0.8205764408195588,-1.2607928417112348,0.19230769230769232,0.7508574220347057,1.0,3/5,13.84%,B2M;PGK1;UBC
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.7428241825138003,1.2600349171728726,0.1956521739130435,1.0,1.0,4/10,13.91%,GRIK2;BCR;PXK;NLGN1
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.7242882796279121,-1.2600162633890442,0.21311475409836064,0.7523856496479783,1.0,2/13,0.47%,HES1;PARP14
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,-0.6036249246927669,-1.2599057326197869,0.1527777777777778,0.7506859840876228,1.0,3/60,3.48%,HES1;SLC22A5;CXCL12
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),-0.8401236912553935,-1.2595781557011452,0.21153846153846154,0.7498757397852512,1.0,1/5,1.58%,RREB1
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),0.7092004873931695,1.2592668209440125,0.2,1.0,1.0,6/9,25.34%,GSN;TRIOBP;ADD3;CAPZB;ADD1;SVIL
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),0.7092004873931695,1.2592668209440125,0.2,1.0,1.0,6/9,25.34%,GSN;TRIOBP;ADD3;CAPZB;ADD1;SVIL
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),-0.6165016542963764,-1.258640014088156,0.12307692307692308,0.7510329759351806,1.0,7/42,9.40%,CYLD;BTG2;PSMB9;PSMA1;SMAD3;ANAPC16;AFAP1L2
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),0.7750682109065349,1.258551257032481,0.24444444444444444,1.0,1.0,2/6,13.03%,SLC26A3;LRRK2
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.5509611347477188,1.2581511649027748,0.0975609756097561,1.0,1.0,17/29,32.97%,BCR;EVI5;RALGAPB;TIAM2;TBC1D5;RALGAPA2;TIAM1;RABGAP1L;TBC1D22A;TBC1D9;BCAS3;RALGAPA1;SIPA1L1;CORO1C;ECT2;ABR;TBCK
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),-0.7959788461607595,-1.2581025333344649,0.19642857142857142,0.7511793610186016,1.0,1/8,1.35%,PPARG
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),0.7452880867363335,1.2580836272609,0.2653061224489796,1.0,1.0,1/6,0.91%,ABL2
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),-0.6789528832084408,-1.2580498884450584,0.1694915254237288,0.7493718292562745,1.0,1/13,1.79%,RIMS1
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),-0.5549619726335566,-1.2579743687614453,0.1935483870967742,0.7476761244690459,1.0,4/42,5.43%,GBP1;ISG15;OPTN;TMEM30A
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),-0.8099006366861351,-1.2576784940641597,0.20689655172413793,0.7472163657511447,1.0,5/8,16.46%,RPS8;RPS28;RPS14;RPS19;RIOK3
prerank,MSigDB_Hallmark_2020__Apical Junction,-0.5910299901333925,-1.2563371512711277,0.11864406779661017,0.7502272743740314,1.0,2/64,0.44%,VCAM1;CX3CL1
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),0.675729634706996,1.2559572604414315,0.16,1.0,1.0,6/12,22.90%,YTHDF2;DIS3L2;SND1;MTREX;XRN2;HSPA1A
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),-0.7715162884141923,-1.2556770654468097,0.16981132075471697,0.7511878401065667,1.0,1/11,1.45%,OPTN
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),-0.8157446761543783,-1.2556412316650754,0.23529411764705882,0.7493271657421591,1.0,1/5,6.28%,CEP57
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.7513857968559599,-1.255426077409306,0.22641509433962265,0.7481845643656928,1.0,1/13,1.19%,CEMIP
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),0.7734959675890078,1.2553345042971835,0.1951219512195122,1.0,1.0,1/7,0.31%,HSD17B4
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),-0.678359512914629,-1.254804561159394,0.2037037037037037,0.7490420298020817,1.0,4/18,14.67%,ULK4;EIF2AK2;TAOK3;FOXO1
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),-0.5092776700304751,-1.2547953721516822,0.10256410256410256,0.7472008701684762,1.0,31/180,14.46%,HES1;TBX3;CX3CL1;BTG2;STAT1;IRF1;UFL1;SOD2;FN1;CNOT8;EIF2AK2;GRK5;WARS1;COL18A1;JUN;STAT5B;RPS6;TFRC;ACER2;BRD7;EFNB2;ADAMTS1;CD47;CDH13;RHOA;CLU;ITGAV;SMYD2;JAK2;RAPGEF2;SMARCA2
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),-0.8269732753199363,-1.2544473324104097,0.18,0.7468759996182364,1.0,1/5,3.30%,SPG7
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.8337964397163985,-1.2534768878000144,0.16981132075471697,0.7492836244268904,1.0,1/5,7.92%,JCAD
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),0.7965004743195493,1.2532811115842446,0.18,1.0,1.0,1/6,2.05%,NDUFAF2
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),0.7965004743195493,1.2532811115842446,0.18,1.0,1.0,1/6,2.05%,NDUFAF2
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.6011443089517858,1.2531936916711341,0.14285714285714285,1.0,1.0,3/17,7.09%,TTC7A;PIK3CA;PI4KA
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),0.6032077771973844,1.2530092544747329,0.15555555555555556,1.0,1.0,4/13,7.66%,GRIK2;INPP5F;HOMER1;ANXA2
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),-0.720092083029672,-1.2527489076881881,0.2553191489361702,0.7502796851587084,1.0,3/14,6.80%,PIGC;GPCPD1;PLA1A
prerank,PanglaoDB_Augmented_2021__Sebocytes,-0.7940344543083502,-1.2523917117839205,0.2692307692307692,0.7499495541001198,1.0,2/7,11.76%,LGALS3;CDA
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),0.7324691934779277,1.252374940630494,0.14893617021276595,1.0,1.0,5/7,25.96%,PEX14;DNAJC15;HSPD1;SEC63;C2CD5
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),-0.800463454035516,-1.2523251243909985,0.2653061224489796,0.748328019238203,1.0,1/9,0.36%,TBX3
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),0.797966101104179,1.2520181191681665,0.14545454545454545,1.0,1.0,3/6,14.28%,PIK3CA;GSN;SLC8A1
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),0.797966101104179,1.2520181191681665,0.14545454545454545,1.0,1.0,3/6,14.28%,PIK3CA;GSN;SLC8A1
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),0.6003561257761855,1.2516719288799092,0.16279069767441862,1.0,1.0,10/26,15.78%,CALR;STIM1;VAPB;ATP2A2;ATP2B4;NPTN;SLC24A2;SLC8A1;ANK2;RYR2
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),0.8056262438179059,1.2515759775181259,0.2,1.0,1.0,2/6,6.41%,PNP;ACAT1
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.8127195964352806,-1.2512497450286846,0.1875,0.7500879631885654,1.0,2/7,10.72%,SHLD1;PARP9
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),-0.7771485542893224,-1.2506376598592193,0.1956521739130435,0.7507504832789391,1.0,1/9,0.44%,CX3CL1
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),-0.7194066899442733,-1.2500819095505393,0.19230769230769232,0.7509654529380522,1.0,3/20,8.15%,TPM1;SOD2;JUN
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,0.6356630665886984,1.250015729704043,0.2564102564102564,1.0,1.0,9/16,11.66%,GRM5;SNAP25;CADM2;GRIA2;NRXN1;ADGRB3;RBFOX1;YWHAZ;RTN4
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),-0.8345711474881273,-1.249286731341034,0.14583333333333334,0.752164191383752,1.0,1/6,10.72%,PARP9
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.5846813495880469,-1.2484373151957093,0.12698412698412698,0.7536763062331998,1.0,14/54,13.32%,CD74;CX3CL1;PLK2;APOL3;SHISA5;PRKN;TNFSF10;ZDHHC17;TFRC;TRIM25;TBK1;BST2;RHOA;NDFIP1
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),0.7310256261854602,1.2480631190013862,0.24390243902439024,1.0,1.0,3/9,17.78%,RTN4;RAB7A;CD81
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),-0.7536646057490657,-1.2479971935797045,0.21311475409836064,0.7533190078254427,1.0,2/11,4.75%,CYLD;PRKN
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),-0.6176587279967245,-1.247658981762814,0.16393442622950818,0.752841262259793,1.0,5/30,13.24%,CX3CL1;LIMCH1;ACER2;CDH13;RHOA
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.7968562098565585,-1.2473303514933602,0.22,0.752609652551363,1.0,1/7,0.26%,HES1
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),-0.8310905482035993,-1.2463723584904465,0.2777777777777778,0.7543248131238812,1.0,3/6,7.61%,CX3CL1;CXCL12;STK39
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),0.8029158265054668,1.24575149521842,0.25,1.0,1.0,1/5,1.06%,CALR
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),-0.6756741958463566,-1.2457343062156578,0.2909090909090909,0.7548185608168312,1.0,4/13,18.64%,COL18A1;RAPGEF2;PPP1R16B;MSN
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),-0.7891225703379705,-1.24555782044824,0.1320754716981132,0.7537609551796759,1.0,2/10,4.70%,SHLD1;CYREN
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),-0.7225344244190327,-1.2455060786406265,0.27450980392156865,0.7521531627144087,1.0,1/7,0.44%,CX3CL1
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),0.77530658878629,1.2454548158554288,0.21568627450980393,1.0,1.0,2/5,7.87%,NRCAM;ABL1
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),0.8215658660354088,1.2451690261871577,0.18,1.0,1.0,3/5,17.50%,SLC8A1;ANK3;CALM1
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),0.7885767946152726,1.2447769532454058,0.20754716981132076,1.0,1.0,1/5,2.15%,AGTPBP1
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),-0.6781116364022077,-1.2446863195114213,0.17543859649122806,0.7537565122187102,1.0,9/21,17.00%,IRF1;CDC37;SAMHD1;ERAP1;APPL2;PARP9;HLA-E;RIOK3;N4BP1
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),-0.6082998231365653,-1.2435548658428446,0.26229508196721313,0.756096986860007,1.0,2/26,2.52%,ITGB5;TPM1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),0.7004478279396108,1.2430596053495795,0.20833333333333334,1.0,1.0,1/8,1.40%,ERBB4
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),-0.6447244252762949,-1.2428569356136097,0.16363636363636364,0.756652449240795,1.0,8/16,16.48%,RPS28;RPS6;RPL38;RPS15;RPS19;RPS7;RPL11;NPM1
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),-0.7150232799101357,-1.2427853686941333,0.2,0.7550531452067027,1.0,2/15,5.56%,PSMB9;SERPINE1
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),0.721014018171556,1.242198692774112,0.17647058823529413,1.0,1.0,2/10,8.26%,HSD17B4;INSIG1
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),0.8282800665731352,1.2419358814021704,0.17777777777777778,1.0,1.0,3/5,13.47%,NRCAM;RTN4;EPHA4
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),-0.845855098692299,-1.2412957855265507,0.16666666666666666,0.7588527327781704,1.0,1/5,0.44%,CX3CL1
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.7078940424516884,1.2412571549629687,0.2127659574468085,1.0,1.0,4/10,14.10%,ROBO2;NRXN1;NLGN1;IL1RAPL1
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),-0.8565887177307268,-1.2411609834485948,0.25,0.7576127830071762,1.0,2/5,4.75%,HEBP2;PRKN
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),-0.7260655446806238,-1.2409586538727946,0.2857142857142857,0.7568060837923501,1.0,2/10,9.50%,ATP6V1E1;TFRC
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),0.6471554944236233,1.2407393627594812,0.1875,1.0,1.0,3/14,7.32%,IFNAR1;TAB2;SMAD6
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),-0.5622904402969998,-1.2406350207779329,0.15789473684210525,0.7560032168778322,1.0,4/86,3.30%,CD74;HES1;RIMS1;SPG7
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),-0.6930541611356167,-1.2406073618999793,0.19642857142857142,0.754258997915786,1.0,3/17,6.15%,SLC16A2;SLC6A6;SLC38A3
prerank,MSigDB_Hallmark_2020__Complement,-0.573497952284948,-1.2400956455671748,0.16666666666666666,0.754361725097479,1.0,17/60,14.59%,LAP3;PSMB9;IRF2;IRF1;FN1;SERPINE1;CPQ;CPM;GPD2;LCP2;LGALS3;DGKG;CDA;CDH13;CLU;JAK2;DUSP5
prerank,PanglaoDB_Augmented_2021__Fibroblasts,-0.605407936656025,-1.239446067176425,0.20634920634920634,0.7553811490623689,1.0,7/49,5.87%,VCAM1;NR4A1;LAMA4;ITIH5;CXCL12;FN1;COL8A1
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),-0.7195349870533221,-1.2393528202179058,0.22916666666666666,0.7538853272748476,1.0,2/12,0.44%,HES1;CX3CL1
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),-0.7677152824136912,-1.2389541884845334,0.25,0.7535434740518459,1.0,1/5,2.52%,TPM1
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.7646709720848301,-1.2382155234145036,0.3,0.7550013446693044,1.0,3/9,3.40%,PPARG;TPM1;SOD2
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),0.6340930015946081,1.2381848537569853,0.21818181818181817,1.0,1.0,3/13,7.87%,HDAC9;CDH2;ABL1
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),-0.7609917179908994,-1.237679890919853,0.24489795918367346,0.7548681605025549,1.0,1/8,4.75%,PRKN
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),0.7175536732255533,1.2373239600303376,0.2916666666666667,1.0,1.0,5/10,17.50%,ATP2A2;SLC8A1;ANK2;RYR2;CALM1
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),-0.5573461080026008,-1.2368808730072693,0.18461538461538463,0.7554793852090972,1.0,22/63,19.76%,RPL31;RPL15;SMAD3;RPS28;RPL7A;RPS6;RPL38;RPS15;RPL30;RPS14;RPL34;RPS19;RPS7;RPL24;RPL11;RPL23;RPL41;RPL36;RPL10;RPS27;RPL9;RPL27A
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),0.658981950833052,1.2366798221796431,0.23404255319148937,1.0,1.0,2/14,8.44%,HDAC9;MORF4L1
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),-0.7713707655593747,-1.2358746888902423,0.25925925925925924,0.7577342087047897,1.0,1/7,1.51%,IFIH1
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),-0.7290881101286468,-1.23485677052734,0.2833333333333333,0.7599091624340488,1.0,2/9,6.15%,SLC6A6;SLC38A3
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),-0.7883524294767453,-1.2344795274452518,0.14035087719298245,0.7596042770329756,1.0,6/7,19.42%,FN1;SMAD3;ITGAV;LRRC32;HIF1A;CD34
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),-0.728776759990692,-1.234454985905299,0.20754716981132076,0.7579651379110419,1.0,4/11,13.94%,SP100;JUN;NFKBIA;JAK2
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.7141168432743129,1.2344524880091927,0.19148936170212766,1.0,1.0,4/9,14.17%,NRXN1;NLGN1;IL1RAPL1;SPEN
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),-0.7988939538642779,-1.2342080736074528,0.22,0.7568390154759315,1.0,1/5,1.82%,PLK2
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),-0.5608701412482645,-1.234116462680172,0.16901408450704225,0.7554659200820888,1.0,6/58,8.13%,CD74;CX3CL1;TPM1;SERPINE1;SRGAP2C;LIMCH1
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.7766712981233111,1.2339299481984878,0.22448979591836735,1.0,1.0,3/5,14.10%,NRXN1;NLGN1;IL1RAPL1
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.8448478661746254,-1.2337482967523603,0.11363636363636363,0.7552883737204468,1.0,2/5,4.23%,PARP14;ZC3HAV1
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),-0.7673817936297687,-1.2332165419676224,0.16,0.7552029113920127,1.0,4/8,13.84%,RFC3;NPLOC4;RFC1;UBC
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),-0.8360888804449906,-1.233169643939742,0.1346153846153846,0.7537974246177389,1.0,3/5,13.76%,PDXDC1;ACER2;ENPP2
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,0.5502477058019104,1.2327103164571303,0.11764705882352941,1.0,1.0,13/37,16.25%,SNAP25;MAPK10;GRIA2;TTLL7;NRXN1;ADGRB3;RBFOX1;NOVA2;CNTN1;DST;LSAMP;ANK2;AKAP12
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),-0.7075010654198036,-1.2319965455806898,0.1509433962264151,0.7564868451647304,1.0,2/12,5.43%,ATP9A;TMEM30A
prerank,PanglaoDB_Augmented_2021__Mller Cells,-0.6018800302033823,-1.231216779094235,0.18181818181818182,0.7577136545351048,1.0,5/46,6.15%,HES1;DOK5;CXCL12;SPC25;SLC38A3
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),-0.6430917761841705,-1.2310710181462754,0.1694915254237288,0.7566285882176107,1.0,4/16,19.96%,PPARG;RORA;OTULIN;PTPN2
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),0.614881702756255,1.2300175877036188,0.2,1.0,1.0,3/22,3.43%,VAPB;PRKD1;KDSR
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),-0.743161371479363,-1.229657574378347,0.21739130434782608,0.7600603807735665,1.0,4/13,8.20%,NR4A1;PPARG;FAM120B;ERAP1
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),0.658775835386731,1.2296417582879886,0.25,1.0,1.0,4/13,10.12%,ANKH;SMAD6;CHSY1;S1PR1
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),0.7531667577237343,1.2296043800771064,0.2894736842105263,1.0,1.0,1/5,4.85%,PHACTR4
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),0.7143676872795208,1.2295968089419362,0.26666666666666666,1.0,1.0,4/7,22.56%,ETFA;NDUFS4;MTFR1;UQCRC2
prerank,MSigDB_Hallmark_2020__Adipogenesis,-0.5536457603425563,-1.228133430876377,0.15625,0.7636342416523625,1.0,15/58,13.84%,OMD;PPARG;RREB1;LAMA4;ITIH5;CAVIN2;SLC5A6;AGPAT3;GPD2;CMPK1;TANK;HIBCH;ARL4A;ENPP2;UBC
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),-0.7760482911729089,-1.2279557996156742,0.22033898305084745,0.762655462832776,1.0,1/8,0.21%,VCAM1
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),0.7937148969409216,1.2277241797974972,0.24561403508771928,1.0,1.0,3/5,19.47%,CDH2;ANXA1;CDK6
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,-0.5155389525810957,-1.2274815017036411,0.13414634146341464,0.7625101663349505,1.0,8/104,5.40%,VCAM1;IFI27;LAMA4;CXCL12;CAVIN2;TIE1;GPM6A;MMRN2
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),-0.629299327219337,-1.2264874099006076,0.2413793103448276,0.7641541146549897,1.0,3/26,4.39%,NR4A1;STAT1;TIE1
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),-0.7018272762460535,-1.2254287398714208,0.20930232558139536,0.7666160812723544,1.0,1/22,0.39%,MX1
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),-0.7386297495692272,-1.225070423859311,0.1935483870967742,0.7664184018641709,1.0,2/11,12.41%,SERPINE1;RECK
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),0.7558651282784061,1.2246133847654752,0.20689655172413793,1.0,1.0,3/7,4.93%,CHD7;FUT8;MBNL1
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),-0.6997767158074042,-1.224144695038602,0.22807017543859648,0.7684868224970244,1.0,1/12,1.79%,RIMS1
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.7481534628356666,-1.223987997400443,0.24528301886792453,0.7673773584494157,1.0,1/8,0.65%,CYLD
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),0.7244911904527522,1.222412387093984,0.24,1.0,1.0,1/7,1.17%,CRY1
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),0.8007588496467943,1.222152443648426,0.23636363636363636,1.0,1.0,2/5,13.53%,PXK;WNK1
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),-0.8087065919835545,-1.2220054072710491,0.1590909090909091,0.7732815420489058,1.0,1/5,4.41%,MAP2
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),0.7495017527991867,1.2214556884842536,0.1702127659574468,1.0,1.0,1/5,7.32%,SMAD6
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.5874009856819231,1.2211149867505788,0.17857142857142858,1.0,1.0,4/21,7.87%,DEPP1;ABL2;HSPB1;ABL1
prerank,PanglaoDB_Augmented_2021__Alpha Cells,0.5650384175691971,1.2209751904238362,0.18181818181818182,1.0,1.0,6/24,10.93%,DEPP1;SNAP25;MAPK10;FGF14;PDZRN3;PGR
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),0.717445130839393,1.220796992314123,0.23404255319148937,1.0,1.0,3/8,11.40%,HSPG2;EXT1;GCNT2
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),0.7776534251599895,1.2200500600392679,0.17647058823529413,1.0,1.0,3/7,10.85%,MT2A;MT1M;MT1E
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),-0.7440097998029551,-1.2200357602138512,0.3541666666666667,0.7785639637716878,1.0,4/5,11.34%,TAP1;ERAP1;B2M;HLA-A
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),-0.7933538192740481,-1.2199907545418485,0.24444444444444444,0.7770213750207065,1.0,2/6,14.64%,IGF2R;CFL1
prerank,MSigDB_Hallmark_2020__Apical Surface,-0.6792420497484952,-1.21828064708147,0.2608695652173913,0.7820306906678588,1.0,4/13,11.97%,CX3CL1;NTNG1;AFAP1L2;SULF2
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),-0.7436695067690746,-1.2177349615687452,0.27450980392156865,0.7823281385677925,1.0,5/9,13.01%,CX3CL1;STAT1;JUN;ADAMTS1;CDH13
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),-0.6435323501216891,-1.2168230667580358,0.25925925925925924,0.7840675118969194,1.0,7/16,24.45%,FOXK1;FOXO1;HIF1A;UNC13B;RACK1;GAS6;ZBTB20
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",0.7709356385396634,1.2163194049318635,0.3,1.0,1.0,1/7,1.74%,PRPF8
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),-0.5446584329059279,-1.2159649130842463,0.20634920634920634,0.7851010563749149,1.0,8/51,10.57%,RHOBTB1;TPM1;CARMIL1;CASS4;PPP1R9A;ARHGAP17;ACTN1;CD2AP
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.4168378538394677,1.2156792149232878,0.038461538461538464,1.0,1.0,24/142,14.30%,PDK4;ERBB4;COL4A2;PRKD1;ACTG1;YES1;PIK3CA;HSP90AA1;PLCB1;ANGPT2;IDE;ELMO1;GRB10;AP2B1;ACTB;FRS2;SETX;CHN1;APPL1;EPHA4;PSEN1;NRP1;FOXC1;FES
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),0.6719896305843608,1.2153520284591852,0.23529411764705882,1.0,1.0,4/9,23.62%,PTBP3;SFSWAP;SRSF7;PTBP2
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),0.5112150032005446,1.2146812402236618,0.1891891891891892,1.0,1.0,3/55,3.01%,PDK4;PRKD1;SLC38A9
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.7508648549513676,-1.2141887102998203,0.27419354838709675,0.7884146385009858,1.0,4/8,20.09%,WARS1;LARS1;PPA2;LARS2
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.7508648549513676,-1.2141887102998203,0.27419354838709675,0.7884146385009858,1.0,4/8,20.09%,WARS1;LARS1;PPA2;LARS2
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),-0.5460525408973367,-1.2132064874399144,0.18333333333333332,0.790234040186604,1.0,4/65,4.75%,PARP14;LRPAP1;OPTN;PRKN
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.6740298531460516,-1.2130582875933609,0.24528301886792453,0.7892985448024625,1.0,6/15,18.17%,PPARG;SMAD3;JUN;FOS;HIF1A;PDGFB
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),-0.7500800139827853,-1.2127967400552442,0.2978723404255319,0.7884750148469012,1.0,1/7,5.63%,AGPAT3
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),0.5717447627676598,1.2124202919226459,0.1794871794871795,1.0,1.0,8/23,20.33%,MCPH1;NAA50;TENT4A;DIS3L2;INO80;SMC1A;ZNF207;NIPBL
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),0.706480563695489,1.2122303919845463,0.2916666666666667,1.0,1.0,3/9,13.91%,GRIA2;LRRC7;NLGN1
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),-0.714848272206316,-1.2113334619194267,0.24489795918367346,0.7918761996203949,1.0,2/8,4.44%,PLCG2;VAV3
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),0.7713587052463202,1.2109356868031549,0.2909090909090909,1.0,1.0,3/5,10.85%,MT2A;MT1M;MT1E
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),-0.8102945306792071,-1.2104342206868872,0.22641509433962265,0.7938658674680013,1.0,2/5,8.67%,MYRIP;ACSL4
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),0.6035127933609252,1.210389339095455,0.20408163265306123,1.0,1.0,5/19,13.63%,PSMD14;YY1;MORF4L1;SEM1;INO80
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),0.7450162663694017,1.2098464440246008,0.25,1.0,1.0,5/6,25.49%,ELF1;CBFB;CD81;SLC39A10;ELF2
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),-0.7823340652308287,-1.2097698854316767,0.25,0.7946246760463973,1.0,2/8,8.80%,GBP1;LGALS3
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,-0.5967372151463904,-1.209681003597702,0.20967741935483872,0.7932404409297897,1.0,5/38,4.10%,ZIC1;EML1;LAMA4;CXCL12;SMARCA1
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),0.6141818935958655,1.2093336453469201,0.21951219512195122,1.0,1.0,1/16,0.13%,TRIM5
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.800330209988577,1.2092762525495633,0.3137254901960784,1.0,1.0,2/5,18.20%,CD81;SLC39A10
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),-0.6978672071998393,-1.2085384530576182,0.28,0.7958976715042837,1.0,2/11,11.66%,SAMHD1;PRIMPOL
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),0.47707018186509215,1.2078834853635487,0.27586206896551724,1.0,1.0,9/73,3.61%,TRIM5;DEPP1;ABL2;EIF4G3;UBQLN1;PRKD1;SLC38A9;MTDH;HSPB1
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),0.6994627534870986,1.207405748888749,0.3076923076923077,1.0,1.0,4/9,21.44%,PITPNC1;SCP2;PITPNB;PRELID2
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),0.6407210215788075,1.2065138938096946,0.25925925925925924,1.0,1.0,3/15,14.25%,WRNIP1;YLPM1;KPNA1
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),-0.6733409388450866,-1.206210289495065,0.21818181818181817,0.8023573966768349,1.0,4/11,13.76%,PDXDC1;CPQ;ERAP1;ENPP2
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),0.5464680189172434,1.2062067858581644,0.20454545454545456,1.0,1.0,4/29,3.61%,STIM1;PRKD1;MTDH;HSPB1
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),0.6901298659070614,1.2056373742167696,0.28888888888888886,1.0,1.0,2/8,15.37%,PCM1;CEP290
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.71169299894417,-1.205595865687988,0.25,0.8030703669375987,1.0,3/11,10.72%,SHLD1;CYREN;PARP9
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),0.6303557564733425,1.2051275204470173,0.1590909090909091,1.0,1.0,3/16,8.41%,PEX14;TRAK2;TRAK1
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.7700028034042591,-1.204751647556226,0.20833333333333334,0.8043955603376091,1.0,1/6,0.26%,HES1
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),0.7662912043400978,1.204371386566519,0.2857142857142857,1.0,1.0,3/6,10.96%,PKM;ITGA5;SMAD1
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),0.6693484888475538,1.204321679163185,0.25,1.0,1.0,1/10,2.05%,NDUFAF2
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),-0.7920890482908441,-1.203642647981257,0.2542372881355932,0.8070277110092184,1.0,1/6,1.95%,PSMB9
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),0.5420060992235767,1.20346534053146,0.24390243902439024,1.0,1.0,8/35,12.38%,STIM1;PRKD1;MTDH;HSPB1;PKM;ITGA5;SMAD1;PRKCA
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),-0.6432187385234889,-1.2018845593958982,0.3114754098360656,0.8120148051823903,1.0,9/22,19.24%,SLC6A6;HEBP2;MAP3K5;ACER2;EFNB2;CLU;FOS;RAMP3;APC
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),-0.6726744024429564,-1.2017118389794592,0.3103448275862069,0.8110991575667653,1.0,6/15,18.67%,RAPGEF2;RAB1A;PPP1R16B;TJP1;MSN;AFDN
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.82357235496549,-1.2017073039819413,0.3684210526315789,0.8094090146340235,1.0,1/5,0.21%,VCAM1
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.7384405443026438,-1.2016228034957968,0.2692307692307692,0.8079569048966168,1.0,1/9,0.26%,HES1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),-0.7800117326586151,-1.2011626573702416,0.2558139534883721,0.807893486568846,1.0,1/5,3.71%,CHKA
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),0.8146962514495087,1.2010786252736643,0.32075471698113206,1.0,1.0,1/5,2.62%,UBQLN1
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),0.7432784054895285,1.2009070112217535,0.2391304347826087,1.0,1.0,2/7,11.79%,RANBP9;CLASP1
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),0.7144452072980929,1.2001781553583977,0.2826086956521739,1.0,1.0,1/7,3.53%,INVS
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),0.7068516853228679,1.1989674523244043,0.28888888888888886,1.0,1.0,2/8,6.39%,TET2;WDR82
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),-0.7872673514403805,-1.198881460802269,0.17391304347826086,0.8142897993476258,1.0,4/7,19.96%,NFKBIA;NFKB1;ITGAV;PTPN2
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),-0.6705446429584231,-1.1987818722544257,0.2807017543859649,0.8128783137930492,1.0,11/15,22.40%,RPS28;RPS15;RPS14;RPS19;RPL24;RPL11;NPM1;RPL10;RPS27;DHX29;RPL3
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),0.7123291720306697,1.1984815483571527,0.3181818181818182,1.0,1.0,2/7,13.55%,STIM1;CACNA1C
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",0.5060779520188613,1.1982784124580572,0.1702127659574468,1.0,1.0,8/42,15.32%,NOVA1;MBNL1;RBFOX1;KHDRBS3;NOVA2;REST;SFSWAP;CELF2
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),-0.7195907730621904,-1.1980874471502856,0.26229508196721313,0.8137001551026779,1.0,4/8,21.29%,CXCL12;LGALS3;PDGFB;PKD2
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.7661024298593692,1.1976799071293325,0.2222222222222222,1.0,1.0,1/5,2.67%,CDH2
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.6006633910517568,-1.1975139222828282,0.27941176470588236,0.8139369066390992,1.0,2/32,3.92%,VCAM1;NTNG1
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,-0.7930397069724124,-1.1971543604664823,0.2916666666666667,0.8133227201123063,1.0,1/5,8.33%,LCP2
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),0.5746320800214832,1.1969995021643451,0.25,1.0,1.0,1/17,1.06%,CALR
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),-0.6173231746069534,-1.1968822954216107,0.21739130434782608,0.8124628312695132,1.0,5/29,7.27%,CX3CL1;RREB1;FN1;CARMIL1;CASS4
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),-0.6050077181557835,-1.1961530125869495,0.3018867924528302,0.8131755029726185,1.0,8/32,17.32%,PPARG;PLK2;PLCG2;RPS19;RORA;PRKAR1A;OTULIN;RAMP3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),-0.6294458213080816,-1.1958596480780446,0.19642857142857142,0.8124636861276668,1.0,4/17,10.72%,ZIC1;SMAD3;TFRC;PARP9
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),0.7029799237647089,1.195495580101688,0.21153846153846154,1.0,1.0,1/7,2.28%,TRAM2
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.7015028907299172,-1.195473110423278,0.23728813559322035,0.8122893542874899,1.0,7/12,23.91%,PMAIP1;RPS15;RPS7;ATM;RPL23;DDX5;RPL37
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),0.7734136105336911,1.1951446706486082,0.2391304347826087,1.0,1.0,1/6,0.13%,TRIM5
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),0.7551413476478704,1.195003508395878,0.3111111111111111,1.0,1.0,1/6,3.06%,ZBTB1
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),-0.6755497988062331,-1.1947396847046332,0.25,0.8135314335121974,1.0,2/11,9.50%,SHLD1;TFRC
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.7294960286289627,1.1944335607939693,0.26666666666666666,1.0,1.0,7/9,24.82%,ZMYND11;CDK12;RNF168;WDR43;TCERG1;CDC73;BRD4
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),0.7137676014742239,1.1942433612691468,0.1875,1.0,1.0,2/8,9.22%,VAPB;CTDSP2
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),0.6740898334293249,1.194158521959032,0.28846153846153844,1.0,1.0,4/10,16.64%,PLEKHA1;PPP2R5C;PTEN;PHLPP1
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),-0.5834474324726042,-1.1940348336789575,0.23333333333333334,0.8147274614569381,1.0,4/36,8.39%,CYLD;ULK4;PRKN;MAP3K5
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),0.6570791473244373,1.1928248592143849,0.23809523809523808,1.0,1.0,5/13,21.05%,ABL1;PPM1F;NRP1;ROCK1;RAC1
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",-0.4678556200837628,-1.1921974241424456,0.08045977011494253,0.8193309340487782,1.0,37/334,11.24%,CD74;HES1;TBX3;CX3CL1;ZIC1;NR4A1;PPARG;STAT1;RREB1;MAP3K2;HMGN1;IRF2;IRF1;SP100;NLRC5;SMARCA1;PRKN;TNIP1;SERPINE1;SMAD3;MEF2A;FOXK1;MAML3;JUN;MAP3K5;CEBPZ;STAT5B;NFKBIA;AFAP1L2;LMO2;PAXBP1;BRD7;AHI1;PARP9;NFKB1;TBK1;ARHGEF11
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,-0.5746475312845365,-1.1916824193896993,0.16129032258064516,0.819449856178227,1.0,3/42,4.10%,TBX3;FN1;SMARCA1
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),0.7165767649422933,1.1914164244394558,0.35714285714285715,1.0,1.0,4/7,23.18%,MORC3;TAF3;PINK1;HK1
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.7253029038211666,-1.1913464449345694,0.25,0.8189374487666132,1.0,1/8,2.67%,PLCG2
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),0.7321871899286652,1.191233305227766,0.3023255813953488,1.0,1.0,4/7,23.18%,HECTD4;CHST15;GALK2;HK1
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",-0.742519351036686,-1.19111115302111,0.2916666666666667,0.8181225030721399,1.0,1/7,1.58%,RREB1
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),0.598530056807608,1.190946922764104,0.2608695652173913,1.0,1.0,6/14,16.51%,PRAG1;CBFA2T2;RTN4;EPHA4;NLGN1;PTEN
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),-0.7011929589299655,-1.1908906192459185,0.2459016393442623,0.8172298018118139,1.0,1/11,2.52%,TPM1
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),-0.6976106107069261,-1.1908715296267,0.2857142857142857,0.8156328128068029,1.0,2/10,8.62%,STAT1;STAT5B
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),0.7401113034658628,1.1908096167646107,0.2564102564102564,1.0,1.0,2/6,20.43%,DICER1;AGO2
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),0.7614755748955682,1.190559066659959,0.23076923076923078,1.0,1.0,1/5,4.72%,ZEB1
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),0.6354909750172678,1.1905156587073926,0.3125,1.0,1.0,3/16,12.44%,RBM20;HNRNPLL;SETX
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.7551015795790242,1.1897768163613935,0.21568627450980393,1.0,1.0,2/6,5.87%,SOX5;TRPS1
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),-0.4937700700108512,-1.189332644958291,0.1282051282051282,0.8196133590921226,1.0,28/149,14.17%,CD74;CX3CL1;DDX60;PLK2;APOL3;SHISA5;PLCG2;FN1;PRKN;TNFSF10;EIF2AK2;NR3C2;CASS4;ZDHHC17;JCAD;PMAIP1;TFRC;RPS15;TRIM25;LARS1;TBK1;BST2;CDH13;RHOA;NDFIP1;ITGAV;JAK2;RAPGEF2
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),0.7905547526040708,1.1886505478013338,0.2558139534883721,1.0,1.0,4/5,19.21%,TET2;UPP1;DPYSL2;DPYD
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),-0.7366574545270834,-1.1886458965474769,0.28,0.820475606711924,1.0,1/11,0.57%,DDX60
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),0.6812149615094182,1.188500818184953,0.28,1.0,1.0,5/7,31.23%,URI1;UBE3A;NR3C1;ATP1A1;YAP1
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.7169517795275558,-1.1882624831509203,0.3269230769230769,0.8201281588840061,1.0,1/9,0.65%,CYLD
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),-0.77595147433282,-1.188207455315627,0.2826086956521739,0.8185783175929632,1.0,3/5,18.64%,PRKN;MTMR2;MSN
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.5776172619095699,-1.1876950381154165,0.1791044776119403,0.8184563269270807,1.0,9/29,20.30%,ISG15;WARS1;LGALS3;TFRC;CLU;ATM;PSMC6;UNC13B;RACK1
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.7424183129109754,1.1875195800901253,0.2962962962962963,1.0,1.0,3/6,15.78%,CACNA1C;SLC8A1;RYR2
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,-0.6193641062140045,-1.1863589539044206,0.3392857142857143,0.8216919323182177,1.0,7/15,24.53%,GMPS;RFC3;MSH2;NPM1;ALPL;FUBP1;KDM1A
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.6988569194532781,1.1860167894652751,0.24444444444444444,1.0,1.0,2/10,9.53%,PRKD1;AMBRA1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),-0.6730762286368605,-1.1860048777494892,0.25,0.8214046598663937,1.0,1/18,0.36%,TBX3
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),0.7200442103564814,1.1857645273211315,0.32653061224489793,1.0,1.0,4/7,25.31%,DLGAP2;DLGAP1;ROCK2;DLGAP4
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),0.7192743920159471,1.1857274231041561,0.36585365853658536,1.0,1.0,1/7,2.78%,PRKD1
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),0.4930940724970996,1.185541685034356,0.1794871794871795,1.0,1.0,11/46,15.11%,SLC26A3;TAF1;HSP90B1;URI1;INSIG1;NCOA3;DIAPH1;ACTB;LRRK2;FES;ADCY2
prerank,PanglaoDB_Augmented_2021__T Cells,-0.6752122546255739,-1.185181969850159,0.3225806451612903,0.8224321327966364,1.0,5/16,19.83%,IL32;LCP2;RORA;IL18R1;MAFF
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),-0.6519250220856494,-1.1847549978523293,0.2222222222222222,0.822204120437973,1.0,3/18,6.78%,TPM1;SMAD3;DSP
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),-0.6137873808283493,-1.1845431269716264,0.19642857142857142,0.8213426507958276,1.0,1/21,0.65%,CYLD
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),-0.7814961813469252,-1.1844479384583402,0.2903225806451613,0.8199504171421965,1.0,2/7,9.71%,SERPINE1;ACER2
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),-0.4708479998275792,-1.184181503685252,0.12941176470588237,0.8192942756526286,1.0,27/264,11.11%,HES1;TBX3;CX3CL1;NR4A1;PPARG;STAT1;RREB1;IRF2;IRF1;NLRC5;SMARCA1;PRKN;TNIP1;SERPINE1;PLXND1;SMAD3;MEF2A;MAML3;JUN;CEBPZ;STAT5B;NFKBIA;LMO2;PAXBP1;AHI1;NFKB1;TBK1
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),0.7466600419677474,1.1839074697627956,0.30612244897959184,1.0,1.0,2/5,13.99%,SEMA3F;NRP1
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),0.7369839167186619,1.1837158307117006,0.28205128205128205,1.0,1.0,3/6,13.91%,NRXN1;LRRC7;NLGN1
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),0.5436155211403577,1.1834142681727873,0.24489795918367346,1.0,1.0,3/24,3.61%,HDAC9;PRKD1;HSPB1
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),0.7378893719324392,1.183397405937329,0.3,1.0,1.0,5/7,19.18%,ATP2A2;MICU3;CACNA1C;SLC8A1;MICU2
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),-0.7173845195282929,-1.1830373939008787,0.2692307692307692,0.8212419643330267,1.0,3/9,13.73%,LRPAP1;MTMR2;ITGAV
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,-0.6564759384052602,-1.182779399714319,0.3103448275862069,0.8204875263908996,1.0,1/16,0.26%,HES1
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.7360309915197251,-1.182533716218864,0.36538461538461536,0.8195593998835361,1.0,3/5,25.75%,JCAD;PPP1R16B;DLL4
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),0.7261708615913984,1.1823736002383278,0.375,1.0,1.0,2/6,15.37%,AGTPBP1;CEP290
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),0.5841152523294197,1.1818471208717483,0.22916666666666666,1.0,1.0,6/24,8.57%,INPP5F;PIK3CA;PLEKHA1;PITPNM2;PI4KA;PLCB1
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),-0.7121968728905578,-1.1813895620351618,0.3,0.8217889410618421,1.0,6/10,25.70%,PABPC1;PARN;DHX36;FUS;TENT2;LARP1
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.7493743984068431,1.1811674777601155,0.3018867924528302,1.0,1.0,1/5,1.61%,SOX5
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),0.7736407337914027,1.1809583319754493,0.2826086956521739,1.0,1.0,1/5,2.67%,CDH2
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),0.7480501418836379,1.1807418730706436,0.2619047619047619,1.0,1.0,2/5,20.43%,DICER1;AGO2
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),0.45427079744733234,1.1802508107465692,0.2222222222222222,1.0,1.0,6/48,7.14%,BTBD10;GRM5;HSPB1;CCDC88A;NUP58;RANBP2
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),-0.7786481588390031,-1.1800868982366457,0.2826086956521739,0.82463539587927,1.0,1/5,1.66%,ABCA5
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),0.6610094730821092,1.1800602869226435,0.30434782608695654,1.0,1.0,2/9,7.89%,BAG3;HSP90AA1
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),-0.7697512932099928,-1.1797237915885852,0.28,0.8241143849617772,1.0,1/5,0.36%,TBX3
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.6640811758734084,-1.179374278122425,0.25,0.8236927862690318,1.0,1/10,1.84%,HMGN1
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),0.7208530916578377,1.1792485658765683,0.2711864406779661,1.0,1.0,2/8,11.81%,WAPL;YLPM1
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),-0.7490959736315173,-1.1792477423046166,0.24489795918367346,0.8225536459034617,1.0,1/10,1.79%,RIMS1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.6611905959921418,-1.1789681105322587,0.288135593220339,0.8205209801850578,1.0,6/17,13.94%,IFIH1;PLCG2;OAS3;HLA-E;CLU;JAK2
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),-0.6611905959921418,-1.1789681105322587,0.288135593220339,0.8205209801850578,1.0,6/17,13.94%,IFIH1;PLCG2;OAS3;HLA-E;CLU;JAK2
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),-0.8033594553080445,-1.178504222805029,0.22641509433962265,0.8204574534566464,1.0,3/6,18.90%,SEC23A;RAB1A;SEC24D
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),-0.6934354094434072,-1.1779731923690067,0.3125,0.8208377747451429,1.0,3/12,13.47%,ABCA5;LIMA1;CLU
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),-0.7461455729220353,-1.1768422089389117,0.20833333333333334,0.8230068609950445,1.0,2/6,4.75%,ATP9A;PRKN
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.8339397196754742,1.176272629673895,0.2,1.0,1.0,3/5,14.04%,PIK3CA;NRP1;FOXC1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.6872119613160642,1.1762285191496926,0.2391304347826087,1.0,1.0,5/8,19.70%,ANK2;VMP1;RYR2;CALM1;AKAP6
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),-0.7047176609038186,-1.1758391166407491,0.29508196721311475,0.8248601848332808,1.0,2/11,4.75%,CYLD;PRKN
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),-0.6604355210604563,-1.1752577816145586,0.21153846153846154,0.8254024272213584,1.0,4/16,13.24%,SERPINE1;VIM;NFKB1;RHOA
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),-0.5376216802953934,-1.1750868429228793,0.22580645161290322,0.8244306088165361,1.0,15/70,12.59%,CD74;ISG15;IFIH1;IRF1;PLCG2;EIF2AK2;SERPINE1;AFAP1L2;NFKB1;LRRFIP1;TBK1;HLA-A;HLA-E;SULF2;RORA
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),0.7352162587928547,1.1734405293787387,0.391304347826087,1.0,1.0,1/7,0.05%,PDK4
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),-0.5155065947311329,-1.1730768814915151,0.22857142857142856,0.8298426864350038,1.0,14/109,15.65%,CD74;PPARG;OPTN;SNX6;ATP6V1E1;ZDHHC17;TFRC;USO1;COPA;ARL4A;CLU;TBC1D1;STX17;RAB1A
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),0.5767218953292519,1.172881213559311,0.28888888888888886,1.0,1.0,8/31,11.73%,SLC26A3;SLC38A9;TAF1;HSP90B1;CPEB3;CAPN2;DIAPH1;ACTB
prerank,GO_Biological_Process_2021__action potential (GO:0001508),-0.731336488650859,-1.1723666471031806,0.2631578947368421,0.8309061337556897,1.0,4/8,12.07%,SCN3A;SCN2A;DMD;GNA14
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.762708439573988,-1.1723238975527723,0.35714285714285715,0.8294726702553491,1.0,1/6,1.35%,PPARG
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),-0.7230640657073052,-1.1717708470827009,0.32653061224489793,0.8295641201317183,1.0,1/7,5.32%,EIF2AK2
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),0.649675117533905,1.171429625385803,0.3,1.0,1.0,5/8,32.14%,SMAD5;SMAD1;ADAMTS9;AKAP13;BMPR2
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),-0.7493502997804883,-1.171117702079644,0.2826086956521739,0.8300533203058771,1.0,3/8,13.73%,PPARG;NFKBIA;ITGAV
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),-0.6282974201441588,-1.170757775118106,0.29411764705882354,0.8294810836348963,1.0,3/14,13.24%,RHOBTB1;FMNL3;RHOA
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),0.8001227403729063,1.1703366000753592,0.40816326530612246,1.0,1.0,3/5,15.91%,SEMA3F;NRP1;UNC5C
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),0.6518332646766005,1.169784804869492,0.30434782608695654,1.0,1.0,3/12,8.41%,HSPB1;TRAK2;TRAK1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),-0.7938029678589049,-1.1696552937149565,0.2765957446808511,0.8320648498370516,1.0,1/8,1.35%,PPARG
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.77910223184991,-1.1695820784297537,0.32142857142857145,0.8307369924589342,1.0,1/5,3.32%,SNX6
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),0.7782725039693064,1.1695199189971677,0.2653061224489796,1.0,1.0,1/5,2.41%,CHD7
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),0.7727444633080419,1.1694803069011221,0.32727272727272727,1.0,1.0,3/5,17.50%,STIM1;RYR2;CALM1
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),-0.5191053140175226,-1.1683758265237207,0.2714285714285714,0.8332898249843433,1.0,4/106,2.67%,CD74;CX3CL1;CEMIP;PLCG2
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),-0.739149552420742,-1.1681837382625446,0.29545454545454547,0.8323965685683603,1.0,1/5,0.26%,HES1
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),0.5775526029191789,1.1677516233939387,0.26,1.0,1.0,4/17,6.80%,FUT8;MCFD2;MGAT5;STT3B
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),-0.6540614914538206,-1.1676924877156472,0.25,0.8323313731307731,1.0,1/10,4.47%,CNOT8
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),0.6005191031843904,1.1674597121641506,0.2857142857142857,1.0,1.0,7/16,15.76%,UBQLN1;PACS2;ATP2A2;AMBRA1;ATG2B;VMP1;RAB7A
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.7457688633977957,-1.1669559279041242,0.3333333333333333,0.8335946961164932,1.0,2/6,13.47%,CXCL12;CLU
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),0.6879472257310557,1.1665498607143923,0.3409090909090909,1.0,1.0,5/10,21.05%,ABL1;PPM1F;NRP1;ROCK1;RAC1
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),0.556783942306247,1.1661344143284742,0.2391304347826087,1.0,1.0,2/17,4.88%,ARHGEF4;CCDC88A
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),-0.6304076938473172,-1.1659768282843148,0.23214285714285715,0.8354508250803732,1.0,3/27,10.85%,NR4A1;CEP57;POLR2A
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),-0.7632322476644717,-1.1658982107133393,0.2549019607843137,0.8340569780559692,1.0,2/10,4.75%,CX3CL1;PRKN
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.757237505544802,-1.1655472278593335,0.35294117647058826,0.8335240870700312,1.0,1/5,2.49%,RNF213
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),-0.6153566282256497,-1.1654880616290597,0.2903225806451613,0.8320647443329099,1.0,4/21,13.24%,CX3CL1;PLXND1;CAPRIN1;RHOA
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),0.7693495197124156,1.1649174679559506,0.3191489361702128,1.0,1.0,1/6,1.53%,MT2A
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),0.6816050073868741,1.1647798636019218,0.30434782608695654,1.0,1.0,5/9,29.44%,ANO6;WNK1;AKAP6;NEDD4L;YWHAE
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),-0.4713420289276199,-1.1647369445958538,0.23684210526315788,0.8330944114162201,1.0,29/147,15.55%,BTG2;NR4A1;LRPAP1;IRF1;SOD2;SP100;PRKN;EIF2AK2;PLXND1;SMAD3;WARS1;UBR2;COL18A1;APPL2;ACTN1;BRD7;ADAMTS1;GNG4;CDA;BST2;CDH13;CLU;SMYD2;JAK2;RAPGEF2;SMARCA2;NPAS2;FTH1;PDS5B
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),0.5344691675374237,1.1643537566418725,0.21621621621621623,1.0,1.0,4/29,7.87%,ABL2;PRAG1;BCR;ABL1
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),-0.6675307694139264,-1.1642244832481086,0.3090909090909091,0.8330657676300419,1.0,1/13,1.35%,PPARG
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),0.8168934638699875,1.1636737268299913,0.22,1.0,1.0,1/5,0.13%,TRIM5
prerank,PanglaoDB_Augmented_2021__Myoblasts,-0.5854860664385877,-1.163626647159479,0.234375,0.833425006888239,1.0,3/33,3.58%,TBX3;TPM1;FN1
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),-0.7270270848726077,-1.163380455862123,0.3333333333333333,0.8326954633037406,1.0,2/7,14.07%,NTNG1;MFSD2A
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),-0.6591787595268004,-1.1626549291504127,0.3220338983050847,0.8332932267734187,1.0,2/10,6.67%,ZIC1;SMAD3
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,0.6955180309861297,1.1622621860236177,0.3023255813953488,1.0,1.0,2/8,2.83%,BCL6;IL6R
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",0.622312718917825,1.1621641163988659,0.28888888888888886,1.0,1.0,3/13,14.36%,AEBP2;DNMT3A;PPHLN1
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),0.4124572457578253,1.1620545940644675,0.041666666666666664,1.0,1.0,24/152,14.54%,PDK4;PRKD1;MAPK10;TAF1;PRKG1;PRAG1;MORC3;BCR;IGFBP3;STK38L;PIK3CA;PI4KA;ABL1;PXK;YWHAZ;NLK;PRKCA;OXSR1;LRRK2;PPP3CB;WNK1;RPS6KA5;DGKI;ADAM10
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),0.7633633555368913,1.16170981742006,0.3125,1.0,1.0,3/5,23.60%,STARD4;ABCG1;ABCA1
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),-0.6387671536743327,-1.1610169404080373,0.21153846153846154,0.8368085929266282,1.0,7/15,13.84%,ISG15;RFC3;TRIM25;PRIMPOL;NPLOC4;RFC1;UBC
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),0.6891984682808517,1.1610038036426586,0.25,1.0,1.0,3/6,19.94%,ANXA2;RALB;RAB3GAP2
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),-0.6426705261893518,-1.1607117055538405,0.2608695652173913,0.8363884592158736,1.0,2/19,1.04%,CX3CL1;GBP1
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),0.7474057310238709,1.1604520496999144,0.3157894736842105,1.0,1.0,2/5,13.24%,CDH2;PLEKHA7
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),-0.7274944297816798,-1.160235891115397,0.37254901960784315,0.8364638636124484,1.0,1/5,3.95%,LYPLA1
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),-0.5639666503932037,-1.1602328524201997,0.22950819672131148,0.8349318785142572,1.0,3/38,1.01%,TBX3;TLL1;KIAA1217
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.7208827794971668,-1.1601239547194118,0.3225806451612903,0.8336971630492482,1.0,2/10,6.78%,TPM1;DSP
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),0.6659204202343126,1.1593933789070705,0.2653061224489796,1.0,1.0,4/7,30.48%,DIAPH1;ANK2;FYN;PRNP
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),0.6960155569114703,1.1592086546002824,0.33962264150943394,1.0,1.0,4/6,25.75%,ANK2;ANK3;AKAP6;KCNMB4
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,0.49290057970382356,1.1591821589193412,0.14285714285714285,1.0,1.0,16/39,15.91%,NOVA1;ERBB4;SNAP25;MAPK10;GRIA2;FGF12;NRXN1;RNF180;GAREM1;CNTN1;PXK;FGF14;ADGRL2;ANK2;THSD7A;UNC5C
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),0.7281528707764126,1.1584880029131273,0.2641509433962264,1.0,1.0,2/6,12.59%,GSN;ANO6
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),0.7062646537653905,1.1580716304840828,0.3953488372093023,1.0,1.0,3/9,18.17%,MAP4;CLASP1;CDK5RAP2
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),0.7372472856464213,1.1578914385045593,0.2857142857142857,1.0,1.0,2/5,19.34%,ABL1;DYRK1A
prerank,PanglaoDB_Augmented_2021__Schwann Cells,0.5536672366906359,1.1576057107757127,0.2564102564102564,1.0,1.0,5/27,10.83%,BAG3;GRIA2;NTM;RBFOX1;PDZRN3
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),-0.7318961096714114,-1.1574475175543555,0.32653061224489793,0.8412556213577854,1.0,3/7,14.49%,MAP3K5;TAOK3;MAP3K4
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),-0.5927697496674403,-1.157444073695667,0.28,0.8397414424617733,1.0,1/36,0.13%,RSAD2
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.7805817417463365,-1.1569859609212154,0.39622641509433965,0.8382497149763493,1.0,1/5,0.47%,PARP14
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.7805817417463365,-1.1569859609212154,0.39622641509433965,0.8382497149763493,1.0,1/5,0.47%,PARP14
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),-0.6943832560881004,-1.1564068811816395,0.2711864406779661,0.8385194969007903,1.0,3/10,12.72%,PRKN;B2M;IREB2
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),-0.6892828513919542,-1.1562577070574345,0.38,0.8374179107785186,1.0,3/10,3.40%,PPARG;TPM1;SOD2
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),-0.48695678204997306,-1.1557797826775233,0.2318840579710145,0.8374182362564643,1.0,9/129,4.75%,CD74;TBX3;CX3CL1;KLHL20;PLK2;RNF213;SNX6;SOD2;PRKN
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,-0.6193223222007096,-1.1555047621345538,0.288135593220339,0.8366639675655163,1.0,1/24,0.44%,CX3CL1
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,-0.5666260009732151,-1.1549188089662665,0.2857142857142857,0.8370243316067718,1.0,5/38,8.23%,TBX3;ITGB5;CXCL12;COL18A1;CST3
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),-0.7247230370383,-1.154654202362608,0.38461538461538464,0.836362988372318,1.0,4/6,18.98%,GBP4;HLA-A;HLA-E;GBP2
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),-0.6764406537953961,-1.1545830673973196,0.38596491228070173,0.8349892193109519,1.0,3/14,4.75%,SNX6;SOD2;PRKN
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),-0.7054948273550676,-1.1544287178118,0.2826086956521739,0.8339949620465678,1.0,1/12,1.35%,PPARG
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.6133811746000053,1.1541265854019196,0.25,1.0,1.0,5/19,8.57%,INPP5F;PIK3CA;PITPNM2;PI4KA;PLCB1
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),0.6859473142777859,1.1537534032318748,0.3333333333333333,1.0,1.0,5/9,14.54%,AHCTF1;RTN4;ANO6;PLEKHA7;ADAM10
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.697397104650529,1.1532390643353014,0.3050847457627119,1.0,1.0,2/7,7.37%,DSE;CHSY1
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),0.6776005810588305,1.1525878841767523,0.32558139534883723,1.0,1.0,3/9,18.54%,RANBP9;CLASP1;ZNF207
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),-0.5547347377203449,-1.1523854564877605,0.3275862068965517,0.8388802636609123,1.0,6/50,14.17%,CX3CL1;RGS6;LARS1;NET1;RHOA;RAPGEF2
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),0.6098967724185734,1.1517677660419163,0.24324324324324326,1.0,1.0,2/12,15.37%,PCM1;CEP290
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),0.6975052980900918,1.1508575541995698,0.34210526315789475,1.0,1.0,5/10,25.75%,ANO6;WNK1;ANK2;AKAP6;KCNMB4
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),-0.7072289910387085,-1.150409983306804,0.2708333333333333,0.8438014719046913,1.0,4/9,13.84%,RFC3;PRIMPOL;RFC1;UBC
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,0.660402099527783,1.1501890083798592,0.24489795918367346,1.0,1.0,1/13,0.26%,AFF3
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),0.7322606096640968,1.150168810433994,0.32558139534883723,1.0,1.0,2/6,5.87%,SOX5;TRPS1
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),-0.78183994721915,-1.1495823167550565,0.34,0.8450501670691106,1.0,1/5,1.01%,KIAA1217
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),-0.6293113819055843,-1.1491667169659832,0.31666666666666665,0.8448243964991738,1.0,2/24,2.67%,VCAM1;PLCG2
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),-0.4811356336619025,-1.1489426744550053,0.2222222222222222,0.8439629537183195,1.0,19/152,11.24%,CD74;HES1;ZIC1;PPARG;STAT1;RREB1;MAP3K2;IRF1;SP100;SMARCA1;SMAD3;FOXK1;JUN;MAP3K5;AFAP1L2;BRD7;PARP9;NFKB1;ARHGEF11
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),0.6616107899692094,1.1486288555066244,0.32653061224489793,1.0,1.0,2/8,13.76%,BAG3;XPO4
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),0.6876359416311467,1.1471458671426322,0.3,1.0,1.0,1/6,1.51%,RARB
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),-0.6488468740724382,-1.1471412861312325,0.3103448275862069,0.8480990882703946,1.0,3/13,6.67%,BTG2;PLK2;SMAD3
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),0.5254808523104595,1.1466729436858283,0.2564102564102564,1.0,1.0,9/32,15.68%,FUT8;TET2;MGAT5;STT3B;TRAK1;ST8SIA4;GCNT2;GALNT10;GALNT2
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,-0.6143898849566942,-1.1461996328935227,0.3384615384615385,0.8495956256869053,1.0,5/20,11.55%,TPM1;LAMA4;CXCL12;ADAMTS1;NID1
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),-0.6327419852198571,-1.1461927230044606,0.2653061224489796,0.8481499794728922,1.0,3/18,6.02%,NR4A1;STAT1;PLXND1
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),-0.5985888584881552,-1.1461128688111815,0.2835820895522388,0.8469727529844692,1.0,2/17,10.72%,SHLD1;PARP9
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),0.6919670623986814,1.1455841659663366,0.27906976744186046,1.0,1.0,1/7,7.32%,SMAD6
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),-0.5392616929448897,-1.1455157423731177,0.2028985507246377,0.8475696330077142,1.0,4/52,5.32%,CD74;CX3CL1;PLCG2;EIF2AK2
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),0.7357382508381817,1.1454548576036427,0.2857142857142857,1.0,1.0,1/7,1.17%,CRY1
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),-0.7338927058986062,-1.1449431727843917,0.3673469387755102,0.848041962834158,1.0,2/6,10.72%,STAT1;PARP9
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),-0.7797532798278741,-1.1448968767749512,0.32608695652173914,0.8466964799913261,1.0,1/6,5.56%,SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),-0.4710880743682567,-1.1445605891288242,0.22388059701492538,0.8460181377930353,1.0,7/112,6.70%,CD74;RIMS1;PLCG2;FN1;PRKN;SMAD3;WARS1
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),0.7103979554413267,1.1442812267010778,0.32075471698113206,1.0,1.0,2/5,11.66%,AHCTF1;RTN4
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),0.6348183113492807,1.1436320791841708,0.3333333333333333,1.0,1.0,3/10,15.78%,LRRK2;ANK2;RYR2
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.7187741327671179,1.1434678325621792,0.35714285714285715,1.0,1.0,4/6,20.38%,EXT1;GLCE;HS6ST3;NDST1
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),-0.610290168742754,-1.1428620558588547,0.32,0.8491880289808117,1.0,4/21,13.47%,LRPAP1;SERPINE1;B2M;CLU
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),0.7260841571282146,1.142677431481892,0.4186046511627907,1.0,1.0,2/5,14.20%,DICER1;PARD3
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),-0.8260286479391638,-1.1425198676297827,0.2962962962962963,0.8488551454660573,1.0,2/5,8.59%,DSP;VIM
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),0.6999126306763062,1.1409771153820918,0.3488372093023256,1.0,1.0,4/8,23.62%,PTBP3;SHQ1;NCOR2;PTBP2
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),-0.7503673659202738,-1.1402906458823856,0.3617021276595745,0.8541074079774105,1.0,1/6,6.07%,YTHDC1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.6932710795686835,-1.1390670590097214,0.3148148148148148,0.8560695653975585,1.0,5/13,11.29%,PPARG;TPM1;SOD2;JUN;ADAMTS1
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.7124735201421963,1.1386475363145303,0.3541666666666667,1.0,1.0,3/6,20.64%,RTN4;ATL2;RTN3
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.7015802451954871,1.1380439005761616,0.36363636363636365,1.0,1.0,2/7,9.53%,PRKD1;AMBRA1
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.5815135200526502,-1.1379644299959575,0.30612244897959184,0.8579385142352526,1.0,1/25,0.65%,CYLD
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),-0.5035358926271346,-1.1375388259720798,0.265625,0.8578343171444858,1.0,7/71,10.62%,CX3CL1;ARHGAP15;VAV3;PLXND1;RGS6;LARS1;NET1
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),-0.5272121023649182,-1.1372972986404841,0.3157894736842105,0.8571966049644613,1.0,8/63,10.57%,CYLD;STAT1;TMSB4X;TNIP1;UBR2;DGKG;TANK;CD2AP
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),0.5821764844658059,1.137275516700837,0.28,1.0,1.0,3/14,4.85%,ERBB4;SEMA3F;PHACTR4
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),0.6702089872602466,1.1369051896688354,0.32608695652173914,1.0,1.0,3/10,9.97%,GULP1;GSN;ELMO1
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),0.6999541282369328,1.1364576971313542,0.32653061224489793,1.0,1.0,6/8,29.88%,GSN;PARVA;RAC1;CYFIP1;CDC42;NCKAP1
prerank,PanglaoDB_Augmented_2021__Podocytes,-0.5044301476074692,-1.1347427811308255,0.25,0.8636958057412077,1.0,9/88,10.57%,KIAA1217;OPTN;ITGB5;CLIC5;TPM1;SMARCA1;LIMCH1;CTNNAL1;CD2AP
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),-0.6641860521097345,-1.1342070883665931,0.3448275862068966,0.8627494732107631,1.0,2/9,6.67%,ZIC1;SMAD3
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),-0.6641860521097345,-1.1342070883665931,0.3448275862068966,0.8627494732107631,1.0,2/9,6.67%,ZIC1;SMAD3
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),0.687505244019053,1.1339231949967645,0.4,1.0,1.0,2/6,13.53%,GCNT2;WNK1
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),-0.6694585419572462,-1.1334844257122092,0.37037037037037035,0.8636983417944415,1.0,3/8,9.45%,TPM1;CARMIL1;LIMA1
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,-0.5352867732584945,-1.1334785779377865,0.29508196721311475,0.8622364806054905,1.0,5/23,15.76%,ATP9A;MAP2;MAPKAP1;HOMER2;KLHL5
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),-0.6352557114004407,-1.1328362646790249,0.3469387755102041,0.8613015883146249,1.0,2/17,10.85%,MLLT1;POLR2A
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",-0.6352557114004407,-1.1328362646790249,0.3469387755102041,0.8613015883146249,1.0,2/17,10.85%,MLLT1;POLR2A
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),0.6721904590996479,1.1319974296530775,0.4,1.0,1.0,3/8,15.03%,PKM;CPEB3;CPEB4
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),0.4474887376906392,1.131806836089391,0.23076923076923078,1.0,1.0,15/65,24.66%,PACS2;TTC7A;MAP7;NRXN1;LRRC7;DPP10;NLGN1;ANK2;ANK3;CD81;ROCK1;DPP6;SMURF1;ROCK2;RFTN1
prerank,MSigDB_Hallmark_2020__Allograft Rejection,-0.5648581776842838,-1.1316959429893163,0.25757575757575757,0.8629259402176344,1.0,13/39,13.94%,CD74;STAT1;TAP1;WARS1;LCP2;B2M;IFNGR2;HLA-A;RPS19;CD47;HLA-E;GCNT1;JAK2
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),0.7115318977585636,1.1310398232742365,0.33962264150943394,1.0,1.0,1/5,7.19%,URI1
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),-0.7074942898385315,-1.1299472525547052,0.40425531914893614,0.8669019535685144,1.0,3/6,26.06%,SENP6;ATG7;ATG10
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.5792815626581238,1.129861106622703,0.3333333333333333,1.0,1.0,7/18,20.53%,PLCB1;NLK;PPP3CA;PPP3CB;CALM1;AGO2;FZD4
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),-0.7002429624790647,-1.1283622084963467,0.30158730158730157,0.8698317735730821,1.0,2/9,13.53%,VPS36;STAM2
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,-0.6173330087649193,-1.1280454209073543,0.4,0.8692701197232057,1.0,3/16,3.58%,LAMA4;CXCL12;FN1
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),0.6770752153419414,1.1270541611311455,0.4090909090909091,1.0,1.0,2/9,11.09%,FGF12;ATP2B4
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),0.7593352578694982,1.1268904258958703,0.3541666666666667,1.0,1.0,1/5,0.62%,PNP
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.7067851564829117,-1.1266719975066646,0.35714285714285715,0.8720847853270176,1.0,1/8,3.32%,SNX6
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),-0.6983439452424905,-1.126651732822868,0.4423076923076923,0.8706453563229083,1.0,5/11,14.85%,SOD2;SAMHD1;B2M;APPL2;CBR4
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),0.5747803014417158,1.1265963259793137,0.39473684210526316,1.0,1.0,4/15,24.14%,ANXA1;PCSK5;ABCA1;CANX
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),0.6885428077703736,1.1265256110018458,0.4583333333333333,1.0,1.0,1/5,4.34%,UGCG
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),-0.6307149746861113,-1.1265094724562308,0.2727272727272727,0.869698422553159,1.0,2/20,4.80%,CX3CL1;CARMIL1
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.7319464792210568,-1.1264943025309957,0.3181818181818182,0.8682510706758763,1.0,1/8,1.35%,PPARG
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),0.7509877447945682,1.1264846194725069,0.3409090909090909,1.0,1.0,4/5,24.82%,CDK12;TCERG1;CDC73;BRD4
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),0.6941482444733418,1.1261548484050121,0.35185185185185186,1.0,1.0,7/7,30.71%,ACTG1;ROCK1;RAC1;ROCK2;CDC42;AKAP13;ALMS1
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),-0.6307130716977601,-1.1260846352263674,0.3148148148148148,0.8680990012812574,1.0,2/16,8.67%,PPARG;ACSL4
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),-0.6515101279567832,-1.1260432615498497,0.3541666666666667,0.8667093815304306,1.0,2/12,2.67%,VCAM1;PLCG2
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),-0.6412632647108594,-1.1258311076287248,0.35,0.8657586827731175,1.0,1/14,1.45%,OPTN
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),0.4676807368075044,1.1256288873124152,0.2647058823529412,1.0,1.0,21/53,25.23%,BTRC;PPP4R2;DUSP6;PPM1F;CTDSP2;CDC14B;PPP1CB;PPP3CA;PPP2R5C;PPP3CB;PPP2CB;PTEN;PLPPR4;PTPN21;MTMR3;PTPN1;PPP6C;PPP2R5E;CTTNBP2NL;PPM1A;PPP4R1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),-0.761966693080578,-1.1255494298440882,0.375,0.8651113063093886,1.0,1/5,2.67%,PLCG2
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,-0.5692804553720612,-1.1253851712733407,0.3561643835616438,0.8642996237996763,1.0,9/46,15.91%,SLC22A5;CXCL12;PRSS23;ELOVL5;COX6C;JAK2;HOMER2;FLNB;FOS
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),0.6674908401900541,1.125329533899722,0.35294117647058826,1.0,1.0,2/8,9.09%,MBNL1;REST
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),0.6681849462470919,1.125175946507107,0.33962264150943394,1.0,1.0,3/8,11.73%,ACTG1;HSPB1;ACTB
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),-0.7624100974650828,-1.1250544216116396,0.375,0.863972598258275,1.0,2/5,9.97%,TNIP1;TANK
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),-0.652616369322721,-1.1242827956224275,0.4222222222222222,0.8650403352404072,1.0,5/9,30.66%,ELOVL5;MFSD2A;ZBTB20;LPGAT1;MTOR
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),-0.720418351212456,-1.1242102975091723,0.34615384615384615,0.8638849757576184,1.0,1/8,5.63%,AGPAT3
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),0.7790486093059525,1.1241840371848633,0.33962264150943394,1.0,1.0,5/5,22.20%,PSEN1;ADAM10;DYRK1A;ADAM17;ABCG1
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.5480211569564537,-1.1232841348931533,0.3230769230769231,0.8650319982882944,1.0,3/29,3.87%,EML1;PLK2;SPC25
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),-0.47447396141360204,-1.1228898332938577,0.25,0.864788470702047,1.0,37/123,20.15%,RPL31;TNIP1;RPS18;RPS12;RPL15;YTHDC1;WARS1;MEF2A;RPS8;RPS28;RPL7A;RPS6;RPL38;RPS15;RPL30;RPS14;RPL34;POLR2A;RPS19;PTMA;RPS7;SRRM1;POM121C;RPL24;SRSF5;NUP54;RPL11;GSPT1;RPL23;RPL41;NUP98;RPL36;RPL10;RPS27;RPL9;RPL27A;EEF1A1
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.7292114128017984,1.122521357051652,0.3695652173913043,1.0,1.0,1/5,2.54%,BACH2
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),0.750418541585166,1.1224493036535947,0.3404255319148936,1.0,1.0,2/5,13.99%,SEMA3F;NRP1
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),-0.5498895774894267,-1.1220711190550061,0.25,0.8659796530382365,1.0,2/20,4.80%,RREB1;CARMIL1
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),-0.6097142329898924,-1.1220045581404199,0.3877551020408163,0.8647316428548708,1.0,2/15,2.67%,VCAM1;PLCG2
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),0.6652713722644099,1.1212006348960712,0.3541666666666667,1.0,1.0,2/7,20.43%,DICER1;AGO2
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.47761288133364227,1.121133615615587,0.275,1.0,1.0,9/54,17.68%,NOVA1;FASTKD1;HNRNPR;DICER1;SETX;SND1;CELF2;RBPMS;MTREX
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),-0.7975165201754706,-1.1206161587860417,0.39215686274509803,0.8677095762205731,1.0,2/5,5.56%,CXCL12;SERPINE1
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.688936029754565,-1.1204397406100246,0.2857142857142857,0.8667088311834107,1.0,2/10,6.18%,BTG2;PABPC1
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.7403049372237559,1.1204097867090388,0.423728813559322,1.0,1.0,1/5,0.36%,HDAC9
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.6544419098131433,1.1199888059739789,0.3111111111111111,1.0,1.0,1/8,2.93%,BAG3
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),-0.6956591088760867,-1.1195903754496788,0.3333333333333333,0.867741675659419,1.0,1/10,0.21%,VCAM1
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,-0.7059884574451716,-1.1194961967069874,0.35714285714285715,0.8665806934356403,1.0,3/9,12.02%,MAP3K2;LCP2;BST2
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,-0.5474213414473561,-1.1193715192181086,0.2857142857142857,0.8655377501915302,1.0,4/30,3.58%,PPARG;LAMA4;CXCL12;FN1
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),0.6801638890043589,1.118698724858063,0.34,1.0,1.0,2/7,11.06%,CRY1;PPP1CB
prerank,PanglaoDB_Augmented_2021__Adipocytes,-0.5657259349471191,-1.1186277266116034,0.25806451612903225,0.8664696863389125,1.0,3/35,3.48%,EPSTI1;PPARG;CXCL12
prerank,MSigDB_Hallmark_2020__Angiogenesis,-0.6453649295518241,-1.1183264030205995,0.3684210526315789,0.8660484565965589,1.0,1/9,0.86%,LRPAP1
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),-0.47461144172529857,-1.118314869697339,0.26666666666666666,0.8646379542242519,1.0,23/128,13.94%,VCAM1;CX3CL1;GBP1;STAT1;IRF1;CXCL12;FN1;GBP4;IL32;SMAD3;STK39;VIM;STAT5B;TANK;NFKB1;TBK1;IFNGR2;CD47;RORA;INPP5D;RHOA;UBC;JAK2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.7594950763429086,-1.1180808624904912,0.40816326530612246,0.8638967993480061,1.0,3/6,13.84%,RFC3;RFC1;UBC
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.738450997542855,-1.117675270169363,0.4107142857142857,0.8635789219123098,1.0,1/7,0.47%,PARP14
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),0.4522538681721052,1.1174555946957632,0.2962962962962963,1.0,1.0,13/52,24.33%,PACS2;TTC7A;CCDC88A;MAP7;DPP10;ANK2;ANK3;NECTIN3;CD81;ROCK1;DPP6;SMURF1;ROCK2
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),0.4687158176695971,1.1168857006798671,0.3333333333333333,1.0,1.0,18/65,20.12%,CALR;BAG3;TAF1;MORC3;UBE2B;HSP90AA1;NLK;HSPD1;RTN4;PARVA;EPHA4;ATF7IP;ANK2;PTEN;EP300;ZNF207;USP9X;PINK1
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),0.6237625322480317,1.11688267625575,0.40816326530612246,1.0,1.0,1/10,1.92%,SLC26A3
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.5819396850942156,1.116116005495544,0.2926829268292683,1.0,1.0,1/17,0.36%,HDAC9
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.7618775570060672,-1.1158987521132708,0.375,0.8674801256736594,1.0,2/7,12.23%,CD2AP;MAPKAP1
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),0.718380366739403,1.1151584363100864,0.4,1.0,1.0,1/8,1.53%,MT2A
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),0.6942698828972359,1.114860290476462,0.41304347826086957,1.0,1.0,3/6,19.86%,PHACTR4;SKI;DEAF1
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),0.6942698828972359,1.114860290476462,0.41304347826086957,1.0,1.0,3/6,19.86%,PHACTR4;SKI;DEAF1
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),0.6942698828972359,1.114860290476462,0.41304347826086957,1.0,1.0,3/6,19.86%,PHACTR4;SKI;DEAF1
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),0.4591740467771458,1.1145397011037985,0.17647058823529413,1.0,1.0,22/60,25.23%,BTRC;PPP4R2;DUSP6;PPM1F;CTDSP2;CDC14B;PPP1CB;PPP3CA;PPP2R5C;PPP3CB;PPP2R2B;PPP2CB;PTEN;PTPN21;MTMR3;RPAP2;PTPN1;PPP6C;PPP2R5E;CTTNBP2NL;PPM1A;PPP4R1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),-0.6702008319016779,-1.1140690217414833,0.3620689655172414,0.8720463726474,1.0,2/14,4.02%,PPARG;SP100
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),0.7028515494111742,1.1140170735361212,0.425531914893617,1.0,1.0,1/5,7.66%,ANXA2
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),-0.7628537973644922,-1.113870702766765,0.4117647058823529,0.8712819298771877,1.0,3/5,19.42%,RAPGEF2;RIN2;CD34
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),-0.523277404740567,-1.1124517828401979,0.2727272727272727,0.8739134481664739,1.0,1/65,0.18%,CD74
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),0.7341670806786468,1.1119434523311196,0.37037037037037035,1.0,1.0,3/5,20.43%,PLCB1;SMURF2;AGO2
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),0.558527199067717,1.1114312206467696,0.3191489361702128,1.0,1.0,8/22,21.75%,MT2A;ITPR3;HOMER1;PPP3CA;PPP2CB;CALM1;TRPC1;PAM
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,-0.5319886772867585,-1.1113116901711826,0.3384615384615385,0.8756212413976825,1.0,3/46,5.40%,CX3CL1;CXCL12;MMRN2
prerank,MSigDB_Hallmark_2020__DNA Repair,0.5185915129579555,1.1112580560009666,0.325,1.0,1.0,4/23,10.88%,PNP;RALA;AK3;SMAD5
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.7328707934922951,-1.1112068686493717,0.41304347826086957,0.8745341142393951,1.0,1/6,1.51%,IFIH1
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),-0.7194538302141287,-1.1108220376277922,0.32,0.8743467833433181,1.0,3/6,20.07%,MTERF4;ZC3H13;WTAP
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),0.5337857349906712,1.110799562466395,0.2972972972972973,1.0,1.0,7/19,15.76%,UBQLN1;PACS2;ATP2A2;AMBRA1;ATG2B;VMP1;RAB7A
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),0.7154442067625569,1.110221729890519,0.35714285714285715,1.0,1.0,1/5,6.44%,PEX14
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),0.5512141488674062,1.109810663166992,0.35714285714285715,1.0,1.0,5/20,17.42%,CADM2;CDH2;ACTB;CDH12;NECTIN3
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),-0.5783603447738062,-1.1093052425198286,0.35,0.8773400369725213,1.0,1/22,1.82%,PLK2
prerank,PanglaoDB_Augmented_2021__Chondrocytes,-0.5538413144348481,-1.1089091649132463,0.3620689655172414,0.877196678814685,1.0,6/33,11.55%,STAT1;LAMA4;CXCL12;FN1;HMCN1;NID1
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.7050311026112275,-1.108724900738632,0.4444444444444444,0.8762891979074118,1.0,1/5,5.40%,MMRN2
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),0.6466958584227942,1.1085799271879935,0.3673469387755102,1.0,1.0,1/7,12.36%,YTHDF2
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),-0.6351878448887656,-1.1084552073290543,0.3541666666666667,0.8755754520099954,1.0,1/11,2.18%,TMSB4X
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),0.7021989986449797,1.1083140009896146,0.3902439024390244,1.0,1.0,5/6,26.95%,ABL1;NRP1;FES;CDC42;BCAS3
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),0.5770642040022453,1.1079432366749453,0.375,1.0,1.0,9/14,24.33%,SLC2A13;RTN4;RTN1;EPHA4;PICALM;ROCK1;RTN3;ABCG1;ROCK2
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),0.6039931531655194,1.1076011784479645,0.4473684210526316,1.0,1.0,6/8,27.60%,DPP10;ANK2;ANK3;DPP6;KIF5B;KCNIP4
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",-0.6453355767897967,-1.1075748836346466,0.3157894736842105,0.87686461189305,1.0,1/9,1.84%,HMGN1
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.7301900708200024,-1.1073178458422275,0.375,0.8761997790324392,1.0,4/8,25.75%,MMRN2;RHOA;MAP2K5;DLL4
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),-0.6129280336301617,-1.1069424837764568,0.3728813559322034,0.8758694370005767,1.0,5/13,20.40%,COL18A1;ATXN7;ZIC2;EYS;OPA1
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),-0.6538623991257762,-1.1065068665962314,0.3541666666666667,0.8756191547489035,1.0,5/12,28.58%,PABPC1;FUS;MAPK14;LARP1;ZFP36
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),-0.6724463374392486,-1.1062131724917164,0.4528301886792453,0.8751645564650947,1.0,1/8,3.48%,CXCL12
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.5851978378141073,-1.1060591417660002,0.3,0.874286073813979,1.0,3/27,3.14%,CX3CL1;GBP1;NUB1
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),-0.6265700525617206,-1.1054572626018306,0.32608695652173914,0.874621400845407,1.0,2/11,8.62%,STAT1;STAT5B
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),-0.489765879751614,-1.105422924829313,0.2676056338028169,0.8733382623317651,1.0,17/87,11.19%,TLL1;RHOBTB1;TPM1;PRKN;CARMIL1;COL8A1;DSP;CCDC88C;PPP1R9A;COL18A1;CST3;VIM;ARHGAP17;B2M;ACTN1;CD2AP;SPAST
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,-0.4617515357847246,-1.1053506605576555,0.29411764705882354,0.8722316202944536,1.0,5/72,6.78%,HES1;ZIC1;SMARCA1;SMAD3;DSP
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),-0.6689455442396784,-1.1050292388082432,0.36666666666666664,0.8715980638261985,1.0,1/11,0.21%,VCAM1
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),-0.4920808849462529,-1.104616670926488,0.2714285714285714,0.8713728517255962,1.0,6/50,7.71%,CYLD;PSMB9;RNF213;PSMA1;PRKN;CCDC88C
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.44661875052613714,1.1038283092301244,0.25806451612903225,1.0,1.0,12/45,15.11%,GRM5;CADM2;MAPK10;GRIA2;NRXN1;ADGRB3;BAALC;RBFOX1;ZEB2;NRXN3;LSAMP;ADCY2
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),-0.7125087719970638,-1.1036748314086229,0.38333333333333336,0.8730677234124754,1.0,1/7,2.52%,TPM1
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.6044019350614301,1.1034866071995213,0.43137254901960786,1.0,1.0,4/8,20.12%,BTRC;CDC14B;PTEN;PINK1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.72250662510728,-1.1033465310628823,0.42857142857142855,0.8714325644022967,1.0,3/7,13.84%,RFC3;RFC1;UBC
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",-0.72250662510728,-1.1033465310628823,0.42857142857142855,0.8714325644022967,1.0,3/7,13.84%,RFC3;RFC1;UBC
prerank,MSigDB_Hallmark_2020__E2F Targets,-0.5468932426877345,-1.1031704541932916,0.3220338983050847,0.8706654007240872,1.0,12/36,21.08%,SPC25;RFC3;TFRC;CBX5;LBR;RFC1;PDS5B;MSH2;GSPT1;SMC3;RAD21;ORC2
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),-0.6637105080261507,-1.1029191059510186,0.36538461538461536,0.8699626537754964,1.0,1/9,5.56%,SERPINE1
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),-0.6412835899542746,-1.102819321481746,0.38461538461538464,0.8688904840243677,1.0,1/12,0.75%,ZIC1
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),0.5387161191253313,1.1027521477512516,0.3076923076923077,1.0,1.0,2/22,2.62%,CRY1;UBQLN1
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),-0.704175053340447,-1.1027505134809845,0.39215686274509803,0.8678525579234664,1.0,3/7,11.47%,CX3CL1;LGALS3;RPS19
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.7718767953105259,-1.102679149856728,0.38596491228070173,0.8666634890636337,1.0,1/5,2.93%,UFL1
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.6514546932800057,-1.1025687987617308,0.3225806451612903,0.8655397428738291,1.0,3/11,12.59%,NR4A1;LCP2;RORA
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),0.6801239255254802,1.1023748559235118,0.3157894736842105,1.0,1.0,2/6,10.10%,FUT8;ST8SIA4
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),-0.6657342382834485,-1.1021739190690478,0.3829787234042553,0.8651734757847807,1.0,1/8,1.51%,IFIH1
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.7278103848612232,-1.1021426551849396,0.42592592592592593,0.8639172100859377,1.0,3/6,21.42%,ACSL4;ELOVL5;HACD2
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),-0.6792120851915427,-1.1021156216522632,0.4,0.8626341285663308,1.0,1/6,1.79%,RIMS1
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),0.5841304034283961,1.1019954224486175,0.35555555555555557,1.0,1.0,4/15,11.84%,PKM;ITGA5;SMAD1;KLF2
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.6963078523140925,1.1017651772172057,0.3584905660377358,1.0,1.0,6/6,30.48%,RANBP9;PICALM;ROCK1;ROCK2;TMED10;PRNP
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),-0.7182804901294144,-1.101630083202206,0.40816326530612246,0.8626569392065502,1.0,3/10,14.49%,MAP3K5;TAOK3;MAP3K4
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),0.5345134101530273,1.101476797421523,0.3488372093023256,1.0,1.0,4/14,16.51%,PRAG1;CBFA2T2;EPHA4;PTEN
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),0.4954120829250498,1.1009565802502683,0.2972972972972973,1.0,1.0,11/30,15.78%,STIM1;ATP2A2;ATP2B4;ANO6;CALCRL;SLC24A2;CACNA1C;PSEN1;SLC8A1;ANK2;RYR2
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),-0.4429094190869332,-1.1006722787402974,0.3108108108108108,0.8642855046944234,1.0,26/209,11.24%,CD74;TBX3;CX3CL1;KLHL20;STAT1;PLK2;VAV3;PRKN;TNFSF10;RASGRF2;GRK5;BCL2L14;JUN;MAP3K5;NDRG1;PMAIP1;NFKBIA;RPS6;TFRC;ACER2;ACTN1;BABAM2;AHI1;NET1;NFKB1;ARHGEF11
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),0.6922641457468806,1.1003936983827547,0.425531914893617,1.0,1.0,4/6,26.17%,ADGRB3;SKI;SORT1;MEF2C
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),0.7028265550380443,1.1002964673254407,0.4772727272727273,1.0,1.0,1/6,7.66%,ANXA2
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),0.48772485030585744,1.1002788739261729,0.2727272727272727,1.0,1.0,5/41,9.03%,RBM20;PTBP3;MBNL1;KHDRBS3;HNRNPLL
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),-0.5355373465514672,-1.1001973055006962,0.26229508196721313,0.8644431479067958,1.0,8/42,10.31%,BTG2;TPM1;MAP2;CARMIL1;GPM6A;PPP1R9A;LIMA1;FRYL
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),0.7277318304358,1.100135553829989,0.4166666666666667,1.0,1.0,2/5,24.33%,ROCK1;ROCK2
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),-0.6481120867106824,-1.1001034464259176,0.4107142857142857,0.8634872926022464,1.0,4/12,15.32%,TFRC;IREB2;ATP7B;FTH1
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),-0.686206583216245,-1.0989114102644217,0.32727272727272727,0.8654724958441231,1.0,1/8,3.30%,SPG7
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.6445690769214153,1.0988972441671494,0.4090909090909091,1.0,1.0,3/8,17.19%,BMP6;RBPMS;ACVR2A
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),-0.650466082450081,-1.0986506932333215,0.32142857142857145,0.8649587947753042,1.0,3/14,6.15%,SLC16A2;SLC6A6;SLC38A3
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.6167468866448957,-1.098104836032838,0.40476190476190477,0.8651144534170062,1.0,6/15,19.00%,STAT1;TNIP1;TANK;RORA;RIOK3;CARD8
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),0.5108051257280655,1.0976289744914862,0.3181818181818182,1.0,1.0,3/26,8.26%,HDAC9;PKM;INSIG1
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.6765096686645463,-1.0973649135474695,0.38181818181818183,0.8656939541426547,1.0,5/11,13.94%,STAT1;CDC37;PARP9;IFNGR2;JAK2
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),0.6129946464444727,1.0969358242756408,0.35294117647058826,1.0,1.0,4/12,18.67%,KDM4C;NCOA2;EP300;NCOR2
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),0.716469370361461,1.095492710924094,0.4782608695652174,1.0,1.0,1/6,5.30%,SYNE2
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),-0.6581867099731653,-1.0954846772612856,0.3695652173913043,0.8691920021154178,1.0,1/7,3.30%,SPG7
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),0.49941860537008315,1.0954535017238338,0.2903225806451613,1.0,1.0,7/29,13.53%,PRKD1;TAF1;NLK;PRKCA;OXSR1;LRRK2;WNK1
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),0.4706373670020151,1.0943818727120291,0.391304347826087,1.0,1.0,6/35,11.66%,MT2A;BCL6;CCDC85B;MT1M;MT1E;RTN4
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),-0.5432800578999133,-1.0940194006876436,0.37735849056603776,0.8717125255842975,1.0,4/26,8.98%,ISG15;PRKN;NGLY1;PMAIP1
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),-0.7042449161877276,-1.093644249080628,0.45454545454545453,0.8712385260252294,1.0,3/5,20.92%,VIM;NOD1;NLRP1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),-0.5670560207356882,-1.0936325312644422,0.32075471698113206,0.8699676433912662,1.0,6/29,10.88%,BTG2;CNOT8;EIF2AK2;CST3;CAPRIN1;NFKB1
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.6463539459972875,-1.0927444913844029,0.4107142857142857,0.8710618478379518,1.0,3/9,12.02%,KLHL20;EIF2AK2;BST2
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),-0.6607368026208102,-1.0924317845252238,0.3492063492063492,0.870545918239851,1.0,2/10,13.53%,VPS36;STAM2
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.5820698972025022,-1.092095750223047,0.42,0.8700465349073792,1.0,2/20,2.67%,PLK2;PLCG2
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),0.6227518032256067,1.0920152737984896,0.3617021276595745,1.0,1.0,1/8,0.91%,ABL2
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),0.5776833983116878,1.091996092646165,0.3333333333333333,1.0,1.0,3/17,11.24%,INPP5F;SGIP1;AP2B1
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),-0.5833160905713721,-1.0919185065333903,0.4032258064516129,0.8691444049766969,1.0,2/19,6.44%,SLC5A6;CPM
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),0.6525336054661783,1.091516410592212,0.3877551020408163,1.0,1.0,1/9,1.61%,SOX5
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.6628929922535102,-1.0904000818897956,0.42,0.8718478424442522,1.0,2/5,8.98%,TNFSF10;PMAIP1
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),0.5465367020604921,1.0899071019560223,0.35555555555555557,1.0,1.0,6/20,19.26%,TAF1;ZBTB1;YY1;INO80;EP300;CREBBP
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),-0.6951456654402106,-1.0896305966100108,0.4166666666666667,0.8726026424221899,1.0,3/9,11.84%,MEF2A;POLR2A;PTMA
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),-0.7011878499609154,-1.0895589652870104,0.36538461538461536,0.8714622580268184,1.0,2/7,14.28%,STK39;HECW2
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),0.6649596985176373,1.0892092453964521,0.3695652173913043,1.0,1.0,6/10,29.88%,GSN;PARVA;RAC1;CYFIP1;CDC42;NCKAP1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),-0.664436063813848,-1.088930506075759,0.43636363636363634,0.8707223197478916,1.0,3/6,18.07%,SULF2;RORA;HIF1A
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),-0.664436063813848,-1.088930506075759,0.43636363636363634,0.8707223197478916,1.0,3/6,18.07%,SULF2;RORA;HIF1A
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),-0.7147358183660326,-1.088896931301496,0.41379310344827586,0.8695007940298675,1.0,4/6,27.41%,KIDINS220;RAPGEF2;RAPGEF1;MAGI2
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),0.6901742759675478,1.0888356442331513,0.36363636363636365,1.0,1.0,2/6,14.36%,ATF7IP;PPHLN1
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.5778694412624562,-1.0886143009727427,0.36363636363636365,0.869068165260038,1.0,6/27,16.12%,HMGN1;RFC3;POLR2A;RFC1;UBC;RNF111
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),0.6137954401303801,1.0876210543890894,0.39622641509433965,1.0,1.0,5/7,28.19%,AGTPBP1;SKI;NIPBL;NF1;STAT3
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),-0.606205204723248,-1.0876037939387855,0.38333333333333336,0.8706784437383486,1.0,5/20,7.79%,SLC6A6;SLCO1A2;SLC5A6;SLC38A3;SLCO2B1
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),0.5639551691772429,1.0875010678816255,0.3191489361702128,1.0,1.0,3/19,8.41%,CCDC186;TRAK2;TRAK1
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),0.7232451594914607,1.0874967435453136,0.35555555555555557,1.0,1.0,2/5,14.36%,ATF7IP;PPHLN1
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.7232451594914607,1.0874967435453136,0.35555555555555557,1.0,1.0,2/5,14.36%,ATF7IP;PPHLN1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.6317662408981854,-1.08706165246132,0.43243243243243246,0.8708805677508282,1.0,4/12,19.29%,FHIT;RPL11;N4BP1;USP14
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),0.40938137300034927,1.0864376702270746,0.3076923076923077,1.0,1.0,16/91,13.03%,NRG2;PSMD14;ERBB4;YWHAB;PIK3CA;KRAS;BTRC;NCAM1;DUSP6;LRRC7;RASA2;RANBP9;PPP1CB;FRS2;SETX;LRRK2
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.566103403447755,-1.0863510049691179,0.38095238095238093,0.8716131154616399,1.0,4/24,7.27%,GBP1;RREB1;CARMIL1;CASS4
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,0.5883742307093378,1.0856328023717363,0.36363636363636365,1.0,1.0,7/14,15.11%,GRIA2;DLGAP2;ST18;NRXN1;SLC24A2;RPS6KA5;ADCY2
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),0.7018580199777658,1.0854480070483203,0.41304347826086957,1.0,1.0,3/5,29.44%,AKAP6;NEDD4L;YWHAE
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",0.47915124866598513,1.0854404496573116,0.32608695652173914,1.0,1.0,7/28,17.58%,AEBP2;DNMT3A;ACTB;ERCC6;PPHLN1;BAZ1B;EP300
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),-0.6751169468477897,-1.084972050102979,0.41509433962264153,0.8739342110437521,1.0,3/8,19.42%,SERPINE1;PDGFB;CD34
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),-0.44851137331588997,-1.0843839028498592,0.34615384615384615,0.8742188812292997,1.0,41/125,20.15%,SHISA5;SPG7;FN1;RPL31;PRKN;TNIP1;RPS18;DENND3;RPS12;RPL15;WARS1;RPS8;RPS28;RPL7A;CST3;RPS6;RPL38;RPS15;UBE2D2;RPL30;RPS14;RPL34;PRSS23;RPS19;RPS7;RPL24;ERO1A;GPC3;RPL11;GSPT1;RPL23;SERP1;ST3GAL6;RPL41;RPL36;RPL10;RPS27;UBE2G2;RPL9;RPL27A;EEF1A1
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),0.4808060024288068,1.083294769045247,0.2926829268292683,1.0,1.0,8/30,23.83%,PRPF8;HNRNPR;YTHDF2;DIS3L2;SRSF7;TCERG1;HSPA1A;SRSF11
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),-0.5302785834097238,-1.083123649107588,0.3225806451612903,0.8765146169227831,1.0,6/49,10.23%,LAP3;SPG7;CPQ;CPM;ERAP1;SPPL2A
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),0.6496373733242378,1.083011004064214,0.38461538461538464,1.0,1.0,5/9,24.33%,CBFB;NCOA3;FOXC1;ROCK1;ROCK2
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),-0.46898284776107796,-1.0824799551246995,0.27631578947368424,0.8770586041492109,1.0,9/90,7.27%,CEMIP;RREB1;PLCG2;SOD2;CXCL12;FN1;CARMIL1;SRGAP2C;CASS4
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),0.7137292558955068,1.081852818742614,0.42857142857142855,1.0,1.0,2/6,13.55%,STIM1;CACNA1C
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),0.447248382719494,1.08159252923545,0.35135135135135137,1.0,1.0,11/62,12.56%,HDAC9;CALR;NOVA1;MCC;SMAD6;CHSY1;KLF7;NOVA2;ZNF706;ATP2B4;NPTN
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),0.6612754498485629,1.0815100058532627,0.3442622950819672,1.0,1.0,2/6,8.57%,IGFBP3;PLCB1
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),0.6487644269686311,1.0802899031591184,0.4339622641509434,1.0,1.0,3/7,23.60%,STARD4;ABCG1;ABCA1
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),0.6274597064685956,1.0786754973886628,0.391304347826087,1.0,1.0,1/9,1.61%,SOX5
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),-0.6204708020589613,-1.0784131295497101,0.4074074074074074,0.8870013514440928,1.0,2/11,15.94%,SP100;ATM
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),0.6337803380075556,1.0783247598095713,0.4107142857142857,1.0,1.0,2/7,14.04%,PBX3;FOXC1
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),0.5755298827691071,1.0780990386172997,0.37209302325581395,1.0,1.0,6/17,19.26%,TAF1;ZBTB1;YY1;INO80;EP300;CREBBP
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),0.6214282463762529,1.0780832979864672,0.40816326530612246,1.0,1.0,8/11,20.33%,ROBO2;PRKX;FOXC1;CEP290;PCSK5;C1GALT1;ZBTB16;NIPBL
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.72373779822639,-1.0774879759169675,0.46,0.888069337741738,1.0,1/5,10.85%,POLR2A
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),-0.5361822136443566,-1.0765063732163673,0.3548387096774194,0.8892655915275665,1.0,3/35,4.75%,PLK2;CENATAC;PRKN
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),-0.5001104142969965,-1.075923636578843,0.375,0.8896565530368382,1.0,4/44,3.22%,CX3CL1;GBP1;PSMB9;PSMA1
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),0.6784765542972006,1.0756412512854865,0.4375,1.0,1.0,1/5,2.31%,UGP2
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.4891319768285185,1.0756204412006045,0.34375,1.0,1.0,10/32,19.91%,PRKD1;TAF1;NLK;PRKCA;OXSR1;LRRK2;WNK1;GALNT2;DYRK1A;ROCK1
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),0.621371861506944,1.0755216148929752,0.46808510638297873,1.0,1.0,3/8,24.12%,DICER1;AGO2;TUT7
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.5548406676118524,-1.0753906103291857,0.3787878787878788,0.8897843506671794,1.0,4/26,3.22%,STAT1;PSMB9;TMSB4X;PSMA1
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),-0.5707256426067924,-1.0753171970570514,0.40350877192982454,0.8887780005188934,1.0,2/19,6.67%,ZIC1;SMAD3
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),-0.6083393582503253,-1.0752533394787038,0.4074074074074074,0.8877165223800806,1.0,2/12,5.56%,RREB1;SERPINE1
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),-0.6596562121578192,-1.0750829757100124,0.48214285714285715,0.8868900231299769,1.0,1/6,10.67%,NNT
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),-0.558719245725596,-1.075056254725231,0.3389830508474576,0.8856751711910883,1.0,7/16,16.02%,ISG15;RFC3;TRIM25;PRIMPOL;RFC1;UBC;MSH2
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),-0.7168428216122489,-1.0749682786295487,0.4375,0.8834003199704817,1.0,3/7,8.90%,TPM1;VIM;DMD
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),-0.7168428216122489,-1.0749682786295487,0.4375,0.8834003199704817,1.0,3/7,8.90%,TPM1;VIM;DMD
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),-0.6153923726421221,-1.0737961675867131,0.46296296296296297,0.8850776873211973,1.0,2/11,4.02%,IFI27;SP100
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),0.5423139936723056,1.073510367464097,0.32558139534883723,1.0,1.0,7/17,25.55%,PIK3CA;WASF2;CAPZB;FSCN1;RAC1;CYFIP1;CDC42
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,-0.5452616122145453,-1.0731491756981995,0.288135593220339,0.8852681719853935,1.0,3/34,4.41%,VCAM1;DOK5;MAP2
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),-0.5934704257701745,-1.0731080416219196,0.44642857142857145,0.8840787775656495,1.0,2/16,5.43%,ATP9A;TMEM30A
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),0.6018837590283792,1.0729710583800305,0.391304347826087,1.0,1.0,2/9,15.76%,STX8;RAB7A
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,0.6999176102470556,1.072922839313539,0.5,1.0,1.0,1/5,1.43%,TEAD4
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.49177670389308176,-1.0726488040061921,0.3382352941176471,0.8840549411200902,1.0,5/42,7.71%,CYLD;PSMB9;PSMA1;PRKN;CCDC88C
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),-0.7218231796779762,-1.0723382659808114,0.5333333333333333,0.883544064185577,1.0,1/5,1.97%,PIGC
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),-0.4672584571710713,-1.0723020237475442,0.40298507462686567,0.8824194874428022,1.0,2/82,1.79%,CD74;RIMS1
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),-0.7489729083750524,-1.0719483383897601,0.5581395348837209,0.8819124173958911,1.0,1/5,4.39%,TIE1
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),-0.7098473579093697,-1.0714103490216578,0.3958333333333333,0.8821057952817472,1.0,2/6,13.01%,MVB12B;CDH13
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),0.7299089243073307,1.0713813676560422,0.45098039215686275,1.0,1.0,2/5,15.21%,STIM1;ANK2
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),-0.6516504433653347,-1.0713796353632379,0.4423076923076923,0.8796602110401955,1.0,1/7,10.85%,POLR2A
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),-0.6516504433653347,-1.0713796353632379,0.4423076923076923,0.8796602110401955,1.0,1/7,10.85%,POLR2A
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),-0.5551392347132726,-1.0712275178793031,0.4067796610169492,0.8787622409193102,1.0,4/25,14.67%,PPARG;SMAD3;RORA;FOXO1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.6980753690178552,-1.0711324720613886,0.4583333333333333,0.8778100891632233,1.0,1/5,4.47%,CNOT8
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),-0.6777913760648877,-1.0695133347447985,0.4482758620689655,0.8812231331418439,1.0,4/6,19.39%,CXCL12;LGALS3;PDGFB;ATP2B1
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),-0.4336324803677669,-1.0694150157702484,0.3611111111111111,0.880185328856121,1.0,28/146,14.80%,CYLD;GBP1;OPTN;ULK4;TMSB4X;PLCG2;UFL1;ARHGAP15;VAV3;RFC3;ARAP2;RASGRF2;ARHGAP17;NFKBIA;TOPBP1;BRD7;NET1;ARHGEF11;GNA12;MAPKAP1;TAOK3;RHOA;ITGAV;MCF2L;SMYD2;PRKAR1A;VRK2;FBXO9
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),-0.6742304788841974,-1.069141409196751,0.45098039215686275,0.8796730453694295,1.0,4/5,11.47%,OPTN;SERPINE1;RPL30;RPS19
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.5634864388980606,-1.0687689466947732,0.4,0.8794442876478246,1.0,2/21,2.67%,PLK2;PLCG2
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),-0.6380085645616145,-1.0685436618007282,0.46296296296296297,0.878835910596234,1.0,4/8,24.45%,UNC13B;RACK1;GAS6;ZBTB20
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),-0.6843854832344705,-1.0684753635264235,0.43103448275862066,0.8777510721918932,1.0,2/7,9.84%,IRF1;APPL2
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.6697969660986439,1.0679001684755405,0.4489795918367347,1.0,1.0,1/6,2.62%,UBQLN1
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),0.5090235523922059,1.0674927244042896,0.42857142857142855,1.0,1.0,4/25,8.90%,TRIM5;WDPCP;HSP90AA1;PPM1F
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.6899017162080913,1.0674768972213817,0.3953488372093023,1.0,1.0,1/5,1.51%,RARB
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),0.6638970578009994,1.0673900018894364,0.3877551020408163,1.0,1.0,3/6,17.50%,UGP2;GBE1;CALM1
prerank,PanglaoDB_Augmented_2021__Thymocytes,0.6490874997628816,1.0671038636700554,0.4782608695652174,1.0,1.0,1/8,1.58%,BCL6
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),0.6373474302273834,1.0669914776393579,0.4222222222222222,1.0,1.0,3/8,17.78%,PRKD1;AMBRA1;CD81
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),0.6203675141516406,1.066966169288229,0.40476190476190477,1.0,1.0,4/9,29.47%,LRRK2;WNK1;BCAS3;ARFGEF1
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),-0.6675944170610766,-1.0669565273060497,0.4339622641509434,0.8803348352248971,1.0,1/11,1.79%,RIMS1
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),0.5936025638652309,1.0669106667673025,0.3333333333333333,1.0,1.0,3/9,15.39%,DUSP6;PPM1F;PPP2CB
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),-0.7001876970431147,-1.0653953353349257,0.4528301886792453,0.882672914076934,1.0,1/8,2.93%,UFL1
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),0.5543213355889108,1.0651520417404223,0.358974358974359,1.0,1.0,4/20,15.50%,RALA;CLASP1;IL1RAPL1;ANXA1
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),0.7188890661957512,1.0651105887101522,0.4716981132075472,1.0,1.0,3/5,18.43%,HSP90AA1;CALM1;GCH1
prerank,MSigDB_Hallmark_2020__heme Metabolism,-0.4678264992722147,-1.065062690806078,0.3584905660377358,0.8822874968581126,1.0,9/64,10.67%,BTG2;OPTN;KLF3;GMPS;RNF19A;CDR2;TFRC;LMO2;NNT
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),-0.5978614325287899,-1.0648334083637772,0.39344262295081966,0.88169338359824,1.0,5/12,24.84%,COL18A1;ATXN7;ZIC2;OPA1;PITPNA
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),-0.5912936588389096,-1.064414039908159,0.4230769230769231,0.8816036945605202,1.0,2/14,15.94%,SP100;ATM
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),0.6978244068442461,1.064266188773749,0.39473684210526316,1.0,1.0,1/5,8.44%,MORF4L1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),-0.5526925405535702,-1.0638114390535094,0.3283582089552239,0.8819605291820789,1.0,2/25,1.58%,NR4A1;RREB1
prerank,GO_Biological_Process_2021__limb development (GO:0060173),0.6949739891684011,1.0631717279211748,0.5,1.0,1.0,1/7,2.41%,CHD7
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),0.4636039506248215,1.0625579437657626,0.275,1.0,1.0,9/42,13.63%,PSMD14;UIMC1;TENT4A;YY1;MORF4L1;SEM1;SETX;HERC2;INO80
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.4935042276479782,1.061992480162817,0.425531914893617,1.0,1.0,6/18,15.11%,ADGRB3;S1PR1;ADGRL4;CALCRL;ADGRL2;ADCY2
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,-0.6220660246304441,-1.0611753525658074,0.42857142857142855,0.887246364595604,1.0,1/12,3.40%,SOD2
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),-0.5247348470136053,-1.0610782670929642,0.42857142857142855,0.8863009715576605,1.0,4/29,10.07%,IFI27;ARIH2;PRKN;UBE2D2
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),0.5116349635399726,1.0606846775616308,0.3953488372093023,1.0,1.0,10/25,17.50%,ITPR3;STIM1;ATP2A2;ITPR2;ATP2B4;SLC8A1;ANK2;CELF2;RYR2;CALM1
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.6996414813051535,1.0606506135091978,0.45098039215686275,1.0,1.0,3/5,25.42%,PIAS1;ZMIZ1;HDAC4
prerank,PanglaoDB_Augmented_2021__Pericytes,-0.5336832139932202,-1.0604692741559831,0.38333333333333336,0.8867053240746605,1.0,4/35,8.59%,ZIC1;LAMA4;CXCL12;VIM
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.4985387428255039,-1.0600243818540613,0.328125,0.8865538142788372,1.0,6/36,9.71%,PPARG;TNFSF10;SMAD3;MAP3K5;PMAIP1;ACER2
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.7161258823461452,-1.0594719835354256,0.44680851063829785,0.8870259383090046,1.0,2/6,14.28%,STK39;HECW2
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),0.4256244034925816,1.0583499629068673,0.3870967741935484,1.0,1.0,11/49,24.33%,PACS2;TTC7A;MAP7;DPP10;ANK2;ANK3;CD81;ROCK1;DPP6;SMURF1;ROCK2
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),-0.6141560174154529,-1.05826049284319,0.42592592592592593,0.8885478303251956,1.0,5/13,11.63%,HLA-F;HLA-B;B2M;HLA-A;HLA-E
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),0.5420196265548654,1.0581802008944106,0.38095238095238093,1.0,1.0,2/10,6.07%,GRIK2;HOMER1
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),0.6078384389405606,1.0580112090354021,0.39622641509433965,1.0,1.0,5/10,15.03%,SLC38A9;CPEB3;CAPN2;KLF2;CPEB4
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),0.6941034569332036,1.057118982874809,0.4897959183673469,1.0,1.0,3/6,18.43%,HSP90AA1;CALM1;GCH1
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),0.6640129893435505,1.057015481006012,0.47619047619047616,1.0,1.0,2/6,13.14%,PPP3CA;PPP3CB
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),0.6640129893435505,1.057015481006012,0.47619047619047616,1.0,1.0,2/6,13.14%,PPP3CA;PPP3CB
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),-0.5049955487791503,-1.0569294217751395,0.3382352941176471,0.890825101324158,1.0,4/42,6.72%,MX1;SPG7;PRKN;MEF2A
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),-0.656401868485833,-1.0563604341522181,0.38596491228070173,0.8911238580673246,1.0,1/7,1.35%,PPARG
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.6757294056104001,-1.0555965104780425,0.46,0.8919038326933142,1.0,1/9,5.27%,SLC2A3
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),-0.6153246444266344,-1.0553943553310945,0.38461538461538464,0.8912925354552844,1.0,3/12,11.45%,ABCA5;SCARF1;LBR
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),-0.7186723402313903,-1.055271799612318,0.41379310344827586,0.8903258194856434,1.0,4/5,27.41%,KIDINS220;RAPGEF2;RAPGEF1;MAGI2
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),0.5937990364730964,1.0550301567874598,0.4074074074074074,1.0,1.0,3/9,19.57%,CHD7;ANXA1;ADAM17
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,0.4592864298130722,1.054899382840326,0.34146341463414637,1.0,1.0,7/47,11.29%,CALR;YWHAB;MAPK10;HSP90B1;PLCB1;ITPR2;RALB
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),-0.5624836096605191,-1.0545838803796754,0.32,0.8907744933358037,1.0,3/14,8.02%,TLL1;COL8A1;COL18A1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),0.5565714354873653,1.0543732671042605,0.4418604651162791,1.0,1.0,7/15,31.91%,OTUD7B;PICALM;CTNNA1;ROCK2;NEDD4L;LATS1;TTBK2
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.43465069954375196,1.0540112501834584,0.4,1.0,1.0,6/44,7.89%,HSPH1;BAG3;NUP58;RANBP2;ABL1;HSP90AA1
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),-0.6339230779951982,-1.0536466082519333,0.40350877192982454,0.8920711478370945,1.0,3/5,18.48%,RPL11;HIF1A;EPAS1
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.6088038453425744,-1.0534163267538308,0.4915254237288136,0.8913535496583669,1.0,1/10,2.67%,PLCG2
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),0.6811328261868664,1.0532574508066932,0.5,1.0,1.0,2/6,11.06%,CRY1;PPP1CB
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,-0.6936148061667958,-1.0527990611128866,0.42592592592592593,0.891621398784505,1.0,3/6,14.67%,SRP14;LMO2;FOXO1
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),0.6582852791963191,1.0526945025215277,0.4807692307692308,1.0,1.0,2/6,16.51%,DUSP6;PTEN
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),-0.6746993215001719,-1.0510978779511861,0.47058823529411764,0.8948894858588247,1.0,1/5,4.75%,PRKN
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,-0.6291423203681913,-1.0507763133874695,0.45652173913043476,0.8946068869899648,1.0,4/8,26.01%,DSP;ABCG2;LAMA3;LSR
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),0.5154540155932994,1.0506897657994287,0.3404255319148936,1.0,1.0,10/19,30.37%,PLCB1;PPM1F;INO80;ADAM10;ADAM17;AKAP6;RFTN1;CDC42;EIF4G2;INSR
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),0.6953338145920134,1.0503343891896644,0.49019607843137253,1.0,1.0,3/7,25.55%,YWHAZ;UVRAG;CDC42
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),0.6346787147132311,1.0501645016564731,0.42857142857142855,1.0,1.0,5/9,15.78%,CDH2;PIK3CA;GSN;SLC8A1;RYR2
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),0.6176432428045638,1.0494589101895972,0.40816326530612246,1.0,1.0,1/10,1.61%,SOX5
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.6427576483052581,-1.0491901929214882,0.46774193548387094,0.8971001848700219,1.0,7/12,19.96%,UFL1;RPS14;RPS19;JAK2;ACIN1;CDIN1;PTPN2
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),-0.6164501848590943,-1.0490543692851773,0.43137254901960786,0.8961360929853159,1.0,3/11,17.08%,MAP2;SSH1;KANK3
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),0.6353692639080889,1.0484832540950724,0.3953488372093023,1.0,1.0,2/8,3.95%,ANO5;CLIC1
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,-0.6122800716028242,-1.0479821558438587,0.48214285714285715,0.8977387006805837,1.0,4/11,7.79%,IFI27;SAT1;TNFSF10;SLCO2B1
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),-0.5883715950142352,-1.0469258112427353,0.4230769230769231,0.8988221253617452,1.0,3/10,11.60%,PLCG2;HLA-B;CD47
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),-0.6239136088896517,-1.0467339712055643,0.4339622641509434,0.8980219781507546,1.0,2/7,8.20%,CPQ;ERAP1
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),-0.4808686831231891,-1.046206155760444,0.391304347826087,0.8981562854225218,1.0,14/68,16.48%,BTG2;SP100;RFC3;SAMHD1;TOPBP1;PRIMPOL;RFC1;UBC;PWWP3A;PDS5B;ATM;MSH2;SMARCAD1;NPM1
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),-0.5655150983142503,-1.045493818395668,0.4,0.8987085155851119,1.0,4/12,18.64%,VAV3;LARS1;RHOA;MSN
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),0.648659443676312,1.0454635610591418,0.47058823529411764,1.0,1.0,2/5,6.57%,AGTPBP1;NRXN1
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),0.5329465712666116,1.0437331228352582,0.35555555555555557,1.0,1.0,4/19,13.03%,EIF4G3;PIK3CA;TAB2;LRRK2
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),-0.5841653661216953,-1.043625994783792,0.43103448275862066,0.9024932232166083,1.0,2/11,4.41%,ATP9A;MAP2
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,0.5289178392731679,1.043421880801668,0.45454545454545453,1.0,1.0,4/18,6.62%,SNAP25;GRIA2;NTM;ADGRB3
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),0.6297171308533714,1.0432017255576813,0.46938775510204084,1.0,1.0,4/7,26.53%,ST8SIA4;SPTLC1;ST6GALNAC3;SAMD8
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.6036247540969976,-1.0431902351096884,0.43103448275862066,0.9011088341794715,1.0,4/11,13.84%,TANK;UBE2D2;TBK1;UBC
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.6036247540969976,-1.0431902351096884,0.43103448275862066,0.9011088341794715,1.0,4/11,13.84%,TANK;UBE2D2;TBK1;UBC
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),-0.5269804032420234,-1.0425647698458982,0.3333333333333333,0.9012380830496403,1.0,4/25,7.04%,PPARG;SERPINE1;CTNNA2;CD109
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),-0.6273057288988461,-1.0417927952560313,0.4166666666666667,0.9017824597869076,1.0,2/8,21.08%,TOPBP1;ORC2
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,0.6024409310017032,1.0417796401714963,0.4318181818181818,1.0,1.0,5/11,9.01%,ATRNL1;SNAP25;GRIA2;NRXN1;NOVA2
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),-0.6151335163352722,-1.0414595602497811,0.4339622641509434,0.9013750799037427,1.0,1/8,2.18%,TMSB4X
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),-0.5977507839459627,-1.040992671896453,0.4339622641509434,0.9003633631997845,1.0,2/10,8.83%,AGPAT3;DGKG
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),-0.5977507839459627,-1.040992671896453,0.4339622641509434,0.9003633631997845,1.0,2/10,8.83%,AGPAT3;DGKG
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),-0.4227217129069744,-1.0407741372443315,0.38571428571428573,0.8996795684501041,1.0,26/136,18.85%,CD74;RIMS1;PLCG2;FN1;PRKN;EIF2AK2;SMAD3;WARS1;TAF1D;VIM;TFRC;POLR2A;RPS7;CLU;VSIR;UPF3A;RPL11;ATM;NPM1;RPL23;RAMP3;HIF1A;PDGFB;MSN;AFDN;DHX36
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),-0.6770847326882713,-1.0400622653205531,0.5084745762711864,0.9004087734052263,1.0,1/6,5.17%,ATP6V1E1
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),0.6063232857350861,1.0398284185921822,0.425531914893617,1.0,1.0,3/9,18.15%,REST;ANXA1;KLF9
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),0.5670432605706474,1.0395424964067843,0.35555555555555557,1.0,1.0,5/13,22.09%,GRM5;FOXO3;PICALM;ROCK1;CYFIP1
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),-0.6762879949469289,-1.039135464804715,0.46153846153846156,0.9016545470010533,1.0,3/5,18.95%,ANKFY1;CCDC91;AP1G1
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.6002804397867281,1.0380062478264869,0.4375,1.0,1.0,3/11,19.26%,NAA50;EP300;CREBBP
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),-0.6716068642745711,-1.037885138466323,0.5370370370370371,0.9042247536162191,1.0,6/6,32.97%,BCOR;KDM1A;AUTS2;KMT2A;CTNNB1;MACROH2A1
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),-0.5375248606865125,-1.0378198628239756,0.4262295081967213,0.9031814452860989,1.0,8/30,14.85%,RNF213;SOD2;SAMHD1;B2M;APPL2;SPAST;CLYBL;CBR4
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),0.6453276248992545,1.0375284051817175,0.5106382978723404,1.0,1.0,2/6,25.96%,APPL1;C2CD5
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,0.5254453163372367,1.0373858567398444,0.4146341463414634,1.0,1.0,4/24,7.58%,RBM20;PRKG1;ATP2A2;CKMT2
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),-0.6913133540368765,-1.036897018898826,0.4782608695652174,0.9043126355456104,1.0,3/8,25.70%,PABPC1;FUS;LARP1
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),-0.6639550134906712,-1.036783021649115,0.49019607843137253,0.9034174495187389,1.0,1/5,7.61%,STK39
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.5541655394701119,-1.0360878704604914,0.4098360655737705,0.9039510083611997,1.0,3/24,15.65%,ATP9A;COPA;RAB1A
prerank,PanglaoDB_Augmented_2021__Neuroblasts,0.5220170061937286,1.0356182521385706,0.35555555555555557,1.0,1.0,3/17,6.67%,GRM5;ERBB4;NCAM1
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.5785112583296061,-1.0354800833983004,0.5294117647058824,0.9044699659799407,1.0,1/9,6.33%,NGLY1
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),-0.5326708971839729,-1.035241228314953,0.43636363636363634,0.9039074264706715,1.0,4/27,9.16%,LRPAP1;SP100;JUN;NFKBIA
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),0.5628062145917796,1.035013832602548,0.36585365853658536,1.0,1.0,2/15,2.91%,UIMC1;WRNIP1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.6890441208759801,1.0346992058252404,0.49122807017543857,1.0,1.0,4/5,31.02%,ADAM17;AKT3;FGFR1;HMGB1
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.5807463284698362,-1.0343383427763535,0.4375,0.9050433521852821,1.0,6/20,18.17%,PPARG;SMAD3;JUN;FOS;HIF1A;PDGFB
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.6511813962123485,1.0338264861992579,0.4878048780487805,1.0,1.0,2/5,10.36%,ITGA5;GRB10
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),-0.4865639323295446,-1.0336181513575702,0.39622641509433965,0.9054668564854323,1.0,3/44,2.52%,KLHL20;RHOBTB1;TPM1
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),0.6391799301325445,1.031863128394661,0.5384615384615384,1.0,1.0,5/6,26.58%,CTNND2;PTEN;DIP2A;CDC42;WASL
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),-0.5789056387978877,-1.0314830016003211,0.4262295081967213,0.9089462698995111,1.0,1/16,0.21%,VCAM1
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),-0.6099991930546967,-1.0312949340962325,0.4444444444444444,0.9082628778108637,1.0,2/6,20.51%,KANSL1;MSL2
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.6601815155933978,1.031267622724782,0.42,1.0,1.0,3/6,23.96%,ANKRD11;SKI;FGFR1
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),-0.49366354144755376,-1.0312053609835514,0.42857142857142855,0.9072541334886186,1.0,7/34,13.73%,SCN3A;SLC6A6;SCN2A;TRPM3;NNT;TRPM6;ITGAV
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),-0.6161055515944961,-1.0308162611971763,0.4423076923076923,0.9069145363071981,1.0,2/10,13.76%,AGPAT3;ENPP2
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.3783574341252019,1.0305207994500578,0.3870967741935484,1.0,1.0,16/118,14.12%,CALR;GRM5;FOXN2;CHD7;YAF2;GPBP1L1;CCDC88A;NFYC;ABL1;ZNF708;REST;FOXO3;NLK;NCOA2;FOXC1;RPS6KA5
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),0.6590679287395587,1.0300396416097415,0.5370370370370371,1.0,1.0,3/6,29.08%,SLC8A1;NEDD4L;ATP1A1
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),0.6590679287395587,1.0300396416097415,0.5370370370370371,1.0,1.0,3/6,29.08%,SLC8A1;NEDD4L;ATP1A1
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),0.6590679287395587,1.0300396416097415,0.5370370370370371,1.0,1.0,3/6,29.08%,SLC8A1;NEDD4L;ATP1A1
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),-0.454799375028367,-1.0299225368817249,0.391304347826087,0.9074763871731807,1.0,13/90,14.20%,MX1;RIMS1;SUN1;IGF2R;TFRC;FNBP1;SPAST;CLTA;USO1;DNM3;STAM2;UBC;SYNJ2
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),-0.6066634976251776,-1.0297173048761372,0.4666666666666667,0.9067854552722899,1.0,3/10,16.64%,ABCA5;LBR;FAXDC2
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),0.5220827597824882,1.0293538743084238,0.3488372093023256,1.0,1.0,5/12,19.94%,KATNBL1;ANXA2;ANXA1;UVRAG;RAB3GAP2
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),0.6281838899979251,1.029281355927446,0.4230769230769231,1.0,1.0,1/7,2.28%,TRAM2
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),0.46533649146402384,1.0291792998164833,0.4878048780487805,1.0,1.0,3/23,1.77%,BTBD10;INPP5A;RRAS2
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),0.5242346805329012,1.0287927988651078,0.4489795918367347,1.0,1.0,3/18,12.44%,RBM20;HNRNPLL;SETX
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),-0.6690262491043069,-1.0284364332899378,0.45098039215686275,0.908556635474941,1.0,2/5,19.06%,ARHGAP17;ALS2
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),-0.4488883641642538,-1.0283891322055563,0.42857142857142855,0.9074500798154989,1.0,12/88,10.44%,CYLD;IFIH1;PSMB9;PSMA1;PRKN;TNIP1;SMAD3;FOXK1;SENP7;NFKBIA;ATXN7;BABAM2
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),0.6160549805090038,1.0267064493011573,0.5,1.0,1.0,3/8,10.85%,MT2A;MT1M;MT1E
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),0.6160549805090038,1.0267064493011573,0.5,1.0,1.0,3/8,10.85%,MT2A;MT1M;MT1E
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),-0.6361583492814983,-1.0262414311266874,0.4827586206896552,0.9119033880866544,1.0,1/8,3.32%,SNX6
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),0.7054860957280087,1.0253997433630682,0.4897959183673469,1.0,1.0,3/6,24.22%,FRS2;GRB2;SORT1
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),-0.6425854183956481,-1.0251220519108015,0.5272727272727272,0.913725836902847,1.0,4/8,21.42%,ACSL4;ELOVL5;CBR4;HACD2
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),0.5962018885716531,1.0249927265763397,0.4772727272727273,1.0,1.0,3/8,19.18%,PDZD8;MICU3;MICU2
prerank,GO_Biological_Process_2021__eye development (GO:0001654),0.5539548156435093,1.024928679370296,0.4583333333333333,1.0,1.0,6/13,20.33%,PBX3;CACNA1C;FOXC1;SKI;CEP290;NIPBL
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),-0.5324611584462321,-1.0247305818078607,0.4576271186440678,0.913743518793343,1.0,1/19,1.79%,RIMS1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),-0.675199503098149,-1.0238793986694628,0.5106382978723404,0.9144336751630492,1.0,4/5,30.66%,DHX36;ICE1;RPTOR;MTOR
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),0.4611126253469333,1.0234414019133804,0.4146341463414634,1.0,1.0,4/24,12.36%,ZNF160;TET2;PRKX;YTHDF2
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),-0.5735722457363441,-1.0231175367302563,0.45,0.915328704857127,1.0,1/14,1.69%,IFI27
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),-0.5522061830613185,-1.0228651202881154,0.4339622641509434,0.9146734642367853,1.0,2/13,8.62%,STAT1;STAT5B
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),-0.6549377750515508,-1.0220589944757845,0.5087719298245614,0.9155658713876308,1.0,4/5,33.96%,CCDC3;PDE3B;PPP2R5A;PRKAA1
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),0.565324879611533,1.0219483172873138,0.4909090909090909,1.0,1.0,4/10,15.03%,SLC38A9;CPEB3;CAPN2;CPEB4
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.5977065048855427,-1.0216229649160835,0.5178571428571429,0.9156325302921288,1.0,2/16,5.40%,PPARG;MMRN2
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),-0.6595455439847296,-1.0213344934457633,0.5,0.9151464780651363,1.0,3/6,20.40%,SPAST;HIF1A;OPA1
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),0.5551278612623811,1.0208378039856825,0.5111111111111111,1.0,1.0,5/12,18.61%,HOMER1;LRRK2;EPHA4;IL1RAPL1;TANC2
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),0.6475844956024654,1.0202509203706007,0.4782608695652174,1.0,1.0,4/7,27.00%,ITGA1;CALM1;MEF2C;HSP90AB1
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.6193059966191976,-1.0200594632552875,0.44680851063829785,0.9172796526382374,1.0,3/8,15.97%,PRKN;CLU;PSMC6
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),0.40244296384687295,1.0198960628897589,0.40625,1.0,1.0,7/51,13.47%,GRM5;IL6R;CCDC88A;TAB2;HSP90AA1;RALB;EPHA4
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),-0.545959718841296,-1.0189264505371354,0.47761194029850745,0.9187793242369724,1.0,7/25,9.84%,CYLD;TMSB4X;IRF1;UFL1;SAMHD1;ERAP1;APPL2
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),0.580147213387283,1.0176113356468215,0.46153846153846156,1.0,1.0,2/10,11.81%,PPP1R10;YLPM1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.6745082309075737,-1.0176094379879634,0.4827586206896552,0.9205951522451831,1.0,2/5,11.63%,HLA-A;HLA-E
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),0.538674369830044,1.0175932465791542,0.46875,1.0,1.0,3/17,13.40%,CCDC88A;WAPL;SLFN11
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),-0.6525881971459692,-1.017437646061909,0.5087719298245614,0.919657795308325,1.0,2/6,8.67%,MYRIP;ACSL4
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),0.6606219414260163,1.0173928713830134,0.5,1.0,1.0,3/5,32.53%,ANO6;RGCC;PRKCI
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),-0.5768047452851337,-1.0172955757394162,0.47540983606557374,0.9187866762089949,1.0,4/14,8.90%,CPQ;CPM;ERAP1;DMD
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),0.46963823416775163,1.017056566190152,0.425,1.0,1.0,8/29,19.26%,TAF1;ZBTB1;UBE2B;YY1;ERCC6;INO80;EP300;CREBBP
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),0.48406174962864645,1.0169433076760694,0.425,1.0,1.0,8/32,15.65%,RALA;MICALL2;GSN;S1PR1;PARVA;NRP1;ANXA1;THSD7A
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),-0.5541674207566306,-1.0168999215736092,0.4603174603174603,0.9185553430566676,1.0,5/18,16.30%,SLC5A6;SLC2A3;CD320;BTD;PDXK
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),-0.580710716369842,-1.0159384459440848,0.45,0.9200056043479271,1.0,2/17,4.75%,PSTPIP2;PRKN
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),-0.45458067319816753,-1.0157390404638083,0.4153846153846154,0.9193663103535806,1.0,9/72,11.47%,LRPAP1;RREB1;SHLD1;EIF2AK2;SERPINE1;SMAD3;TFRC;APPL2;RPS19
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),0.6630760621989061,1.0155908454236398,0.4791666666666667,1.0,1.0,1/5,18.67%,NCOR2
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),0.5664409769840927,1.0155318939107285,0.45652173913043476,1.0,1.0,1/10,5.30%,SYNE2
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),0.6064425798289481,1.0143484267670053,0.4888888888888889,1.0,1.0,2/8,13.47%,ABL1;EPHA4
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.40910663639105715,-1.0141508182912022,0.4050632911392405,0.9224758619450912,1.0,16/168,10.70%,HES1;TBX3;BTG2;PPARG;IRF1;SNX6;CNOT8;EIF2AK2;FOXK1;JUN;RCOR1;SCML1;BRD7;BCOR;CBX5;CAPRIN1
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),-0.6452108487007816,-1.0139468603651727,0.42857142857142855,0.9216320715273825,1.0,2/5,12.10%,SULF2;CHST12
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),0.49637184216216257,1.0139195097425762,0.4897959183673469,1.0,1.0,3/22,6.80%,UBQLN1;HSP90B1;STT3B
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),0.45569923428039055,1.0136617146442402,0.4666666666666667,1.0,1.0,5/34,13.99%,CALR;PRKD1;ABL1;PRKCA;NRP1
prerank,PanglaoDB_Augmented_2021__Parietal Cells,-0.4883970234932269,-1.013552547458277,0.46551724137931033,0.9213605821464678,1.0,6/34,8.52%,ATP9A;PATJ;PIK3C2B;MYRIP;PPP1R9A;RAPGEF5
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),0.5649761617203641,1.0128633015200248,0.5,1.0,1.0,1/9,0.62%,PNP
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),-0.6367342838492301,-1.0128225235436044,0.5272727272727272,0.9217604475542089,1.0,2/8,10.72%,IFIH1;PARP9
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),0.6482844328322418,1.0120872972095103,0.46808510638297873,1.0,1.0,1/6,2.31%,UGP2
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.6163451318531545,-1.0119527594036337,0.49019607843137253,0.9228164770385489,1.0,2/15,4.78%,GBP1;TNIP1
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),0.5823831445443034,1.0117461436233213,0.45,1.0,1.0,5/11,17.50%,UBQLN1;ATP2A2;VMP1;UVRAG;CALM1
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.6507977397331096,1.0113373020425784,0.559322033898305,1.0,1.0,3/5,30.58%,PLCB1;EIF2AK3;GIGYF2
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),0.5220677698180622,1.0110766571246874,0.4888888888888889,1.0,1.0,4/20,15.50%,CALR;ANXA2;ACTB;ANXA1
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.5061777569993235,1.010667200495549,0.5116279069767442,1.0,1.0,9/19,21.31%,CDH2;ROBO2;TIAM2;RTN4;CHN1;EPHA4;PTEN;TIAM1;LRRC4C
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),-0.6069626908109792,-1.0101994002342345,0.425531914893617,0.9256495399293182,1.0,3/10,17.08%,TMSB4X;SSH1;KANK3
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),0.5868447953233977,1.0099079561854918,0.4782608695652174,1.0,1.0,2/7,4.44%,UGCG;ATP2A2
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),-0.5725476358422485,-1.0096801496295886,0.5102040816326531,0.9258281632629664,1.0,4/14,7.79%,SLC16A2;SLCO1A2;SLC5A6;SLCO2B1
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),0.6362211543291876,1.0086471262792676,0.48148148148148145,1.0,1.0,3/7,25.91%,ACTB;CTTNBP2NL;NEDD4L
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),-0.4998505894930946,-1.00861019644381,0.43636363636363634,0.9271394500102209,1.0,3/29,8.80%,PLK2;PLCG2;LGALS3
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),0.6661435061336614,1.0085105798986291,0.4772727272727273,1.0,1.0,1/5,10.38%,MAP4
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),-0.5871993431109404,-1.0084391543733426,0.5098039215686274,0.9263349498411881,1.0,2/8,18.64%,MTMR2;MSN
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.5809608066902953,1.00829720499777,0.43333333333333335,1.0,1.0,6/9,24.33%,SLC2A13;RANBP9;EPHA4;PICALM;ABCG1;ROCK2
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),0.49586353130005295,1.0082240320090614,0.5135135135135135,1.0,1.0,4/25,7.14%,HDAC9;NUP58;PIAS1;RANBP2
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),0.5890471314268269,1.007934894430366,0.46808510638297873,1.0,1.0,3/10,11.73%,ACTG1;PRKX;ACTB
prerank,PanglaoDB_Augmented_2021__Interneurons,0.4243817776633621,1.00783381541305,0.42424242424242425,1.0,1.0,12/62,9.97%,SRGAP1;GRM5;SNAP25;CADM2;GRIA2;FGF12;NRXN1;ADGRB3;RBFOX1;SLC16A1;TRIM9;ELMO1
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.5384276094489023,-1.0073765364606084,0.5263157894736842,0.9277553213579031,1.0,5/16,15.26%,YTHDC1;USP39;LUC7L;SRPK1;SRSF5
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),0.6739411175124204,1.0067077811573482,0.52,1.0,1.0,4/6,26.17%,SKI;MYL6;SVIL;MEF2C
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),-0.5067371854521204,-1.0066190367286447,0.45454545454545453,0.9282188781462951,1.0,7/33,13.73%,ISG15;ITGB5;FN1;ITGA10;ADAMTS1;CD47;ITGAV
prerank,PanglaoDB_Augmented_2021__Erythroblasts,0.5332265787200345,1.0065125666474604,0.43902439024390244,1.0,1.0,4/17,9.68%,PNP;SLC25A37;FBXO7;ELF1
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),-0.43986868286128766,-1.0053788620313462,0.417910447761194,0.929545625889808,1.0,14/106,11.37%,HES1;TBX3;ZIC1;SPG7;FN1;PRKN;GPM6A;PLXND1;SCN2A;RAPGEF5;ZC4H2;AHI1;APBA1;FEZ2
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),-0.4392072383132543,-1.0045103266290938,0.45588235294117646,0.9303310637014336,1.0,11/88,10.44%,CYLD;IFIH1;PSMB9;PSMA1;PRKN;TNIP1;SMAD3;FOXK1;NFKBIA;ATXN7;BABAM2
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.5415348278434181,1.0044046305182113,0.5,1.0,1.0,4/12,17.19%,BMP6;SMAD6;RBPMS;ACVR2A
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),-0.6422898203790381,-1.0040752163586535,0.5384615384615384,0.9303648031139963,1.0,1/6,2.18%,TMSB4X
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),0.5802838216350239,1.0020215809453423,0.4166666666666667,1.0,1.0,5/8,35.20%,OTUD7B;CTNNA1;LATS1;UFM1;MFHAS1
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),-0.6500012400435455,-1.0019667492776019,0.6071428571428571,0.9343296136993084,1.0,1/5,6.05%,CTNNA2
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),0.6110722975164344,1.00195530026831,0.5272727272727272,1.0,1.0,5/7,25.75%,KLF2;ROCK1;EDN1;ROCK2;KCNMB4
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),-0.6106546534086993,-1.0019082948512066,0.5283018867924528,0.9333237370532005,1.0,3/10,5.87%,ITGB5;FN1;COL8A1
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,0.5271528673471669,1.001860172165593,0.46511627906976744,1.0,1.0,4/15,16.15%,ATN1;PDZRN3;ANK2;CTNND2
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),-0.4353831297468943,-1.001014270468495,0.4027777777777778,0.9342250228199591,1.0,7/86,9.50%,CD74;FN1;PRKN;WARS1;CCDC88C;LIMCH1;TFRC
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,-0.5290428578896714,-1.0007183546481682,0.45161290322580644,0.9337688447671754,1.0,2/21,3.48%,LAMA4;CXCL12
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.56557865040462,-0.9997714695150112,0.4642857142857143,0.9349281029836758,1.0,6/13,26.48%,PMAIP1;FHIT;MSH2;ZNF385B;DDX5;HIPK2
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),-0.6377868302385984,-0.9994804634663211,0.5,0.9345465987127639,1.0,3/8,13.47%,PRKN;TFRC;CLU
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),-0.6635622091579977,-0.9993787011175239,0.6274509803921569,0.9336334080919318,1.0,3/5,20.28%,PMAIP1;RIOK3;SLC3A2
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),0.5520648250701231,0.9991391576988146,0.4883720930232558,1.0,1.0,1/8,7.89%,HSP90AA1
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.5865336554554923,0.9990310765782492,0.5714285714285714,1.0,1.0,2/8,6.07%,GRM5;HOMER1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.5953441983274683,-0.998929933134931,0.45161290322580644,0.9336503439472511,1.0,2/7,4.75%,SOD2;PRKN
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),-0.5427011973890811,-0.998537971364562,0.46551724137931033,0.9335189641135041,1.0,6/27,11.24%,ITGB5;TPM1;MYL12A;VIM;DMD;ARHGEF11
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),-0.6203000920264288,-0.9976070381143123,0.5,0.9345232677510505,1.0,4/10,20.40%,SPG7;PMAIP1;MFN1;OPA1
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,-0.5114132566372596,-0.9974404026933296,0.4426229508196721,0.9337378770905604,1.0,4/25,3.58%,TPM1;LAMA4;CXCL12;FN1
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),-0.6544119205558291,-0.9973145628845057,0.5,0.9329421152867046,1.0,4/9,13.47%,PRKN;TNFSF10;PMAIP1;CLU
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),0.6051576447162699,0.9962579548323564,0.54,1.0,1.0,2/6,20.98%,SFSWAP;SRSF7
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.6051576447162699,0.9962579548323564,0.54,1.0,1.0,2/6,20.98%,SFSWAP;SRSF7
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.5766790070568059,-0.9961115266110474,0.4727272727272727,0.9345704703641017,1.0,6/11,22.40%,RPL7A;RPL24;RPL11;NPM1;RPL10;RPL3
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),-0.44078681400289016,-0.9954399999457068,0.4626865671641791,0.9349545288130299,1.0,12/101,16.48%,CD74;SNX6;DMD;SEPTIN11;AHI1;USO1;COPA;ARL4A;TBC1D1;STX17;RAB1A;NPM1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),-0.5363233958376742,-0.9954270048217219,0.49206349206349204,0.9338167881963435,1.0,1/16,2.23%,SHLD1
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),-0.51885767329063,-0.9952749128023566,0.43137254901960786,0.9330738393727068,1.0,6/17,13.84%,ISG15;RFC3;TRIM25;PRIMPOL;RFC1;UBC
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),0.40139730882762803,0.9951065144391036,0.45714285714285713,1.0,1.0,11/56,14.04%,SMAD9;SOX5;PRKD1;HSPB1;BMP6;URI1;GAREM1;SETX;APPL1;NRP1;FOXC1
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.4378002598706137,0.9950157813542858,0.45454545454545453,1.0,1.0,7/38,14.30%,ABL2;INPP5F;RALA;ABL1;LRRK2;NRP1;FES
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),0.6118306229107462,0.9945475267462608,0.5416666666666666,1.0,1.0,3/5,25.44%,ROBO2;NIPBL;NF1
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),-0.4603320153164506,-0.9944621640328509,0.4264705882352941,0.9336907827261017,1.0,3/42,3.87%,EML1;PLK2;SPC25
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),-0.5313676340589081,-0.9943837203161229,0.49122807017543857,0.9327176318946482,1.0,2/15,8.62%,STAT1;STAT5B
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),-0.564685462282067,-0.9943591141213779,0.5084745762711864,0.9316492240767635,1.0,1/11,4.39%,TIE1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),-0.6404161857277407,-0.9939898232452423,0.48936170212765956,0.9314367274287277,1.0,1/7,1.04%,GBP1
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),-0.638364730766758,-0.9935197906319645,0.5576923076923077,0.9315291272147268,1.0,3/5,24.66%,LGALS3;MSN;STK10
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),0.5484369763435419,0.9933079486370158,0.5106382978723404,1.0,1.0,1/9,8.64%,OTUD7B
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),0.605586733331837,0.9932389102961616,0.5217391304347826,1.0,1.0,2/7,19.42%,TAOK1;DIP2A
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),-0.5412589865479598,-0.9931170170745524,0.5084745762711864,0.9312929748048175,1.0,3/15,9.79%,SNX6;PRKN;B2M
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),0.43377624345104193,0.9926563094984858,0.40425531914893614,1.0,1.0,6/36,13.99%,CALR;PRKD1;HSPB1;ABL1;PRKCA;NRP1
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),0.3750369089409423,0.991972570660348,0.4482758620689655,1.0,1.0,19/88,22.33%,ARHGEF4;PCM1;CCDC88A;WDPCP;CDC14B;GSN;S1PR1;ANO6;PARVA;NRP1;CEP290;ABCC4;BBS9;FSCN1;RAC1;ARF4;CC2D2A;CYFIP1;OPHN1
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),-0.5043984877282303,-0.9918970278924623,0.47619047619047616,0.9330006683100895,1.0,6/21,22.51%,CARMIL1;SSH1;KANK3;CTTN;NCK1;HIP1R
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),-0.6083657085853228,-0.9918464751632526,0.5961538461538461,0.9319626763286624,1.0,1/9,8.23%,CST3
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),-0.6637358951866799,-0.9916923490157581,0.5918367346938775,0.9311574094085463,1.0,2/7,15.94%,NLRC5;ATM
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),-0.5594076356262438,-0.9914710062559322,0.5,0.93047510924609,1.0,2/24,4.78%,GBP1;TNIP1
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),-0.6299573714778037,-0.9914009843082182,0.5370370370370371,0.9295527320550055,1.0,3/8,18.25%,CAMKMT;GSPT1;PRMT2
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),0.41169791202754136,0.9913589166167922,0.375,1.0,1.0,12/38,22.69%,ZBTB1;KDM4C;ACTB;ERCC6;KDM5A;INO80;ARID1A;BAZ1B;BAZ2A;TOP1;PBRM1;JARID2
prerank,GO_Biological_Process_2021__sodium-independent organic anion transport (GO:0043252),-0.6327342073531901,-0.991293045029038,0.5813953488372093,0.9286084443790398,1.0,3/6,7.79%,SLC16A2;SLCO1A2;SLCO2B1
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.557720163892854,0.9911499062323422,0.5833333333333334,1.0,1.0,5/11,28.06%,TLE4;EP300;CREBBP;CDC73;TCF7L2
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.6164425930833389,-0.9905983590724785,0.5121951219512195,0.929282121846085,1.0,2/7,12.95%,EIF2AK2;TAOK3
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),-0.5968969347826315,-0.9902823070769428,0.5357142857142857,0.9288703234373117,1.0,3/10,5.87%,ITGB5;FN1;COL8A1
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),0.6077432846777833,0.9897209430025272,0.5348837209302325,1.0,1.0,3/6,17.19%,LEMD3;SKI;ACVR2A
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),0.5393351144149593,0.9890811082047132,0.5111111111111111,1.0,1.0,7/13,31.39%,ROBO2;PTEN;ROCK1;ROCK2;BCAS3;PHLDB2;CORO1C
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),0.5307650620433484,0.9888065070663166,0.4634146341463415,1.0,1.0,6/15,25.55%,PIK3CA;WASF2;FSCN1;RAC1;CYFIP1;CDC42
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),-0.4631263941304476,-0.9882425796344194,0.45161290322580644,0.9328979375072065,1.0,9/42,18.17%,TMSB4X;FN1;SERPINE1;CD109;ACTN1;CLU;FAM3C;SRGN;PDGFB
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.588272802948063,0.9872082293321235,0.5454545454545454,1.0,1.0,6/10,17.50%,ATP2A2;CACNA1C;SLC8A1;ANK2;RYR2;CALM1
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),0.49409027102657893,0.9870185242285219,0.5121951219512195,1.0,1.0,7/21,25.44%,LRRK2;TPD52L1;CDK12;EDN1;PTPN1;FGFR1;NF1
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),0.5936299098465595,0.986854281366428,0.46,1.0,1.0,4/7,35.90%,IHO1;ZNF207;SMC6;PUM2
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),-0.5397384020678138,-0.9863518453810091,0.4807692307692308,0.9365554341655901,1.0,2/18,6.72%,PLCG2;MEF2A
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.4473232751760665,0.9862004295558481,0.47368421052631576,1.0,1.0,6/47,7.89%,ABL2;STK38L;CHPT1;URI1;ABL1;HSP90AA1
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),-0.5762899068933395,-0.9858441084168847,0.5178571428571429,0.9365563449548395,1.0,5/13,17.81%,SUN1;ATXN7;RPS19;NUP54;NUP98
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),-0.6522208898506845,-0.9857063546946259,0.6111111111111112,0.9356104492418017,1.0,2/5,13.47%,SOD2;CLU
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.6483549650040074,0.9856903728919957,0.46808510638297873,1.0,1.0,2/5,25.91%,WNK1;NEDD4L
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),-0.6216388891970587,-0.9848383215965936,0.5714285714285714,0.9362828389991013,1.0,1/6,1.79%,RIMS1
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),-0.5953666764129429,-0.9839201692624266,0.49019607843137253,0.9369894846830519,1.0,4/15,11.99%,PPARG;TDRD7;LGALS3;PGK1
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),0.6184723303695051,0.9833235416697872,0.5370370370370371,1.0,1.0,3/8,23.91%,PIGU;ANK2;SMURF1
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),-0.6033634694121431,-0.9830821090273286,0.5555555555555556,0.937849681271727,1.0,3/7,22.38%,ZDHHC17;ZDHHC20;ZDHHC21
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),-0.601352450232217,-0.982916785862174,0.5254237288135594,0.9371214596981438,1.0,2/7,20.72%,MSH2;RAD21
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),-0.48889869499596544,-0.982213421643126,0.49122807017543857,0.937896050288823,1.0,1/27,1.79%,RIMS1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.5672190821708026,-0.9816563695511459,0.5471698113207547,0.9380619404487314,1.0,1/15,0.65%,CYLD
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),-0.5025055825902613,-0.9815058846922651,0.43103448275862066,0.937252875673019,1.0,6/27,9.81%,NTNG1;MAP2;CTNNA2;MEF2A;ZDHHC17;S100A6
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.6267083988979094,-0.9814635160940566,0.5918367346938775,0.9362083227789829,1.0,1/7,17.81%,NUP98
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),-0.49135002158270097,-0.981119640904385,0.4482758620689655,0.9358302240143508,1.0,3/25,4.52%,RNF213;HGSNAT;ZNHIT6
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),0.5503919648034818,0.981008002677465,0.5526315789473685,1.0,1.0,4/8,26.90%,ANXA2;MTMR3;PIKFYVE;RAB5A
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),-0.5958282829116441,-0.9804455553288265,0.5909090909090909,0.9362109450527432,1.0,1/9,1.82%,PLK2
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),0.56804869728091,0.9803064974785427,0.5833333333333334,1.0,1.0,7/11,39.20%,RASA1;CCM2;TGFBR3;ADM;RASIP1;SOX18;SPRED1
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),-0.49704415295868026,-0.979950890769687,0.5,0.9363896787024307,1.0,6/27,15.68%,PLK2;PRKN;HECW2;VSIR;FOXO1;GPC3
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.4809908019621215,-0.9791761748672402,0.49206349206349204,0.9368751648714626,1.0,10/27,11.63%,ITGB5;PSMB9;HLA-F;PSMA1;HLA-C;TAP1;HLA-B;B2M;HLA-A;HLA-E
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.6121566607714681,-0.9784762473517921,0.5862068965517241,0.9373949034073621,1.0,3/8,21.42%,ACSL4;ELOVL5;HACD2
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.622632076158909,0.9779290167077922,0.5208333333333334,1.0,1.0,2/5,25.99%,DIP2A;SETD5
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,0.5036790964900917,0.9776239563151775,0.475,1.0,1.0,5/20,8.49%,GRM5;SNAP25;GRIA2;NRXN1;RBFOX1
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),0.5966518394633727,0.9771523621713649,0.5102040816326531,1.0,1.0,2/5,29.54%,BIRC2;ARHGEF2
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),0.5966518394633727,0.9771523621713649,0.5102040816326531,1.0,1.0,2/5,29.54%,BIRC2;ARHGEF2
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),-0.6605544662279892,-0.9764626740622238,0.5454545454545454,0.9405300237118142,1.0,1/5,4.75%,PRKN
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.4799076595260482,0.9759328927756137,0.4473684210526316,1.0,1.0,7/26,16.51%,MED4;CBFB;MED27;ATF7IP;CCNC;MED15;PTEN
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),0.5360907468927423,0.9756947337034971,0.55,1.0,1.0,3/16,17.06%,MICALL2;RAB7A;DENND1A
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),-0.4541093608035849,-0.9753729059373167,0.5362318840579711,0.9414444889505367,1.0,6/52,8.98%,ZIC1;CEMIP;ARIH2;TMEM30A;SMAD3;PMAIP1
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),0.5420543909559624,0.9743017613648578,0.4807692307692308,1.0,1.0,7/10,27.00%,HSP90AA1;ANKRD28;SHQ1;PPP6R3;POT1;PPP6C;HSP90AB1
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),0.5420543909559624,0.9743017613648578,0.4807692307692308,1.0,1.0,7/10,27.00%,HSP90AA1;ANKRD28;SHQ1;PPP6R3;POT1;PPP6C;HSP90AB1
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),0.5420543909559624,0.9743017613648578,0.4807692307692308,1.0,1.0,7/10,27.00%,HSP90AA1;ANKRD28;SHQ1;PPP6R3;POT1;PPP6C;HSP90AB1
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),-0.5444545709093463,-0.9741222474672493,0.5166666666666667,0.9430740802786443,1.0,3/15,6.72%,MAP2;CTNNA2;MEF2A
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),0.5726393691393007,0.9736215274566944,0.5675675675675675,1.0,1.0,3/9,21.88%,ABL1;NRP1;PTPN1
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),0.640373410457798,0.9736047836313666,0.6181818181818182,1.0,1.0,3/6,14.59%,DICER1;PARD3;SKI
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),0.48540998048888095,0.9735385631431579,0.5,1.0,1.0,5/15,32.40%,PPP4R2;POT1;UBR5;SPIDR;TRIP12
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),-0.6027455567049149,-0.9734978408430591,0.5614035087719298,0.9433961505121823,1.0,1/7,1.04%,GBP1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),0.3010110744257813,0.9730028471085366,0.7142857142857143,1.0,1.0,76/514,12.62%,CREB5;HDAC9;SMAD9;IRF2BP2;JAZF1;CALR;TSHZ2;CRY1;TEAD4;ZBTB10;RARB;BCL6;SOX5;ZNF160;AEBP2;BACH2;PRKD1;TAF1;ZBTB1;MCPH1;MTDH;ATN1;KDM4C;BMP6;TET2;ZEB1;CNOT2;BRWD1;MED4;ID3;ST18;TRPS1;PIAS1;GABPB1;ZNF608;URI1;SMAD6;NFYC;KLF7;YY1;ABL1;PBX3;TRAK1;OTUD7B;SLTM;TAF3;DICER1;REST;CTBP2;TOX2;CPEB3;ELF1;EPC2;MRTFA;ZNF704;DNMT3A;ZNF644;FOXO3;CBFB;ZEB2;NCOA3;SMAD5;PGR;SMAD1;TFCP2;ATP2B4;MED27;HSPD1;KLF2;NCOA2;PSIP1;PPP3CA;FOXJ3;CRTC3;SETX;HIVEP1
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),0.5081138751441739,0.9718824873090806,0.48717948717948717,1.0,1.0,2/19,2.65%,PSMD14;UIMC1
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),0.6224400305070291,0.9713615178820096,0.5531914893617021,1.0,1.0,5/6,32.14%,MYL6;PGM5;SVIL;MEF2C;BMPR2
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),0.5655219514858634,0.9709441090453849,0.5306122448979592,1.0,1.0,5/10,20.79%,TAF1;NCOA3;NRP1;ADAM17;EDN1
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),0.4195030941639549,0.9708137186639155,0.4897959183673469,1.0,1.0,9/34,18.77%,ITPR3;STIM1;HOMER1;CPNE8;PPP3CA;NLGN1;RYR2;CALM1;CLIC4
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),0.5652234072765348,0.9699034743482832,0.5306122448979592,1.0,1.0,2/11,5.58%,SLC38A9;PIK3CA
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,-0.5191819020466327,-0.9698569420256441,0.5660377358490566,0.9504159025243735,1.0,3/20,8.80%,PPARG;CHKA;LGALS3
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),0.563215642811739,0.9697942164341493,0.46808510638297873,1.0,1.0,3/8,9.09%,PCM1;ROBO2;REST
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),-0.6136947082595865,-0.9697017746068529,0.5925925925925926,0.9496154467059815,1.0,2/7,9.94%,SP100;ACTN1
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.5966281760467811,0.9695921823472569,0.5306122448979592,1.0,1.0,2/5,19.94%,RALB;RAB3GAP2
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),-0.47952487134364635,-0.9688351638768941,0.4838709677419355,0.9502798111253018,1.0,10/38,11.14%,CX3CL1;CYLD;TMSB4X;IRF1;UFL1;SAMHD1;ERAP1;CAMKMT;APPL2;EFNB2
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,-0.46927974416352625,-0.96794800834797,0.46551724137931033,0.9512231732584472,1.0,6/50,10.20%,EML1;TPM1;SLC16A2;LAMA4;LIMCH1;DIXDC1
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),-0.5728910323495143,-0.9672266060422797,0.48148148148148145,0.9516155484193649,1.0,1/12,1.17%,PSTPIP2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),-0.5973753099962478,-0.966806147049735,0.4782608695652174,0.9515055197550791,1.0,1/5,2.67%,PLCG2
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),-0.5625387324804679,-0.9666954539359108,0.5357142857142857,0.9494827693316151,1.0,1/11,6.18%,PABPC1
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),-0.5625387324804679,-0.9666954539359108,0.5357142857142857,0.9494827693316151,1.0,1/11,6.18%,PABPC1
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.4597369651173726,0.9663667536777263,0.4411764705882353,1.0,1.0,4/36,8.44%,HDAC9;NAA50;UBE2B;MORF4L1
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.636943344250028,0.9660659765651904,0.625,1.0,1.0,2/5,26.06%,SLC1A1;SLC1A2
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,0.6498890040546442,0.9657356700911842,0.5952380952380952,1.0,1.0,2/6,29.75%,FES;ICAM2
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),0.5987736741014101,0.9653683036407964,0.56,1.0,1.0,1/9,4.91%,CCDC186
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),-0.6008367689230796,-0.9652987243469446,0.5,0.9514791364866937,1.0,4/8,27.49%,KPNB1;PIBF1;EML4;RAB11A
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),-0.574860015539045,-0.9648679245086258,0.5740740740740741,0.9515439013477826,1.0,5/14,14.85%,SOD2;SAMHD1;B2M;APPL2;CBR4
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),0.5594600711465706,0.9645330778280409,0.5319148936170213,1.0,1.0,4/8,24.33%,ANKH;S1PR1;ROCK1;ROCK2
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),0.4364946004285162,0.964440431149172,0.4827586206896552,1.0,1.0,6/33,8.57%,IL1R1;PSMD14;ST18;BTRC;TAB2;PLCB1
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),0.5519841761580256,0.9643238797085912,0.5490196078431373,1.0,1.0,3/7,30.48%,FOXO3;NF1;PRNP
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),-0.634098426548878,-0.9643040349036714,0.6122448979591837,0.9516664888920268,1.0,3/7,11.60%,LGALS3;RPS19;CD47
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),-0.570875515679626,-0.9634770357275946,0.5666666666666667,0.9521941334462151,1.0,2/13,4.75%,OPTN;PRKN
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),0.6358249959776785,0.96294235663584,0.5102040816326531,1.0,1.0,1/5,6.88%,PKM
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.4816837015338621,-0.9627049656310336,0.5,0.9528246635896329,1.0,10/26,11.63%,ITGB5;PSMB9;HLA-F;PSMA1;HLA-C;TAP1;HLA-B;B2M;HLA-A;HLA-E
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.6645650835770731,-0.9624720442559572,0.631578947368421,0.9522405253179436,1.0,3/6,23.05%,PMAIP1;ATM;DDX5
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),-0.6194133322620241,-0.962271688849521,0.5471698113207547,0.950569084499369,1.0,2/7,10.25%,UBR2;LARS1
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),-0.6194133322620241,-0.962271688849521,0.5471698113207547,0.950569084499369,1.0,2/7,10.25%,UBR2;LARS1
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.4355588902220541,0.9611689261569493,0.5526315789473685,1.0,1.0,3/25,5.92%,CRY1;UBQLN1;PIAS1
prerank,PanglaoDB_Augmented_2021__Crypt Cells,-0.5078715029401237,-0.9608231094631763,0.5396825396825397,0.9529257278592368,1.0,7/22,19.91%,CLIC5;PPP1R9A;APCDD1;MCF2L;PDE9A;NEBL;ZNF423
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),-0.4284879271504246,-0.9607270632516082,0.5522388059701493,0.9519991366064664,1.0,7/59,6.31%,CLEC1A;ITGB5;LAMA4;CXCL12;FN1;MMRN2;CPQ
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.4277419405460435,0.9603336882858116,0.5116279069767442,1.0,1.0,10/31,22.09%,RALA;CCDC88A;PIK3CA;NLGN1;NRP1;WASF2;FSCN1;RAC1;TENM2;CYFIP1
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),-0.598221184975353,-0.960319467314291,0.5882352941176471,0.9516375823898894,1.0,2/6,14.43%,PGK1;VSIR
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.6052062175400723,0.9600421601800468,0.532258064516129,1.0,1.0,3/6,22.09%,GSN;WASF2;CYFIP1
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),0.4196598569668986,0.9595379489942398,0.4,1.0,1.0,4/27,15.37%,BMP6;PCM1;FRMD4A;CEP290
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),0.6148972554264736,0.9588456793387778,0.631578947368421,1.0,1.0,3/8,4.85%,ERBB4;SEMA3F;PHACTR4
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),-0.47312987672729684,-0.9584932942604625,0.5423728813559322,0.9546044876302816,1.0,3/34,5.32%,BTG2;CNOT8;EIF2AK2
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),0.48898162425159264,0.9582949213663301,0.5333333333333333,1.0,1.0,3/16,11.97%,UIMC1;FAM168A;ERCC6
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),0.6302509552132202,0.9578863896221143,0.6818181818181818,1.0,1.0,1/5,7.11%,TPST2
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),-0.45005033736537825,-0.9578029196720856,0.5666666666666667,0.9550889126188753,1.0,11/44,26.09%,KLHL20;CLTA;FTH1;AP1G1;RAB14;AP4S1;EXOC1;STXBP6;EXOC6;GOLGB1;CLINT1
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),-0.5238266621189619,-0.9577406937665457,0.46938775510204084,0.9541183001840875,1.0,2/12,10.25%,VAV3;LARS1
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,-0.4550270064550184,-0.9576996881629788,0.5172413793103449,0.9530813033229081,1.0,7/28,13.79%,SLC22A5;GPD2;ACSL4;GABARAPL1;HIBCH;ELOVL5;SUCLG2
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),0.37789126431756725,0.9576762456297548,0.45454545454545453,1.0,1.0,19/66,16.87%,SEMA3F;PIK3CA;ROBO2;ALCAM;NRXN1;NCAM1;KLF7;RANBP9;GRB10;FRS2;PRKCA;CHN1;NPTN;NRXN3;EPHA4;NRP1;RPS6KA5;UNC5C;RYK
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),0.3894195499193156,0.9575858780156452,0.5405405405405406,1.0,1.0,4/63,4.70%,ARHGEF4;SRGAP1;FAM13B;BCR
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),0.5575486545889335,0.9568423232040488,0.5813953488372093,1.0,1.0,1/10,1.35%,COG6
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),-0.49622695493987135,-0.9561360085278336,0.5818181818181818,0.9551877326263205,1.0,6/28,15.68%,TMEM30A;WARS1;LGALS3;TFRC;CLU;GPC3
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),0.4598714008386124,0.956133773991761,0.5641025641025641,1.0,1.0,7/24,13.55%,ITPR3;SNAP25;REST;ITPR2;PRKCA;PPP3CB;CACNA1C
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.5582065792121207,0.956083983647688,0.5217391304347826,1.0,1.0,2/6,3.61%,UBQLN1;HSPB1
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),-0.6247706646765597,-0.9555341247218065,0.5517241379310345,0.955509548176458,1.0,2/7,18.12%,MAP3K4;GADD45B
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),0.4444398362746368,0.9546055670133473,0.5319148936170213,1.0,1.0,3/27,6.65%,MAPK10;BTRC;TAB2
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),0.4943009214532461,0.9545151726332965,0.5,1.0,1.0,2/15,6.65%,MAPK10;TAB2
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),-0.5484392066156512,-0.9544742385802517,0.5423728813559322,0.9566739243208684,1.0,1/9,4.41%,MAP2
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),-0.6352654382901897,-0.9540828553554013,0.5689655172413793,0.956446930076191,1.0,1/5,4.80%,CARMIL1
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),0.47972353867040063,0.953803303991013,0.575,1.0,1.0,3/15,13.47%,GRM5;DOCK3;EPHA4
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.5218502092057193,-0.9534928534576843,0.5344827586206896,0.9565274409507406,1.0,3/12,6.05%,ULK4;NTNG1;CTNNA2
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),0.6841538534334703,0.9529173547418615,0.6122448979591837,1.0,1.0,2/5,25.55%,YWHAZ;CDC42
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),-0.5624429572676966,-0.9528784102579574,0.56,0.9567781227705733,1.0,1/10,0.18%,CD74
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.6007424855796291,-0.9525710172858051,0.6274509803921569,0.9561887755634106,1.0,1/8,7.11%,SRGAP2C
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),0.5973548694346351,0.9519107540814185,0.5961538461538461,1.0,1.0,1/5,12.95%,CA5B
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.5860624029945207,0.9517564131149684,0.5818181818181818,1.0,1.0,2/7,16.25%,ADCY2;AKAP12
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.589564287526525,-0.9515847978325609,0.5614035087719298,0.9573344329401435,1.0,3/7,21.42%,ELOVL5;CBR4;HACD2
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),0.5816691991446621,0.9497191519704921,0.6101694915254238,1.0,1.0,2/8,15.50%,REST;ANXA1
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),0.5009483568210635,0.9495832297614077,0.4722222222222222,1.0,1.0,3/14,13.47%,GRM5;SH3BP5;EPHA4
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,-0.4750310396795776,-0.9494825878783568,0.5,0.9608430106820308,1.0,4/31,6.78%,KIAA1217;CLIC5;SMARCA1;DSP
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),0.6324902053335659,0.9493742161910086,0.6382978723404256,1.0,1.0,4/6,23.05%,HSPA9;CDK6;ZBTB16;CDC73
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),0.5688569634510591,0.9489181370011797,0.5849056603773585,1.0,1.0,4/7,24.33%,KLF7;CBFB;ROCK1;ROCK2
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),0.55161041007114,0.9487479872949899,0.5416666666666666,1.0,1.0,4/7,21.75%,ACAT1;ACACA;FAR2;PAM
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),-0.4240491573541725,-0.948690093033048,0.47761194029850745,0.9612233280941027,1.0,2/69,4.39%,CD74;TIE1
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.5539872652141625,0.9486237264858708,0.5416666666666666,1.0,1.0,5/7,20.64%,RTN4;RTN1;PICALM;ROCK1;RTN3
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),-0.48000529368398315,-0.9476545798873686,0.4745762711864407,0.9621448311490273,1.0,4/25,13.24%,RHOBTB1;ARHGAP17;BST2;RHOA
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.4984901829774765,0.9475217019451067,0.5370370370370371,1.0,1.0,4/12,11.89%,CALR;KDM4C;CBFB;NCOA2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),-0.6322146280653296,-0.9474309938367879,0.576271186440678,0.9613722684537458,1.0,3/5,31.49%,TGM2;MICU1;MCU
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),-0.5584102215540825,-0.9469485057853663,0.5961538461538461,0.9615253560816924,1.0,2/12,4.75%,GBP1;PRKN
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),-0.5240700847619607,-0.9465893192322247,0.5161290322580645,0.9612166673207122,1.0,2/13,6.15%,SLC6A6;SLC38A3
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),0.38729535464903425,0.9464921248499525,0.46153846153846156,1.0,1.0,17/48,20.15%,BCL6;NREP;TRPS1;REST;CBFB;PLEKHB2;CLASP1;NLGN1;FES;MBOAT2;BIRC2;CDK5RAP2;CREBBP;TIAM1;CDK6;ROCK1;YWHAG
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),-0.615329475723012,-0.9461731620581851,0.5576923076923077,0.961133509029253,1.0,1/6,9.99%,TMEM50B
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),-0.5788798053967255,-0.9460960580614145,0.47058823529411764,0.9602420455355282,1.0,2/5,34.58%,LPGAT1;PLAAT3
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),0.649483553495728,0.9454640461955105,0.6122448979591837,1.0,1.0,4/5,30.40%,SKI;SORT1;MEF2C;AKAP13
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),0.5675545404670057,0.9447549997775394,0.5581395348837209,1.0,1.0,2/11,6.07%,STIM1;HOMER1
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),0.47142227005969217,0.9445176974175954,0.5483870967741935,1.0,1.0,8/30,17.60%,CCNI;ABL1;RALB;ACTB;SLC8A1;UVRAG;CALM1;CDK12
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),-0.4947732359986076,-0.9442357157125615,0.4727272727272727,0.9628521141570991,1.0,3/21,9.79%,LRPAP1;MAP2;B2M
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",0.4986498173962369,0.9439532880346975,0.5925925925925926,1.0,1.0,1/12,4.26%,MAN1A2
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),-0.4148844139719493,-0.9437899641356617,0.559322033898305,0.9626889717936263,1.0,5/71,4.75%,TBX3;ZIC1;EML1;SMARCA1;PRKN
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),0.537555337949383,0.9435981712747915,0.52,1.0,1.0,2/10,4.91%,CCDC88A;CCDC186
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),0.5635131149625335,0.9434752370678803,0.5625,1.0,1.0,3/8,19.60%,ABL1;POT1;EIF4A2
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),-0.49266204734123586,-0.9434670001247228,0.5357142857142857,0.9623471355643539,1.0,2/27,2.67%,RREB1;PLCG2
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),-0.5563451703635235,-0.9433845440505757,0.5625,0.961380058141604,1.0,2/11,7.61%,SCN2A;STK39
prerank,PanglaoDB_Augmented_2021__Glomus Cells,0.40597189044833853,0.9420758622067807,0.525,1.0,1.0,11/42,20.85%,IL1R1;COL4A2;NTM;PDZRN3;MPDZ;ADGRL2;ANK2;PLPPR4;BOC;PTPN21;MAGI1
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),-0.4270292507735088,-0.941699178961124,0.5555555555555556,0.9637873359303712,1.0,5/69,4.75%,KLHL20;IFI27;PSMB9;PSMA1;PRKN
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,0.4140876399380253,0.9416835993782998,0.5952380952380952,1.0,1.0,2/34,2.34%,TEAD4;COL4A2
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),0.5521200206512152,0.9414515206899826,0.6410256410256411,1.0,1.0,2/7,17.78%,HSP90AA1;CD81
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),-0.4890197430564052,-0.9410072946775097,0.5483870967741935,0.9641592549820481,1.0,4/23,10.62%,TPM1;JUN;MAP3K5;NET1
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),-0.6253175357593763,-0.9410061152254614,0.5777777777777777,0.9630931233088247,1.0,2/5,17.52%,FOXO1;RHEB
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),-0.596399608273727,-0.940526804092,0.6724137931034483,0.9629085468271987,1.0,2/7,13.29%,RFC3;RFC1
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.5322492661455048,0.9403280734677598,0.5636363636363636,1.0,1.0,3/11,14.72%,YWHAB;YWHAZ;YWHAQ
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.5322492661455048,0.9403280734677598,0.5636363636363636,1.0,1.0,3/11,14.72%,YWHAB;YWHAZ;YWHAQ
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),0.5733024674999112,0.9402594770966498,0.5686274509803921,1.0,1.0,2/6,11.66%,AHCTF1;RTN4
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.36613447843249836,0.9402345925108152,0.4722222222222222,1.0,1.0,5/39,7.89%,PSMD14;AVEN;PCM1;TUBB4B;HSP90AA1
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.48723613749674505,-0.9393065686403337,0.5918367346938775,0.9643029101565633,1.0,2/15,2.93%,ISG15;UFL1
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),0.5270855914302489,0.9392796462385705,0.54,1.0,1.0,2/9,11.09%,CRY1;ATP2B4
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),-0.4931144460585335,-0.9392171439685265,0.6140350877192983,0.9633623243873085,1.0,3/36,3.22%,PPARG;PSMB9;PSMA1
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),-0.4088256280839767,-0.9384957175663672,0.5970149253731343,0.9637437393496993,1.0,12/39,19.16%,PSMB9;PSMA1;SCN2A;NDRG1;PMAIP1;PGK1;RORA;UBC;PSMC6;HIF1A;EPAS1;PSMD12
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.4338885071454627,0.93848414464852,0.5428571428571428,1.0,1.0,14/35,25.55%,PRKD1;HSPB1;PIK3CA;HSP90AA1;ELMO1;NRP1;WASF2;ROCK1;RAC1;CYFIP1;CRK;ROCK2;PTK2;CDC42
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),-0.6307296434578162,-0.9383957221815574,0.6842105263157895,0.9618147374216153,1.0,1/6,14.17%,RAPGEF2
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),-0.6307296434578162,-0.9383957221815574,0.6842105263157895,0.9618147374216153,1.0,1/6,14.17%,RAPGEF2
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),-0.6288872329278097,-0.938376424921868,0.5740740740740741,0.9607815882918149,1.0,2/5,30.58%,PDGFB;NFATC3
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),-0.6455714721636345,-0.9381271697736816,0.6862745098039216,0.9602145138143285,1.0,2/5,15.94%,TNKS2;ATM
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),0.4239819424693257,0.9377603486567211,0.5,1.0,1.0,4/31,4.34%,VAPB;PRKD1;KDSR;UGCG
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",0.3077600415658687,0.9371204929731916,0.8888888888888888,1.0,1.0,75/490,12.10%,CREB5;HDAC9;SMAD9;IRF2BP2;CALR;TSHZ2;CRY1;ERBB4;TEAD4;ZBTB10;BCL6;SOX5;FOXN2;ZNF160;AEBP2;CHD7;BACH2;UIMC1;ZBTB1;MTDH;KDM4C;YAF2;ZEB1;GPBP1L1;CNOT2;BRWD1;MED4;ID3;ST18;TRPS1;PIAS1;BTRC;ZNF608;PEX14;URI1;CCDC85B;SMAD6;NFYC;KLF7;CBFA2T2;BICRAL;YY1;ABL1;PBX3;ZNF708;TRAK1;PLCB1;SLTM;PPM1F;REST;CTBP2;TOX2;ELF1;ZNF706;EPC2;ZNF704;ATP8B1;ZNF644;FOXO3;ZMYND11;CBFB;ZEB2;SMAD5;PGR;SMAD1;TFCP2;ATP2B4;NLK;MED27;HSPD1;KLF2;NCOA2;PSIP1;ERCC6;FOXJ3
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.47526781408015784,0.9368521545432895,0.4634146341463415,1.0,1.0,8/20,17.19%,SMAD9;SMAD6;SMAD5;SMAD1;LEMD3;SKI;SMURF2;ACVR2A
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),-0.5785267355729731,-0.93683774127893,0.6666666666666666,0.9619319697467038,1.0,3/11,16.87%,UBR2;ATM;SPAAR
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.6548636073351926,0.9366884255817598,0.6976744186046512,1.0,1.0,2/6,17.50%,ITGA1;CALM1
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),0.35783616204375585,0.93641731395021,0.5185185185185185,1.0,1.0,13/95,13.84%,ARHGEF4;BCL6;TNFAIP8;IGFBP3;DUSP6;ABL1;REST;TIAM2;FOXO3;HSPD1;ANO6;TPD52L1;PSEN1
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),0.5761620218704568,0.9361624597498142,0.5849056603773585,1.0,1.0,2/7,7.01%,PEX5L;UBE2B
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.437767394036371,0.9359174331759261,0.475,1.0,1.0,8/28,17.19%,SMAD9;SMAD6;SMAD5;SMAD1;LEMD3;SKI;SMURF2;ACVR2A
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),0.5338447269719007,0.935407019355824,0.574468085106383,1.0,1.0,1/8,2.65%,UIMC1
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),0.49006243777447794,0.935274807102944,0.5555555555555556,1.0,1.0,11/20,26.17%,CBFB;HSPA9;FES;EP300;CNOT4;CREBBP;CDK6;ZBTB16;CDC73;KMT2E;MEF2C
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.468597021612539,-0.9352498701023594,0.5873015873015873,0.9640422828682867,1.0,7/20,17.11%,UFL1;NUB1;GNA12;RPS7;CLU;RPL11;RPL23
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),0.5877227872897619,0.9351404422141069,0.6545454545454545,1.0,1.0,1/5,4.67%,HSP90B1
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),-0.5075422232806981,-0.934944551577708,0.5892857142857143,0.9635065050256761,1.0,3/17,6.33%,PRKN;DENND3;NGLY1
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.3957080190626227,-0.9341231979171122,0.5806451612903226,0.9639723475065229,1.0,9/69,10.88%,CX3CL1;PPARG;PLCG2;EIF2AK2;SMAD3;NFKBIA;TFRC;TRIM25;NFKB1
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),-0.3967108498945038,-0.9339982704263644,0.527027027027027,0.9631962288348483,1.0,16/104,16.48%,CD74;SNX6;RANBP17;CDC37;VPS36;APPL2;USO1;COPA;ARL4A;POM121C;TBC1D1;STX17;RAB1A;RPL11;KPNB1;NPM1
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),-0.5689601417364933,-0.9333774387138641,0.6071428571428571,0.9634639340848706,1.0,3/8,18.64%,PATJ;RHOA;MSN
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),0.5833646369005692,0.9333428374625303,0.5833333333333334,1.0,1.0,3/6,32.27%,DST;KIF5B;DYNC1H1
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),0.5927251523788818,0.9333156660481612,0.6071428571428571,1.0,1.0,2/7,15.50%,REST;ANXA1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),-0.4724855486073107,-0.9332228765722331,0.5645161290322581,0.9627339102269912,1.0,10/34,21.03%,TMEM117;SCN2A;MAP3K5;PMAIP1;FHIT;ERO1A;ATM;DNAJC10;TNFRSF10B;ZNF385B
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,0.36070117259836787,0.9328469664962431,0.5357142857142857,1.0,1.0,10/67,8.26%,PNP;PSMD14;CALR;ATP2A2;HSP90B1;P4HA1;TES;SKAP2;NFYC;INSIG1
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),-0.4640986271737706,-0.9318079140252068,0.6,0.9646214784959882,1.0,2/42,1.27%,CYLD;RHOBTB1
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),-0.5967894904515947,-0.9313391020507247,0.6166666666666667,0.9644493979309915,1.0,3/9,13.24%,CXCL12;STK39;RHOA
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),0.555563586911917,0.931122947063214,0.5614035087719298,1.0,1.0,2/5,26.64%,WDR43;EIF2AK3
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,-0.48426133089364687,-0.9309171961297761,0.5961538461538461,0.9643759885906984,1.0,4/18,5.53%,OPTN;ABCA5;SLCO1A2;NR3C2
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",-0.4592259015610113,-0.930477617389995,0.5862068965517241,0.964280920611222,1.0,4/29,12.33%,SNX6;SNX2;GOSR1;ANKFY1
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),-0.5324358356309549,-0.9299975662598468,0.5833333333333334,0.9644040146917475,1.0,4/16,13.84%,CCDC88C;MAP3K5;NFKB1;UBC
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),0.36129009073310686,0.9291893913741655,0.5483870967741935,1.0,1.0,13/90,13.84%,ARHGEF4;BCL6;TNFAIP8;IGFBP3;DUSP6;ABL1;REST;TIAM2;FOXO3;HSPD1;ANO6;LRRK2;PSEN1
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),0.5844314323993073,0.9291843927437966,0.6122448979591837,1.0,1.0,5/7,31.57%,INO80;SMC1A;ZNF207;TOP2B;LATS1
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),-0.5024362745758789,-0.9284880375611066,0.5660377358490566,0.9664318578062144,1.0,4/20,8.98%,PRKN;DENND3;NGLY1;PMAIP1
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),0.5285749974282744,0.9284693723644988,0.6363636363636364,1.0,1.0,4/9,24.45%,DNMT3A;ATF7IP;BAZ2A;KMT2E
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),0.5285749974282744,0.9284693723644988,0.6363636363636364,1.0,1.0,4/9,24.45%,DNMT3A;ATF7IP;BAZ2A;KMT2E
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),0.5285749974282744,0.9284693723644988,0.6363636363636364,1.0,1.0,4/9,24.45%,DNMT3A;ATF7IP;BAZ2A;KMT2E
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),0.4408920131456536,0.9282504882715155,0.5384615384615384,1.0,1.0,4/19,16.90%,ACTG1;MICALL2;PARD3;ESAM
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.568583706268776,-0.9281624963286833,0.5964912280701754,0.9660847581620035,1.0,4/12,22.27%,PMAIP1;RPS7;RACK1;NCK1
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),0.4810356031332094,0.9281361011878634,0.6,1.0,1.0,6/26,16.15%,GRM5;ACTG1;ACTB;PSEN1;VMP1;CTNND2
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),-0.6141754892898235,-0.9280747186173403,0.6111111111111112,0.9651627234465391,1.0,4/5,31.26%,APC;LRP6;CTNNB1;GSK3B
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),0.3562318838991565,0.9279122989401772,0.6060606060606061,1.0,1.0,11/71,14.12%,PRKD1;TAF1;MORC3;STK38L;CSNK1G3;PRKX;NLK;PRKCA;LRRK2;WNK1;RPS6KA5
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),-0.49681053545652565,-0.9279062568517376,0.5081967213114754,0.9644054495375363,1.0,6/23,18.33%,NR4A1;JCAD;CDH13;HIF1A;PDGFB;PPP1R16B
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),-0.5683704299858563,-0.9274446733152133,0.5555555555555556,0.9643001310574978,1.0,1/6,4.65%,ARIH2
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),-0.6073087549654143,-0.9271433465026551,0.6326530612244898,0.9638702397365747,1.0,2/5,22.38%,RAPGEF2;ZDHHC21
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),-0.5569214716988344,-0.9260377480254484,0.5,0.9650743422412067,1.0,2/10,2.67%,VCAM1;PLCG2
prerank,PanglaoDB_Augmented_2021__Osteocytes,-0.4564320394134941,-0.9259608765704668,0.5645161290322581,0.9641583970051553,1.0,2/35,2.57%,TPM1;SLC16A2
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),-0.5148179562422158,-0.9257377526335024,0.5849056603773585,0.963557389763086,1.0,2/10,11.06%,LYPLA1;NOSTRIN
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),-0.43919263908586004,-0.9256278029810571,0.5833333333333334,0.9626558447977346,1.0,3/46,4.57%,KLHL20;SNX6;SNX2
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),0.6179530773328922,0.9255440779240733,0.6326530612244898,1.0,1.0,2/5,20.38%,EXT1;NDST1
prerank,MSigDB_Hallmark_2020__Coagulation,0.41036793755559325,0.925534472845557,0.55,1.0,1.0,6/30,9.92%,CRIP2;DUSP6;ITGA2;KLF7;GSN;CAPN2
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),0.4929313957352254,0.9253415779858911,0.5333333333333333,1.0,1.0,7/18,24.33%,CPEB3;YTHDF2;DIS3L2;ROCK1;RC3H1;TUT7;ROCK2
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),-0.44205247639620393,-0.9253057277851143,0.515625,0.9621977456156053,1.0,5/40,10.31%,BTG2;MAP2;GPM6A;PPP1R9A;FRYL
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.4278900187189037,0.9250739668540133,0.4878048780487805,1.0,1.0,8/23,17.19%,PRKD1;IL6R;BMP6;SMAD6;REST;SKI;HDAC7;ACVR2A
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),0.5526127260369298,0.9238968593642559,0.5952380952380952,1.0,1.0,3/6,28.12%,ABL1;PINK1;DCUN1D4
prerank,MSigDB_Hallmark_2020__Pperoxisome,0.43689006701360883,0.9238749094488921,0.5416666666666666,1.0,1.0,3/22,9.66%,HSD17B4;PEX14;IDE
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.5019649495526748,0.9237270410653541,0.5535714285714286,1.0,1.0,3/13,14.72%,YWHAB;YWHAZ;YWHAQ
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),0.47281235641489194,0.9234772745718772,0.5714285714285714,1.0,1.0,5/15,32.55%,YTHDF2;G3BP1;PRRC2C;DYNC1H1;YTHDF3
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.45209570632607887,0.9233924946874434,0.5641025641025641,1.0,1.0,7/22,19.57%,BMP6;ZEB2;RBPMS;ACVR2A;EP300;CREBBP;ADAM17
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),0.5775172086070084,0.9232300842949298,0.6470588235294118,1.0,1.0,2/5,16.51%,SETX;PTEN
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),0.5078756674869345,0.9231470489896774,0.5686274509803921,1.0,1.0,3/11,9.09%,ZEB1;NRCAM;REST
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.37624956205465143,0.9229466801496289,0.7727272727272727,1.0,1.0,13/53,21.11%,COG6;VAPB;MCFD2;BET1;ANK2;COG5;TFG;ANK3;CAPZB;CD59;ATL2;TRAPPC8;ARF4
prerank,PanglaoDB_Augmented_2021__Mast Cells,-0.39545708977379035,-0.9229084556305699,0.5522388059701493,0.9659142120082962,1.0,7/72,4.91%,VCAM1;OPTN;LRATD1;TRANK1;CXCL12;SMARCA1;GPM6A
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),0.48481416181346915,0.9217677574389507,0.5471698113207547,1.0,1.0,5/11,29.47%,GSN;ROCK1;ROCK2;BCAS3;ARFGEF1
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),0.4758120384047972,0.9217671244257971,0.5833333333333334,1.0,1.0,8/23,19.81%,VAPB;MCFD2;BET1;TFG;ANKRD28;PPP6R3;CD59;TRAPPC9
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),0.5362081587991981,0.9211749617698831,0.5686274509803921,1.0,1.0,1/8,3.61%,HSPB1
prerank,PanglaoDB_Augmented_2021__Paneth Cells,0.515905788555556,0.9207764012655587,0.5510204081632653,1.0,1.0,1/8,1.92%,SLC26A3
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),-0.5895511430665935,-0.9206410081660444,0.6440677966101694,0.9692788271390322,1.0,2/6,15.58%,RPS19;CAVIN1
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),-0.41715069166930324,-0.9206153984749574,0.625,0.9683213378305697,1.0,15/45,18.59%,YTHDC1;RPS28;RPL38;RPS15;RPS14;RPS19;USP39;GEMIN5;LUC7L;RPL24;SRPK1;SRSF5;RPL11;RPL10;RPS27
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),-0.37457709517314947,-0.9199445488700358,0.5625,0.9689956430496162,1.0,12/141,10.54%,HES1;TBX3;PPARG;IRF1;SNX6;FOXK1;JUN;RCOR1;SCML1;BRD7;BCOR;CBX5
prerank,PanglaoDB_Augmented_2021__Platelets,-0.4604209763845336,-0.9196772145912782,0.6031746031746031,0.9685974570171559,1.0,11/35,17.06%,CAVIN2;SLC2A3;SERPINE1;CD109;LCP2;HLA-A;HLA-E;GIMAP8;ERO1A;LRRC32;SRGN
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),0.3304318233168035,0.9196571329753507,0.6551724137931034,1.0,1.0,24/82,16.87%,SEMA3F;PIK3CA;ROBO2;NRXN1;NCAM1;NRCAM;KLF7;HSP90AA1;RANBP9;GRB10;ACTB;FRS2;PRKCA;NPTN;NRXN3;PPP3CB;EPHA4;NRP1;RPS6KA5;PARD3;UNC5C;ANK3;PTEN;RYK
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),0.5666299349614349,0.9196444340730351,0.5882352941176471,1.0,1.0,2/5,15.78%,SLC8A1;RYR2
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),-0.5935053976313647,-0.9194856907343537,0.6140350877192983,0.9679647488905191,1.0,2/7,14.17%,SRGAP2C;RAPGEF2
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.4990773908851428,-0.9194154512524021,0.5961538461538461,0.9670768978244628,1.0,4/24,13.73%,TNFSF10;SERPINE1;LGALS3;ITGAV
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),-0.4836066459640637,-0.9190036869815991,0.45,0.9667781293191404,1.0,2/24,1.48%,PPARG;STAT1
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),0.5465295877984451,0.9186686420393266,0.6923076923076923,1.0,1.0,5/9,35.88%,LRRK2;ABCA1;TMEM165;GNPTAB;ARSB
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),0.6143431729685509,0.9185467342838415,0.6037735849056604,1.0,1.0,2/5,21.05%,CD59;RAC1
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),-0.49687499392529483,-0.9183696793871724,0.5666666666666667,0.9669599072011253,1.0,1/14,0.36%,TBX3
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),-0.5148479656041297,-0.9181483007258023,0.5555555555555556,0.9663209992613213,1.0,3/12,13.73%,NFKB1;CLU;ITGAV
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.5724241975858007,0.9181154691660457,0.5660377358490566,1.0,1.0,2/6,17.50%,PARD3;CALM1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.6100368805590115,0.9181055737426039,0.5909090909090909,1.0,1.0,3/6,29.62%,CEP290;GAPVD1;SPIDR
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),-0.4324925454275508,-0.9168509461362082,0.578125,0.9682162138277085,1.0,9/48,12.98%,PSMB9;PLCG2;PSMA1;VAV3;LCP2;NFKB1;HLA-A;BTNL9;INPP5D
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),-0.49817928771673176,-0.9165045145365533,0.5714285714285714,0.967811199782457,1.0,1/20,1.17%,PSTPIP2
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.5169715155724426,-0.9164560347697966,0.6071428571428571,0.9668336128148886,1.0,5/12,29.15%,MSH2;ACVRL1;DACH1;XRCC5;KMT2A
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,0.4946346880859103,0.9163659398872713,0.5581395348837209,1.0,1.0,2/16,7.66%,IL1R1;ANXA2
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),-0.5167858543122111,-0.9163389365177196,0.6041666666666666,0.9660490476643244,1.0,1/22,0.26%,HES1
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),0.5640705794762967,0.9159930539178107,0.6153846153846154,1.0,1.0,1/5,15.45%,AGPS
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),0.39198601355839546,0.9158085041625499,0.6388888888888888,1.0,1.0,4/35,4.67%,PDIA3;UBQLN1;ATP2A2;HSP90B1
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),0.5498572121807959,0.915615585794613,0.5882352941176471,1.0,1.0,4/9,15.21%,FGF12;CACNA1C;SLC8A1;ANK2
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),-0.4501681112290338,-0.9155618023886574,0.5818181818181818,0.9665695327223683,1.0,3/24,10.07%,RNF213;PRKN;UBE2D2
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),-0.6086805182479091,-0.9150006484110725,0.6744186046511628,0.966665498387629,1.0,1/5,2.70%,CCDC68
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),0.5423152066230386,0.9149937351497007,0.5192307692307693,1.0,1.0,5/9,24.12%,DICER1;DIS3L2;SND1;AGO2;TUT7
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),0.553246408713509,0.9144535252534681,0.5961538461538461,1.0,1.0,1/6,9.09%,REST
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),0.4543258480070622,0.9141063523717077,0.5609756097560976,1.0,1.0,2/16,1.48%,PSMD14;AVEN
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.5450394405470439,0.9140764498013791,0.6585365853658537,1.0,1.0,2/9,8.90%,BMP6;PPM1F
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),-0.5890231580973044,-0.9140027651728765,0.6170212765957447,0.967522598098345,1.0,4/5,30.66%,CLEC16A;LARP1;RPTOR;MTOR
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),-0.4906270628354188,-0.9135527991246306,0.4918032786885246,0.9674800327323348,1.0,1/14,4.34%,SLC5A6
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),0.592597322860248,0.9135038459485879,0.72,1.0,1.0,1/7,2.93%,BAG3
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),0.5807420837101673,0.913418812091758,0.6530612244897959,1.0,1.0,3/8,26.17%,MYL6;SVIL;MEF2C
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),0.4128192822408436,0.9133984794037067,0.6829268292682927,1.0,1.0,14/33,29.02%,ACTG1;ABL1;PPM1F;CLASP1;NRP1;PTEN;ROCK1;RAC1;ROCK2;PTK2;EFNA5;BCAS3;PHLDB2;MAP4K4
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.52940414760037,-0.9129862571986532,0.5909090909090909,0.9677646618230378,1.0,1/8,6.05%,CTNNA2
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.5100088383941876,-0.9129299067299917,0.5967741935483871,0.9669313855780333,1.0,3/23,4.75%,SOD2;CXCL12;PRKN
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),-0.5392974780862874,-0.9126067071639278,0.5555555555555556,0.9665315773983117,1.0,2/12,4.75%,ARIH2;PRKN
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.4425218744318565,0.9123342395570211,0.5581395348837209,1.0,1.0,2/17,1.48%,PSMD14;AVEN
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),-0.4286657763239143,-0.9121105213637047,0.5588235294117647,0.9663534983037692,1.0,7/55,9.94%,RIMS1;TMSB4X;FN1;SERPINE1;CD109;ARHGAP17;ACTN1
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.517628895725861,0.9120613045900874,0.627906976744186,1.0,1.0,2/10,7.14%,NUP58;RANBP2
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),0.517628895725861,0.9120613045900874,0.627906976744186,1.0,1.0,2/10,7.14%,NUP58;RANBP2
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),0.517628895725861,0.9120613045900874,0.627906976744186,1.0,1.0,2/10,7.14%,NUP58;RANBP2
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.4739823419030379,-0.9108785312643787,0.5625,0.9675627552905889,1.0,3/18,8.98%,TNFSF10;MAP3K5;PMAIP1
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),-0.5192221033967523,-0.9105581739621403,0.5789473684210527,0.9672265223735089,1.0,2/15,9.71%,SERPINE1;ACER2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),0.4960950509456535,0.9103521309054429,0.5681818181818182,1.0,1.0,5/14,21.21%,YAF2;WAPL;PPP1R10;TOM1L2;PHC3
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.49039869068008113,-0.9099921617660968,0.5576923076923077,0.9672789482801712,1.0,9/24,22.53%,TNFSF10;MAP3K5;PMAIP1;CARD8;NOD1;DELE1;MAP2K5;XIAP;GAS6
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),-0.47910848440592696,-0.9093860770342362,0.6333333333333333,0.967561695733077,1.0,6/20,14.64%,CTNNAL1;ARHGEF11;GNA12;CDH13;RHOA;CFL1
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),-0.47694138537171926,-0.9069216450015555,0.639344262295082,0.9722593103924796,1.0,5/22,17.81%,PPARG;POLR2A;POM121C;NUP54;NUP98
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),-0.5941038599851978,-0.906869377654783,0.6595744680851063,0.9712819794903791,1.0,2/8,14.28%,STK39;HECW2
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",0.5747998800463513,0.9063817569292913,0.6458333333333334,1.0,1.0,2/5,14.25%,DICER1;KPNA1
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.49621009421033957,0.9063804624950608,0.6222222222222222,1.0,1.0,1/10,1.66%,NREP
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),-0.4010177168195943,-0.9057896521551458,0.5970149253731343,0.9726350973029578,1.0,4/62,6.36%,CX3CL1;LRPAP1;MMRN2;GRB14
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),-0.48297969498819004,-0.9057577247013622,0.5909090909090909,0.9716594179436331,1.0,2/17,3.22%,PSMB9;PSMA1
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),0.508774453551518,0.9050787498979179,0.5849056603773585,1.0,1.0,3/12,14.04%,CHD7;PBX3;FOXC1
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.5673550102625794,-0.9049845232146917,0.56,0.9723112108105091,1.0,3/7,14.41%,PKIG;RAPGEF2;PRKAR1A
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),0.32986353447212324,0.9047794886060329,0.631578947368421,1.0,1.0,19/109,18.82%,UBQLN1;PACS2;ATP2A2;PCM1;WDPCP;AMBRA1;CDC14B;GSN;YTHDF2;PARVA;INO80;ATG2B;VMP1;CEP290;RAB7A;ABCC4;NEK7;G3BP1;BBS9
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),-0.45126184612253395,-0.9046904171577247,0.578125,0.9719520119152689,1.0,2/28,2.39%,CX3CL1;APOL3
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),0.4787540667823079,0.9046063425791395,0.6136363636363636,1.0,1.0,8/14,22.74%,UGCG;SLC8A1;ANK2;ANXA1;RYR2;YWHAG;PTPN1;CRK
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),-0.4965452805187178,-0.9044717579136645,0.6296296296296297,0.9714479941394555,1.0,4/19,17.06%,SPG7;CPM;VSIR;SRGN
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),-0.5578117070929343,-0.9043537638723108,0.5892857142857143,0.970778836276556,1.0,1/8,5.17%,ATP6V1E1
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),0.3798526151725246,0.9036175680360262,0.6097560975609756,1.0,1.0,10/52,14.59%,SMAD9;SOX5;SMAD6;SMAD5;SMAD1;NLK;GCNT2;APPL1;PARD3;SKI
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),0.3321346473640314,0.9036048838647278,0.6388888888888888,1.0,1.0,15/93,12.44%,HDAC9;TEAD4;RARB;SOX5;TAF1;ZBTB1;MED4;TAF3;CBFB;PGR;TFCP2;ELL2;MED27;ERCC6;SETX
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),-0.516659747695207,-0.9030945204895325,0.6037735849056604,0.9724871920672706,1.0,1/10,8.23%,CST3
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",-0.5170554261813489,-0.9025284293507171,0.5892857142857143,0.9726061070565346,1.0,4/12,21.00%,TAF1D;POLR2A;CAVIN1;MTERF1
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.5830137695040722,0.9021801083815207,0.62,1.0,1.0,2/5,13.91%,BTRC;NLGN1
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.43507617898208306,0.9021139812375768,0.6216216216216216,1.0,1.0,7/21,11.53%,HSPH1;BAG3;HSPB1;STT3B;HSP90AA1;HSPA9;HSPD1
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),-0.5669565255848348,-0.9020167704098487,0.68,0.9729939927245602,1.0,3/8,13.24%,CXCL12;STK39;RHOA
prerank,PanglaoDB_Augmented_2021__Reticulocytes,0.4414354892089802,0.9019013940385999,0.6222222222222222,1.0,1.0,3/21,10.07%,PRPF8;STT3B;XPO1
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,0.5281188164674506,0.9018158473053977,0.5789473684210527,1.0,1.0,2/8,5.61%,SLCO2A1;MAP7
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.45901375389282917,-0.9018152564889523,0.6451612903225806,0.972357039068308,1.0,3/21,8.44%,PSMB9;PSMA1;ANAPC16
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),0.5607788040927374,0.9004656587181636,0.6595744680851063,1.0,1.0,4/6,34.29%,PSEN1;INSR;PRNP;ARF1
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),-0.43866632841543124,-0.9004327259892204,0.5818181818181818,0.9738500168539472,1.0,3/28,6.02%,ARHGAP15;VAV3;PLXND1
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),0.5382714996253329,0.8997260207011811,0.6271186440677966,1.0,1.0,5/8,24.33%,SLC2A13;EPHA4;PICALM;ABCG1;ROCK2
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),0.4277270083530473,0.8995137886218525,0.6222222222222222,1.0,1.0,4/27,10.85%,MT2A;BMP6;MT1M;MT1E
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),-0.4222472518630781,-0.8991689890039829,0.5737704918032787,0.9756082851551711,1.0,8/63,7.50%,CX3CL1;ZIC1;DOK5;SP100;GIT2;RGS6;GRK5;ZDHHC17
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),0.34368620453319293,0.8988192857088363,0.6470588235294118,1.0,1.0,14/105,14.12%,CALR;FOXN2;CHD7;YAF2;GPBP1L1;NFYC;ABL1;ZNF708;REST;RALY;NLK;NCOA2;FOXC1;RPS6KA5
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),0.5339676608512034,0.8978153201295622,0.65,1.0,1.0,2/11,8.41%,TRAK2;TRAK1
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",0.4174769399565523,0.8977548285324383,0.5526315789473685,1.0,1.0,7/25,16.51%,MED4;CBFB;MED27;SETX;CCNC;MED15;PTEN
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),0.36173224071877724,0.8973599577517174,0.5833333333333334,1.0,1.0,13/56,20.12%,ERBB4;PRKD1;TAF1;ABL1;PRKX;OXSR1;LRRK2;EPHA4;FES;CDK12;TAOK1;DYRK1A;PINK1
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),-0.419814633319827,-0.8973595961210244,0.6885245901639344,0.978156917300064,1.0,4/68,10.62%,CX3CL1;RGS6;LARS1;NET1
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),0.39927753911502933,0.8972618153875204,0.5277777777777778,1.0,1.0,4/37,5.53%,TRIM5;PRKD1;MTDH;FBXO7
prerank,PanglaoDB_Augmented_2021__Microglia,-0.4981615924235697,-0.8960691227211784,0.6274509803921569,0.9795980723156853,1.0,5/14,15.91%,ITGB5;SLCO2B1;LCP2;GIMAP8;FOS
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.5541474906242095,-0.8959342366803694,0.5957446808510638,0.9778866765206163,1.0,1/5,10.85%,POLR2A
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.5541474906242095,-0.8959342366803694,0.5957446808510638,0.9778866765206163,1.0,1/5,10.85%,POLR2A
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),0.599773513142783,0.895794373078177,0.6666666666666666,1.0,1.0,2/5,15.50%,PPP3CA;ANXA1
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),0.2970398311668061,0.8951264604914101,0.8333333333333334,1.0,1.0,33/279,11.40%,TRIM5;AFF3;RBM20;CALR;NOVA1;BCL6;FOXN2;CHD7;TAF1;PTBP3;ACTG1;BMP6;YAF2;GPBP1L1;MBNL1;KRAS;NFYC;UTY;YY1;ABL1;ZNF708;DICER1;PPM1F;NOVA2;HNRNPLL;REST;LARP4;GSN;PGR;SMAD1;ATP2B4;NLK;GCNT2
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,-0.4476413693974994,-0.8949675139639828,0.6,0.9786664275188486,1.0,5/42,6.78%,KIAA1217;CXCL12;FN1;PKHD1L1;DSP
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),-0.47097792780660797,-0.8946078572455979,0.5614035087719298,0.9784392264267338,1.0,5/19,13.24%,TPM1;CARMIL1;LIMCH1;CD47;RHOA
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),-0.4324125247708098,-0.8944564879252729,0.582089552238806,0.9777308313491804,1.0,2/31,3.22%,PSMB9;PSMA1
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),-0.5523953362853772,-0.893932285138332,0.56,0.9776381459605226,1.0,1/6,2.52%,TPM1
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),-0.4434065919180989,-0.893587385159234,0.5789473684210527,0.9772490652434646,1.0,4/27,7.79%,ABCA5;SLCO1A2;CHKA;SLCO2B1
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),0.42226117578939065,0.8934415798847704,0.5641025641025641,1.0,1.0,6/26,16.15%,CDH2;ACTG1;ACTB;PRKCA;CDH12;CTNND2
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),-0.5231721482051862,-0.8933772457192339,0.6440677966101694,0.9756261828944959,1.0,2/11,3.22%,PSMB9;PSMA1
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.5231721482051862,-0.8933772457192339,0.6440677966101694,0.9756261828944959,1.0,2/11,3.22%,PSMB9;PSMA1
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),-0.4547070362188774,-0.8928718569483876,0.65,0.9756379857108285,1.0,5/38,8.85%,CX3CL1;NTNG1;GPM6A;PLXND1;ZC4H2
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),0.531458719528785,0.892846069423035,0.6086956521739131,1.0,1.0,2/9,10.07%,BACH2;XPO1
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),-0.5859099295008982,-0.8920794566973562,0.66,0.9762812529358337,1.0,1/6,5.53%,NR3C2
prerank,PanglaoDB_Augmented_2021__Myocytes,-0.470002918044357,-0.8916890691229071,0.59375,0.9761397396425938,1.0,4/19,11.55%,TPM1;MEF2A;DMD;NID1
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),-0.46745194294165465,-0.8913329086506353,0.6101694915254238,0.9758562113874031,1.0,4/25,13.24%,PLK2;CDC14A;SPAST;RHOA
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),0.5466732005456346,0.8909293378899505,0.723404255319149,1.0,1.0,2/7,19.29%,ARID1A;ZMIZ1
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),0.3429461305939676,0.8903335025599038,0.6774193548387096,1.0,1.0,20/70,24.33%,PRKD1;TAF1;MORC3;STK38L;CSNK1G3;PRKX;PRKCA;LRRK2;WNK1;RPS6KA5;GALNT2;DYRK1A;ROCK1;PINK1;MAST2;TOP1;TNKS;AKT3;CAB39;ROCK2
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),-0.5412244736076045,-0.8898174062824867,0.5964912280701754,0.9779798018913618,1.0,2/12,4.75%,OPTN;PRKN
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),-0.42791321995502657,-0.8893516843143483,0.6666666666666666,0.9779181433799135,1.0,8/44,12.98%,PSMB9;PLCG2;PSMA1;LCP2;NFKB1;HLA-A;BTNL9;INPP5D
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),-0.5967539454471736,-0.8893019727657021,0.7358490566037735,0.976985125393433,1.0,1/7,1.38%,ISG15
prerank,MSigDB_Hallmark_2020__Hypoxia,0.3448169565481374,0.888902533413167,0.6571428571428571,1.0,1.0,14/73,12.38%,MT2A;UGP2;P4HA1;IGFBP3;TES;TPST2;KLF7;ANXA2;EXT1;FOXO3;MT1E;GCNT2;PLIN2;PRKCA
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),-0.4602470386033832,-0.8888820720687157,0.6101694915254238,0.9768334925941637,1.0,5/30,11.99%,PPARG;STAT1;SERPINE1;ADAMTS1;PGK1
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),0.3709706626762569,0.8886382770797168,0.7027027027027027,1.0,1.0,10/47,12.46%,NRG2;ERBB4;MTDH;PIK3CA;PLEKHA1;HSP90AA1;GCNT2;RTN4;FRS2;PPP2R5C
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),0.5083662192485204,0.8883992261047492,0.6458333333333334,1.0,1.0,3/12,15.21%,FGF12;HOMER1;ANK2
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),-0.4727027384171768,-0.8880465076258217,0.5370370370370371,0.9773799636280103,1.0,2/23,5.43%,ATP9A;TMEM30A
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),0.49826974689319464,0.8877612618756358,0.5952380952380952,1.0,1.0,6/10,30.37%,TOM1L2;PHIP;CDK5RAP2;EDN1;RGCC;INSR
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),-0.5035275263072995,-0.8875983791676643,0.578125,0.9763400658196387,1.0,3/12,13.24%,CDC14A;SPAST;RHOA
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),-0.5035275263072995,-0.8875983791676643,0.578125,0.9763400658196387,1.0,3/12,13.24%,CDC14A;SPAST;RHOA
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),-0.5345698162865423,-0.886485907277941,0.6724137931034483,0.977409658391326,1.0,1/9,1.27%,RHOBTB1
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),-0.40008950940344934,-0.886339527348684,0.5757575757575758,0.9767245397701374,1.0,7/61,6.70%,PPARG;STAT1;SP100;TIE1;SERPINE1;PLXND1;WARS1
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),-0.5599269139277953,-0.8862848705449726,0.65,0.975859688457923,1.0,3/6,24.53%,BCOR;MTF2;KDM1A
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),-0.40316756832059586,-0.8858856722780145,0.6142857142857143,0.974506754396856,1.0,7/45,10.88%,PSMB9;PLCG2;PSMA1;VAV3;JUN;LCP2;NFKB1
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),-0.40316756832059586,-0.8858856722780145,0.6142857142857143,0.974506754396856,1.0,7/45,10.88%,PSMB9;PLCG2;PSMA1;VAV3;JUN;LCP2;NFKB1
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),-0.5157584683837357,-0.8856817601993837,0.5660377358490566,0.9738875028009811,1.0,1/9,1.79%,RIMS1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),-0.48223732684983317,-0.8853271387889691,0.6271186440677966,0.9736603350178006,1.0,2/19,9.79%,STAT1;B2M
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),-0.5702260089742213,-0.8851039529297753,0.6610169491525424,0.973003130904639,1.0,1/8,5.17%,ATP6V1E1
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),0.5469556256270962,0.8837572747316482,0.6730769230769231,1.0,1.0,3/6,12.82%,PIK3CA;GSN;PARVA
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),0.5673695311824146,0.8832409725406043,0.6296296296296297,1.0,1.0,3/5,14.69%,EXT1;GLCE;HS6ST3
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),-0.5781041260848789,-0.8827790736010146,0.6326530612244898,0.9768878860585105,1.0,3/8,4.34%,SLC16A2;SLC6A6;SLC5A6
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),-0.5557622502086218,-0.8823044795412076,0.6909090909090909,0.9769181708942857,1.0,3/10,11.24%,TPM1;DMD;ARHGEF11
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,-0.4521655890174816,-0.8822124612256845,0.639344262295082,0.9761099584375362,1.0,3/28,3.48%,TPM1;LAMA4;CXCL12
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),0.421162449902365,0.8819629230211062,0.4864864864864865,1.0,1.0,6/24,19.78%,UIMC1;PPP1R10;ERCC6;POT1;RNF168;USP9X
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),0.5968439366142427,0.8817004677327765,0.6875,1.0,1.0,4/6,25.44%,MORC3;SKI;CDC73;NF1
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),0.5404277947475777,0.8813207386310262,0.717391304347826,1.0,1.0,4/7,22.46%,ENTPD1;SND1;MTREX;XRN2
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.4722279535506665,0.8810775084215745,0.6363636363636364,1.0,1.0,1/12,1.66%,NREP
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",0.549015231498104,0.8809420217896891,0.6909090909090909,1.0,1.0,1/6,4.67%,HSP90B1
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),-0.5312162459642373,-0.8805200314942877,0.660377358490566,0.9775764647687023,1.0,1/10,1.38%,ISG15
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),-0.5312162459642373,-0.8805200314942877,0.660377358490566,0.9775764647687023,1.0,1/10,1.38%,ISG15
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),-0.5152893047197935,-0.8799542369425456,0.62,0.9777751170780783,1.0,2/12,7.04%,SERPINE1;CD109
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),-0.514777442201618,-0.8798757664198957,0.6031746031746031,0.976899682339687,1.0,4/11,21.26%,CD47;PTPRR;AFDN;SMAD7
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),0.5413258848628546,0.8796017593683981,0.6829268292682927,1.0,1.0,1/10,1.06%,CALR
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),-0.4623547632525419,-0.8793621604666211,0.5769230769230769,0.9770588862905191,1.0,4/17,13.24%,STAT1;PLXND1;CDH13;RHOA
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),-0.5664015905756504,-0.8791332947752626,0.6140350877192983,0.9765232475257271,1.0,2/7,13.94%,STAT5B;JAK2
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),0.4120076042068524,0.8788231352068588,0.6,1.0,1.0,3/22,4.88%,GRM5;HSPB1;CCDC88A
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),0.49794227807206365,0.8786671496203016,0.6,1.0,1.0,1/10,3.61%,HSPB1
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),0.5741751992707618,0.8784496268630525,0.6923076923076923,1.0,1.0,2/6,11.73%,ACTG1;ACTB
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),0.4889505199311459,0.8773525055443705,0.6829268292682927,1.0,1.0,1/8,10.12%,S1PR1
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),-0.5093856866907802,-0.8770565706863812,0.6111111111111112,0.9796362660353691,1.0,2/8,18.09%,FOXF1;ACVRL1
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,-0.570079677974106,-0.876930309816947,0.7115384615384616,0.9789902086170181,1.0,1/5,6.78%,DSP
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),0.4281791678275092,0.8766025384152212,0.6829268292682927,1.0,1.0,8/23,22.64%,NAA50;HSPD1;PSEN1;ADAM10;GALNT2;PCSK5;ADAM17;TASP1
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),0.4384310649796897,0.8763863060160899,0.5909090909090909,1.0,1.0,7/16,21.05%,NAV3;ABL1;CLASP1;FES;CDK5RAP2;DYRK1A;RAC1
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),-0.5071792443960266,-0.876301751693087,0.6888888888888889,0.9793742290650761,1.0,3/12,17.03%,LIMA1;SHROOM2;PAWR
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),-0.48454095915099266,-0.8762580376294937,0.6818181818181818,0.978541945095993,1.0,3/15,17.00%,FHIT;RPL11;N4BP1
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),-0.4114594332486574,-0.8761430994467082,0.7049180327868853,0.9777902906591032,1.0,7/37,19.24%,PLK2;PRKN;HECW2;FOXO1;GPC3;MSN;APC
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),-0.44161887537779965,-0.8742445213906168,0.6326530612244898,0.9803540627416159,1.0,2/16,9.97%,TNIP1;TANK
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),-0.479351794690031,-0.8737687435760535,0.6296296296296297,0.9802327060002258,1.0,3/28,5.32%,BTG2;CNOT8;EIF2AK2
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),0.4778322801322984,0.8735641421090283,0.631578947368421,1.0,1.0,5/10,22.09%,ELMO1;HACE1;TIAM1;RAC1;CYFIP1
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),0.4194484096215162,0.8734699571554505,0.6136363636363636,1.0,1.0,5/15,21.13%,INPP5F;PTEN;PLPPR4;MTMR3;MTMR10
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),0.3960205106698315,0.8727072778643716,0.65625,1.0,1.0,5/30,14.28%,HSPB1;ABL1;PPM1F;SH3BP5;SLC8A1
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.45421677410900047,-0.8725122137860802,0.6607142857142857,0.9816668528028956,1.0,1/28,1.19%,CEMIP
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),-0.5592160541527342,-0.8721082543575249,0.6896551724137931,0.9813575997912151,1.0,2/6,18.33%,MTMR2;PPP1R16B
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),0.5318137434289212,0.8719297338629948,0.6851851851851852,1.0,1.0,4/8,35.88%,LRRK2;ABCA1;GNPTAB;ARSB
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),0.5178063843199281,0.8712719366821978,0.6486486486486487,1.0,1.0,2/6,28.30%,ACACA;CPT1A
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),-0.5326246940034737,-0.8709013652334403,0.6538461538461539,0.9825716833906988,1.0,4/9,24.45%,UNC13B;RACK1;GAS6;ZBTB20
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),0.34943308190588707,0.8706844967622591,0.6176470588235294,1.0,1.0,7/43,7.17%,INPP5F;TTC7A;PIK3CA;PLEKHA1;PITPNM2;PI4KA;PIGU
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),0.4854024971565496,0.8706442345680051,0.6538461538461539,1.0,1.0,4/11,16.80%,CALR;XPO1;XPO4;XPO7
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),-0.37437054400041514,-0.8706282743929663,0.6388888888888888,0.9822228910538678,1.0,5/78,4.75%,CYLD;PSMB9;PSMA1;CDK14;PRKN
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),-0.45523743427966157,-0.8704374171406258,0.6333333333333333,0.9815708381013161,1.0,2/25,2.18%,PPARG;TMSB4X
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),-0.47367582782177625,-0.8704164321296994,0.578125,0.980626213324099,1.0,6/21,15.94%,UFL1;PRKN;CALCOCO2;VIM;UBC;ATM
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.43117148957635454,-0.8688995661197353,0.7391304347826086,0.980430580031243,1.0,3/29,3.22%,PSMB9;PLCG2;PSMA1
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.43117148957635454,-0.8688995661197353,0.7391304347826086,0.980430580031243,1.0,3/29,3.22%,PSMB9;PLCG2;PSMA1
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),-0.43117148957635454,-0.8688995661197353,0.7391304347826086,0.980430580031243,1.0,3/29,3.22%,PSMB9;PLCG2;PSMA1
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,0.49891850102446017,0.8686389344319175,0.5918367346938775,1.0,1.0,1/8,3.17%,SEMA3F
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),-0.5586024973481276,-0.8685455046938231,0.6610169491525424,0.9803103358633599,1.0,2/6,7.79%,SLCO1A2;SLCO2B1
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),0.4623471305706247,0.8677470645763959,0.6530612244897959,1.0,1.0,5/14,15.03%,SLC38A9;CPEB3;CAPN2;SESN1;CPEB4
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),-0.47928754915405974,-0.8676331769722936,0.6730769230769231,0.980979851706772,1.0,6/18,15.68%,SERPINE1;B2M;APPL2;ANKFY1;CLU;GPC3
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),-0.5871800504405453,-0.8676329009307959,0.7543859649122807,0.9800218635703397,1.0,1/5,3.48%,CXCL12
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.34186027816769726,0.8668807549525415,0.7352941176470589,1.0,1.0,11/71,9.09%,SOX5;CDH2;PRKD1;IL6R;BMP6;ZEB1;IGFBP3;NRCAM;ABL1;PLCB1;REST
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),-0.461224760946236,-0.8667201603736149,0.6226415094339622,0.9808654621207322,1.0,3/19,11.58%,PRKN;DENND3;CLTA
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),0.4061616424947165,0.8660412440735847,0.717948717948718,1.0,1.0,7/29,13.03%,PRKD1;PIK3CA;ABL1;FOXO3;STX2;SETX;LRRK2
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),-0.47693179108108164,-0.8656279621940044,0.6363636363636364,0.9818629157608455,1.0,6/17,15.32%,TFRC;B2M;ACO1;IREB2;NDFIP1;FTH1
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),-0.5045206736296253,-0.8651692171312543,0.6470588235294118,0.9816836067832517,1.0,5/10,19.96%,MYCBP2;EFNB2;PDGFB;USP14;PTPN2
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),-0.531675248215,-0.8646574425348346,0.7115384615384616,0.9815822451573432,1.0,1/11,5.56%,SERPINE1
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),0.5747713157421932,0.864557479977532,0.7843137254901961,1.0,1.0,3/5,30.40%,SLC8A1;MEF2C;AKAP13
prerank,PanglaoDB_Augmented_2021__Osteoclasts,0.3927341693464321,0.8643244399582501,0.6904761904761905,1.0,1.0,6/30,13.03%,IL1R1;ITPR3;ITGA2;GSN;KCTD12;LRRK2
prerank,GO_Biological_Process_2021__brain development (GO:0007420),-0.38938438541565135,-0.8640752772733703,0.7121212121212122,0.9818686959912379,1.0,4/48,6.05%,ZIC1;EML1;SMARCA1;CTNNA2
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),-0.4562787446669559,-0.8629075414061858,0.6909090909090909,0.9829871547268677,1.0,2/30,1.35%,NR4A1;PPARG
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),-0.4498216442891667,-0.8615055482049693,0.6551724137931034,0.984693410685393,1.0,4/24,9.50%,PRKN;SRGAP2C;CST3;TFRC
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.5192053834872006,-0.8615037067512816,0.6779661016949152,0.9837392504037209,1.0,2/10,8.70%,UFL1;SRARP
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),0.3733181581140707,0.8614731449278825,0.6428571428571429,1.0,1.0,7/28,15.39%,TAF1;ABL1;IDE;RALB;LRRK2;PSEN1;PPP2CB
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),0.5328882751061337,0.8609589186946753,0.6976744186046512,1.0,1.0,1/6,4.54%,PCM1
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),-0.4885434404867988,-0.86087585580374,0.6491228070175439,0.9839452810361063,1.0,1/11,4.80%,CARMIL1
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),-0.5623192249934952,-0.8607326802334035,0.6666666666666666,0.9832637086255493,1.0,2/6,6.96%,NGLY1;SAMHD1
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),0.4540706843440109,0.8605876287402232,0.5813953488372093,1.0,1.0,5/14,26.17%,CBFB;EP300;CNOT4;KMT2E;MEF2C
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),-0.4037239437674138,-0.8604929881490232,0.639344262295082,0.9826990637842552,1.0,8/58,14.72%,BTG2;MAP2;GPM6A;PPP1R9A;FRYL;TAOK3;RAPGEF2;DCLK1
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.39600612098631494,0.8600457927345603,0.6739130434782609,1.0,1.0,6/29,8.39%,RNF217;UBQLN1;TAF1;COP1;PIAS1;RNF180
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),-0.451861999388289,-0.8598932265982377,0.6984126984126984,0.9827611281840297,1.0,10/24,21.78%,TPM1;CXCL12;CD47;ITGAV;JAK2;ATM;PDGFB;AFDN;SMAD7;TGM2
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.5041268690391162,0.8598190947807005,0.6744186046511628,1.0,1.0,4/9,18.77%,UGCG;BCR;ANXA1;CLIC4
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),0.399465513595728,0.8589574582749643,0.6585365853658537,1.0,1.0,5/28,12.85%,CALR;MORC3;TAF3;PPP1R10;APPL1
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),-0.43874562726534055,-0.858855622397497,0.6774193548387096,0.9837173263965191,1.0,5/31,13.94%,DENND3;ARHGAP17;ARHGEF28;MAPKAP1;JAK2
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.36024973504748775,0.858263662401004,0.6756756756756757,1.0,1.0,12/54,15.58%,SMAD9;BMP6;SMAD6;SMAD5;SMAD1;NLK;GCNT2;HIVEP1;APPL1;PARD3;SKI;SMURF2
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.462372271986238,-0.8580942242698426,0.6271186440677966,0.9839800239032093,1.0,4/16,13.84%,NFKBIA;TANK;TBK1;UBC
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),-0.5226428780599617,-0.8576504472150045,0.7169811320754716,0.9838967194242297,1.0,3/11,13.84%,CDC14A;ANAPC16;UBC
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),-0.4866133268379271,-0.8573960177987083,0.6226415094339622,0.9832862410984855,1.0,3/15,7.79%,SLC16A2;SLCO1A2;SLCO2B1
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),-0.4330309349361116,-0.857389398391003,0.6557377049180327,0.982341681789073,1.0,8/24,26.14%,SEPTIN11;SPAST;RHOA;APC;SPTBN1;SEPTIN2;IST1;EFHC1
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),0.5375785119619791,0.8571428606730053,0.6808510638297872,1.0,1.0,3/8,10.85%,MT2A;MT1M;MT1E
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),-0.5578782382252565,-0.856611500863836,0.6595744680851063,0.9827960808346534,1.0,1/6,8.15%,JUN
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.44049009107339415,-0.8565251450989615,0.631578947368421,0.9820354486780485,1.0,5/25,16.20%,SNX6;SMAD3;CD109;UBC;SNX25
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),0.47310295726416973,0.8565051789716557,0.7391304347826086,1.0,1.0,5/13,21.18%,BTRC;SPOPL;TRAF3;ITCH;ASPH
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),0.47858334117799384,0.8555225034196073,0.64,1.0,1.0,3/9,27.00%,PICALM;NEDD4L;HSP90AB1
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),0.539114268910056,0.8543885691897187,0.7083333333333334,1.0,1.0,2/6,25.91%,WNK1;NEDD4L
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),0.47904424058308415,0.8534836943069407,0.6086956521739131,1.0,1.0,2/13,17.50%,ITGA1;CALM1
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),0.5039383860944654,0.8526254405379892,0.6470588235294118,1.0,1.0,4/7,32.55%,YTHDF2;KHDRBS1;HABP4;YTHDF3
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),0.5187317410620155,0.8516830561997291,0.673469387755102,1.0,1.0,4/6,20.64%,RTN4;RTN1;ROCK1;RTN3
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),-0.3775411702794473,-0.8512115095003652,0.6349206349206349,0.9907605721338314,1.0,9/39,17.11%,RFC3;TOPBP1;RPS15;BRD7;MAPKAP1;SMYD2;RPL11;ATM;RPL23
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),0.44605037195078123,0.8497776951965309,0.6666666666666666,1.0,1.0,4/14,17.99%,GXYLT1;GALNT10;GALNT2;C1GALT1
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),0.41876399386974117,0.8493921882033018,0.7441860465116279,1.0,1.0,4/12,21.13%,INPP5F;PTEN;MTMR3;MTMR10
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),0.46139768948485416,0.8488846810119299,0.6904761904761905,1.0,1.0,5/11,29.62%,ADCY2;KLF9;CTNNA1;GRAMD1A;SPIDR
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),-0.5337324206392082,-0.8488299055531663,0.6956521739130435,0.994669362390736,1.0,1/5,7.27%,CASS4
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,0.47142551205199923,0.8487836680690071,0.6888888888888889,1.0,1.0,4/13,6.57%,SNAP25;GRIA2;ALCAM;NRXN1
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),-0.5304419436607751,-0.8487429886069304,0.6491228070175439,0.9938137646011382,1.0,1/6,9.71%,ACER2
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),0.4081882884919336,0.8486677052661589,0.7272727272727273,1.0,1.0,8/25,19.11%,KPNA3;RANBP2;PPP1R10;APPL1;CBLB;KPNA1;IPO8;KPNA5
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),-0.5684539565658738,-0.848523529572916,0.7413793103448276,0.9932550386610542,1.0,2/6,13.24%,MAP2;RHOA
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),0.5230857494628716,0.8484401405996829,0.7111111111111111,1.0,1.0,2/5,22.61%,KLF2;ADAMTS9
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),-0.4124877312211851,-0.8483321527315028,0.676923076923077,0.9926212613777479,1.0,8/41,14.17%,CX3CL1;CARMIL1;PLXND1;KIDINS220;CAPRIN1;SCARF1;RHOA;RAPGEF2
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,-0.4374107018713457,-0.8479248727750152,0.6610169491525424,0.9924069402262252,1.0,3/29,3.48%,TPM1;LAMA4;CXCL12
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),-0.49048488185751693,-0.8474993725798312,0.6607142857142857,0.9922120204625097,1.0,5/15,9.84%,CX3CL1;IRF1;SAMHD1;ERAP1;APPL2
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),-0.5124267258771111,-0.8474057870153815,0.7037037037037037,0.9914671941408423,1.0,1/12,1.38%,ISG15
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,-0.5457388521496398,-0.8468225279547599,0.6538461538461539,0.9915294583948888,1.0,1/7,3.48%,CXCL12
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),0.3838638766713272,0.8461097184405245,0.6666666666666666,1.0,1.0,7/22,20.15%,PCM1;TUBB4B;HSP90AA1;CLASP1;CEP290;CDK5RAP2;YWHAG
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),-0.5181928598407971,-0.845835188936569,0.7454545454545455,0.9923491662075905,1.0,3/9,15.94%,MAP3K4;TNKS2;ATM
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),-0.43233692858899997,-0.845778924682826,0.6923076923076923,0.9914549611516401,1.0,3/20,10.72%,PRKN;TFRC;PARP9
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),-0.4464695622655298,-0.8453445286004522,0.6666666666666666,0.9912335128149877,1.0,2/17,7.50%,PIGC;ZDHHC17
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),-0.43989408161993343,-0.8447922814462682,0.6724137931034483,0.9912013363018356,1.0,2/22,1.19%,OMD;CEMIP
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),-0.5164160981054443,-0.8447050979777778,0.6792452830188679,0.990518296249585,1.0,5/8,23.78%,LARS1;ATM;SPAAR;CLEC16A;C9ORF72
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),0.48618953751438604,0.8443576412332474,0.7551020408163265,1.0,1.0,3/13,10.05%,HDAC9;INSIG1;RALY
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),0.48618953751438604,0.8443576412332474,0.7551020408163265,1.0,1.0,3/13,10.05%,HDAC9;INSIG1;RALY
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),0.5589739050242555,0.8443523547841622,0.7021276595744681,1.0,1.0,2/5,18.87%,PPIG;FKBP5
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),0.5589739050242555,0.8443523547841622,0.7021276595744681,1.0,1.0,2/5,18.87%,PPIG;FKBP5
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),-0.5024725923971967,-0.844200301731113,0.7272727272727273,0.9904397327159753,1.0,4/9,29.31%,POLR2A;IFITM3;ZFP36;POLR2B
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),-0.47689417506444515,-0.8437210411800491,0.7419354838709677,0.9904178127817521,1.0,3/13,18.41%,PRKN;TMEFF2;TJP1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),0.47643714639512225,0.8433160951993668,0.7209302325581395,1.0,1.0,2/11,2.83%,CALR;IL6R
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),-0.5637555508128528,-0.8432148751378689,0.6666666666666666,0.9902454223953723,1.0,2/7,8.90%,TPM1;DMD
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.49781290501265674,0.8430578293824879,0.6909090909090909,1.0,1.0,3/8,24.33%,CBFB;ROCK1;ROCK2
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),-0.5903444760832914,-0.8424152952698708,0.7169811320754716,0.9907876142396768,1.0,3/8,16.61%,STAT1;SULF2;FOXF1
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),-0.42920194897517683,-0.8424012195162366,0.7213114754098361,0.9898828370344995,1.0,1/30,0.44%,CX3CL1
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),0.43221568032442514,0.8420318973847242,0.7073170731707317,1.0,1.0,3/17,11.79%,WDPCP;PLCB1;CLASP1
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),0.5229748249951226,0.8419388859771373,0.6938775510204082,1.0,1.0,1/6,13.91%,NLGN1
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.36253177236361683,0.8415203387257755,0.6944444444444444,1.0,1.0,6/39,8.57%,INPP5F;PIK3CA;PLEKHA1;PITPNM2;PI4KA;PLCB1
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.3434724481849949,0.841508414309052,0.6666666666666666,1.0,1.0,6/71,10.05%,NOVA1;PRPF8;HNRNPR;U2SURP;NOVA2;RALY
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.46557514720200266,0.8407594541882861,0.660377358490566,1.0,1.0,1/10,0.93%,PSMD14
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),-0.3579824332873692,-0.8405660171791103,0.7631578947368421,0.9922066334099713,1.0,28/132,18.54%,KLHL20;ISG15;IFIH1;RNF213;UFL1;KLHL7;NUB1;ARIH2;PRKN;UBR2;ANAPC16;MYCBP2;UBE2D2;HLA-A;UBC;POM121C;HECW2;FBXO9;NUP54;RNF111;OTULIN;NFX1;CHFR;TRPC4AP;NUP98;HIF1A;EPAS1;TRIM38
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),-0.47264048557094607,-0.8397234563836187,0.6981132075471698,0.9928860276275461,1.0,2/16,12.85%,CNOT8;ZC3H7A
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),-0.4720802135493521,-0.838891462611485,0.6349206349206349,0.9933675266856609,1.0,2/12,8.23%,MAP2;CST3
prerank,PanglaoDB_Augmented_2021__Neurons,0.3343354982379786,0.8387928359365394,0.8055555555555556,1.0,1.0,14/61,15.89%,GRM5;SNAP25;CADM2;GRIA2;SGIP1;NRXN1;ADGRB3;CNTNAP2;RBFOX1;ZMYND11;CHN1;SFSWAP;RYR2;ZCCHC7
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),0.5409159249741009,0.8387102162368987,0.7446808510638298,1.0,1.0,2/5,23.49%,ST8SIA4;ST6GALNAC3
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),0.5029175854498183,0.8385477880066411,0.68,1.0,1.0,1/8,5.58%,PIK3CA
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),-0.49681746992535214,-0.8384682618568194,0.6851851851851852,0.9931839854746722,1.0,3/7,22.53%,BCOR;SRGN;GAS6
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),-0.3711462395413907,-0.8382087360744997,0.6621621621621622,0.9927391206216049,1.0,5/72,7.74%,OPTN;PLK2;CDK14;CEP57;CEP70
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),0.4458941309423776,0.8378054271082436,0.6666666666666666,1.0,1.0,4/11,15.78%,ATP2A2;CACNA1C;ANK2;RYR2
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),0.47829016005069847,0.8376762952419856,0.6956521739130435,1.0,1.0,3/9,23.47%,PPP2R5C;CALM1;PPP2R5E
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),-0.5061755962358948,-0.837501577899365,0.631578947368421,0.9932287412314788,1.0,2/8,18.09%,RHOA;ACVRL1
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),-0.4372534287922819,-0.8371095548240446,0.75,0.9929339114514736,1.0,1/28,1.35%,PPARG
prerank,GO_Biological_Process_2021__skin development (GO:0043588),0.48861021316259035,0.8354556753315665,0.6744186046511628,1.0,1.0,2/10,4.70%,UGCG;BCR
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),0.5305133825356101,0.8353219475824417,0.6976744186046512,1.0,1.0,2/6,12.59%,ENTPD1;ANO6
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),0.44573180980717086,0.8350399142612962,0.6739130434782609,1.0,1.0,3/8,20.33%,WAPL;PPHLN1;NIPBL
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),-0.36500150947235976,-0.8348256207509247,0.7066666666666667,0.9961715611873843,1.0,6/85,3.58%,KLHL20;PSMB9;SHISA5;NUB1;PSMA1;FN1
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),0.32998853425904406,0.8346171313319151,0.75,1.0,1.0,6/85,10.05%,NOVA1;PRPF8;HNRNPR;U2SURP;NOVA2;RALY
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),0.46338896642136046,0.8345824060571227,0.6739130434782609,1.0,1.0,5/11,17.50%,ATP2A2;CACNA1C;ANK2;RYR2;CALM1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),0.5061172541981601,0.834304506405696,0.7083333333333334,1.0,1.0,4/7,27.21%,ANK2;AKAP6;KCNMB4;KIF5B
prerank,PanglaoDB_Augmented_2021__Melanocytes,-0.4169729887712641,-0.8342845946163405,0.7246376811594203,0.996163155749551,1.0,8/51,14.36%,PPARG;LAMA4;FN1;PRKN;HMCN1;ZC3H7A;ITGAV;FILIP1L
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),-0.49554994251802453,-0.834127706700544,0.7307692307692307,0.9954943462838518,1.0,1/14,2.52%,TPM1
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),-0.3864602889735093,-0.8337310669968158,0.6857142857142857,0.9952821412765328,1.0,5/65,7.27%,CEMIP;SOD2;CXCL12;CARMIL1;CASS4
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),-0.43278254868016575,-0.8330089491087672,0.6122448979591837,0.9957295213146163,1.0,2/15,8.62%,STAT1;STAT5B
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),0.5134845620663013,0.8323430005545668,0.6481481481481481,1.0,1.0,2/5,32.27%,RC3H1;DYNC1H1
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),0.4943452612165291,0.8322030740344961,0.723404255319149,1.0,1.0,4/9,18.77%,UGCG;BCR;ANXA1;CLIC4
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.35497791581409044,0.8317656907068773,0.75,1.0,1.0,13/52,18.61%,BCL6;CDH2;ADGRB3;PDZD8;LARP4;CLASP1;CHN1;LRRK2;EPHA4;ZRANB1;PHIP;CAPZB;TANC2
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.5242343994662804,-0.8313429259423266,0.6730769230769231,0.9977343912978578,1.0,2/10,8.98%,PRKN;PMAIP1
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),-0.46354300168923457,-0.831040466246343,0.6792452830188679,0.9974465592556231,1.0,1/19,1.82%,PLK2
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),0.527504255272226,0.8309006216147438,0.8043478260869565,1.0,1.0,2/6,23.16%,MECOM;SETD7
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),0.2907550623432048,0.8306333829048621,1.0,1.0,1.0,46/324,13.21%,PDK4;ABL2;PSMD14;DCAF10;CDH2;PRKD1;MAPK10;TAF1;PRKG1;PRAG1;MORC3;UGCG;COP1;HSP90B1;BCR;YES1;IGFBP3;STK38L;CSNK1G3;FBXO7;BTRC;PPP4R2;DUSP6;STT3B;GOLM1;PIGU;ABL1;PPM1F;CTDSP2;PXK;CDC14B;YWHAZ;ST8SIA4;FEM1C;PPP1CB;NLK;GCNT2;PGGT1B;PPP3CA;PRKCA;PPP2R5C;TRIOBP;OXSR1;LRRK2;PPP3CB;FBXL20
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.4953494140334372,0.8298961940037777,0.6976744186046512,1.0,1.0,3/8,20.33%,NAA50;SMC1A;NIPBL
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),0.5211293357537587,0.8291193594818161,0.6481481481481481,1.0,1.0,2/5,29.78%,WASL;ASAP1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.4240569868644418,-0.8290234072925402,0.7205882352941176,0.9999275540386272,1.0,2/24,3.22%,PSMB9;PSMA1
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),0.38252812486950405,0.8287872021192679,0.7272727272727273,1.0,1.0,4/42,3.04%,HDAC9;TEAD4;RARB;TAF1
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,0.3036061367107845,0.8282086979754129,0.9736842105263158,1.0,1.0,19/102,20.30%,PCM1;BCR;CCDC88A;STK38L;PPP4R2;DOCK4;ABL1;RASA2;RANBP9;GSN;CLASP1;DST;WASF2;SMC1A;CAPZB;CDK5RAP2;TIAM1;ROCK1;FSCN1
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.45793637160649664,-0.8281225164351542,0.7192982456140351,1.0,1.0,9/18,11.63%,HLA-F;HLA-C;TAP1;HLA-B;SEC23A;ERAP1;B2M;HLA-A;HLA-E
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),-0.5081273269029667,-0.8271963715708999,0.6610169491525424,1.0,1.0,1/6,10.38%,BCOR
prerank,PanglaoDB_Augmented_2021__Ductal Cells,-0.5054271556865314,-0.8270620654842995,0.6851851851851852,1.0,1.0,1/8,6.78%,DSP
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.49937128893600474,0.8265980361904849,0.6666666666666666,1.0,1.0,1/5,17.29%,PNPLA8
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),-0.476438798294057,-0.826421650231325,0.6666666666666666,1.0,1.0,3/10,13.94%,STAT1;STAT5B;JAK2
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.465321753007593,0.8263221995493978,0.7674418604651163,1.0,1.0,4/14,17.42%,CDH2;ROBO2;NPTN;NECTIN3
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),0.41712505732554817,0.8250437792008115,0.7317073170731707,1.0,1.0,2/15,7.14%,NUP58;RANBP2
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),-0.41455233049260487,-0.8246779103277837,0.7346938775510204,1.0,1.0,1/25,1.82%,PLK2
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),-0.5045535627589742,-0.8240560153740519,0.74,1.0,1.0,4/11,25.18%,SLC38A3;SLC36A4;SLC3A2;SLC38A5
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),-0.47316062301739226,-0.8239351039796392,0.6111111111111112,1.0,1.0,2/12,8.98%,HEBP2;PMAIP1
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),-0.49055742336557545,-0.8237115128603877,0.7368421052631579,1.0,1.0,1/12,1.48%,STAT1
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.5198882894373413,-0.8237097305789882,0.7454545454545455,1.0,1.0,4/8,25.52%,ITGAV;JAK2;TGM2;RAPGEF1
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),-0.4235099369195034,-0.8233930398844822,0.7288135593220338,1.0,1.0,8/33,15.97%,PSMB9;PSMA1;RFC3;TOPBP1;PRIMPOL;RFC1;UBC;PSMC6
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.4942798634181054,0.8233208933517117,0.7142857142857143,1.0,1.0,4/8,19.57%,ZEB2;EP300;CREBBP;ADAM17
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.4942798634181054,0.8233208933517117,0.7142857142857143,1.0,1.0,4/8,19.57%,ZEB2;EP300;CREBBP;ADAM17
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.49322623393583376,-0.8228495467872944,0.6326530612244898,1.0,1.0,2/6,13.24%,CD47;RHOA
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),0.4844340240793642,0.8224324877203083,0.7446808510638298,1.0,1.0,2/6,28.30%,ACACA;CPT1A
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),0.49783173716907536,0.8222337449781478,0.72,1.0,1.0,2/8,11.84%,SMAD6;KLF2
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,0.34228448928010125,0.82145662609889,0.7272727272727273,1.0,1.0,8/50,15.21%,COL4A2;GULP1;NTM;PDZRN3;MPDZ;PARVA;ADGRL2;ANK2
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),0.5244296446611805,0.8214410137620489,0.7391304347826086,1.0,1.0,4/6,31.10%,NLGN1;KIF5B;SPG11;RAB27A
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),0.36710449326155464,0.820450172557264,0.7837837837837838,1.0,1.0,8/38,11.94%,NRG2;ERBB4;MTDH;PIK3CA;HSP90AA1;GCNT2;RTN4;FRS2
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,-0.39857916598326076,-0.8204108730227275,0.7384615384615385,1.0,1.0,7/53,11.06%,TPM1;LAMA4;CXCL12;FN1;HMCN1;ACTN1;NOSTRIN
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),0.4378392759860073,0.8198213560239471,0.717948717948718,1.0,1.0,3/11,20.12%,PIK3CA;LRRK2;PINK1
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),0.46104614907376623,0.8192079608533656,0.6976744186046512,1.0,1.0,2/11,7.14%,NUP58;RANBP2
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),-0.43980744248055836,-0.8188927529100728,0.696969696969697,1.0,1.0,2/22,4.39%,NR4A1;TIE1
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",0.44841160086088405,0.8188170730722377,0.675,1.0,1.0,6/16,19.29%,ACTB;ERCC6;ARID1A;BAZ1B;EP300;ZMIZ1
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),0.4132144705351024,0.8186915386231743,0.7317073170731707,1.0,1.0,2/15,7.14%,NUP58;RANBP2
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),0.3312171421944316,0.818543114949473,0.7297297297297297,1.0,1.0,8/57,12.38%,PSMD14;YWHAB;HSPB1;FASTKD1;YWHAZ;XPO1;YTHDF2;PRKCA
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),0.48564754859183007,0.8182436110553338,0.717391304347826,1.0,1.0,4/8,35.83%,PHF14;LEF1;YEATS2;KAT6A
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),-0.4845918181245745,-0.818239953907664,0.7142857142857143,1.0,1.0,2/7,20.17%,CDA;PRKRIP1
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.4660642834849084,-0.817737135021471,0.7936507936507936,1.0,1.0,1/16,0.78%,NR4A1
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),0.4903815479422503,0.8177337555512706,0.7727272727272727,1.0,1.0,2/7,7.37%,SMAD6;CHSY1
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.42149070537829736,-0.8167379949983748,0.7169811320754716,1.0,1.0,6/21,20.04%,SNX2;GPM6A;TAOK3;DCLK1;ALS2;CTTN
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),-0.4480252979891364,-0.8166837525996674,0.6984126984126984,1.0,1.0,1/16,1.51%,IFIH1
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),0.3731909041904282,0.8166030649159306,0.6666666666666666,1.0,1.0,3/27,6.80%,UBQLN1;HSP90B1;STT3B
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),0.47296431842348663,0.8163190283180368,0.6976744186046512,1.0,1.0,2/9,15.50%,ACTG1;ANXA1
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),0.4189091304364419,0.8161812707972194,0.7142857142857143,1.0,1.0,2/14,7.14%,NUP58;RANBP2
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,-0.41375621711495647,-0.816158128817552,0.7301587301587301,1.0,1.0,6/28,15.06%,STAT1;IRF1;JUN;IFNGR2;STAM2;IL18R1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.458468150848521,-0.815782808937584,0.7321428571428571,1.0,1.0,2/16,11.29%,PLCG2;ADAMTS1
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),-0.34641147904642927,-0.8151132428178038,0.78125,1.0,1.0,9/131,5.04%,KLHL20;IFI27;PSMB9;RNF213;NUB1;PSMA1;ARIH2;PRKN;RNF19A
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),0.34062211897693284,0.8149218860840198,0.8235294117647058,1.0,1.0,11/44,14.54%,ABL2;ABL1;PRKX;FRMD5;PPP1CB;PPP3CA;YTHDF2;PRKCA;EPHA4;FES;ADAM10
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),-0.49211480797460944,-0.8146717765410935,0.7166666666666667,1.0,1.0,1/12,1.48%,STAT1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.3947669949489269,0.8146447926952801,0.7368421052631579,1.0,1.0,9/28,17.19%,SMAD9;SMAD6;SMAD5;SMAD1;ATP2B4;LEMD3;SKI;SMURF2;ACVR2A
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),-0.5309893211306301,-0.8146329963401685,0.7037037037037037,1.0,1.0,2/5,18.46%,KPNB1;SREBF2
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),-0.4940121239371627,-0.8144884080533064,0.6896551724137931,1.0,1.0,3/8,13.94%,STAT1;STAT5B;JAK2
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,0.3964022472414074,0.8143587489708857,0.7894736842105263,1.0,1.0,5/21,10.59%,SLC26A3;NTM;ITGA1;SGIP1;FGF14
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.38339028749655746,-0.8142323613373222,0.6949152542372882,1.0,1.0,5/42,5.04%,UFL1;NUB1;ARIH2;PRKN;RNF19A
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",0.33186162700837035,0.8140552411986399,0.8285714285714286,1.0,1.0,6/77,10.05%,NOVA1;PRPF8;HNRNPR;U2SURP;NOVA2;RALY
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),-0.4042238448626249,-0.8138175359495559,0.7222222222222222,1.0,1.0,4/25,9.58%,PSMB9;PSMA1;EIF2AK2;LMO2
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),-0.49791142406962174,-0.8135582792126967,0.7,1.0,1.0,2/10,9.84%,GRB14;APPL2
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),0.4335781931829043,0.8133564458974977,0.717948717948718,1.0,1.0,1/11,2.70%,VAPB
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),-0.43149221841327345,-0.8130207830627152,0.6557377049180327,1.0,1.0,6/29,14.75%,LRPAP1;PRKN;ACER2;TBK1;CLU;NPAS2
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),0.33839729470743785,0.8128504144644801,0.7380952380952381,1.0,1.0,9/45,14.59%,SMAD9;SMAD6;SMAD5;SMAD1;NLK;GCNT2;APPL1;PARD3;SKI
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.39031907145383055,0.8122529865264592,0.7090909090909091,1.0,1.0,6/21,20.15%,YWHAB;MICALL2;YWHAZ;YWHAQ;PINK1;YWHAG
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),0.3167890470778263,0.8121891393250377,0.8717948717948718,1.0,1.0,9/50,14.93%,SLC25A37;HSP90AA1;LARP4;CPEB3;ZEB2;KLF2;EIF3E;APPL1;STARD4
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),-0.4675058079178489,-0.8120859505213054,0.7407407407407407,1.0,1.0,2/16,2.67%,GBP1;PLCG2
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.35019917806641115,0.8120607404177462,0.7560975609756098,1.0,1.0,3/45,3.32%,TRIM5;PRKD1;MTDH
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.44434869563553575,0.8119540212731633,0.7058823529411765,1.0,1.0,5/15,26.01%,PPM1F;HSPA8;PTPN1;GAPVD1;STXBP5L
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),0.38665742525175595,0.8118246108985667,0.7948717948717948,1.0,1.0,7/21,21.05%,NAV3;HSP90AA1;CLASP1;FES;CDK5RAP2;PINK1;RAC1
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),0.40660723062260823,0.8116620466033376,0.7619047619047619,1.0,1.0,6/14,15.78%,ITPR3;ITPR2;ATP2B4;SLC24A2;SLC8A1;RYR2
prerank,MSigDB_Hallmark_2020__Myc Targets V1,0.329506820105527,0.8110818968995477,0.7647058823529411,1.0,1.0,8/57,16.04%,PSMD14;GLO1;HNRNPR;XPO1;HSPD1;YWHAQ;SSBP1;RAD23B
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),0.5457546297129928,0.8109318047704186,0.74,1.0,1.0,3/5,27.62%,EIF5;EIF4A2;EIF3A
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),0.3482524597431623,0.8106701715466319,0.813953488372093,1.0,1.0,2/24,2.67%,CADM2;CDH2
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),0.32444426643157415,0.8103470478169731,0.7647058823529411,1.0,1.0,8/59,10.44%,CALR;GRM5;EIF4G3;HSPB1;EIF5;LARP4;CPEB3;FOXO3
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),0.4456119817180785,0.8097737511327817,0.7755102040816326,1.0,1.0,4/11,15.50%,PLEKHA1;ABL1;SETX;ANXA1
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),0.46288630436737027,0.8095800712241152,0.7037037037037037,1.0,1.0,2/8,11.66%,CCDC88A;RTN4
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),0.4822326704179697,0.8095572687070632,0.7045454545454546,1.0,1.0,3/10,31.33%,ABCA1;CANX;ARFGAP3
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),-0.49496060012099613,-0.8089354490536853,0.7115384615384616,1.0,1.0,2/9,8.90%,TPM1;DMD
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),0.4685300934878715,0.8088119180002509,0.6904761904761905,1.0,1.0,1/8,4.54%,PCM1
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),-0.43318941825077156,-0.8084085492621925,0.7777777777777778,1.0,1.0,6/23,24.87%,PABPC1;SRRM1;SRSF5;SRSF3;TENT2;CSTF3
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),0.50439941602297,0.8082379202698831,0.76,1.0,1.0,1/6,3.17%,SEMA3F
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),0.40690974679742614,0.8080160873417533,0.6904761904761905,1.0,1.0,2/19,8.90%,HSPB1;PPM1F
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.44397012504707106,0.8078945474529848,0.6666666666666666,1.0,1.0,4/12,13.03%,RALA;DDHD1;MFF;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),0.36330209799197066,0.8078457830427459,0.6744186046511628,1.0,1.0,7/28,20.43%,PKM;LARP4;CPEB3;YTHDF2;EIF3E;KHDRBS1;AGO2
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.4049940937601848,0.8077911351630904,0.717948717948718,1.0,1.0,3/25,11.09%,PRKD1;HSP90AA1;ATP2B4
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),0.287944688001208,0.807177496821711,0.84375,1.0,1.0,34/126,22.17%,AGTPBP1;VAPB;PRKD1;BRWD1;GABPB1;WDPCP;FAM174B;PEX14;PDZD8;RANBP9;LARP4;ATP8B1;HACE1;DPYSL2;DIAPH1;CLASP1;DST;YTHDF2;LRRK2;ZRANB1;SSBP1;VMP1;RAB7A;PHIP;CAPZB;TOR1AIP2;PITPNB;PINK1;ATL2;TRAPPC8;FMNL2;MAST2;REEP5;MTFR1
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.4509049360204043,-0.8064753633765266,0.7627118644067796,1.0,1.0,3/18,7.27%,RREB1;CARMIL1;CASS4
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),-0.44408040311109553,-0.806317508437511,0.6851851851851852,1.0,1.0,2/12,10.62%,TANK;NET1
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),0.43877543309603984,0.8062049607230174,0.7380952380952381,1.0,1.0,2/12,14.25%,PPP4R2;KPNA1
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),-0.39601201866036256,-0.8053803203954062,0.7727272727272727,1.0,1.0,7/45,13.47%,POMP;SPAG1;SMAD3;DMD;RPL38;CLTA;CLU
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),-0.4538358924179081,-0.8041000121002722,0.7586206896551724,1.0,1.0,3/14,10.88%,ERAP1;SPPL2A;NFKB1
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),0.5273601041607011,0.8040332663061195,0.7222222222222222,1.0,1.0,1/5,2.91%,WRNIP1
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),-0.4025230217244191,-0.8030512267847073,0.7192982456140351,1.0,1.0,6/28,13.47%,MAP2;PRKN;ATXN7;LIMA1;SSH1;CLU
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),-0.5292824359439675,-0.8028039094138598,0.7454545454545455,1.0,1.0,1/7,3.30%,SPG7
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),0.35044083853583685,0.8024454194793459,0.7714285714285715,1.0,1.0,5/36,12.69%,HSPH1;SLC25A37;LARP4;CPEB3;EIF3E
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),0.5065295510172796,0.8023170307574499,0.7446808510638298,1.0,1.0,3/6,17.68%,DIS3L2;SND1;MTREX
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),0.4989441643398057,0.8022320658849391,0.6808510638297872,1.0,1.0,2/5,3.61%,PRKD1;HSPB1
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),0.4535585955484458,0.8020644402459357,0.6458333333333334,1.0,1.0,2/8,9.09%,PCM1;REST
prerank,MSigDB_Hallmark_2020__Spermatogenesis,0.39525724266735884,0.8017900012827017,0.7297297297297297,1.0,1.0,4/23,10.31%,MAP7;IDE;STRBP;TLE4
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,0.38958270646219223,0.8015251198512341,0.8048780487804879,1.0,1.0,8/28,20.85%,CDH2;MPDZ;ADGRL2;FOXC1;RAI14;BOC;PTPN21;MAGI1
prerank,GO_Biological_Process_2021__cardiac atrium development (GO:0003230),0.4917611111812093,0.7997849153791077,0.5471698113207547,1.0,1.0,1/5,15.21%,ANK2
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.40768375606581064,-0.7997418242789104,0.7333333333333333,1.0,1.0,2/27,3.22%,PSMB9;PSMA1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),0.4921522646152964,0.7994846621592524,0.6956521739130435,1.0,1.0,1/5,19.70%,AKAP6
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.4921522646152964,0.7994846621592524,0.6956521739130435,1.0,1.0,1/5,19.70%,AKAP6
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),0.5217038143002706,0.7989219689231561,0.78,1.0,1.0,3/6,28.58%,SETX;PAPOLA;SCAF8
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.504528050376224,-0.7987241815414224,0.7454545454545455,1.0,1.0,4/10,20.40%,PRKN;CLU;RACK1;OPA1
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),0.47338277770237497,0.7986191517445816,0.7906976744186046,1.0,1.0,4/12,8.90%,PRKD1;IL6R;HSPB1;PPM1F
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),0.5216488676068092,0.7979276258569258,0.7894736842105263,1.0,1.0,3/5,20.48%,SERINC1;SPTLC1;MGST2
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.4079941866455891,-0.7977472130039458,0.8,1.0,1.0,3/22,8.67%,PPARG;SLC5A6;ACSL4
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),-0.4092704978318199,-0.7968084876542556,0.76,1.0,1.0,7/21,18.48%,SCN2A;NDRG1;PMAIP1;PGK1;RORA;HIF1A;EPAS1
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),0.5029732185412904,0.7965822779373086,0.6875,1.0,1.0,3/5,25.26%,SCP2;GCH1;FDFT1
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),-0.49454161960654125,-0.7960182689048427,0.7222222222222222,1.0,1.0,2/6,11.99%,FOXK1;PGK1
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),-0.49454161960654125,-0.7960182689048427,0.7222222222222222,1.0,1.0,2/6,11.99%,FOXK1;PGK1
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),-0.49454161960654125,-0.7960182689048427,0.7222222222222222,1.0,1.0,2/6,11.99%,FOXK1;PGK1
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),0.4259959738010608,0.7959460071571682,0.7333333333333333,1.0,1.0,4/12,35.07%,PTPN1;NF1;IRAK3;HYAL2
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,-0.42294940862193603,-0.7959328693262988,0.7666666666666667,1.0,1.0,4/23,11.29%,LAMA4;CXCL12;HMCN1;ADAMTS1
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),0.355038164090162,0.79561446939681,0.6764705882352942,1.0,1.0,3/24,6.10%,PSMD14;TAF1;BTRC
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.450494727124121,0.7954564132002607,0.6530612244897959,1.0,1.0,1/11,4.70%,BCR
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.48416251548112643,-0.7953159003006318,0.7894736842105263,1.0,1.0,3/12,22.53%,MAP2K5;XIAP;GAS6
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.4939502383647575,0.7951948979707272,0.7560975609756098,1.0,1.0,6/10,19.70%,CACNA1C;SLC8A1;ANK2;RYR2;CALM1;AKAP6
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),0.49360873914826386,0.7948367866302309,0.7777777777777778,1.0,1.0,2/6,11.53%,HSP90AA1;HSPD1
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),0.29494102037637093,0.7947829292888279,0.8620689655172413,1.0,1.0,10/48,16.36%,PSMD14;CSNK1G3;UBE2B;ZEB2;LRRK2;WNK1;ZRANB1;SKI;SMURF2;SPIN1
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.5146152060250965,-0.7947815193592981,0.7368421052631579,1.0,1.0,1/7,4.75%,PRKN
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),0.37286159266697744,0.7943996346307705,0.6585365853658537,1.0,1.0,7/17,26.90%,RALB;LRRK2;RAB3GAP2;MTMR3;PINK1;PIKFYVE;RAB5A
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),-0.4366897603465107,-0.7942732460526697,0.7037037037037037,1.0,1.0,2/18,11.40%,CENATAC;SSH1
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),0.49887385502474413,0.7941949188504919,0.7708333333333334,1.0,1.0,1/5,8.90%,PPM1F
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),-0.4431661911448494,-0.7940527136914696,0.8,1.0,1.0,4/17,13.24%,SERPINE1;VIM;NFKB1;RHOA
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),0.42159749485719994,0.7939474746139185,0.7872340425531915,1.0,1.0,3/12,11.79%,NAV3;PIK3CA;CLASP1
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),0.4027077784462614,0.7935504780397532,0.75,1.0,1.0,4/15,15.50%,PLEKHA1;ABL1;SETX;ANXA1
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),-0.385009770675583,-0.7934699694040861,0.75,1.0,1.0,7/37,15.91%,TPM1;SOD2;JUN;ERO1A;FOXO1;VRK2;FOS
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),0.41482867037557514,0.793386333807095,0.7560975609756098,1.0,1.0,4/11,32.53%,APPL1;C2CD5;INSR;PRKCI
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),-0.5257368649851375,-0.7931133844299895,0.7241379310344828,1.0,1.0,3/5,22.98%,ATM;SQSTM1;PIK3C3
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),0.4673190408023715,0.7928638969545967,0.7111111111111111,1.0,1.0,2/5,26.17%,LRRK2;MEF2C
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.39676803154561024,-0.7922982086112816,0.7397260273972602,1.0,1.0,4/25,9.58%,PSMB9;PSMA1;EIF2AK2;LMO2
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),-0.3584861226546774,-0.7921631017737449,0.7741935483870968,1.0,1.0,6/49,8.59%,PSMB9;PSMA1;ZC3HAV1;CNOT8;PABPC1;VIM
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),0.4677340366523849,0.7920358334628796,0.7333333333333333,1.0,1.0,3/9,16.07%,ANO6;ANK2;ANK3
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),0.353174520430296,0.7917804387893433,0.725,1.0,1.0,4/31,7.87%,ABL2;CCDC88A;PIK3CA;ABL1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),0.5191122263075957,0.791708800452219,0.7619047619047619,1.0,1.0,1/5,5.24%,CNOT2
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),-0.49736031648545564,-0.7916052603821914,0.7037037037037037,1.0,1.0,2/7,18.64%,RHOA;MSN
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),-0.4555702177215636,-0.7913639344941269,0.7346938775510204,1.0,1.0,5/15,15.32%,TFRC;ACO1;IREB2;NDFIP1;FTH1
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),0.4972693645420857,0.7912820002289729,0.8163265306122449,1.0,1.0,2/5,8.41%,TRAK2;TRAK1
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),-0.5236657008219805,-0.7911403795992197,0.7291666666666666,1.0,1.0,2/5,5.56%,TPM1;SERPINE1
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),-0.4571183518510949,-0.7910856878578454,0.7419354838709677,1.0,1.0,2/13,9.87%,PRKN;TRIM25
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,-0.35865831275346266,-0.7904898490489158,0.7647058823529411,1.0,1.0,13/63,15.06%,ITIH5;TNFSF10;GBP4;SLC2A3;IGF2R;NDRG1;GABARAPL1;BHLHE40;RORA;ARL4A;ITGAV;PHTF2;IL18R1
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),0.5122770130203469,0.7904538334779937,0.7636363636363637,1.0,1.0,3/5,29.88%,WASF2;CYFIP1;NCKAP1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),-0.42768549470035455,-0.7895124115496277,0.7017543859649122,1.0,1.0,2/11,4.75%,SOD2;PRKN
prerank,PanglaoDB_Augmented_2021__Leydig Cells,-0.39290166564855933,-0.7894767296120037,0.7941176470588235,1.0,1.0,2/35,3.48%,KIAA1217;CXCL12
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),-0.4521779499583746,-0.7890637693920699,0.7962962962962963,1.0,1.0,1/14,1.35%,PPARG
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),-0.4439151718315876,-0.7889479243896497,0.7543859649122807,1.0,1.0,1/12,4.75%,PRKN
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.3627445687973911,0.7884804668134737,0.8709677419354839,1.0,1.0,4/47,3.04%,HDAC9;TEAD4;RARB;TAF1
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),0.45264399538993627,0.7881849144272378,0.8,1.0,1.0,2/11,5.97%,PIK3CA;PLEKHA1
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),0.4772033303026611,0.7880924171752071,0.7586206896551724,1.0,1.0,3/8,23.91%,IDE;UVRAG;SMURF1
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),-0.40567655655741197,-0.7879570722255905,0.7796610169491526,1.0,1.0,8/29,12.15%,ISG15;IFIH1;HLA-B;EIF2AK2;AFAP1L2;TBK1;CD47;BTNL9
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),-0.4974280605400976,-0.7871603387340194,0.6909090909090909,1.0,1.0,2/6,18.64%,RHOA;MSN
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),-0.41220787942024395,-0.7868278174274655,0.7169811320754716,1.0,1.0,2/15,2.93%,ISG15;UFL1
prerank,MSigDB_Hallmark_2020__Myogenesis,0.35207983508657736,0.7865254052323036,0.6511627906976745,1.0,1.0,6/38,9.87%,TEAD4;COL4A2;IGFBP3;NCAM1;CKMT2;GSN
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),0.45924761838276584,0.7864275634740658,0.8301886792452831,1.0,1.0,1/7,6.93%,SLC25A46
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),-0.44312134716056917,-0.786301754260982,0.7454545454545455,1.0,1.0,3/11,14.07%,CHKA;ENPP2;MFSD2A
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),0.33426174536573755,0.7860229949971655,0.8421052631578947,1.0,1.0,9/44,15.29%,PRKD1;FAM174B;YWHAZ;ATP8B1;HACE1;BET1;CLASP1;LRRK2;VMP1
prerank,MSigDB_Hallmark_2020__Protein Secretion,-0.36167046082230125,-0.7852442428709672,0.7368421052631579,1.0,1.0,10/52,20.46%,SNX2;ICA1;IGF2R;CLTA;USO1;GNAS;CLCN3;SEC24D;AP1G1;RAB14
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),-0.4868304570450627,-0.7847739740786315,0.76,1.0,1.0,3/5,25.80%,GSPT1;MRPL33;PTCD3
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),0.3724814324782499,0.7846299778574987,0.7692307692307693,1.0,1.0,6/27,13.47%,SLC2A13;LARP4;CPEB3;EIF3E;NSMAF;EPHA4
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),-0.35265343236048424,-0.7840993251781565,0.7878787878787878,1.0,1.0,7/63,11.14%,CX3CL1;ULK4;NTNG1;CTNNA2;KIDINS220;SCARF1;EFNB2
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",-0.30714931907981574,-0.7840851141792872,0.9404761904761905,1.0,1.0,25/272,10.98%,HES1;TBX3;PPARG;STAT1;RREB1;IFI27;IRF2;IRF1;SNX6;SP100;PRKN;SMAD3;MEF2A;FOXK1;JUN;RCOR1;SCML1;BRD7;RPS14;BCOR;CBX5;PARP9;TCF25;NFKB1;LRRFIP1
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),-0.5346565459019293,-0.7840010668951296,0.8125,1.0,1.0,1/6,3.30%,SPG7
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),0.48792849088235235,0.7840002390748941,0.7708333333333334,1.0,1.0,3/6,13.03%,TRAK2;TRAK1;LRRK2
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),-0.36846457138897554,-0.7833958852727333,0.7301587301587301,1.0,1.0,4/48,7.74%,OPTN;CDK14;CEP57;CEP70
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.41641428539706227,-0.7832304263015439,0.7096774193548387,1.0,1.0,4/24,10.70%,RREB1;CARMIL1;CASS4;CAPRIN1
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),-0.47481907220679476,-0.782813629664953,0.7346938775510204,1.0,1.0,2/7,7.22%,SP100;SUN1
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),0.3864728285834238,0.7822043209887987,0.7727272727272727,1.0,1.0,4/19,10.10%,FUT8;MAN1A2;STT3B;ST8SIA4
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),-0.5255368499887689,-0.7820489253371101,0.7659574468085106,1.0,1.0,1/6,1.45%,OPTN
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),0.4185989420940255,0.7809693494445722,0.74,1.0,1.0,2/12,15.76%,CLASP1;RAB7A
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),0.4911636750337553,0.7802594742707015,0.8292682926829268,1.0,1.0,3/7,36.19%,HSPA1A;DYNC1H1;HNRNPU
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),-0.4272712816486423,-0.7802117249962804,0.84375,1.0,1.0,5/19,13.50%,TDRD7;YTHDC1;PARP9;ZC3H7A;GEMIN5
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),-0.4193420407162246,-0.7801487330421168,0.7540983606557377,1.0,1.0,4/22,13.84%,PLCG2;TNIP1;UBE2D2;UBC
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),0.41982198673598686,0.7798825408857358,0.7435897435897436,1.0,1.0,4/15,13.03%,ACAT1;TPST2;AK3;LRRK2
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),-0.487296170867441,-0.7797169149220091,0.7843137254901961,1.0,1.0,2/8,18.41%,DSP;TJP1
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),-0.4291167095641476,-0.7796672874111791,0.7454545454545455,1.0,1.0,3/25,11.11%,OPTN;CALCOCO2;TBK1
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),0.5012784485147689,0.779653784946386,0.78,1.0,1.0,1/6,4.67%,HSP90B1
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),-0.4459909222753571,-0.7794261012586636,0.7272727272727273,1.0,1.0,2/12,8.98%,STAT5B;PMAIP1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),-0.40249491825928974,-0.7792382374730059,0.7966101694915254,1.0,1.0,4/36,8.98%,CEMIP;PRKN;LGALS3;PMAIP1
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),0.35602371018447737,0.7789249952313568,0.7567567567567568,1.0,1.0,17/37,26.58%,ACTG1;YES1;AP2B1;ACTB;CHN1;EPHA4;PSEN1;TIAM1;ROCK1;RAC1;CRK;ROCK2;PTK2;RASA1;CDC42;EFNA5;WASL
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.35552580162942393,0.7784926785496797,0.7142857142857143,1.0,1.0,10/27,22.33%,UGCG;PBX3;ERCC6;DTNB;WNK1;IL1RAPL1;RYK;FZD4;TENM2;OPHN1
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),-0.49838465926857306,-0.7783201451337552,0.7636363636363637,1.0,1.0,2/6,14.07%,CHKA;MFSD2A
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),-0.43496851715919105,-0.7774486325136566,0.7931034482758621,1.0,1.0,2/17,1.82%,RIMS1;PLK2
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),0.4962148450103794,0.7766368910539138,0.8409090909090909,1.0,1.0,3/7,15.37%,CACNA1C;SKI;CEP290
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),0.48029666690541073,0.7762305552789625,0.7647058823529411,1.0,1.0,2/5,9.09%,UBQLN1;REST
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),0.3361574268197721,0.7760968107191107,0.8913043478260869,1.0,1.0,5/36,13.03%,UBQLN1;SLC38A9;PIK3CA;SESN1;LRRK2
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),0.44445755632739714,0.775921816203165,0.7777777777777778,1.0,1.0,2/9,11.73%,ACTG1;ACTB
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),0.46784084879437904,0.7755661818675683,0.7307692307692307,1.0,1.0,1/5,8.90%,PPM1F
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.3866269409605338,0.7754182713375872,0.7916666666666666,1.0,1.0,6/10,22.90%,UBQLN1;HSP90AA1;ITCH;ZMIZ1;PINK1;HSPA1A
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),-0.495340224802155,-0.7742168474636307,0.7142857142857143,1.0,1.0,1/5,12.67%,MTMR2
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),-0.495340224802155,-0.7742168474636307,0.7142857142857143,1.0,1.0,1/5,12.67%,MTMR2
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.48881429089397066,-0.7742161919422926,0.7321428571428571,1.0,1.0,2/5,13.24%,TMEFF2;RHOA
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),0.3273364222940947,0.7741765825353671,0.8333333333333334,1.0,1.0,15/46,23.29%,INPP5A;PIK3CA;PI4KA;PLCB1;PPP3CA;LRRK2;PPP3CB;PTEN;CALM1;PLPPR4;TAOK1;TOP1;INPP4A;HK1;PPIP5K2
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),-0.36582599384989545,-0.7740660401356009,0.8103448275862069,1.0,1.0,5/49,4.47%,OPTN;PLK2;UFL1;ZC3HAV1;CNOT8
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),-0.4862971569830752,-0.7722571855991803,0.7903225806451613,1.0,1.0,1/7,4.41%,MAP2
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),-0.3180455333028535,-0.7721672754057594,0.92,1.0,1.0,19/199,10.98%,HES1;TBX3;PPARG;STAT1;RREB1;IFI27;IRF2;SP100;PRKN;SMAD3;MEF2A;JUN;RPS14;BCOR;CBX5;PARP9;TCF25;NFKB1;LRRFIP1
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),-0.44756047830288503,-0.7721507676169116,0.7,1.0,1.0,4/13,22.38%,ZDHHC17;FOXO1;ZDHHC20;ZDHHC21
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),-0.4488919229009315,-0.7718793902563333,0.7903225806451613,1.0,1.0,4/14,17.26%,STAT1;NFKB1;JAK2;ST3GAL6
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),-0.3635905417685765,-0.7717989148060217,0.7833333333333333,1.0,1.0,8/39,15.68%,PLK2;PRKN;NFKBIA;CLU;HECW2;FOXO1;RAB1A;GPC3
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),-0.3956465675185719,-0.7710000672615609,0.8125,1.0,1.0,2/30,8.80%,GBP1;LGALS3
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),0.41114195987521646,0.7708443249088898,0.7959183673469388,1.0,1.0,3/15,8.57%,NRCAM;ABL1;PLCB1
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.5210619465741406,-0.7701824718671635,0.7894736842105263,1.0,1.0,3/5,26.32%,CAMKMT;NMT2;NMT1
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),-0.4434273833137016,-0.7698276266147643,0.7307692307692307,1.0,1.0,5/19,17.26%,TNIP1;CHST12;GCNT1;SERP1;ST3GAL6
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),0.5107186789031134,0.7695987358828984,0.85,1.0,1.0,1/6,7.87%,ABL1
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),0.5237522799218096,0.7695339791099113,0.8055555555555556,1.0,1.0,4/6,31.02%,ABL1;TOP1;TOP2B;HMGB1
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.34617137068834647,0.7690458664400176,0.7959183673469388,1.0,1.0,8/25,16.25%,ADGRB3;S1PR1;ADGRL4;CALCRL;ADGRL2;ADCY2;WASF2;AKAP12
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),-0.36866694714665693,-0.7683904595009039,0.7704918032786885,1.0,1.0,4/47,7.74%,OPTN;CDK14;CEP57;CEP70
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),-0.32366880469330794,-0.7678197890556576,0.9305555555555556,1.0,1.0,9/119,5.06%,KLHL20;IFI27;PSMB9;RNF213;PSMA1;ARIH2;PRKN;RNF19A;HERC6
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),0.5154165777787537,0.7677388669832689,0.717391304347826,1.0,1.0,3/7,34.92%,CDK5RAP2;NDEL1;ITGB1
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),-0.3143215051205416,-0.7675185974716794,0.922077922077922,1.0,1.0,17/174,10.07%,KLHL20;ISG15;PSMB9;RNF213;KLHL7;NUB1;PSMA1;ARIH2;PRKN;RNF19A;HERC6;UBR2;ANAPC16;MYCBP2;TRIM25;WSB1;UBE2D2
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.49957832286034853,-0.7673168910872583,0.8214285714285714,1.0,1.0,3/7,18.85%,TNKS2;ATM;DHX36
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.4486765140370001,-0.7672400757651775,0.8076923076923077,1.0,1.0,4/14,22.53%,CARD8;MAP2K5;XIAP;GAS6
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),-0.519964684153021,-0.767008947557407,0.8431372549019608,1.0,1.0,3/5,22.38%,ATP2B1;CTTN;ZDHHC21
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),-0.5093210943302221,-0.766546534947029,0.803921568627451,1.0,1.0,2/5,10.38%,UBR2;BCOR
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),0.5087341459861017,0.7665064569703569,0.7608695652173914,1.0,1.0,1/5,3.50%,ATN1
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),-0.42863774410904365,-0.765277351034744,0.7222222222222222,1.0,1.0,1/10,4.65%,ARIH2
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),-0.4772802264005463,-0.7651262089589193,0.75,1.0,1.0,2/7,7.79%,SLCO1A2;SLCO2B1
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",0.4666464916894971,0.7644882163770543,0.782608695652174,1.0,1.0,2/6,26.17%,LRRK2;MEF2C
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),0.4666464916894971,0.7644882163770543,0.782608695652174,1.0,1.0,2/6,26.17%,LRRK2;MEF2C
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),-0.4494353506090682,-0.7644456170164236,0.7192982456140351,1.0,1.0,1/12,0.65%,CYLD
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),0.38237825603368486,0.7643465813281036,0.8536585365853658,1.0,1.0,1/15,5.17%,ITGA1
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),0.4886241611231391,0.7636191265609037,0.8431372549019608,1.0,1.0,2/7,15.11%,RAB11FIP2;ADCY2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.4890278483915384,0.7632766481857344,0.8048780487804879,1.0,1.0,5/8,17.50%,CACNA1C;SLC8A1;ANK2;RYR2;CALM1
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),0.37015111109356585,0.7632510046992755,0.8421052631578947,1.0,1.0,7/21,25.05%,CALCRL;CACNA1C;PSEN1;SLC8A1;RYR2;TRPC1;SLC30A9
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),-0.41934851467550927,-0.7629749816825055,0.7407407407407407,1.0,1.0,2/17,9.94%,FN1;ACTN1
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),-0.49023285263878064,-0.7625845006327622,0.7446808510638298,1.0,1.0,2/9,18.85%,NUP98;DHX36
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),-0.4819830510909057,-0.7621211394320121,0.7450980392156863,1.0,1.0,2/7,18.25%,SMYD2;PRMT2
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.43966843825576796,0.7617749087689035,0.7608695652173914,1.0,1.0,4/10,14.10%,ABL1;YWHAZ;EPHA4;IL1RAPL1
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),0.34636662575764704,0.7617322612283248,0.8857142857142857,1.0,1.0,9/40,11.29%,RRAS2;PRKD1;RALA;BCR;CCDC88A;KRAS;TIAM2;ARHGAP31;RALB
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),-0.44061602022378943,-0.761220009262969,0.7454545454545455,1.0,1.0,3/15,14.67%,SMAD3;RORA;FOXO1
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),-0.41520824384828614,-0.7610910735407358,0.7857142857142857,1.0,1.0,5/14,15.06%,ISG15;HLA-A;CD47;VSIR;IL18R1
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),0.46431202378819625,0.7609384125003793,0.7857142857142857,1.0,1.0,3/7,32.37%,NRP1;DSCAM;GOLGA4
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),-0.5168738962492422,-0.7604224375356098,0.8431372549019608,1.0,1.0,3/5,29.47%,PARN;CHD1;ST3GAL1
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),0.4939182567089177,0.7603288734891575,0.8181818181818182,1.0,1.0,1/5,3.04%,TAF1
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),0.4939182567089177,0.7603288734891575,0.8181818181818182,1.0,1.0,1/5,3.04%,TAF1
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),-0.35031857062435373,-0.7601963165582691,0.8208955223880597,1.0,1.0,4/59,4.75%,RREB1;SHLD1;SLC6A6;PRKN
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),0.4015706985822558,0.7591148980624558,0.8163265306122449,1.0,1.0,4/10,27.86%,ADCY2;KLF9;ROCK2;NR3C1
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),-0.4800374081514245,-0.7582774558140287,0.7241379310344828,1.0,1.0,1/6,1.79%,RIMS1
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),-0.47713465793562077,-0.758269119432032,0.6964285714285714,1.0,1.0,1/6,6.67%,SMAD3
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.49785963861689786,-0.7582556530718565,0.8070175438596491,1.0,1.0,1/5,9.84%,APPL2
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),-0.36901172031657425,-0.7573467716607216,0.7857142857142857,1.0,1.0,3/24,10.85%,TOPBP1;DDX24;POLR2A
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),-0.4067024208781991,-0.7572279085905196,0.7796610169491526,1.0,1.0,4/19,4.75%,HLA-F;SNX6;SOD2;PRKN
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),0.5139610595803203,0.7566520985566914,0.8113207547169812,1.0,1.0,3/5,19.78%,DIAPH2;IHO1;USP9X
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),-0.49087430640622765,-0.7564477968769181,0.7777777777777778,1.0,1.0,2/5,31.18%,ACTR3;ARPC2
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),-0.3983997946830776,-0.7552536233549377,0.8301886792452831,1.0,1.0,5/25,16.54%,HMGN1;UBC;PWWP3A;MSH2;SAFB
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),0.47372724648141035,0.7551279633538055,0.7959183673469388,1.0,1.0,3/5,28.17%,PNPLA8;HADHB;PGS1
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),-0.408015122024014,-0.7546041202395686,0.7936507936507936,1.0,1.0,7/18,19.96%,UFL1;RPS14;RPS19;JAK2;ACIN1;CDIN1;PTPN2
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),0.33246418036746733,0.7540246704098081,0.8333333333333334,1.0,1.0,8/41,13.99%,CALR;PRKD1;ABL1;PPM1F;RTN4;CLASP1;PRKCA;NRP1
prerank,PanglaoDB_Augmented_2021__Enterocytes,0.3762151449481888,0.7527116058366916,0.8444444444444444,1.0,1.0,3/16,4.62%,SLC26A3;GULP1;TTC7A
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),0.49163511993257225,0.7522349449760518,0.7551020408163265,1.0,1.0,2/5,25.91%,LRRK2;NEDD4L
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),0.4700197941355899,0.7516347358263658,0.7547169811320755,1.0,1.0,1/5,12.38%,PRKCA
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,-0.4275588283224648,-0.7512017477599026,0.8360655737704918,1.0,1.0,2/17,3.48%,TPM1;CXCL12
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),-0.3476702303723759,-0.751095737660444,0.8571428571428571,1.0,1.0,7/51,9.81%,NTNG1;MAP2;GPM6A;CTNNA2;MEF2A;ZDHHC17;S100A6
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.44476392967056233,-0.7509886086101971,0.8085106382978723,1.0,1.0,3/13,13.84%,RFC3;RFC1;UBC
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),0.4475279851921236,0.7504331275225291,0.75,1.0,1.0,2/6,13.03%,AK3;LRRK2
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),0.4475279851921236,0.7504331275225291,0.75,1.0,1.0,2/6,13.03%,AK3;LRRK2
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),-0.3912103414224895,-0.7502478692820759,0.8064516129032258,1.0,1.0,2/16,10.72%,TFRC;PARP9
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),0.4119796637524551,0.750038645883842,0.7884615384615384,1.0,1.0,3/14,3.95%,ACTG1;HSPB1;CLIC1
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),-0.4104007135550928,-0.7498403391493023,0.7301587301587301,1.0,1.0,2/21,3.22%,PSMB9;PSMA1
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),0.4671308903131427,0.749527345543247,0.7692307692307693,1.0,1.0,1/6,6.39%,WDR82
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),0.40792079587222096,0.7491115113706793,0.8076923076923077,1.0,1.0,3/15,3.95%,ACTG1;HSPB1;CLIC1
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),0.38217142557711337,0.7490348883785396,0.803921568627451,1.0,1.0,6/13,27.00%,HSP90AA1;NEK7;HMBOX1;POT1;TNKS;HSP90AB1
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),0.43508856720623934,0.7481750603818375,0.7857142857142857,1.0,1.0,3/7,13.91%,CPEB3;PSEN1;NLGN1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),0.50384135292225,0.7481046839358215,0.7692307692307693,1.0,1.0,3/5,36.19%,POT1;DCP2;HNRNPU
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),-0.36725578496136424,-0.7478408835131346,0.8571428571428571,1.0,1.0,4/32,9.11%,ISG15;UFL1;PRKN;MYCBP2
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),0.3932567235359715,0.747721576076843,0.7804878048780488,1.0,1.0,4/15,20.12%,NUP58;RANBP2;EP300;PINK1
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),0.37076746487689216,0.7476855017818823,0.725,1.0,1.0,4/18,12.20%,PCM1;CCDC88A;CLASP1;DST
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),0.4086685578597936,0.74557054769204,0.7916666666666666,1.0,1.0,3/11,19.13%,NAV3;CLASP1;TAOK1
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),-0.3747752455336428,-0.7455246161235525,0.7924528301886793,1.0,1.0,4/29,5.04%,NUB1;ARIH2;PRKN;RNF19A
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.4635375407932928,0.7453293440090375,0.7857142857142857,1.0,1.0,1/6,11.97%,ERCC6
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.34979053360297324,0.7444901357435065,0.868421052631579,1.0,1.0,7/35,11.73%,ACTG1;YES1;PIK3CA;ABL1;HSP90AA1;ELMO1;ACTB
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.34979053360297324,0.7444901357435065,0.868421052631579,1.0,1.0,7/35,11.73%,ACTG1;YES1;PIK3CA;ABL1;HSP90AA1;ELMO1;ACTB
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),0.34979053360297324,0.7444901357435065,0.868421052631579,1.0,1.0,7/35,11.73%,ACTG1;YES1;PIK3CA;ABL1;HSP90AA1;ELMO1;ACTB
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),-0.3963948966657,-0.7443561705042364,0.8775510204081632,1.0,1.0,4/18,13.47%,SERPINE1;B2M;AHI1;CLU
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),-0.3746097818760292,-0.7435989672568142,0.7903225806451613,1.0,1.0,5/32,13.84%,PLCG2;CCDC88C;DIXDC1;FZD6;UBC
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),-0.38535470269711736,-0.743542221336624,0.8421052631578947,1.0,1.0,6/20,18.17%,RFC3;MAP3K4;PARN;TNKS2;ATM;PDGFB
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),0.3575897938154233,0.7432294802204731,0.8333333333333334,1.0,1.0,2/31,1.48%,PSMD14;AVEN
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),0.41509098900718067,0.7417602737800891,0.8636363636363636,1.0,1.0,1/12,6.41%,ACAT1
prerank,MSigDB_Hallmark_2020__UV Response Dn,-0.3166372625181866,-0.7416851890331803,0.9402985074626866,1.0,1.0,10/81,14.20%,PPARG;SERPINE1;YTHDC1;ICA1;GRK5;SMAD3;NFKB1;BHLHE40;GCNT1;SYNJ2
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),-0.47031198339811314,-0.7414817771076909,0.7833333333333333,1.0,1.0,2/7,14.17%,MAP2;RAPGEF2
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),0.35493364708660413,0.7413884273212743,0.8235294117647058,1.0,1.0,4/19,11.47%,RALA;ANXA2;PLCB1;HSPA9
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),-0.4917427846278875,-0.740806652313889,0.7659574468085106,1.0,1.0,2/9,8.90%,STK39;DMD
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),-0.45428592587854727,-0.7406871313669707,0.7704918032786885,1.0,1.0,1/10,1.79%,RIMS1
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),-0.44953656332100544,-0.7406411084448943,0.8260869565217391,1.0,1.0,1/9,13.84%,UBC
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),0.4692218206559298,0.7406340726198885,0.7924528301886793,1.0,1.0,1/6,19.13%,TAOK1
prerank,GO_Biological_Process_2021__bone development (GO:0060348),-0.418939242680362,-0.740434613103469,0.8103448275862069,1.0,1.0,4/11,21.78%,SULF2;GNAS;SLC10A7;TGM2
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),0.30422083868073513,0.739244536492004,0.9148936170212766,1.0,1.0,4/28,13.03%,YWHAB;IGFBP3;ATP2B4;LRRK2
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),-0.5040076572697295,-0.7392158135500673,0.8431372549019608,1.0,1.0,1/5,4.41%,MAP2
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),0.41612881221981346,0.738944136448847,0.725,1.0,1.0,2/11,11.73%,CCNI;ACTB
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),-0.4857432655106587,-0.7378128086221566,0.74,1.0,1.0,1/5,2.54%,HGSNAT
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),0.45247383120420226,0.7375273450862062,0.8148148148148148,1.0,1.0,2/5,18.85%,SSBP1;POT1
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),0.41942259604213816,0.7372699076439683,0.8653846153846154,1.0,1.0,1/7,13.99%,NRP1
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),-0.4183396779397404,-0.7370828531386776,0.7868852459016393,1.0,1.0,4/14,19.50%,AGPAT3;CBR4;PDSS2;LSS
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),-0.5101993439191177,-0.7364653674606921,0.7708333333333334,1.0,1.0,2/5,11.63%,HLA-F;HLA-E
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),-0.3761137887959405,-0.7362692172754834,0.819672131147541,1.0,1.0,5/27,14.67%,PPARG;STAT5B;ACER2;JAK2;FOXO1
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),-0.42050397402948436,-0.7360159248759353,0.7580645161290323,1.0,1.0,1/11,1.79%,RIMS1
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),-0.447255470324859,-0.7359682423544376,0.7321428571428571,1.0,1.0,2/5,21.42%,ELOVL5;HACD2
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),-0.38828237904272134,-0.7359529471856964,0.8833333333333333,1.0,1.0,6/24,15.97%,PSMB9;PSMA1;RHOA;FZD6;DAAM1;PSMC6
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),0.4185377268767249,0.7354040099407997,0.8913043478260869,1.0,1.0,1/11,4.41%,YAF2
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),0.4185377268767249,0.7354040099407997,0.8913043478260869,1.0,1.0,1/11,4.41%,YAF2
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),0.35044430950629596,0.734845279399958,0.8,1.0,1.0,6/23,14.90%,DSE;MAT2A;CHSY1;PAPSS2;GLCE;CHST15
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),-0.32943609409510377,-0.7348131524712262,0.8611111111111112,1.0,1.0,9/53,14.20%,PLCG2;CHKA;AGPAT3;PIK3C2B;DGKG;MTMR2;INPP5D;MFSD2A;SYNJ2
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),0.39751097981761646,0.7347884865380304,0.775,1.0,1.0,4/14,18.85%,SSBP1;ANXA1;RAD23B;POT1
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),-0.4759065375752569,-0.7346292942907927,0.7543859649122807,1.0,1.0,2/5,7.79%,SLCO1A2;SLCO2B1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),0.4854641363841496,0.7340033239894451,0.7209302325581395,1.0,1.0,2/5,3.61%,PRKD1;HSPB1
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),0.3357051684445324,0.7336985785348491,0.9210526315789473,1.0,1.0,4/35,11.09%,PRKD1;HSP90AA1;PPM1F;ATP2B4
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),0.2679954605921063,0.7319663133615262,1.0,1.0,1.0,15/78,21.94%,PCM1;TUBB4B;WDPCP;HSP90AA1;CDC14B;GSN;CLASP1;PARVA;CEP290;ABCC4;CDK5RAP2;BBS9;YWHAG;ARF4;CC2D2A
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),-0.4154025166935541,-0.7317843850108459,0.8653846153846154,1.0,1.0,4/12,32.97%,NPM1;CABIN1;NASP;MACROH2A1
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),0.40935433983646125,0.7316928523011982,0.851063829787234,1.0,1.0,3/10,19.13%,NAV3;CLASP1;TAOK1
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),0.3840411215587596,0.7307885299579424,0.8,1.0,1.0,1/9,12.85%,APPL1
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),0.359962428608768,0.7306767116921769,0.8048780487804879,1.0,1.0,4/23,17.58%,NUP58;RANBP2;PSEN1;EP300
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),-0.41072684454622405,-0.7304425244504016,0.7678571428571429,1.0,1.0,4/15,18.17%,MAP3K5;TAOK3;MAP3K4;PDGFB
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),0.4538005428629541,0.7302315158747265,0.8260869565217391,1.0,1.0,1/7,4.34%,UGCG
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),0.4694764556536305,0.73019165671623,0.8125,1.0,1.0,2/5,36.19%,HSPA1A;HNRNPU
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),-0.39909717179891,-0.7301331878863792,0.8928571428571429,1.0,1.0,3/24,4.75%,LRPAP1;HLA-F;PRKN
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),-0.31894999442110683,-0.7298778748377928,0.8769230769230769,1.0,1.0,17/104,16.48%,BTG2;UFL1;VAV3;RFC3;SAMHD1;TOPBP1;ACER2;TANK;BABAM2;CBX5;TAOK3;FOXO1;PWWP3A;PDS5B;ATM;MSH2;NPM1
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),0.49043032625700483,0.7294349444462297,0.8723404255319149,1.0,1.0,5/6,41.36%,PTEN;MAP4K4;MAPRE2;IQSEC1;ADAM9
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),-0.4541976148237157,-0.7292029962302795,0.7083333333333334,1.0,1.0,1/6,8.83%,DGKG
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),-0.35207435330746667,-0.7285180729344778,0.8412698412698413,1.0,1.0,2/42,4.75%,LRPAP1;PRKN
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),0.3858525845872582,0.7282704560104364,0.8333333333333334,1.0,1.0,7/20,19.81%,MCFD2;BET1;TFG;ANKRD28;PPP6R3;CD59;TRAPPC9
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),0.3858525845872582,0.7282704560104364,0.8333333333333334,1.0,1.0,7/20,19.81%,MCFD2;BET1;TFG;ANKRD28;PPP6R3;CD59;TRAPPC9
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.3858525845872582,0.7282704560104364,0.8333333333333334,1.0,1.0,7/20,19.81%,MCFD2;BET1;TFG;ANKRD28;PPP6R3;CD59;TRAPPC9
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),0.38357553303941316,0.7281762080520754,0.8461538461538461,1.0,1.0,3/13,11.66%,NRCAM;ABL1;RTN4
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),0.3413572559114795,0.7276107732915741,0.9777777777777777,1.0,1.0,5/33,12.69%,BTRC;HSP90AA1;LARP4;CPEB3;EIF3E
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),-0.4444707798871977,-0.7270907799843609,0.8245614035087719,1.0,1.0,1/8,6.78%,DSP
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),0.3073907403716614,0.7267658987479446,0.9473684210526315,1.0,1.0,3/35,8.90%,HSPB1;TAB2;PPM1F
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),-0.41594575612088014,-0.7267578048867638,0.7777777777777778,1.0,1.0,1/9,8.83%,DGKG
prerank,PanglaoDB_Augmented_2021__Hepatocytes,-0.37011408080824276,-0.7261609764647454,0.7704918032786885,1.0,1.0,8/20,25.08%,GRB14;NNT;ATP7B;GPC3;WTAP;SPTBN1;LEPR;OCIAD1
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),0.4518942895735206,0.7260118190306563,0.8181818181818182,1.0,1.0,1/5,5.35%,BRWD1
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),0.4518942895735206,0.7260118190306563,0.8181818181818182,1.0,1.0,1/5,5.35%,BRWD1
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),-0.4173276395857318,-0.725105890889892,0.8181818181818182,1.0,1.0,2/12,7.04%,SERPINE1;CD109
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),-0.42051346068936957,-0.7250427079135029,0.8135593220338984,1.0,1.0,1/10,1.79%,RIMS1
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.3759529766263292,0.7250267590225442,0.8571428571428571,1.0,1.0,4/22,8.57%,CRY1;YWHAB;KCTD8;PLCB1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),0.41919599664370655,0.7243554719389406,0.7608695652173914,1.0,1.0,3/9,12.28%,RALA;DDHD1;MFF
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),-0.4347913067281014,-0.7242924313948692,0.8727272727272727,1.0,1.0,5/14,18.41%,PRKN;LIMA1;SSH1;KANK3;TJP1
prerank,PanglaoDB_Augmented_2021__Tanycytes,-0.35054650650772246,-0.7242667434711558,0.8620689655172413,1.0,1.0,3/40,4.41%,SLC16A2;DOK5;MAP2
prerank,PanglaoDB_Augmented_2021__Keratinocytes,-0.4688462430515301,-0.7240996195081694,0.7916666666666666,1.0,1.0,1/5,17.86%,PLEC
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.3111568207958452,-0.7240961205416876,0.9538461538461539,1.0,1.0,8/108,9.87%,KLHL20;IFI27;PSMB9;PSMA1;PRKN;UBR2;ANAPC16;TRIM25
prerank,PanglaoDB_Augmented_2021__Basal Cells,-0.3870631271099213,-0.7239546453016895,0.8545454545454545,1.0,1.0,3/23,8.80%,OPTN;HEBP2;LGALS3
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.36461030715691767,0.7238736522320597,0.8837209302325582,1.0,1.0,4/13,23.26%,ABL1;EP300;FNIP2;BCL2L1
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),-0.46000387774142953,-0.72311568758256,0.7592592592592593,1.0,1.0,1/5,4.75%,PRKN
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),-0.4062616612656868,-0.7230024639599407,0.7777777777777778,1.0,1.0,3/10,18.17%,NFKB1;HIF1A;PDGFB
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),0.4548476689542401,0.7227581699103639,0.8125,1.0,1.0,1/7,18.51%,KHDRBS1
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),0.4407330421263843,0.7213313015961171,0.8431372549019608,1.0,1.0,1/6,6.88%,PKM
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),0.4809232668641249,0.7209972966827602,0.84,1.0,1.0,3/5,20.46%,XPO1;PSIP1;RSRC1
prerank,MSigDB_Hallmark_2020__Androgen Response,0.29419948454666106,0.7206933856606451,0.9411764705882353,1.0,1.0,16/50,19.55%,ZBTB10;TNFAIP8;MAP7;PIAS1;ANKH;INSIG1;APPBP2;CDC14B;ELL2;UBE2J1;AKAP12;ABCC4;FKBP5;ZMIZ1;CDK6;PTPN21
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.3445120009806129,0.7203271661741669,0.8723404255319149,1.0,1.0,5/24,22.20%,BMP6;CLASP1;FRMD4A;EDN1;ABCG1
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),-0.44461926891326387,-0.7199047905439334,0.75,1.0,1.0,2/5,24.66%,MSN;STK10
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),0.39924375450773436,0.7198508017900686,0.7222222222222222,1.0,1.0,3/9,17.32%,OSBPL10;MBOAT2;SERINC1
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),0.3255513454563873,0.7197075963471702,0.96875,1.0,1.0,4/42,6.46%,VAPB;PRKD1;KDSR;CHPT1
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,0.2939427583032457,0.7196065961952499,0.896551724137931,1.0,1.0,5/52,9.68%,MMRN1;CDH2;TET2;BAALC;ELF1
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),0.5075879584879026,0.7186394293235854,0.8653846153846154,1.0,1.0,1/5,6.70%,MAT2A
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),0.4743412355207025,0.7185798872831186,0.8333333333333334,1.0,1.0,1/5,6.41%,ACAT1
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),0.4743412355207025,0.7185798872831186,0.8333333333333334,1.0,1.0,1/5,6.41%,ACAT1
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.37027774845562217,-0.7182301962773497,0.8166666666666667,1.0,1.0,1/19,3.58%,FN1
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),0.3961534670906832,0.7182286214765236,0.8409090909090909,1.0,1.0,8/12,26.95%,RALA;NLGN1;NRP1;FSCN1;TENM2;CDC42;WASL;BCAS3
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),-0.3585499076051994,-0.7179759600091782,0.8070175438596491,1.0,1.0,2/26,6.70%,PRKN;WARS1
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),-0.3331618850240941,-0.7177800701199123,0.9545454545454546,1.0,1.0,10/57,14.64%,RREB1;PLK2;JUN;CTNNAL1;ARHGEF11;GNA12;CDH13;RHOA;RAPGEF2;CFL1
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.33285366467562927,0.717024459911064,0.851063829787234,1.0,1.0,2/23,5.17%,CCDC88A;ITGA1
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),-0.4842859902026455,-0.7168860445796513,0.851063829787234,1.0,1.0,2/5,26.48%,SERBP1;HIPK2
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),-0.48765583883288477,-0.7161954962062128,0.7954545454545454,1.0,1.0,1/5,11.45%,LBR
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),0.36407107821762036,0.7161411952869342,0.9375,1.0,1.0,6/20,18.15%,ROBO2;URI1;NCOA3;NCOA2;NCOA1;KLF9
prerank,GO_Biological_Process_2021__axon development (GO:0061564),0.3441126393902442,0.7156602335862988,0.7741935483870968,1.0,1.0,9/25,18.80%,NREP;NRCAM;KLF7;RTN4;ACTB;PARD3;ANK3;RYK;PLPPR4
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),0.3599473771802501,0.7156065493886649,0.8478260869565217,1.0,1.0,2/18,9.01%,NOVA1;NOVA2
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),-0.40582453666349155,-0.7153321362986056,0.8301886792452831,1.0,1.0,3/13,13.84%,PRKN;VIM;UBC
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),-0.3629040070058149,-0.7152996046759559,0.8524590163934426,1.0,1.0,3/18,16.38%,SMARCA1;SMARCA2;SMARCAD1
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.4667715826473102,-0.714791752809353,0.8035714285714286,1.0,1.0,1/7,0.44%,CX3CL1
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),0.4223205318349269,0.7143218861253312,0.8536585365853658,1.0,1.0,3/8,12.28%,ERBB4;HSPD1;MFF
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),-0.42660591868138464,-0.7141860780132399,0.7872340425531915,1.0,1.0,3/8,21.86%,NFKB1;PDGFB;MAP2K5
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),0.4408514452786475,0.7141023493614672,0.8,1.0,1.0,1/5,2.47%,INPP5F
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),-0.41905221991248326,-0.7130027110381268,0.8571428571428571,1.0,1.0,3/7,24.43%,SHROOM2;AP1G1;KIF13A
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),-0.36892805653790517,-0.7128801814280568,0.78,1.0,1.0,4/23,10.25%,ATP6V1E1;EIF2AK2;MAP3K5;LARS1
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),0.4153886478476207,0.7114218223384522,0.8095238095238095,1.0,1.0,3/8,13.03%,TRAK2;TRAK1;LRRK2
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),-0.47211774600493056,-0.7104667492200842,0.78,1.0,1.0,1/5,9.71%,ACER2
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),0.4319233019227049,0.7103649067333766,0.8717948717948718,1.0,1.0,2/6,11.66%,SEMA3F;RTN4
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),0.3571447087708323,0.7100178791802356,0.8571428571428571,1.0,1.0,2/20,5.58%,SLC38A9;PIK3CA
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),-0.4072237737592219,-0.7099859811802258,0.8225806451612904,1.0,1.0,4/12,17.81%,SPAST;LBR;KPNB1;NUP98
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),-0.4072237737592219,-0.7099859811802258,0.8225806451612904,1.0,1.0,4/12,17.81%,SPAST;LBR;KPNB1;NUP98
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),-0.4072237737592219,-0.7099859811802258,0.8225806451612904,1.0,1.0,4/12,17.81%,SPAST;LBR;KPNB1;NUP98
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),0.41647997318388597,0.7097864136974253,0.8780487804878049,1.0,1.0,3/7,22.33%,ITGA2;NRP1;OPHN1
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),-0.42987235161929693,-0.7089850749482642,0.7735849056603774,1.0,1.0,2/11,11.79%,APPL2;GNA12
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),0.44999324578508637,0.7083466729160086,0.9090909090909091,1.0,1.0,1/7,6.10%,BTRC
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.4458447260527027,-0.7081706762400254,0.8596491228070176,1.0,1.0,4/7,22.40%,RPL24;RPL11;RPL10;RPL3
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.2919862072080254,-0.7069309313445961,0.9558823529411765,1.0,1.0,18/118,13.73%,HGSNAT;HEBP2;HLA-C;HLA-B;SLC2A3;TMEM30A;DSP;SRP14;IGF2R;CST3;LGALS3;B2M;NFKB1;CD47;CDA;BST2;RHOA;ITGAV
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.2919862072080254,-0.7069309313445961,0.9558823529411765,1.0,1.0,18/118,13.73%,HGSNAT;HEBP2;HLA-C;HLA-B;SLC2A3;TMEM30A;DSP;SRP14;IGF2R;CST3;LGALS3;B2M;NFKB1;CD47;CDA;BST2;RHOA;ITGAV
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),0.38112003083573365,0.7062623375383611,0.8857142857142857,1.0,1.0,4/12,12.28%,SLC25A16;FBXO7;HSP90AA1;MFF
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),-0.3402020630859021,-0.7059325540260616,0.8840579710144928,1.0,1.0,10/50,13.94%,STAT1;PRKN;BCL2L14;NDRG1;PMAIP1;ACER2;ACTN1;CHM;CLU;JAK2
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),0.47171084208108915,0.7059259167060792,0.8780487804878049,1.0,1.0,2/7,18.95%,TRAF3;ITCH
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.4601487993413227,0.7057944207328385,0.8490566037735849,1.0,1.0,1/6,5.40%,MED4
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),-0.4088895988621777,-0.705629775684802,0.7924528301886793,1.0,1.0,2/12,6.15%,SLC5A6;SLC38A3
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),-0.4249527276261236,-0.7052425284606746,0.7872340425531915,1.0,1.0,3/6,22.59%,ATP2B1;ZDHHC21;ECE1
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),0.33818267677557096,0.705141654401697,0.725,1.0,1.0,2/12,12.85%,GRB10;APPL1
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),0.43692899937154467,0.7047375760518716,0.8378378378378378,1.0,1.0,1/10,1.43%,TEAD4
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),0.3656920656144624,0.7045064370883933,0.918918918918919,1.0,1.0,4/15,20.04%,FOXO3;SESN1;CPEB4;MTMR3
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),-0.36851834189611105,-0.704435917274386,0.8979591836734694,1.0,1.0,4/20,15.94%,RFC3;TOPBP1;RFC1;ATM
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),-0.34957844968012064,-0.7042790954224435,0.847457627118644,1.0,1.0,6/33,13.24%,TPM1;CARMIL1;LIMCH1;TMEFF2;CD47;RHOA
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),-0.3821438428856871,-0.7038502533281121,0.7868852459016393,1.0,1.0,4/19,13.94%,IFI27;SMAD3;ITGAV;JAK2
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),-0.3055451585289582,-0.7036838717339569,0.9411764705882353,1.0,1.0,5/113,5.32%,PARP14;BTG2;CNOT8;PRKN;EIF2AK2
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),0.47043993015161834,0.7035264373590634,0.8076923076923077,1.0,1.0,3/5,26.48%,CDK6;AKT3;MARCHF5
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),0.358886706149072,0.7034886051517909,0.8809523809523809,1.0,1.0,2/20,6.65%,EIF4G3;TAB2
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),-0.3371743950174045,-0.703393542636701,0.8888888888888888,1.0,1.0,6/32,14.46%,MAP2;SMAD3;GNG4;CDA;BST2;SMARCA2
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),0.4602457902371858,0.7030779209584764,0.8431372549019608,1.0,1.0,1/5,6.88%,PKM
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),-0.3461834622047753,-0.7025154217859889,0.9473684210526315,1.0,1.0,6/33,16.46%,EIF2AK2;WARS1;LGALS3;TFRC;CLU;RIOK3
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),-0.47757574427887334,-0.7023030174387449,0.8596491228070176,1.0,1.0,2/7,20.82%,B2M;MAP3K3
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),-0.45006813615439395,-0.7015919268702839,0.7962962962962963,1.0,1.0,4/6,28.82%,MRPL33;LARS2;PTCD3;RARS2
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),-0.4434247872616819,-0.7015344520349516,0.8392857142857143,1.0,1.0,1/7,4.75%,PRKN
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.3711984903667269,-0.701376620380389,0.9137931034482759,1.0,1.0,6/26,15.97%,PSMB9;PSMA1;RHOA;FZD6;DAAM1;PSMC6
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.388922950408946,-0.7008347268538384,0.847457627118644,1.0,1.0,5/14,18.85%,MAP3K4;PARN;TNKS2;ATM;DHX36
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),-0.3711346946565456,-0.6997132461537608,0.8888888888888888,1.0,1.0,6/20,13.73%,PRKN;LGALS3;BST2;MTMR2;NDFIP1;ITGAV
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),0.3034802712435605,0.6995685121200024,0.9512195121951219,1.0,1.0,9/29,20.90%,FBXO7;TRAK2;TRAK1;MFF;NLGN1;PARD3;ZDHHC14;AKAP6;SEC63
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),-0.4192682398216138,-0.6993606077269541,0.7678571428571429,1.0,1.0,2/7,30.27%,ACVRL1;ACVR1
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.28801705633149927,-0.6990199363329055,0.9558823529411765,1.0,1.0,18/120,13.73%,HGSNAT;HEBP2;HLA-C;HLA-B;SLC2A3;TMEM30A;DSP;SRP14;IGF2R;CST3;LGALS3;B2M;NFKB1;CD47;CDA;BST2;RHOA;ITGAV
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),-0.44192804579749223,-0.6982777632689136,0.76,1.0,1.0,2/6,15.39%,MAP3K4;TNKS2
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),0.30803789444718577,0.6978590307316076,0.875,1.0,1.0,11/39,16.87%,CDH2;ACTG1;NRXN1;NRCAM;ACTB;NLGN1;VMP1;CDH12;CTNND2;PTEN;RYK
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),-0.33312399453067976,-0.6977472869045873,0.9354838709677419,1.0,1.0,1/50,0.39%,MX1
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.3815678868912906,0.6976921773057555,0.8775510204081632,1.0,1.0,2/13,13.47%,TAF1;EPHA4
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),-0.4276743945442354,-0.6976622913362841,0.7758620689655172,1.0,1.0,1/9,4.75%,PRKN
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.3504977384843206,0.6971387916300994,0.9166666666666666,1.0,1.0,1/17,3.04%,TAF1
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),-0.307546467752107,-0.6969057489493315,0.9166666666666666,1.0,1.0,12/79,13.84%,ISG15;RNF213;NUB1;ARIH2;PRKN;RNF19A;ANAPC16;TRIM25;UBE2D2;NPLOC4;NDFIP1;UBC
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),-0.3265715346514278,-0.6967490438724662,0.9324324324324325,1.0,1.0,7/51,9.84%,PSMB9;PSMA1;CEP57;CEP70;CDC14A;ANAPC16;APPL2
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),0.3325834591030866,0.6965222573747282,0.8863636363636364,1.0,1.0,8/26,23.91%,CALR;XPO1;XPO4;XPO7;SRSF7;WASHC4;SRSF11;SMURF1
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),-0.47375229048373035,-0.6959884714200298,0.8103448275862069,1.0,1.0,1/5,4.75%,PRKN
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),-0.47375229048373035,-0.6959884714200298,0.8103448275862069,1.0,1.0,1/5,4.75%,PRKN
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),0.29057512867926116,0.6958805057988572,0.95,1.0,1.0,8/46,17.50%,HSPB1;IGFBP3;SMAD6;PPM1F;LRRK2;PARD3;PTEN;CALM1
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),-0.4203463501452306,-0.6955702553135761,0.8604651162790697,1.0,1.0,2/8,21.00%,POLR2A;MTERF1
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),0.4573855707408174,0.6945649367749969,0.8666666666666667,1.0,1.0,3/5,32.11%,SLC24A2;KCNMB4;KCNQ5
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),-0.42610108567623695,-0.6935944564249767,0.8113207547169812,1.0,1.0,2/8,10.88%,SPPL2A;NFKB1
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),0.38358063581533497,0.6930521031433872,0.86,1.0,1.0,3/9,11.40%,HSPG2;EXT1;GCNT2
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",0.4147359274207813,0.6930158247715581,0.875,1.0,1.0,4/10,9.97%,XKR6;GULP1;GSN;ELMO1
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.36865054473757,-0.6928735823324822,0.9183673469387755,1.0,1.0,4/29,5.04%,NUB1;ARIH2;PRKN;RNF19A
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),0.43058690769950114,0.6927927000190851,0.8125,1.0,1.0,3/7,24.12%,DICER1;AGO2;TUT7
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),-0.4734978450197822,-0.6926792842280828,0.8653846153846154,1.0,1.0,2/5,23.75%,GSPT1;CLEC16A
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),-0.36334045646539237,-0.6926138885348405,0.8076923076923077,1.0,1.0,4/24,10.25%,ATP6V1E1;EIF2AK2;MAP3K5;LARS1
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),0.3475468809763162,0.6923529784343438,0.8837209302325582,1.0,1.0,2/16,7.50%,IGFBP3;KLF7
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),-0.371913227168007,-0.6919382819012688,0.819672131147541,1.0,1.0,3/17,11.32%,MAP2;PRKN;GOSR1
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),0.2990401304305581,0.691679344322138,0.9473684210526315,1.0,1.0,12/30,28.04%,CAPN2;ZEB2;DIAPH1;MFF;EP300;CLIC4;TAOK1;PINK1;PTK2;ARMH3;MARK2;RHOT1
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),0.36992948462337927,0.6915786739571086,0.8444444444444444,1.0,1.0,2/14,10.44%,GRM5;FOXO3
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.2982027879091353,0.6915123393157125,0.9714285714285714,1.0,1.0,8/40,17.19%,ERBB4;YES1;FRS2;EPHA4;FES;ROR1;RYK;ACVR2A
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),0.3448049692410323,0.6915039508057548,0.8958333333333334,1.0,1.0,2/19,9.01%,NOVA1;NOVA2
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.4288140977577536,-0.691502072330651,0.8269230769230769,1.0,1.0,1/5,6.78%,DSP
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),-0.39912610082167155,-0.691474975851276,0.8166666666666667,1.0,1.0,2/14,11.37%,NBDY;FEZ2
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.4097050201307657,0.6908443114695961,0.84,1.0,1.0,1/8,4.88%,CCDC88A
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),0.3973670853736564,0.690695165245464,0.7555555555555555,1.0,1.0,5/9,30.22%,EPHA4;PICALM;ROCK2;STAT3;FYN
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),-0.4497233781530767,-0.690190524002396,0.8431372549019608,1.0,1.0,1/5,7.35%,CALCOCO2
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),-0.4076498145661109,-0.6898157190142231,0.7636363636363637,1.0,1.0,2/10,7.06%,GMPS;ADSS2
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),0.3636490971433976,0.6896973677031562,0.8085106382978723,1.0,1.0,6/15,16.87%,CDH2;NRXN1;NRCAM;NLGN1;PTEN;RYK
prerank,PanglaoDB_Augmented_2021__Tuft Cells,0.4263199820893543,0.689471113362094,0.8571428571428571,1.0,1.0,1/8,1.66%,NREP
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),-0.4492067674640443,-0.6887484596391376,0.8518518518518519,1.0,1.0,1/7,6.67%,SMAD3
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.4368356903139765,-0.6887344833309088,0.8444444444444444,1.0,1.0,5/8,29.08%,UBC;RNF111;XPC;CUL4A;RPS27A
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),0.41318865073216776,0.688625639312483,0.85,1.0,1.0,2/8,13.99%,SEMA3F;NRP1
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),0.3945588278136262,0.6885220265592912,0.8695652173913043,1.0,1.0,4/7,41.36%,ROCK1;NRDC;TIMP3;ADAM9
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),-0.37185599561164895,-0.6878671272668273,0.9,1.0,1.0,2/15,11.06%,LYPLA1;NOSTRIN
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),0.4456262604939533,0.687595760545351,0.8541666666666666,1.0,1.0,1/6,8.80%,DICER1
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),0.36964073411698106,0.6875906048157822,0.9230769230769231,1.0,1.0,1/15,2.62%,UBQLN1
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),-0.453036731634341,-0.6874395332378709,0.88,1.0,1.0,2/5,26.84%,MAPK14;WWC2
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),-0.29614561104819725,-0.6873151565628995,0.9565217391304348,1.0,1.0,12/76,16.48%,BTG2;RFC3;TOPBP1;BABAM2;PARP9;PRIMPOL;UBC;PWWP3A;PDS5B;ATM;MSH2;NPM1
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),0.4299445411213584,0.6864719783968013,0.8,1.0,1.0,2/5,13.99%,DOCK4;NRP1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),-0.3940489634211128,-0.685553577764385,0.8679245283018868,1.0,1.0,3/16,8.98%,PRKN;TNFSF10;PMAIP1
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.3591373931188912,0.6854955362657352,0.9148936170212766,1.0,1.0,8/12,30.48%,CTNND2;PTEN;DIP2A;CDC42;WASL;FYN;INSR;PRNP
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),0.34354138886557933,0.6849402526109541,0.8809523809523809,1.0,1.0,6/16,25.57%,ACTG1;CLASP1;ROCK1;ROCK2;PTK2;EFNA5
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),-0.33953776014355563,-0.6848176014018572,0.8888888888888888,1.0,1.0,5/36,9.79%,PLCG2;PRKN;MEF2A;JUN;B2M
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),-0.39421479053373587,-0.6843977301327385,0.9354838709677419,1.0,1.0,2/11,10.23%,ERAP1;SPPL2A
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.4369118597400129,-0.6841394494329902,0.86,1.0,1.0,1/6,9.87%,TRIM25
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.46830636341580584,0.684012797055987,0.875,1.0,1.0,2/5,13.99%,SEMA3F;NRP1
prerank,MSigDB_Hallmark_2020__Myc Targets V2,0.44246993290628805,0.6824011386965212,0.8333333333333334,1.0,1.0,2/5,20.20%,HSPD1;WDR43
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),0.3512812794271562,0.681985044904915,0.9230769230769231,1.0,1.0,6/17,24.12%,YTHDF2;DIS3L2;XRN2;HSPA1A;RC3H1;TUT7
prerank,PanglaoDB_Augmented_2021__Ionocytes,-0.42405786248102917,-0.6817754144941658,0.864406779661017,1.0,1.0,2/8,17.96%,CCDC60;NEBL
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),0.4143192581451858,0.6817361232506448,0.8,1.0,1.0,1/5,8.90%,PPM1F
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),0.36535410448580946,0.681085494153796,0.9347826086956522,1.0,1.0,2/12,7.32%,ROBO2;SMAD6
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),-0.38112261382774304,-0.6804634010820694,0.9152542372881356,1.0,1.0,4/17,18.64%,TIE1;RAPGEF2;TJP1;MSN
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),-0.3914978437306821,-0.6803298259573386,0.8958333333333334,1.0,1.0,1/11,16.48%,NPM1
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),-0.46599822413726666,-0.6802570503442529,0.8269230769230769,1.0,1.0,2/5,21.37%,VSIR;IL15
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),0.36005966575974313,0.6800735550848572,0.8695652173913043,1.0,1.0,3/15,17.58%,MORF4L1;ZZZ3;EP300
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),-0.3695956738251991,-0.6797063922697079,0.7777777777777778,1.0,1.0,1/13,1.01%,KIAA1217
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.43237902442046583,-0.6796597089164408,0.835820895522388,1.0,1.0,4/7,27.00%,SRP14;RAB3GAP1;SPCS3;MAN1A1
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),-0.45231417710433414,-0.6792072258136529,0.9090909090909091,1.0,1.0,3/6,22.30%,APPL2;HIF1A;MAPK14
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),0.43354048526980565,0.6784211241863312,0.8913043478260869,1.0,1.0,1/8,2.78%,PRKD1
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),0.3990576631532515,0.6781827120436688,0.8367346938775511,1.0,1.0,1/9,4.88%,CCDC88A
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),0.4237097398058281,0.6779257017433408,0.8604651162790697,1.0,1.0,2/6,23.96%,USP22;FGFR1
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.3472941665475483,-0.6777367570065916,0.8909090909090909,1.0,1.0,4/39,7.04%,PPARG;SNX6;SMAD3;CD109
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),-0.4189834095364891,-0.6770215989268182,0.9387755102040817,1.0,1.0,4/10,25.80%,MRPL33;EEF1A1;RACK1;PTCD3
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),0.3463949176531812,0.6766825917644782,0.8775510204081632,1.0,1.0,2/16,16.23%,INO80;ARID1A
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.3594401037746759,0.6763500287191256,0.8958333333333334,1.0,1.0,4/12,25.55%,CLASP1;PARD3;OPHN1;CDC42
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),-0.3907399994383697,-0.6761471544095605,0.873015873015873,1.0,1.0,1/12,2.67%,PLCG2
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),0.40953347916239347,0.6759853824863347,0.8571428571428571,1.0,1.0,2/5,20.79%,ANXA1;EDN1
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),0.4153104763332599,0.6758833474888482,0.803921568627451,1.0,1.0,2/5,24.33%,ROCK1;ROCK2
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),-0.44859242220915974,-0.6754528304301508,0.8571428571428571,1.0,1.0,3/8,8.80%,CXCL12;SERPINE1;LGALS3
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),0.4017866250328387,0.6744023729888898,0.8367346938775511,1.0,1.0,2/13,12.07%,ADGRB3;CSMD3
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),0.3954325666977348,0.6743012617462326,0.8444444444444444,1.0,1.0,1/9,7.92%,RAB11FIP2
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),0.3701559173694079,0.674279392743735,0.8913043478260869,1.0,1.0,2/13,9.76%,UIMC1;CDC14B
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),-0.39910204557672285,-0.6742027960279287,0.8,1.0,1.0,3/9,17.96%,DMD;RORA;NEBL
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),-0.408949817109762,-0.6736636381811067,0.8367346938775511,1.0,1.0,1/9,1.38%,ISG15
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),0.4131554521215457,0.673662903143157,0.7659574468085106,1.0,1.0,1/5,11.79%,CLASP1
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),0.4131554521215457,0.673662903143157,0.7659574468085106,1.0,1.0,1/5,11.79%,CLASP1
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),0.3929582471140448,0.6729609299964262,0.95,1.0,1.0,2/10,18.17%,CLASP1;CDK5RAP2
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),-0.3628124133308247,-0.6719840048037995,0.8947368421052632,1.0,1.0,1/17,6.36%,GRB14
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),0.3417746815284742,0.6717404753909499,0.8947368421052632,1.0,1.0,2/17,7.14%,NUP58;RANBP2
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),0.3417746815284742,0.6717404753909499,0.8947368421052632,1.0,1.0,2/17,7.14%,NUP58;RANBP2
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),-0.3414319320338486,-0.6715233229889752,0.8909090909090909,1.0,1.0,6/29,17.81%,YTHDC1;SRRM1;POM121C;SRSF5;NUP54;NUP98
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),0.43836139069315017,0.6713625355486419,0.8888888888888888,1.0,1.0,1/5,12.28%,MFF
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),0.43216422835049667,0.670967019243755,0.9130434782608695,1.0,1.0,1/6,12.28%,MFF
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),-0.3440921853308727,-0.6709387021978971,0.9107142857142857,1.0,1.0,6/28,17.81%,YTHDC1;SRRM1;POM121C;SRSF5;NUP54;NUP98
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.3440921853308727,-0.6709387021978971,0.9107142857142857,1.0,1.0,6/28,17.81%,YTHDC1;SRRM1;POM121C;SRSF5;NUP54;NUP98
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.405633521948196,-0.6701970496409243,0.8163265306122449,1.0,1.0,4/8,29.08%,UBC;XPC;CUL4A;RPS27A
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),0.26542872002572565,0.6701373973265201,0.9767441860465116,1.0,1.0,11/57,19.70%,BCL6;CHPT1;URI1;CCDC85B;RTN4;INO80;ADAM10;ST7L;ITCH;ADAM17;AKAP6
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.3999901936190936,-0.6699108076970359,0.8679245283018868,1.0,1.0,1/9,6.18%,PABPC1
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.3999901936190936,-0.6699108076970359,0.8679245283018868,1.0,1.0,1/9,6.18%,PABPC1
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.38653918171541696,0.6698636941591429,0.8793103448275862,1.0,1.0,1/7,4.96%,MGAT5
prerank,GO_Biological_Process_2021__protein import (GO:0017038),-0.35047776219200083,-0.6696700240145014,0.8769230769230769,1.0,1.0,5/24,16.15%,RANBP17;APPL2;CLU;POM121C;KPNB1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.43988138675839056,-0.6693647880707336,0.8958333333333334,1.0,1.0,3/5,31.02%,NPM1;RAB11A;MECP2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),-0.37798473832940843,-0.6693320478624352,0.8571428571428571,1.0,1.0,2/12,16.85%,MEF2A;PDE9A
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.4084281542480479,-0.6679047856184805,0.88,1.0,1.0,2/9,13.84%,TNIP1;UBC
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),0.3543432580912003,0.6670967768652107,0.8909090909090909,1.0,1.0,2/11,7.87%,CDH2;ABL1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.3367021943609599,-0.6670881077986935,0.9047619047619048,1.0,1.0,2/27,3.22%,PSMB9;PSMA1
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),-0.38175574776077736,-0.6663078105011847,0.9333333333333333,1.0,1.0,4/15,19.99%,SRGN;ALS2;CD34;SQSTM1
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),-0.42641751754269175,-0.6650692793191517,0.86,1.0,1.0,1/8,9.71%,ACER2
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),-0.3814439529025646,-0.6649707244760266,0.9272727272727272,1.0,1.0,4/12,15.94%,MAP3K4;PARN;TNKS2;ATM
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),-0.38013010049045604,-0.6648877861534674,0.9056603773584906,1.0,1.0,2/11,22.35%,NPM1;CABIN1
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),-0.4131291438806698,-0.6645921590862393,0.9056603773584906,1.0,1.0,4/6,35.23%,DGLUCY;RIMKLB;GLUD1;SLC39A8
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),-0.3744128698564396,-0.6641957514000543,0.8363636363636363,1.0,1.0,1/15,1.38%,ISG15
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.3656846855478012,-0.6639630235710712,0.9259259259259259,1.0,1.0,2/14,9.32%,MAP2;ATXN7
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),0.27109216943012066,0.6638349811173189,1.0,1.0,1.0,10/65,16.07%,VAPB;PRKD1;FAM174B;ATP8B1;HACE1;CLASP1;LEMD3;LRRK2;VMP1;ANK3
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),-0.39461367324712576,-0.6634933124605752,0.8909090909090909,1.0,1.0,5/12,30.01%,ATM;KDM1A;MDM2;XRCC5;TLK2
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.37266221414301676,-0.6634002498163486,0.8653846153846154,1.0,1.0,3/11,15.06%,IL32;LCP2;IL18R1
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),0.43687010030200596,0.6633930124075962,0.8653846153846154,1.0,1.0,2/5,28.09%,SPEN;RFX3
prerank,GO_Biological_Process_2021__hemidesmosome assembly (GO:0031581),0.41042662856166523,0.6633742652939895,0.8222222222222222,1.0,1.0,1/5,12.20%,DST
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.3703797011010719,-0.6632321583078928,0.9333333333333333,1.0,1.0,1/17,3.32%,SNX6
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),-0.3301403705286489,-0.6628597457710779,0.9298245614035088,1.0,1.0,2/18,7.11%,GPM6A;SRGAP2C
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),0.36373478279274923,0.6625265600587085,0.8846153846153846,1.0,1.0,2/14,8.57%,INPP5A;PLCB1
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),0.36373478279274923,0.6625265600587085,0.8846153846153846,1.0,1.0,2/14,8.57%,INPP5A;PLCB1
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.44157818137489774,0.662441808767544,0.94,1.0,1.0,2/5,14.90%,CHSY1;CHST15
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.44157818137489774,0.662441808767544,0.94,1.0,1.0,2/5,14.90%,CHSY1;CHST15
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),-0.35797505180743217,-0.6622530205829547,0.8214285714285714,1.0,1.0,7/19,25.00%,APPL2;JAK2;GNAS;EPAS1;APC;KDM1A;LEPR
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),0.41762948067386774,0.6620185258251302,0.875,1.0,1.0,3/9,24.33%,ROCK1;ADD1;ROCK2
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),0.33544028929436537,0.661868993498579,0.8918918918918919,1.0,1.0,5/19,16.07%,UGCG;STX2;ANO6;ANK2;ANK3
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),0.3032219663092689,0.6612098284368602,1.0,1.0,1.0,8/26,21.94%,PCM1;TUBB4B;HSP90AA1;CLASP1;CEP290;CDK5RAP2;YWHAG;CC2D2A
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),0.4134667398717781,0.6611025331312969,0.8301886792452831,1.0,1.0,4/5,19.57%,OXSR1;WNK1;ADAM10;ADAM17
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),0.4134667398717781,0.6611025331312969,0.8301886792452831,1.0,1.0,4/5,19.57%,OXSR1;WNK1;ADAM10;ADAM17
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),0.4134667398717781,0.6611025331312969,0.8301886792452831,1.0,1.0,4/5,19.57%,OXSR1;WNK1;ADAM10;ADAM17
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),-0.4188146516526075,-0.6610159261884578,0.9245283018867925,1.0,1.0,5/10,30.01%,ATM;KDM1A;MDM2;XRCC5;TLK2
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),-0.4078659364516841,-0.6609858948226899,0.8727272727272727,1.0,1.0,1/7,10.10%,BRD7
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),-0.37696326541126457,-0.6608721773333709,0.8947368421052632,1.0,1.0,4/15,15.91%,MAP3K5;EFNB2;CLU;FOS
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),-0.3859032005986704,-0.6597524050305164,0.8545454545454545,1.0,1.0,2/9,16.85%,MEF2A;PDE9A
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.4151867444367996,-0.6584005965505314,0.9152542372881356,1.0,1.0,1/7,8.90%,DMD
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),0.3027382249299122,0.657978651279172,0.9761904761904762,1.0,1.0,3/29,7.32%,IFNAR1;TAB2;SMAD6
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),-0.399985029602796,-0.6566458888620957,0.8627450980392157,1.0,1.0,1/6,10.51%,AHI1
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),-0.3937057645690746,-0.6563945147133352,0.8490566037735849,1.0,1.0,2/10,8.85%,MAP2;ZC4H2
prerank,GO_Biological_Process_2021__liver development (GO:0001889),0.3647246063906455,0.6559656793385351,0.8297872340425532,1.0,1.0,4/8,31.31%,ANXA1;NF1;TGFBR3;ARID5B
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.4206680284461817,-0.6549559667212851,0.9019607843137255,1.0,1.0,2/7,11.29%,TPM1;ADAMTS1
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),0.3768930339598282,0.6548591874082812,0.8723404255319149,1.0,1.0,2/8,7.87%,PIK3CA;ABL1
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),-0.33042483629117014,-0.6545054949919896,0.9649122807017544,1.0,1.0,5/28,18.12%,EIF2AK2;MAP3K5;TAOK3;MAP3K4;GADD45B
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.3931273280852102,0.6544843365174939,0.9574468085106383,1.0,1.0,2/7,15.81%,NLGN1;CDH12
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),-0.35339456422084203,-0.6540113632142539,0.8421052631578947,1.0,1.0,2/15,7.71%,PRKN;CCDC88C
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),0.41295879830015225,0.6539173698270456,0.9090909090909091,1.0,1.0,1/7,11.73%,ACTB
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),-0.3407216096654352,-0.6531612492386708,0.9152542372881356,1.0,1.0,1/20,1.79%,RIMS1
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),0.37356799986345757,0.6531084278037765,0.8913043478260869,1.0,1.0,2/10,7.32%,ROBO2;SMAD6
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),0.4210365793281621,0.6530945472472882,0.9565217391304348,1.0,1.0,4/5,30.37%,PHIP;EDN1;RGCC;INSR
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),0.4405909591695295,0.6520442367761841,0.9122807017543859,1.0,1.0,1/5,8.57%,PLCB1
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),-0.30799241928684035,-0.6519224698476802,0.9393939393939394,1.0,1.0,6/42,13.58%,PSMB9;PSMA1;CCDC88C;RHOA;FZD6;DAAM1
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),0.3641106396018897,0.6517732207399849,0.9047619047619048,1.0,1.0,4/12,25.60%,HSPA9;HSPA8;HSPA1A;UGGT1
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),0.38893192918817143,0.651525258239907,0.8,1.0,1.0,2/8,20.43%,DICER1;AGO2
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),0.31291382830531117,0.650876184395177,0.9069767441860465,1.0,1.0,10/22,31.13%,CLASP1;INO80;SMC1A;NEK7;ZNF207;TNKS;STARD9;OFD1;STAG1;TOGARAM1
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,-0.36992566432590945,-0.6497181344862795,0.9056603773584906,1.0,1.0,6/11,18.98%,HLA-F;LCP2;HLA-E;GIMAP8;LRRC32;GBP2
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),0.41591900101963075,0.6492958168196221,0.8653846153846154,1.0,1.0,1/5,10.80%,NCOA3
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),0.4025825545833733,0.6486275099480734,0.8181818181818182,1.0,1.0,1/5,4.02%,BMP6
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.395214758836034,-0.6479721115980437,0.88,1.0,1.0,1/12,7.61%,STK39
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.3736123429664909,0.6478038185505379,0.8723404255319149,1.0,1.0,2/9,9.76%,UIMC1;CDC14B
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),-0.33905776516095804,-0.647194054998759,0.9821428571428571,1.0,1.0,3/20,10.57%,MYRIP;ACSL4;CD2AP
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),0.31920015911690236,0.6470766130667527,0.9714285714285714,1.0,1.0,4/20,11.47%,RALA;ANXA2;PLCB1;HSPA9
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),-0.32834057386854254,-0.6470450276485674,0.9464285714285714,1.0,1.0,6/30,17.81%,YTHDC1;SRRM1;POM121C;SRSF5;NUP54;NUP98
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),-0.3547841261656183,-0.6469084317448205,0.8947368421052632,1.0,1.0,3/12,20.40%,SPAST;HIF1A;OPA1
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),0.3017331481136772,0.6468614367099378,0.9591836734693877,1.0,1.0,2/25,4.52%,UIMC1;COP1
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),0.33541300526084816,0.6465978755331646,0.9090909090909091,1.0,1.0,1/16,2.70%,VAPB
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),-0.34478753669529477,-0.6457694960749724,0.9117647058823529,1.0,1.0,7/34,16.25%,PRKN;VPS36;GABARAPL1;STAM2;STX17;MFN1;ATG12
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.366657894929985,0.6455693767506483,0.8823529411764706,1.0,1.0,2/8,12.44%,MED4;SETX
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),0.3842936457905541,0.6452995691282053,0.8648648648648649,1.0,1.0,4/9,15.78%,ABL1;ATP2B4;LRRK2;RYR2
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),-0.35461104523001385,-0.6450528098920819,0.9090909090909091,1.0,1.0,4/17,15.94%,MAP3K4;PARN;TNKS2;ATM
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),-0.41141769017666685,-0.643836359044049,0.8958333333333334,1.0,1.0,1/9,6.36%,GRB14
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.41512961017109273,0.6437585780847819,0.851063829787234,1.0,1.0,3/6,23.96%,HSPA1A;BCL2L1;FGFR1
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,0.34897924790058005,0.6436500885279401,0.875,1.0,1.0,5/12,37.44%,NCOR2;ADAM17;RBPJ;LEF1;PPARD
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",-0.3047598601484204,-0.643515971592103,0.9180327868852459,1.0,1.0,6/53,11.84%,RREB1;MLLT1;MEF2A;POLR2A;NFKB1;PTMA
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),-0.32848796629734917,-0.643417001136858,0.8909090909090909,1.0,1.0,4/24,13.01%,LRPAP1;LGALS3;MTMR2;CDH13
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),-0.34102737294139773,-0.6432479966805549,0.8620689655172413,1.0,1.0,1/15,4.75%,PRKN
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),-0.40109577784417627,-0.6429104782262667,0.8333333333333334,1.0,1.0,2/7,30.27%,ACVRL1;ACVR1
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),-0.35438205672378903,-0.6424764513000816,0.9333333333333333,1.0,1.0,5/19,16.15%,RANBP17;APPL2;GEMIN5;POM121C;KPNB1
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.4029568900414316,0.6421291025573794,0.8333333333333334,1.0,1.0,1/6,18.67%,NCOR2
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),0.3348324932107971,0.6418477193090191,0.88,1.0,1.0,6/11,36.58%,ROCK1;ROCK2;BCAS3;ARFGEF1;TEK;CYRIB
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),-0.3933127673630926,-0.6411595355547054,0.9423076923076923,1.0,1.0,2/10,9.84%,SLC16A2;APPL2
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),0.3287139667845798,0.6408679453142233,0.9230769230769231,1.0,1.0,2/23,5.19%,ATRNL1;MICALL2
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),-0.37886711709781995,-0.6407029548880535,0.9230769230769231,1.0,1.0,2/12,7.89%,PLCG2;PPP1R9A
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),-0.40843112867033504,-0.640539871165061,0.86,1.0,1.0,2/7,18.85%,CAPRIN1;DHX36
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.2990145882276431,-0.6396357438860273,0.9710144927536232,1.0,1.0,2/39,3.22%,PSMB9;PSMA1
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),0.3797692202352428,0.6391317259061856,0.9056603773584906,1.0,1.0,1/7,8.75%,SLTM
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),0.3938002395434571,0.6386898567668701,0.9111111111111111,1.0,1.0,1/6,20.56%,BAZ2A
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),-0.4486824452259742,-0.6378991614857095,0.9230769230769231,1.0,1.0,1/5,12.59%,RORA
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),0.430586081535407,0.63685981594308,0.9230769230769231,1.0,1.0,2/6,11.79%,MAP4;CLASP1
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),0.4064602913720241,0.6368338071291387,0.9361702127659575,1.0,1.0,1/5,5.58%,PIK3CA
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),-0.3842423699070662,-0.6366563464620766,0.8727272727272727,1.0,1.0,1/6,6.80%,PLA1A
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.39066973536463573,0.6360983955279462,0.88,1.0,1.0,5/9,32.55%,YTHDF2;ROCK1;ROCK2;GIGYF2;YTHDF3
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),0.334108374420961,0.6358110485195405,0.8837209302325582,1.0,1.0,2/11,9.27%,ROBO2;TIAM2
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),-0.36640330577628644,-0.6351382555013116,0.9056603773584906,1.0,1.0,3/13,19.99%,CLCN3;ALS2;SQSTM1
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),0.3742794976565805,0.6350950031892258,0.8780487804878049,1.0,1.0,3/8,16.07%,PDZRN3;LRRK2;ANK3
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),0.3760881018618445,0.6349189972846577,0.88,1.0,1.0,1/8,3.58%,PRAG1
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),-0.34933228664937455,-0.6342350745915244,0.9629629629629629,1.0,1.0,4/17,13.84%,PRKN;CST3;B2M;UBC
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),0.3432818561152741,0.6336385516595426,0.9347826086956522,1.0,1.0,4/14,16.07%,FGF12;FGF14;WNK1;ANK3
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),0.3934448337171887,0.6329750590504144,0.9743589743589743,1.0,1.0,2/9,17.89%,SGIP1;PICALM
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),-0.3783893166953267,-0.6326448286443819,0.9411764705882353,1.0,1.0,4/11,18.85%,MAP3K4;TNKS2;ATM;DHX36
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),-0.33942622016555724,-0.6313275671059992,0.9245283018867925,1.0,1.0,2/18,4.75%,UFL1;PRKN
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),0.3222498984912147,0.6309653112809522,0.9607843137254902,1.0,1.0,5/17,14.30%,ACTG1;ACTB;LRRK2;NRP1;FES
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),-0.42712239535796365,-0.6309632779658704,0.9230769230769231,1.0,1.0,2/6,7.04%,SERPINE1;CD109
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),0.39602861283228014,0.630862262748311,0.8823529411764706,1.0,1.0,2/7,18.04%,ATP2B4;KCNT2
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),-0.3167300418174613,-0.630070671086769,0.9310344827586207,1.0,1.0,7/32,15.71%,FN1;NTNG1;ACTN1;TMEFF2;RHOA;ITGAV;ATRN
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),0.3804736537921809,0.629707090270265,0.8780487804878049,1.0,1.0,1/8,4.34%,UGCG
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),0.360874908399286,0.6292485808760516,0.9361702127659575,1.0,1.0,3/10,22.90%,HSPA9;HSPA8;HSPA1A
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),0.3661895158531827,0.6289206178606322,0.9038461538461539,1.0,1.0,3/8,16.51%,BTRC;CDC14B;PTEN
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),0.34461659307366727,0.6284433785823255,0.9047619047619048,1.0,1.0,4/12,16.51%,PCM1;REST;RTN4;PTEN
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),-0.42189853966425517,-0.6281265970769363,0.8928571428571429,1.0,1.0,1/5,13.94%,JAK2
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),-0.4383814855899071,-0.6276535217346866,0.9259259259259259,1.0,1.0,1/5,13.55%,CLYBL
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),-0.4383814855899071,-0.6276535217346866,0.9259259259259259,1.0,1.0,1/5,13.55%,CLYBL
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.3364481715558951,-0.6273857383079752,0.9333333333333333,1.0,1.0,1/16,4.47%,CNOT8
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.41137813163919335,-0.6272958870261865,0.8695652173913043,1.0,1.0,4/6,21.26%,RPS7;RPL11;RPL23;SMAD7
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),0.2974349949008289,0.6270806534819712,0.975,1.0,1.0,5/32,19.29%,PRAG1;YTHDF2;EP300;CREBBP;ZMIZ1
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),-0.2930895668620098,-0.6259769258166559,0.9841269841269841,1.0,1.0,6/36,16.33%,CDK14;PRKN;SULF2;APCDD1;GPC3;OTULIN
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),-0.3652754239205279,-0.6259240796016876,0.9206349206349206,1.0,1.0,2/12,9.84%,PLCG2;APPL2
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),0.3036417766127189,0.624623168512557,0.9795918367346939,1.0,1.0,3/17,16.90%,MICALL2;PARD3;ESAM
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),-0.42787221426413186,-0.6246107718376039,0.8867924528301887,1.0,1.0,1/5,8.90%,DMD
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),0.410431797333075,0.6242369927602713,0.8723404255319149,1.0,1.0,1/5,9.63%,CPEB3
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",0.3461762250092827,0.6239182051001867,0.8936170212765957,1.0,1.0,2/8,25.78%,RSRC1;RBM17
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),0.3354559968329064,0.6237873227430284,0.9387755102040817,1.0,1.0,1/11,6.75%,DUSP6
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),0.3120265772615951,0.6227956248357857,0.9318181818181818,1.0,1.0,3/20,16.90%,ACTG1;ACTB;ESAM
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.41363406375684725,-0.6224328362217324,0.8679245283018868,1.0,1.0,1/7,8.90%,DMD
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.4086738788073252,-0.6214084287662797,0.8666666666666667,1.0,1.0,4/6,29.08%,UBC;XPC;CUL4A;RPS27A
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.4086738788073252,-0.6214084287662797,0.8666666666666667,1.0,1.0,4/6,29.08%,UBC;XPC;CUL4A;RPS27A
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),-0.322365427740844,-0.6212888493341362,0.9642857142857143,1.0,1.0,6/25,18.17%,PPARG;NFKBIA;AHI1;RAB1A;RAMP3;PDGFB
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),0.3150793345475579,0.6212332247549682,0.90625,1.0,1.0,8/19,30.92%,FOXC1;ROCK1;FGFR1;ROCK2;MEF2C;FBXL17;RBPJ;TGFBR3
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,0.2485668027629392,0.6210239800583561,1.0,1.0,1.0,10/61,18.69%,MT2A;TENT4A;ABL1;XPO1;SS18;RPS6KA5;RAD23B;SMC1A;G3BP1;HSPA8
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),0.3273048997148482,0.6205399811627081,0.926829268292683,1.0,1.0,2/11,18.85%,ANXA1;POT1
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),-0.39290219746732163,-0.6201772539239043,0.8833333333333333,1.0,1.0,3/6,17.58%,BLCAP;KPNB1;ACIN1
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),-0.35383115871753046,-0.6184920046077222,0.8983050847457628,1.0,1.0,5/12,21.86%,STAT5B;ACVRL1;PDGFB;RACK1;MAP2K5
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),-0.3535933148472421,-0.6176956113154299,0.9245283018867925,1.0,1.0,2/22,10.85%,CEP57;POLR2A
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.4075005200393227,-0.6175681866325711,0.875,1.0,1.0,1/6,10.10%,BRD7
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),0.34334359067002374,0.6169761026514579,0.9090909090909091,1.0,1.0,2/11,9.76%,UIMC1;CDC14B
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),-0.3315381405266266,-0.6151102565479033,0.9183673469387755,1.0,1.0,3/15,15.94%,NDRG1;ACER2;ATM
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),-0.40354141145607664,-0.6149842666251253,0.8928571428571429,1.0,1.0,1/6,2.65%,IRF1
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),-0.37949924765527027,-0.6145797392935648,0.8947368421052632,1.0,1.0,2/11,14.17%,KIDINS220;RAPGEF2
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),-0.40443253974770216,-0.6142967140096873,0.9111111111111111,1.0,1.0,2/6,11.60%,LGALS3;CD47
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),0.34357175229314063,0.6141372939233628,0.9148936170212766,1.0,1.0,1/9,6.75%,DUSP6
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),0.31201082144815995,0.613544069261377,0.9069767441860465,1.0,1.0,6/16,27.00%,HSP90AA1;NEK7;HMBOX1;POT1;TNKS;HSP90AB1
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),-0.4027948020600528,-0.613473035768598,0.9245283018867925,1.0,1.0,1/6,13.79%,SUCLG2
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),0.4008181107779306,0.6132876246295376,0.9074074074074074,1.0,1.0,1/5,11.84%,KLF2
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),-0.3369694728466348,-0.6124486562555178,0.9420289855072463,1.0,1.0,1/10,8.23%,CST3
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.3178491967750068,0.6118439785396733,0.9375,1.0,1.0,4/13,24.45%,PLCB1;ANXA1;ADAM17;KMT2E
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),0.38315393757333016,0.6095122136972523,0.8909090909090909,1.0,1.0,1/6,8.31%,PRKX
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),-0.28064175812545983,-0.6086726610369346,1.0,1.0,1.0,2/46,4.10%,HMGN1;SMARCA1
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),-0.38429858885120605,-0.6082267535805109,0.9423076923076923,1.0,1.0,2/8,20.30%,CD47;RACK1
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),0.3217798247002561,0.6082155010548813,0.9787234042553191,1.0,1.0,5/15,18.61%,LRRK2;EPHA4;NLGN1;PTEN;TANC2
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),0.3137495994481436,0.6080768802229324,0.9272727272727272,1.0,1.0,1/13,4.67%,HSP90B1
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.36854930509301476,-0.6075858986402114,0.9803921568627451,1.0,1.0,2/11,14.54%,CNOT8;PARN
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),-0.3663553524160388,-0.6066856604753215,0.9215686274509803,1.0,1.0,4/10,26.40%,SLC36A4;SLC3A2;SLC38A5;SLC25A29
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),0.40307633420452127,0.6065471963631511,0.9038461538461539,1.0,1.0,2/6,13.32%,EXT1;GLCE
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),0.30103782354886655,0.6065135630533879,0.9534883720930233,1.0,1.0,3/17,11.29%,HSP90AA1;PPM1F;RALB
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),-0.37128629352278675,-0.6064701590531794,0.8823529411764706,1.0,1.0,2/8,9.71%,TFRC;ACER2
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),0.36578103392425004,0.6063687712056447,0.8888888888888888,1.0,1.0,4/8,18.61%,CPEB3;PSEN1;NLGN1;TANC2
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),-0.35788478088628994,-0.6020242782319052,0.9090909090909091,1.0,1.0,2/6,21.52%,CD47;SH3KBP1
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.293165298997437,0.601905896299964,0.9767441860465116,1.0,1.0,5/15,27.73%,LRRC7;PARD3;OPHN1;CDC42;MARK2
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),-0.3739180444677768,-0.6008658621272047,0.88,1.0,1.0,1/9,2.67%,PLCG2
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),-0.3739180444677768,-0.6008658621272047,0.88,1.0,1.0,1/9,2.67%,PLCG2
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.2949701062549898,-0.599785220392173,0.9696969696969697,1.0,1.0,4/29,18.33%,FN1;JAK2;PDGFB;PPP1R16B
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),0.304708429919835,0.5997598749733716,0.9772727272727273,1.0,1.0,1/21,4.39%,TENT4A
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),-0.3080538075620705,-0.5979088164448837,0.9649122807017544,1.0,1.0,7/24,27.60%,TANK;NET1;ATM;MAPK14;KDM1A;MDM2;XRCC5
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),-0.31482914370641624,-0.5964775154515116,0.9423076923076923,1.0,1.0,3/16,14.64%,NTNG1;MFSD2A;CFL1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.34955926519651387,-0.5955946213541388,0.9411764705882353,1.0,1.0,5/14,21.29%,BRD7;PRMT2;APC;DLG1;PKD2
prerank,GO_Biological_Process_2021__myelination (GO:0042552),0.3177036210358414,0.5950009883023923,1.0,1.0,1.0,3/13,14.59%,SBF2;PARD3;SKI
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),0.3481910945283096,0.5948158824707652,0.9607843137254902,1.0,1.0,4/8,37.18%,MYO1B;WASL;MYO1E;FNBP1L
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),-0.37535742136729916,-0.5939629187334953,0.8409090909090909,1.0,1.0,5/5,62.54%,PPP2R5A;RBL2;PIK3R1;PIK3R3;RB1
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),0.3097867832645771,0.5925494543410783,0.9166666666666666,1.0,1.0,5/15,26.17%,CBFB;ROCK1;ROCK2;SETD5;MEF2C
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.33499842897642,-0.5925216934852345,0.9230769230769231,1.0,1.0,2/15,12.85%,SMAD3;ZC3H7A
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.3620682988742022,0.5917240310927641,0.918918918918919,1.0,1.0,4/9,34.14%,KLF2;ATF6;RBPJ;ATF3
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),0.3589583731304686,0.5909587906303807,0.9803921568627451,1.0,1.0,1/6,11.97%,ERCC6
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),0.3941759490154718,0.5900003923967234,0.9285714285714286,1.0,1.0,3/6,29.62%,ATP2B4;ROCK2;SPIDR
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),-0.3602821406088417,-0.5899234621061334,0.8928571428571429,1.0,1.0,1/10,4.41%,MAP2
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),-0.3757280480284325,-0.5897304051090057,0.9344262295081968,1.0,1.0,1/7,7.29%,UBR2
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.34918597828648834,-0.5880290007754515,0.9137931034482759,1.0,1.0,1/11,5.40%,MMRN2
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.3385853811142464,-0.5875182592905153,0.9259259259259259,1.0,1.0,2/10,16.85%,MEF2A;PDE9A
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),-0.3992799938121776,-0.5864221834846288,0.9259259259259259,1.0,1.0,1/6,11.19%,SPAST
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.428683800951693,-0.584405973740173,0.9423076923076923,1.0,1.0,1/5,8.90%,DMD
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),-0.32741120384215605,-0.5843000608887876,0.9682539682539683,1.0,1.0,3/12,14.28%,CAPRIN1;RAPGEF2;HECW2
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),0.2739482129889824,0.5839184924205602,0.9555555555555556,1.0,1.0,6/21,23.03%,PLCB1;TPD52L1;TRAF3;ANKRD6;TAOK1;CCN2
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),0.2956985980330148,0.5835363378771127,1.0,1.0,1.0,1/20,2.65%,UIMC1
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.33797501659063905,-0.5834028753089697,0.95,1.0,1.0,1/15,6.67%,SMAD3
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),-0.38711188444889577,-0.5827610917969264,0.92,1.0,1.0,1/5,10.10%,BRD7
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),-0.341880154692546,-0.5814982549538679,0.9272727272727272,1.0,1.0,3/11,15.26%,YTHDC1;LUC7L;SRSF5
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),0.36056216908979016,0.5813887731205784,0.9622641509433962,1.0,1.0,1/5,11.97%,ERCC6
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),-0.3387922315551767,-0.5807288295376135,0.9183673469387755,1.0,1.0,2/7,22.51%,BMP2K;HIP1R
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),0.33637993252796894,0.5803679279141516,0.9555555555555556,1.0,1.0,4/9,31.39%,PTEN;BCAS3;PHLDB2;CORO1C
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),0.33637993252796894,0.5803679279141516,0.9555555555555556,1.0,1.0,4/9,31.39%,PTEN;BCAS3;PHLDB2;CORO1C
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.2969522111059154,0.5793128179174551,1.0,1.0,1.0,4/21,19.57%,CCNI;ACTB;PTEN;ADAM17
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),0.3367883458349927,0.579170010792778,0.8780487804878049,1.0,1.0,3/10,21.37%,ADCY2;AKAP6;PDE7B
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),-0.31795710865257004,-0.5784765887720593,0.9433962264150944,1.0,1.0,6/26,16.46%,CARMIL1;LGALS3;TMEFF2;MTMR2;CLU;RIOK3
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),0.3013980446713839,0.5782621314051707,0.9302325581395349,1.0,1.0,5/11,30.37%,PHIP;EDN1;CDC16;RGCC;INSR
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.35065386888193456,-0.5771616479570031,0.9272727272727272,1.0,1.0,4/9,22.27%,DMD;RACK1;SMAD7;NCK1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),-0.29545336767718333,-0.576431602369937,0.9692307692307692,1.0,1.0,5/24,20.72%,CDC14A;SPAST;RHOA;PDGFB;RAD21
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),-0.355515812634175,-0.5760924442899098,0.9310344827586207,1.0,1.0,3/7,19.50%,LBR;FAXDC2;LSS
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),0.2691505726279725,0.5751640608389309,1.0,1.0,1.0,6/23,25.86%,PLCB1;ANXA1;ADAM17;KMT2E;BRD4;CDC16
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),0.35116301399017663,0.5724886923743958,0.9615384615384616,1.0,1.0,3/6,26.06%,SLC1A1;SLC23A2;SLC1A2
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),-0.2863940293705203,-0.5713224948843789,0.9482758620689655,1.0,1.0,9/27,22.61%,SPG7;TRPM3;TRPM6;ITGAV;TRPC4AP;ATP2B1;PKD2;GAS6;MICU1
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.3684878230909584,-0.5709843935177924,0.9,1.0,1.0,2/5,22.38%,ZDHHC20;ZDHHC21
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.3684878230909584,-0.5709843935177924,0.9,1.0,1.0,2/5,22.38%,ZDHHC20;ZDHHC21
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),-0.3203300374472341,-0.5700155554554013,0.9615384615384616,1.0,1.0,6/16,21.29%,SMAD3;CD47;CLU;JAK2;CD34;PKD2
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),0.37622988435154087,0.5696148700005076,0.9183673469387755,1.0,1.0,4/5,41.36%,MAP4K4;MAPRE2;IQSEC1;ADAM9
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),-0.31950424349114737,-0.5693865204487946,0.9433962264150944,1.0,1.0,3/15,13.24%,CCDC14;MAPKAP1;RHOA
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),0.3533646202905416,0.5689792826645786,0.9302325581395349,1.0,1.0,2/6,16.51%,HSP90AA1;PTEN
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),-0.288505005297868,-0.5671269983779783,0.9508196721311475,1.0,1.0,7/23,25.00%,APPL2;JAK2;GNAS;EPAS1;APC;KDM1A;LEPR
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),-0.316105208521144,-0.5660854237033897,0.8928571428571429,1.0,1.0,2/10,13.47%,SMAD3;CLU
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.316105208521144,-0.5660854237033897,0.8928571428571429,1.0,1.0,2/10,13.47%,SMAD3;CLU
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),-0.3951614673675519,-0.5657012934571178,0.975,1.0,1.0,3/5,38.21%,KDM1A;N4BP2L2;FERMT2
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),0.3635838826204436,0.5640847706245341,0.94,1.0,1.0,1/5,22.69%,JARID2
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.32121976770627875,-0.5625379612402882,0.9811320754716981,1.0,1.0,5/15,21.29%,BRD7;PRMT2;APC;DLG1;PKD2
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),0.29010751809191004,0.56176574043421,0.9772727272727273,1.0,1.0,2/14,14.04%,GAREM1;FOXC1
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),0.22448891505677382,0.5602016687487283,1.0,1.0,1.0,10/58,21.94%,PCM1;WDPCP;CDC14B;GSN;PARVA;CEP290;ABCC4;BBS9;ARF4;CC2D2A
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),0.3425834225047858,0.5601763059578816,0.9333333333333333,1.0,1.0,2/6,9.09%,FBXO7;REST
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.26949284627704206,-0.5594403852965237,0.9666666666666667,1.0,1.0,3/38,7.04%,SNX6;SMAD3;CD109
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),-0.3424158786952021,-0.5592650701240997,0.9583333333333334,1.0,1.0,1/8,16.48%,NPM1
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),-0.3424158786952021,-0.5592650701240997,0.9583333333333334,1.0,1.0,1/8,16.48%,NPM1
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),-0.3424158786952021,-0.5592650701240997,0.9583333333333334,1.0,1.0,1/8,16.48%,NPM1
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),-0.3424158786952021,-0.5592650701240997,0.9583333333333334,1.0,1.0,1/8,16.48%,NPM1
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),-0.353967175176213,-0.5586080423696123,0.9090909090909091,1.0,1.0,1/7,8.15%,JUN
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.3454761321583934,0.5573289369204385,0.9361702127659575,1.0,1.0,1/8,24.74%,ARMH3
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),-0.3674553304040866,-0.5569390467428912,0.9629629629629629,1.0,1.0,1/5,13.86%,SMYD2
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),0.37138962663484304,0.5565714413918679,0.9111111111111111,1.0,1.0,3/5,31.10%,KIF5B;SPG11;RAB27A
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.33009546902427367,-0.5558236167241735,0.9433962264150944,1.0,1.0,2/9,20.61%,HECW2;ANAPC5
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),-0.2955932445982894,-0.5545287482725098,0.9838709677419355,1.0,1.0,6/22,23.83%,LGALS3;RAMP3;SQSTM1;RACK1;DLG1;SPTBN1
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),0.368607511520869,0.5544588019497977,0.92,1.0,1.0,2/6,24.33%,ROCK1;ROCK2
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),-0.3204432012555015,-0.5541749425707051,0.9433962264150944,1.0,1.0,1/12,4.02%,SP100
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),-0.3069186244169274,-0.5531550819764651,0.9473684210526315,1.0,1.0,1/11,9.71%,ACER2
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),0.3075561549067382,0.5522336881265639,0.9555555555555556,1.0,1.0,4/11,20.30%,LRRC7;PARD3;CLIC4;FSCN1
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),-0.3226191942870947,-0.5515655823798639,0.9824561403508771,1.0,1.0,2/13,9.61%,PRKN;GABARAPL1
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),-0.3226191942870947,-0.5515655823798639,0.9824561403508771,1.0,1.0,2/13,9.61%,PRKN;GABARAPL1
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.38395605479318273,-0.5508943476038317,0.9795918367346939,1.0,1.0,1/7,8.90%,DMD
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),0.31989888387006854,0.5490280457343686,0.9795918367346939,1.0,1.0,1/10,4.88%,CCDC88A
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),-0.3501861761215179,-0.5486167297427538,0.9454545454545454,1.0,1.0,1/6,13.86%,SMYD2
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),0.34304618957361876,0.5483599369534743,0.9574468085106383,1.0,1.0,3/6,26.84%,DYRK1A;PINK1;PIKFYVE
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),0.2681924952166809,0.5393896499814163,0.9743589743589743,1.0,1.0,5/26,19.44%,GCNT2;CLASP1;FOXC1;PTEN;TIAM1
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),0.23926350190349072,0.5388359184276996,1.0,1.0,1.0,5/33,20.12%,CCDC88A;ABL1;ADCY2;TAOK1;PINK1
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),-0.35699786943460554,-0.5380665570191924,0.9090909090909091,1.0,1.0,1/5,18.85%,DHX36
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,-0.27685673179921777,-0.5375576445414244,0.9714285714285714,1.0,1.0,6/26,19.47%,PATJ;TFRC;TRPM6;COBLL1;NEBL;FGD4
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),0.3360208631528291,0.5357587437502856,0.9636363636363636,1.0,1.0,3/7,19.70%,LRRK2;AKAP12;AKAP6
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),0.25051607358686057,0.5348710205024407,1.0,1.0,1.0,7/22,26.84%,PARD3;NECTIN3;ZDHHC14;RAB3GAP2;SEC63;RFTN1;PIKFYVE
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.29030390732843064,-0.5328847156578667,0.9655172413793104,1.0,1.0,1/17,5.53%,NR3C2
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),-0.28974841441196214,-0.5328394588796863,0.9838709677419355,1.0,1.0,4/23,16.15%,RANBP17;APPL2;POM121C;KPNB1
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),-0.3309656084558946,-0.5328065169082651,0.9607843137254902,1.0,1.0,4/8,29.85%,MTF2;AUTS2;KMT2A;CTNNB1
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),-0.34951503769082976,-0.5320807928100144,0.9411764705882353,1.0,1.0,2/5,27.60%,ATM;XRCC5
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),0.2908053589719865,0.5320475993996057,0.9615384615384616,1.0,1.0,6/9,31.13%,CLASP1;CDK5RAP2;ZNF207;CLIP1;NAV1;TOGARAM1
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),-0.34594762044681726,-0.5300689963196668,0.9411764705882353,1.0,1.0,2/5,31.46%,CABIN1;NASP
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",0.31321388503146336,0.5295872312330883,0.9090909090909091,1.0,1.0,2/8,10.25%,MRTFA;ITGA5
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),-0.3489054964927861,-0.529502809958118,0.9230769230769231,1.0,1.0,3/6,30.92%,ATM;TENT2;XRN1
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),-0.3489054964927861,-0.529502809958118,0.9230769230769231,1.0,1.0,3/6,30.92%,ATM;TENT2;XRN1
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),-0.26197208258309646,-0.5292808871255869,1.0,1.0,1.0,11/35,21.86%,SMAD3;STAT5B;TBK1;RHOA;IL18R1;RAMP3;ACVRL1;PDGFB;PTPN2;RACK1;MAP2K5
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.30230253219405406,-0.5287793724164349,0.98,1.0,1.0,1/13,11.66%,PRIMPOL
prerank,GO_Biological_Process_2021__morphogenesis of an endothelium (GO:0003159),-0.3731269751727243,-0.528110741012799,1.0,1.0,1.0,2/5,29.85%,ACVRL1;CTNNB1
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),-0.3247698590821331,-0.526349115909547,0.9523809523809523,1.0,1.0,1/7,11.37%,FEZ2
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),0.30567955590250806,0.5262576864590774,0.9767441860465116,1.0,1.0,4/13,25.55%,SMAD6;EP300;PPM1A;CDC42
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),0.2743704549033855,0.5262479750058979,0.9545454545454546,1.0,1.0,8/15,29.44%,DPP10;AKAP6;DPP6;CAB39;KCNMB4;NEDD4L;KCNIP4;YWHAE
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),0.3110817660350357,0.5255057489090308,1.0,1.0,1.0,2/6,18.56%,CD81;CD59
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),0.3110817660350357,0.5255057489090308,1.0,1.0,1.0,2/6,18.56%,CD81;CD59
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),0.3110817660350357,0.5255057489090308,1.0,1.0,1.0,2/6,18.56%,CD81;CD59
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),-0.3224779179242922,-0.5235807201349605,0.96,1.0,1.0,1/6,8.62%,STAT5B
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),-0.3224779179242922,-0.5235807201349605,0.96,1.0,1.0,1/6,8.62%,STAT5B
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),-0.31159305711437313,-0.5213143333471968,0.9215686274509803,1.0,1.0,2/8,16.02%,ATM;MSH2
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),0.3167751400728306,0.5202657246343011,0.9183673469387755,1.0,1.0,1/6,11.79%,CLASP1
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),0.33557149469481856,0.5197393194857204,0.9534883720930233,1.0,1.0,2/5,32.22%,BMPR2;MDM4
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),-0.30116924290333097,-0.5196587845341839,1.0,1.0,1.0,4/12,29.93%,UBC;FANCL;RPS27A;FANCC
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),-0.2729686391056392,-0.5175169811249426,1.0,1.0,1.0,2/21,14.17%,GPM6A;RAPGEF2
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.344127630024436,-0.5174274317988494,0.9811320754716981,1.0,1.0,2/7,21.29%,PDGFB;PKD2
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),-0.27746549934403253,-0.5173980816078699,1.0,1.0,1.0,5/21,20.79%,PATJ;RHOA;AFDN;APC;DLG1
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),0.3218979509341449,0.5171474092074387,1.0,1.0,1.0,2/5,28.17%,PNPLA8;PGS1
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),0.3202891851573296,0.5154113510713032,1.0,1.0,1.0,4/7,31.31%,NIPBL;NF1;TGFBR3;ARID5B
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,-0.25737381344508714,-0.5148148985550269,1.0,1.0,1.0,8/32,22.01%,SERPINE1;SMAD3;IFNGR2;RHOA;TJP1;APC;SMAD7;XIAP
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),0.3048091410509198,0.5136852206994921,1.0,1.0,1.0,2/9,18.69%,RAB7A;HSPA8
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.25070763220842274,0.5136623816470112,1.0,1.0,1.0,8/30,19.57%,PLCB1;APPL1;SLFN11;INO80;ANXA1;PTEN;CDK6;ADAM17
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),-0.25639191068314604,-0.513553775665537,1.0,1.0,1.0,8/35,24.25%,SLC38A3;SHROOM2;FARP1;KIAA1549L;TJP1;EPN2;STXBP1;ABCG2
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.3290876007278398,-0.5133601354990491,0.9807692307692307,1.0,1.0,5/5,67.16%,SH3D19;SNX9;TNFRSF1B;ADAM9;NRDC
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),0.2410863082287428,0.5113238939924842,1.0,1.0,1.0,6/26,25.44%,ABL1;SLC8A1;PTEN;PTPN1;HEG1;NF1
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.33336231880367984,0.5112817042819959,0.9791666666666666,1.0,1.0,3/5,33.33%,HSPA1A;BCL2L1;EYA3
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),0.33336231880367984,0.5112817042819959,0.9791666666666666,1.0,1.0,3/5,33.33%,HSPA1A;BCL2L1;EYA3
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),-0.26560233782361453,-0.5087847781091963,1.0,1.0,1.0,6/20,24.38%,SRP14;CHM;ZDHHC20;TRAM1;ZDHHC21;SIL1
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),0.32954413605465976,0.5084199454285555,0.9803921568627451,1.0,1.0,1/5,8.26%,INSIG1
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),0.32954413605465976,0.5084199454285555,0.9803921568627451,1.0,1.0,1/5,8.26%,INSIG1
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),0.3267629601792026,0.5074515106085549,0.9661016949152542,1.0,1.0,2/5,20.48%,ACOX1;MGST2
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),-0.3346333853354134,-0.5071852570889225,0.9433962264150944,1.0,1.0,6/6,66.61%,MAGI2;PROM1;PODXL;IQGAP1;BASP1;MYO1E
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),-0.28065879668462057,-0.5065728223245322,1.0,1.0,1.0,6/19,25.83%,LGALS3;RAMP3;SQSTM1;DLG1;SPTBN1;EPB41
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),-0.26227649905985967,-0.5059648903029537,1.0,1.0,1.0,3/22,16.54%,YTHDC1;SRPK1;SAFB
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),-0.3263585689224775,-0.5052710403282259,0.9821428571428571,1.0,1.0,1/7,13.86%,SMYD2
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),-0.3226856737189022,-0.503234936313,0.9787234042553191,1.0,1.0,2/6,22.30%,EFNB2;MAPK14
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),-0.281336689648216,-0.5032138681657845,1.0,1.0,1.0,2/11,17.32%,STAT5B;RAMP3
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),0.27821461785944473,0.5015752186472501,1.0,1.0,1.0,4/9,26.90%,NLGN1;OPHN1;CANX;RAB5A
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),-0.3016247206720936,-0.5004117468568631,0.9803921568627451,1.0,1.0,2/7,20.79%,FMNL3;DLG1
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",0.3081061005278653,0.4990862820212587,1.0,1.0,1.0,1/7,20.43%,AGO2
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),0.3081061005278653,0.4990862820212587,1.0,1.0,1.0,1/7,20.43%,AGO2
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),-0.2695227369878067,-0.49560083210769357,0.9807692307692307,1.0,1.0,6/23,25.67%,SRRM1;POM121C;SRSF5;SRSF3;NUP214;ZFP36L1
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),-0.29862359256870064,-0.49255042294804824,1.0,1.0,1.0,1/8,8.83%,DGKG
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),0.3142486605045721,0.4914750304733018,0.9803921568627451,1.0,1.0,3/6,17.50%,ANK2;RYR2;CALM1
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),-0.2771018522688675,-0.48942712241673547,0.9583333333333334,1.0,1.0,2/11,16.20%,CLTA;SNX25
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),0.3034221249190795,0.4890208225918538,1.0,1.0,1.0,1/5,11.79%,CLASP1
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),0.2840395929349476,0.48839248266472407,0.9565217391304348,1.0,1.0,2/6,28.92%,RYR2;RBPJ
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),0.2869037587892827,0.48566072717990605,0.9807692307692307,1.0,1.0,3/8,26.17%,KLF2;MTSS1;MEF2C
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),-0.3179927197087884,-0.4850178597988347,1.0,1.0,1.0,6/6,68.28%,RIMKLB;GLUD1;SLC25A13;GLUL;SLC25A12;GLS
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),0.24872028853013745,0.4847755142763478,1.0,1.0,1.0,3/14,21.47%,ELL2;SNAPC3;RPAP2
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),0.24872028853013745,0.4847755142763478,1.0,1.0,1.0,3/14,21.47%,ELL2;SNAPC3;RPAP2
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.30436792414495684,0.48272758948827993,0.9782608695652174,1.0,1.0,2/5,23.26%,APPL1;BCL2L1
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),-0.3101561273888144,-0.48171285388012325,0.9807692307692307,1.0,1.0,1/6,20.53%,SYTL4
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.3093319469716662,-0.4809334325270953,0.9655172413793104,1.0,1.0,5/5,69.13%,SMAD7;ACVR1;TGFBR2;USP15;TGFBR3
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),-0.3027060463387207,-0.47802483731437967,0.9836065573770492,1.0,1.0,2/5,25.75%,ACVRL1;DLL4
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),-0.3175072094426046,-0.47788348303035505,0.9591836734693877,1.0,1.0,2/6,23.05%,SAFB;DDX5
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),-0.27482031213993713,-0.4770389714382848,0.9824561403508771,1.0,1.0,3/19,13.94%,LPAR6;NET1;JAK2
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),-0.28197068462338165,-0.47629666000830767,1.0,1.0,1.0,2/10,19.91%,ACVRL1;ZNF423
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),0.2676329381332,0.47619156793012857,1.0,1.0,1.0,3/8,24.14%,NLGN1;OPHN1;CANX
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),-0.2770369951948186,-0.46886086943441074,1.0,1.0,1.0,3/13,18.17%,ATM;ACVRL1;PDGFB
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),0.30218624424261986,0.46856663863639253,0.95,1.0,1.0,1/5,16.23%,ARID1A
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",0.2834835744767208,0.46823493529825566,0.9565217391304348,1.0,1.0,3/7,26.92%,POT1;TNKS;ATR
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),-0.29971375645218057,-0.46752365450584127,1.0,1.0,1.0,3/7,28.35%,MAPK14;WWC2;IQCJ-SCHIP1
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),0.2966718668746749,0.4660144883381757,0.9795918367346939,1.0,1.0,6/6,70.38%,UGGT1;VCP;CUL3;DNAJB14;UGGT2;ATXN3
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.2271272744258999,0.465558395465106,1.0,1.0,1.0,4/23,19.29%,ROBO2;EP300;CREBBP;ZMIZ1
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),0.2826667869801993,0.4639204451169377,0.9782608695652174,1.0,1.0,1/7,16.51%,PTEN
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),0.27767865210779374,0.4616064661176123,1.0,1.0,1.0,2/11,15.73%,CLASP1;WASF2
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),-0.30948549043549833,-0.4602545235032838,0.9555555555555556,1.0,1.0,3/6,27.08%,ATG12;ATG7;WIPI1
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),0.29017160686427446,0.45846815419314413,0.9777777777777777,1.0,1.0,6/6,71.03%,SETD5;PARG;HNRNPU;TLK1;TLK2;MLLT3
prerank,PanglaoDB_Augmented_2021__Motor Neurons,-0.29283108339507985,-0.45799582771252384,0.9821428571428571,1.0,1.0,1/6,19.60%,ZIC2
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),-0.2690606297163674,-0.4565149938173206,1.0,1.0,1.0,9/9,73.18%,NPM1;NASP;RSF1;SMARCA5;CENPP;CENPC;MIS18BP1;RBBP4;POGZ
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),-0.30295777619892417,-0.45443295016710317,0.9555555555555556,1.0,1.0,1/5,14.17%,RAPGEF2
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),-0.3029125543804904,-0.45289254204937085,0.9565217391304348,1.0,1.0,1/5,14.41%,PRKAR1A
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),-0.3029125543804904,-0.45289254204937085,0.9565217391304348,1.0,1.0,1/5,14.41%,PRKAR1A
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.2801049213499141,0.450026081700279,1.0,1.0,1.0,4/7,35.80%,PTEN;LATS1;IPO7;CDKN1A
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),-0.2376184720070983,-0.4487533809594082,0.9818181818181818,1.0,1.0,4/17,26.14%,SPAST;APC;SPTBN1;EFHC1
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),-0.2929098973924919,-0.4437173948829895,0.9791666666666666,1.0,1.0,2/5,25.67%,DHX36;ZFP36L1
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),0.28575143005720227,0.4429979977548774,0.9807692307692307,1.0,1.0,6/6,71.47%,STAT3;PUM2;FXR1;PUM1;DHX9;ZFP36
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),-0.27865848126209347,-0.44286782002463826,0.9830508474576272,1.0,1.0,1/6,13.66%,COX6C
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.27865848126209347,-0.44286782002463826,0.9830508474576272,1.0,1.0,1/6,13.66%,COX6C
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),-0.27230169050715214,-0.4387721725948095,1.0,1.0,1.0,7/7,72.85%,SYTL4;ARL8B;TMEM106B;SPAG9;NDEL1;MYH9;KIF5B
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),-0.2849713988559543,-0.4385158014375704,0.9795918367346939,1.0,1.0,6/6,71.57%,DGLUCY;ME3;OGDH;PCK1;MTHFD2L;MTHFD1L
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.28497578349803054,0.43384548888228575,1.0,1.0,1.0,3/6,33.10%,PTEN;LATS1;IPO7
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),0.2941377375626947,0.4301276178669213,1.0,1.0,1.0,1/5,17.50%,CALM1
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),-0.24456115274841755,-0.4298765121379379,1.0,1.0,1.0,3/12,20.72%,TNKS2;MSH2;RAD21
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),-0.263207211600349,-0.42813477452008497,1.0,1.0,1.0,1/6,20.61%,ANAPC5
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.263207211600349,-0.42813477452008497,1.0,1.0,1.0,1/6,20.61%,ANAPC5
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.263207211600349,-0.42813477452008497,1.0,1.0,1.0,1/6,20.61%,ANAPC5
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.2893163504029113,-0.4260965194678902,0.98,1.0,1.0,5/5,71.13%,DLL4;ACVR1;GALNT11;NOTCH1;RBPJ
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),0.23078926803855154,0.4236473422981464,0.9803921568627451,1.0,1.0,13/13,77.00%,AGO2;STAT3;PUM2;TNRC6B;FXR1;MAP2K1;PUM1;DHX9;EGFR;RIPK1;DDX6;ZFP36;DDX5
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),-0.27725008898690284,-0.4217683556212851,0.9818181818181818,1.0,1.0,1/6,18.85%,DHX36
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),0.24203286054328071,0.42093661126770304,0.9736842105263158,1.0,1.0,3/11,21.37%,ADCY2;AKAP6;PDE7B
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),-0.22265821462248203,-0.41898742650506743,1.0,1.0,1.0,7/22,27.49%,SPAST;RHOA;KPNB1;SMC3;PIBF1;NSL1;RAB11A
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),0.2557920675098799,0.41890018575014476,1.0,1.0,1.0,1/5,18.43%,GCH1
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),0.2557920675098799,0.41890018575014476,1.0,1.0,1.0,1/5,18.43%,GCH1
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),-0.2809981804003119,-0.4184138442683484,0.9782608695652174,1.0,1.0,5/5,71.96%,PKD2;GALNT11;NOTCH1;OFD1;RFX3
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),0.24499349804941498,0.4160216896467584,0.9772727272727273,0.9998153428751475,1.0,7/7,75.55%,CC2D2A;TTBK2;ARL13B;KIAA0586;GLI3;HIPK2;SEPTIN2
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.26994777200091347,-0.41425326224767045,1.0,1.0,1.0,2/8,21.29%,PDGFB;PKD2
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),-0.2212985932427593,-0.4086545193213439,1.0,0.9999324760489753,1.0,3/17,19.24%,DIXDC1;FZD6;APC
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.2506949600166975,-0.4058416905142581,1.0,0.9995236419521635,1.0,2/6,26.48%,MSH2;HIPK2
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),-0.25877058168235806,-0.3987050337501875,1.0,0.9994761533012638,1.0,1/7,18.02%,SENP6
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),0.22793758120440483,0.3963944692972755,1.0,0.9996817897903543,1.0,1/8,13.84%,PSEN1
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),0.22793758120440483,0.3963944692972755,1.0,0.9996817897903543,1.0,1/8,13.84%,PSEN1
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),0.2132613010845582,0.39554027443451917,1.0,0.9988801448886291,1.0,3/15,18.54%,CLASP1;SMC1A;ZNF207
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),-0.22997124665772364,-0.38288422164589153,1.0,1.0,1.0,5/10,35.41%,PPP1R16B;PTBP1;PPP2R5A;ANKLE2;CAMTA1
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),0.2429082965182069,0.3801288445121706,1.0,0.9989004045526534,1.0,3/7,28.89%,ITCH;MAPKBP1;IFI16
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.23268315926702143,-0.35640938941108075,1.0,1.0,1.0,1/7,15.39%,TNKS2
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),-0.2516747460285723,-0.35598192428760983,1.0,1.0,1.0,1/5,21.26%,SMAD7
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),-0.18865469685141817,-0.2973158239833981,1.0,0.9999934570817276,1.0,9/9,81.20%,ACVRL1;DACH1;XRN1;HNRNPC;HNRNPU;CDKN1A;DCP2;BMPR2;POT1
